_unit_id,_created_at,_id,_started_at,_tainted,_channel,_trust,_worker_id,_country,_region,_city,_ip,relations,step_1_select_the_valid_relations,step_2a_copy__paste_only_the_words_from_the_sentence_that_express_the_relation_you_selected_in_step1,step_2b_if_you_selected_none_in_step_1_explain_why,b1,b2,baselinedec,e1,e2,rel-type,sent_id,sentence,term1,term2
721148973,5/13/2015 09:55:02,1635676060,5/13/2015 09:54:45,false,neodev,1,32103286,CAN,AB,Edmonton,208.123.223.37,[PREVENTS] [CAUSES] [NONE],"[PREVENTS]
[CAUSES]
[NONE]",no,no,67,39,1,70,45,TWrex-cause,812109-FS1,Specific recommendation: • Distinguish SEPSIS from other causes of SIRS,SIRS,SEPSIS
721148973,5/13/2015 09:58:16,1635676831,5/13/2015 09:57:16,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[CAUSES],[CAUSES],Distinguish SEPSIS from other causes of SIRS,N/A,67,39,1,70,45,TWrex-cause,812109-FS1,Specific recommendation: • Distinguish SEPSIS from other causes of SIRS,SIRS,SEPSIS
721148973,5/13/2015 10:16:02,1635681376,5/13/2015 10:15:00,false,clixsense,1.0,26847653,NLD,03,Warnsveld,213.93.50.164,[CAUSES],[CAUSES],from other causes of,n/a,67,39,1,70,45,TWrex-cause,812109-FS1,Specific recommendation: • Distinguish SEPSIS from other causes of SIRS,SIRS,SEPSIS
721148973,5/13/2015 10:19:48,1635682423,5/13/2015 10:18:00,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[OTHER],[OTHER],Distinguish from other causes,N/A,67,39,1,70,45,TWrex-cause,812109-FS1,Specific recommendation: • Distinguish SEPSIS from other causes of SIRS,SIRS,SEPSIS
721148973,5/13/2015 10:19:55,1635682471,5/13/2015 10:19:27,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[CAUSES],[CAUSES],causes,n/a,67,39,1,70,45,TWrex-cause,812109-FS1,Specific recommendation: • Distinguish SEPSIS from other causes of SIRS,SIRS,SEPSIS
721148973,5/13/2015 10:28:50,1635684981,5/13/2015 10:28:13,false,pocketmoneygpt,1.0,28884030,USA,WI,Minocqua,75.143.134.247,[ASSOCIATED_WITH],[ASSOCIATED_WITH],of,n/a,67,39,1,70,45,TWrex-cause,812109-FS1,Specific recommendation: • Distinguish SEPSIS from other causes of SIRS,SIRS,SEPSIS
721148973,5/13/2015 10:37:09,1635687551,5/13/2015 10:35:54,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[CAUSES],[CAUSES],SIRS,N/A,67,39,1,70,45,TWrex-cause,812109-FS1,Specific recommendation: • Distinguish SEPSIS from other causes of SIRS,SIRS,SEPSIS
721148973,5/13/2015 10:49:59,1635691211,5/13/2015 10:49:03,false,clixsense,1,31482589,NLD,"","",31.201.11.16,[ASSOCIATED_WITH],[ASSOCIATED_WITH],other,n/a,67,39,1,70,45,TWrex-cause,812109-FS1,Specific recommendation: • Distinguish SEPSIS from other causes of SIRS,SIRS,SEPSIS
721148973,5/13/2015 10:52:44,1635692136,5/13/2015 10:49:57,false,neodev,1,29579905,GBR,"","",5.152.206.71,[LOCATION] [PART_OF],"[LOCATION]
[PART_OF]",Distinguish from,N/A,67,39,1,70,45,TWrex-cause,812109-FS1,Specific recommendation: • Distinguish SEPSIS from other causes of SIRS,SIRS,SEPSIS
721148973,5/13/2015 10:54:46,1635692647,5/13/2015 10:54:24,false,neodev,1,31706957,NLD,07,Amsterdam,145.100.72.165,[CAUSES],[CAUSES],causes of,n/a,67,39,1,70,45,TWrex-cause,812109-FS1,Specific recommendation: • Distinguish SEPSIS from other causes of SIRS,SIRS,SEPSIS
721148973,5/13/2015 10:56:22,1635693026,5/13/2015 10:55:53,false,elite,1.0,31856422,GBR,C9,Workington,92.18.169.149,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],from other causes of,N/A,67,39,1,70,45,TWrex-cause,812109-FS1,Specific recommendation: • Distinguish SEPSIS from other causes of SIRS,SIRS,SEPSIS
721148973,5/13/2015 11:05:52,1635695954,5/13/2015 11:05:19,false,instagc,1.0,24252915,GBR,K6,Portsmouth,89.240.160.95,[LOCATION],[LOCATION],SEPSIS causes SIRS,N/a,67,39,1,70,45,TWrex-cause,812109-FS1,Specific recommendation: • Distinguish SEPSIS from other causes of SIRS,SIRS,SEPSIS
721148973,5/13/2015 11:08:22,1635696463,5/13/2015 11:07:53,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[CAUSES],[CAUSES],causes,n/a,67,39,1,70,45,TWrex-cause,812109-FS1,Specific recommendation: • Distinguish SEPSIS from other causes of SIRS,SIRS,SEPSIS
721148973,5/13/2015 11:14:30,1635697825,5/13/2015 11:12:57,false,prodege,1,27934334,GBR,D3,Swadlincote,109.150.228.127,[CAUSES],[CAUSES],causes,N/A,67,39,1,70,45,TWrex-cause,812109-FS1,Specific recommendation: • Distinguish SEPSIS from other causes of SIRS,SIRS,SEPSIS
721148973,5/13/2015 11:17:10,1635698800,5/13/2015 11:14:58,false,points4rewards,1,28703583,USA,"","",97.73.86.35,[OTHER],[OTHER],Distinguish,N/A,67,39,1,70,45,TWrex-cause,812109-FS1,Specific recommendation: • Distinguish SEPSIS from other causes of SIRS,SIRS,SEPSIS
721148974,5/13/2015 13:08:35,1635731300,5/13/2015 13:08:19,false,neodev,1.0,30504276,CAN,ON,Sudbury,66.103.55.12,[PREVENTS],[PREVENTS],individually,N/A,140,9,-1,151,58,TWrex-cause,804575-FS1,1  >     ATORVASTATIN/AMLODIPINE FIXED COMBINATION THERAPY for Dyslipidemias and Prevention of Cardiovascular Events (Atorvastatin) and for HYPERTENSION and/or CAD (Amlodipine)  Oral:  Use the fixed combination as a  substitute  for the individually titrated drugs.,HYPERTENSION,ATORVASTATIN/AMLODIPINE FIXED COMBINATION THERAPY
721148974,5/13/2015 13:19:41,1635734312,5/13/2015 13:19:10,false,clixsense,1.0,24329110,USA,FL,Jacksonville,12.168.136.2,[TREATS],[TREATS],THERAPY,n/a,140,9,-1,151,58,TWrex-cause,804575-FS1,1  >     ATORVASTATIN/AMLODIPINE FIXED COMBINATION THERAPY for Dyslipidemias and Prevention of Cardiovascular Events (Atorvastatin) and for HYPERTENSION and/or CAD (Amlodipine)  Oral:  Use the fixed combination as a  substitute  for the individually titrated drugs.,HYPERTENSION,ATORVASTATIN/AMLODIPINE FIXED COMBINATION THERAPY
721148974,5/13/2015 13:21:26,1635734814,5/13/2015 13:20:53,false,clixsense,1.0,23197581,NLD,11,Den Haag,82.217.5.55,[TREATS],[TREATS],THERAPY for,N/A,140,9,-1,151,58,TWrex-cause,804575-FS1,1  >     ATORVASTATIN/AMLODIPINE FIXED COMBINATION THERAPY for Dyslipidemias and Prevention of Cardiovascular Events (Atorvastatin) and for HYPERTENSION and/or CAD (Amlodipine)  Oral:  Use the fixed combination as a  substitute  for the individually titrated drugs.,HYPERTENSION,ATORVASTATIN/AMLODIPINE FIXED COMBINATION THERAPY
721148974,5/13/2015 13:44:56,1635741204,5/13/2015 13:44:41,false,bitcoinget,1,21614812,USA,PA,Erie,174.100.250.115,[ASSOCIATED_WITH],[ASSOCIATED_WITH],for Dyslipidemias and Prevention of Cardiovascular Events,N/A,140,9,-1,151,58,TWrex-cause,804575-FS1,1  >     ATORVASTATIN/AMLODIPINE FIXED COMBINATION THERAPY for Dyslipidemias and Prevention of Cardiovascular Events (Atorvastatin) and for HYPERTENSION and/or CAD (Amlodipine)  Oral:  Use the fixed combination as a  substitute  for the individually titrated drugs.,HYPERTENSION,ATORVASTATIN/AMLODIPINE FIXED COMBINATION THERAPY
721148974,5/13/2015 13:58:35,1635746877,5/13/2015 13:58:18,false,neodev,1.0,24564999,GBR,H9,London,86.145.227.9,[TREATS],[TREATS],for,N/A,140,9,-1,151,58,TWrex-cause,804575-FS1,1  >     ATORVASTATIN/AMLODIPINE FIXED COMBINATION THERAPY for Dyslipidemias and Prevention of Cardiovascular Events (Atorvastatin) and for HYPERTENSION and/or CAD (Amlodipine)  Oral:  Use the fixed combination as a  substitute  for the individually titrated drugs.,HYPERTENSION,ATORVASTATIN/AMLODIPINE FIXED COMBINATION THERAPY
721148974,5/13/2015 14:01:54,1635748301,5/13/2015 14:01:23,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[TREATS],[TREATS],THERAPY for,N/A,140,9,-1,151,58,TWrex-cause,804575-FS1,1  >     ATORVASTATIN/AMLODIPINE FIXED COMBINATION THERAPY for Dyslipidemias and Prevention of Cardiovascular Events (Atorvastatin) and for HYPERTENSION and/or CAD (Amlodipine)  Oral:  Use the fixed combination as a  substitute  for the individually titrated drugs.,HYPERTENSION,ATORVASTATIN/AMLODIPINE FIXED COMBINATION THERAPY
721148974,5/13/2015 14:26:30,1635758578,5/13/2015 14:25:47,false,prodege,1.0,24403612,CAN,ON,Ajax,99.239.181.149,[PREVENTS],[PREVENTS],ATORVASTATIN/AMLODIPINE FIXED COMBINATION THERAPY for Prevention of HYPERTENSION,N/a,140,9,-1,151,58,TWrex-cause,804575-FS1,1  >     ATORVASTATIN/AMLODIPINE FIXED COMBINATION THERAPY for Dyslipidemias and Prevention of Cardiovascular Events (Atorvastatin) and for HYPERTENSION and/or CAD (Amlodipine)  Oral:  Use the fixed combination as a  substitute  for the individually titrated drugs.,HYPERTENSION,ATORVASTATIN/AMLODIPINE FIXED COMBINATION THERAPY
721148974,5/13/2015 14:36:30,1635764268,5/13/2015 14:36:04,false,onestopgpt,1,21275875,CAN,ON,Hamilton,24.36.121.10,[TREATS],[TREATS],THERAPY for,N/A,140,9,-1,151,58,TWrex-cause,804575-FS1,1  >     ATORVASTATIN/AMLODIPINE FIXED COMBINATION THERAPY for Dyslipidemias and Prevention of Cardiovascular Events (Atorvastatin) and for HYPERTENSION and/or CAD (Amlodipine)  Oral:  Use the fixed combination as a  substitute  for the individually titrated drugs.,HYPERTENSION,ATORVASTATIN/AMLODIPINE FIXED COMBINATION THERAPY
721148974,5/13/2015 15:20:12,1635798190,5/13/2015 15:19:53,false,points4rewards,1,20306700,USA,WA,Bothell,50.125.145.37,[SYMPTOM],[SYMPTOM],THERAPY,n/a,140,9,-1,151,58,TWrex-cause,804575-FS1,1  >     ATORVASTATIN/AMLODIPINE FIXED COMBINATION THERAPY for Dyslipidemias and Prevention of Cardiovascular Events (Atorvastatin) and for HYPERTENSION and/or CAD (Amlodipine)  Oral:  Use the fixed combination as a  substitute  for the individually titrated drugs.,HYPERTENSION,ATORVASTATIN/AMLODIPINE FIXED COMBINATION THERAPY
721148974,5/13/2015 16:10:16,1635836345,5/13/2015 16:08:18,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[PREVENTS],[PREVENTS],Prevention,none,140,9,-1,151,58,TWrex-cause,804575-FS1,1  >     ATORVASTATIN/AMLODIPINE FIXED COMBINATION THERAPY for Dyslipidemias and Prevention of Cardiovascular Events (Atorvastatin) and for HYPERTENSION and/or CAD (Amlodipine)  Oral:  Use the fixed combination as a  substitute  for the individually titrated drugs.,HYPERTENSION,ATORVASTATIN/AMLODIPINE FIXED COMBINATION THERAPY
721148974,5/13/2015 16:33:29,1635851441,5/13/2015 16:32:38,false,prodege,1.0,16101132,GBR,F9,Hayes,2.223.214.149,[TREATS],[TREATS],Use,Treat with,140,9,-1,151,58,TWrex-cause,804575-FS1,1  >     ATORVASTATIN/AMLODIPINE FIXED COMBINATION THERAPY for Dyslipidemias and Prevention of Cardiovascular Events (Atorvastatin) and for HYPERTENSION and/or CAD (Amlodipine)  Oral:  Use the fixed combination as a  substitute  for the individually titrated drugs.,HYPERTENSION,ATORVASTATIN/AMLODIPINE FIXED COMBINATION THERAPY
721148974,5/13/2015 16:34:24,1635851989,5/13/2015 16:33:12,false,clixsense,1.0,31579138,AUS,02,Hurstville,14.200.129.68,[PREVENTS],[PREVENTS],Prevention,N/A,140,9,-1,151,58,TWrex-cause,804575-FS1,1  >     ATORVASTATIN/AMLODIPINE FIXED COMBINATION THERAPY for Dyslipidemias and Prevention of Cardiovascular Events (Atorvastatin) and for HYPERTENSION and/or CAD (Amlodipine)  Oral:  Use the fixed combination as a  substitute  for the individually titrated drugs.,HYPERTENSION,ATORVASTATIN/AMLODIPINE FIXED COMBINATION THERAPY
721148974,5/13/2015 17:15:05,1635874521,5/13/2015 17:14:43,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[TREATS],[TREATS],THERAPY for,n/a,140,9,-1,151,58,TWrex-cause,804575-FS1,1  >     ATORVASTATIN/AMLODIPINE FIXED COMBINATION THERAPY for Dyslipidemias and Prevention of Cardiovascular Events (Atorvastatin) and for HYPERTENSION and/or CAD (Amlodipine)  Oral:  Use the fixed combination as a  substitute  for the individually titrated drugs.,HYPERTENSION,ATORVASTATIN/AMLODIPINE FIXED COMBINATION THERAPY
721148974,5/13/2015 17:17:03,1635875554,5/13/2015 17:16:00,false,gptking,1.0,31799065,USA,IL,Marion,50.45.43.154,[PREVENTS],[PREVENTS],ATORVASTATIN/AMLODIPINE FIXED COMBINATION THERAPY Prevention HYPERTENSION,N/A,140,9,-1,151,58,TWrex-cause,804575-FS1,1  >     ATORVASTATIN/AMLODIPINE FIXED COMBINATION THERAPY for Dyslipidemias and Prevention of Cardiovascular Events (Atorvastatin) and for HYPERTENSION and/or CAD (Amlodipine)  Oral:  Use the fixed combination as a  substitute  for the individually titrated drugs.,HYPERTENSION,ATORVASTATIN/AMLODIPINE FIXED COMBINATION THERAPY
721148974,5/13/2015 17:51:36,1635896553,5/13/2015 17:50:05,false,prodege,1.0,14848125,GBR,L6,Shrewsbury,86.138.223.142,[TREATS],[TREATS],Use the fixed,N/A,140,9,-1,151,58,TWrex-cause,804575-FS1,1  >     ATORVASTATIN/AMLODIPINE FIXED COMBINATION THERAPY for Dyslipidemias and Prevention of Cardiovascular Events (Atorvastatin) and for HYPERTENSION and/or CAD (Amlodipine)  Oral:  Use the fixed combination as a  substitute  for the individually titrated drugs.,HYPERTENSION,ATORVASTATIN/AMLODIPINE FIXED COMBINATION THERAPY
721148975,5/13/2015 13:04:38,1635730236,5/13/2015 13:04:16,false,neodev,1.0,30504276,CAN,ON,Sudbury,66.103.55.12,[SYMPTOM],[SYMPTOM],"mild,",N/A,26,98,1,33,106,TWrex-cause,813321-FS1,"Early treatment, when the HEADACHE is mild, is much more effective than later treatment, when the MIGRAINE is moderate or severe in intensity.",HEADACHE,MIGRAINE
721148975,5/13/2015 13:07:27,1635731063,5/13/2015 13:06:48,false,clixsense,1.0,24329110,USA,FL,Jacksonville,12.168.136.2,[ASSOCIATED_WITH],[ASSOCIATED_WITH],"Early treatment, more effective in",n/a,26,98,1,33,106,TWrex-cause,813321-FS1,"Early treatment, when the HEADACHE is mild, is much more effective than later treatment, when the MIGRAINE is moderate or severe in intensity.",HEADACHE,MIGRAINE
721148975,5/13/2015 13:13:53,1635732687,5/13/2015 13:13:09,false,clixsense,1.0,23197581,NLD,11,Den Haag,82.217.5.55,[SYMPTOM],[SYMPTOM],HEADACHE MIGRAINE,N/A,26,98,1,33,106,TWrex-cause,813321-FS1,"Early treatment, when the HEADACHE is mild, is much more effective than later treatment, when the MIGRAINE is moderate or severe in intensity.",HEADACHE,MIGRAINE
721148975,5/13/2015 13:14:33,1635732862,5/13/2015 13:13:37,false,prodege,1.0,23482077,USA,TX,Garland,71.164.238.226,[IS_A],[IS_A],"when mild, when moderate or severe",N/A,26,98,1,33,106,TWrex-cause,813321-FS1,"Early treatment, when the HEADACHE is mild, is much more effective than later treatment, when the MIGRAINE is moderate or severe in intensity.",HEADACHE,MIGRAINE
721148975,5/13/2015 13:33:18,1635737803,5/13/2015 13:32:07,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[IS_A] [SYMPTOM],"[SYMPTOM]
[IS_A]",HEADACHE is MIGRAINE severe,N/A,26,98,1,33,106,TWrex-cause,813321-FS1,"Early treatment, when the HEADACHE is mild, is much more effective than later treatment, when the MIGRAINE is moderate or severe in intensity.",HEADACHE,MIGRAINE
721148975,5/13/2015 13:38:32,1635739285,5/13/2015 13:38:16,false,bitcoinget,1.0,21614812,USA,PA,Erie,174.100.250.115,[ASSOCIATED_WITH],[ASSOCIATED_WITH],when,N/A,26,98,1,33,106,TWrex-cause,813321-FS1,"Early treatment, when the HEADACHE is mild, is much more effective than later treatment, when the MIGRAINE is moderate or severe in intensity.",HEADACHE,MIGRAINE
721148975,5/13/2015 13:46:11,1635741834,5/13/2015 13:44:15,false,neodev,1.0,24564999,GBR,H9,London,86.145.227.9,[IS_A],[IS_A],"HEADACHE is mild, MIGRAINE is moderate or severe",N/A,26,98,1,33,106,TWrex-cause,813321-FS1,"Early treatment, when the HEADACHE is mild, is much more effective than later treatment, when the MIGRAINE is moderate or severe in intensity.",HEADACHE,MIGRAINE
721148975,5/13/2015 13:54:03,1635744914,5/13/2015 13:52:59,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[SYMPTOM] [TREATS],"[TREATS]
[SYMPTOM]","Early treatment,",N/A,26,98,1,33,106,TWrex-cause,813321-FS1,"Early treatment, when the HEADACHE is mild, is much more effective than later treatment, when the MIGRAINE is moderate or severe in intensity.",HEADACHE,MIGRAINE
721148975,5/13/2015 14:15:08,1635754113,5/13/2015 14:13:34,false,prodege,1.0,24403612,CAN,ON,Ajax,99.239.181.149,[MANIFESTATION],[MANIFESTATION],HEADACHE than later MIGRAINE,N/a,26,98,1,33,106,TWrex-cause,813321-FS1,"Early treatment, when the HEADACHE is mild, is much more effective than later treatment, when the MIGRAINE is moderate or severe in intensity.",HEADACHE,MIGRAINE
721148975,5/13/2015 14:25:00,1635757877,5/13/2015 14:24:11,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[IS_A],[IS_A],in intensity.,N/A,26,98,1,33,106,TWrex-cause,813321-FS1,"Early treatment, when the HEADACHE is mild, is much more effective than later treatment, when the MIGRAINE is moderate or severe in intensity.",HEADACHE,MIGRAINE
721148975,5/13/2015 15:10:13,1635789693,5/13/2015 15:09:55,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,[TREATS],[TREATS],"treatment,",n/a,26,98,1,33,106,TWrex-cause,813321-FS1,"Early treatment, when the HEADACHE is mild, is much more effective than later treatment, when the MIGRAINE is moderate or severe in intensity.",HEADACHE,MIGRAINE
721148975,5/13/2015 15:39:24,1635812797,5/13/2015 15:38:59,false,clixsense,1.0,32549163,CAN,MB,Winnipeg,206.45.167.246,[NONE],[NONE],N/A,Different conditions,26,98,1,33,106,TWrex-cause,813321-FS1,"Early treatment, when the HEADACHE is mild, is much more effective than later treatment, when the MIGRAINE is moderate or severe in intensity.",HEADACHE,MIGRAINE
721148975,5/13/2015 15:55:13,1635824887,5/13/2015 15:54:32,false,instagc,1.0,24252915,GBR,F2,Gosport,92.24.208.155,[PART_OF],[PART_OF],"Early treatment, when the HEADACHE more effective than later treatment, when the MIGRAINE",N/a,26,98,1,33,106,TWrex-cause,813321-FS1,"Early treatment, when the HEADACHE is mild, is much more effective than later treatment, when the MIGRAINE is moderate or severe in intensity.",HEADACHE,MIGRAINE
721148975,5/13/2015 15:57:56,1635827091,5/13/2015 15:57:15,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[MANIFESTATION],[MANIFESTATION],"mild,",none,26,98,1,33,106,TWrex-cause,813321-FS1,"Early treatment, when the HEADACHE is mild, is much more effective than later treatment, when the MIGRAINE is moderate or severe in intensity.",HEADACHE,MIGRAINE
721148975,5/13/2015 16:23:29,1635844483,5/13/2015 16:21:53,false,prodege,1.0,16101132,GBR,F9,Hayes,2.223.214.149,[ASSOCIATED_WITH],[ASSOCIATED_WITH],is,Associated with,26,98,1,33,106,TWrex-cause,813321-FS1,"Early treatment, when the HEADACHE is mild, is much more effective than later treatment, when the MIGRAINE is moderate or severe in intensity.",HEADACHE,MIGRAINE
721148976,5/13/2015 09:56:23,1635676382,5/13/2015 09:56:12,false,neodev,1.0,32103286,CAN,AB,Edmonton,208.123.223.37,[LOCATION] [SYMPTOM] [NONE],"[LOCATION]
[SYMPTOM]
[NONE]",no,no,38,76,1,56,92,TWrex-cause,812597-FS1,13  Trichostrongyliasis  Treatment of TRICHOSTRONGYLIASIS   +    caused by  TRICHOSTRONGYLUS,TRICHOSTRONGYLIASIS,TRICHOSTRONGYLUS
721148976,5/13/2015 10:03:44,1635678299,5/13/2015 10:03:03,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[TREATS] [CAUSES],"[TREATS]
[CAUSES]",Trichostrongyliasis Treatment of TRICHOSTRONGYLIASIS + caused by TRICHOSTRONGYLUS,N/A,38,76,1,56,92,TWrex-cause,812597-FS1,13  Trichostrongyliasis  Treatment of TRICHOSTRONGYLIASIS   +    caused by  TRICHOSTRONGYLUS,TRICHOSTRONGYLIASIS,TRICHOSTRONGYLUS
721148976,5/13/2015 10:19:28,1635682300,5/13/2015 10:18:42,false,clixsense,1.0,26847653,NLD,03,Warnsveld,213.93.50.164,[TREATS] [CAUSES],"[TREATS]
[CAUSES]",Treatment of caused by,n/a,38,76,1,56,92,TWrex-cause,812597-FS1,13  Trichostrongyliasis  Treatment of TRICHOSTRONGYLIASIS   +    caused by  TRICHOSTRONGYLUS,TRICHOSTRONGYLIASIS,TRICHOSTRONGYLUS
721148976,5/13/2015 10:24:09,1635683689,5/13/2015 10:23:49,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[CAUSES],[CAUSES],caused by,n/a,38,76,1,56,92,TWrex-cause,812597-FS1,13  Trichostrongyliasis  Treatment of TRICHOSTRONGYLIASIS   +    caused by  TRICHOSTRONGYLUS,TRICHOSTRONGYLIASIS,TRICHOSTRONGYLUS
721148976,5/13/2015 10:24:58,1635683893,5/13/2015 10:24:39,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[CAUSES],[CAUSES],caused by,N/A,38,76,1,56,92,TWrex-cause,812597-FS1,13  Trichostrongyliasis  Treatment of TRICHOSTRONGYLIASIS   +    caused by  TRICHOSTRONGYLUS,TRICHOSTRONGYLIASIS,TRICHOSTRONGYLUS
721148976,5/13/2015 10:30:05,1635685488,5/13/2015 10:29:56,false,pocketmoneygpt,1.0,28884030,USA,WI,Minocqua,75.143.134.247,[TREATS],[TREATS],Treatment,n/a,38,76,1,56,92,TWrex-cause,812597-FS1,13  Trichostrongyliasis  Treatment of TRICHOSTRONGYLIASIS   +    caused by  TRICHOSTRONGYLUS,TRICHOSTRONGYLIASIS,TRICHOSTRONGYLUS
721148976,5/13/2015 10:40:52,1635688431,5/13/2015 10:40:34,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[CAUSES],[CAUSES],TRICHOSTRONGYLUS,N/A,38,76,1,56,92,TWrex-cause,812597-FS1,13  Trichostrongyliasis  Treatment of TRICHOSTRONGYLIASIS   +    caused by  TRICHOSTRONGYLUS,TRICHOSTRONGYLIASIS,TRICHOSTRONGYLUS
721148976,5/13/2015 10:52:49,1635692168,5/13/2015 10:52:31,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,[TREATS],[TREATS],Treatment,n/a,38,76,1,56,92,TWrex-cause,812597-FS1,13  Trichostrongyliasis  Treatment of TRICHOSTRONGYLIASIS   +    caused by  TRICHOSTRONGYLUS,TRICHOSTRONGYLIASIS,TRICHOSTRONGYLUS
721148976,5/13/2015 10:56:04,1635692974,5/13/2015 10:55:35,false,neodev,1.0,29579905,GBR,"","",5.152.206.71,[SYMPTOM] [PART_OF],"[SYMPTOM]
[PART_OF]",TRICHOSTRONGYLIASIS TRICHOSTRONGYLUS,N/A,38,76,1,56,92,TWrex-cause,812597-FS1,13  Trichostrongyliasis  Treatment of TRICHOSTRONGYLIASIS   +    caused by  TRICHOSTRONGYLUS,TRICHOSTRONGYLIASIS,TRICHOSTRONGYLUS
721148976,5/13/2015 10:56:34,1635693115,5/13/2015 10:55:56,false,neodev,1.0,31706957,NLD,07,Amsterdam,145.100.72.165,[CAUSES],[CAUSES],caused by,n/a,38,76,1,56,92,TWrex-cause,812597-FS1,13  Trichostrongyliasis  Treatment of TRICHOSTRONGYLIASIS   +    caused by  TRICHOSTRONGYLUS,TRICHOSTRONGYLIASIS,TRICHOSTRONGYLUS
721148976,5/13/2015 11:09:42,1635696819,5/13/2015 11:09:29,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[CAUSES],[CAUSES],caused by,n/a,38,76,1,56,92,TWrex-cause,812597-FS1,13  Trichostrongyliasis  Treatment of TRICHOSTRONGYLIASIS   +    caused by  TRICHOSTRONGYLUS,TRICHOSTRONGYLIASIS,TRICHOSTRONGYLUS
721148976,5/13/2015 11:17:31,1635698886,5/13/2015 11:17:08,false,prodege,1.0,27934334,GBR,D3,Swadlincote,109.150.228.127,[CAUSES],[CAUSES],caused by,N/A,38,76,1,56,92,TWrex-cause,812597-FS1,13  Trichostrongyliasis  Treatment of TRICHOSTRONGYLIASIS   +    caused by  TRICHOSTRONGYLUS,TRICHOSTRONGYLIASIS,TRICHOSTRONGYLUS
721148976,5/13/2015 11:21:43,1635699709,5/13/2015 11:20:50,false,points4rewards,1.0,28703583,USA,"","",97.73.86.35,[TREATS] [CAUSES],"[TREATS]
[CAUSES]",Treatment of caused by,N/A,38,76,1,56,92,TWrex-cause,812597-FS1,13  Trichostrongyliasis  Treatment of TRICHOSTRONGYLIASIS   +    caused by  TRICHOSTRONGYLUS,TRICHOSTRONGYLIASIS,TRICHOSTRONGYLUS
721148976,5/13/2015 11:24:59,1635700462,5/13/2015 11:23:44,false,neodev,1,18881135,CAN,ON,Ajax,99.243.87.224,[CAUSES],[CAUSES],TRICHOSTRONGYLIASIS caused by TRICHOSTRONGYLUS,n/a,38,76,1,56,92,TWrex-cause,812597-FS1,13  Trichostrongyliasis  Treatment of TRICHOSTRONGYLIASIS   +    caused by  TRICHOSTRONGYLUS,TRICHOSTRONGYLIASIS,TRICHOSTRONGYLUS
721148976,5/13/2015 11:29:59,1635701695,5/13/2015 11:27:51,false,neodev,1,11001780,AUS,07,Elwood,14.201.215.31,[CAUSES],[CAUSES],caused,N/A,38,76,1,56,92,TWrex-cause,812597-FS1,13  Trichostrongyliasis  Treatment of TRICHOSTRONGYLIASIS   +    caused by  TRICHOSTRONGYLUS,TRICHOSTRONGYLIASIS,TRICHOSTRONGYLUS
721148977,5/13/2015 13:06:52,1635730949,5/13/2015 13:06:37,false,neodev,1.0,30504276,CAN,ON,Sudbury,66.103.55.12,[TREATS],[TREATS],treatment,N/A,36,110,1,51,129,TWrex-cause,814930-FS1,471   Evaluate patients who develop THROMBOCYTOPENIA or thrombosis after treatment discontinuance for HIT and HIT WITH THROMBOSIS.,THROMBOCYTOPENIA,HIT WITH THROMBOSIS
721148977,5/13/2015 13:16:45,1635733524,5/13/2015 13:15:52,false,clixsense,1.0,24329110,USA,FL,Jacksonville,12.168.136.2,[CAUSES],[CAUSES],who develop,n/a,36,110,1,51,129,TWrex-cause,814930-FS1,471   Evaluate patients who develop THROMBOCYTOPENIA or thrombosis after treatment discontinuance for HIT and HIT WITH THROMBOSIS.,THROMBOCYTOPENIA,HIT WITH THROMBOSIS
721148977,5/13/2015 13:18:30,1635733957,5/13/2015 13:17:45,false,clixsense,1.0,23197581,NLD,11,Den Haag,82.217.5.55,[PREVENTS] [TREATS],"[TREATS]
[PREVENTS]",after treatment discontinuance,N/A,36,110,1,51,129,TWrex-cause,814930-FS1,471   Evaluate patients who develop THROMBOCYTOPENIA or thrombosis after treatment discontinuance for HIT and HIT WITH THROMBOSIS.,THROMBOCYTOPENIA,HIT WITH THROMBOSIS
721148977,5/13/2015 13:21:06,1635734750,5/13/2015 13:20:02,false,prodege,1.0,23482077,USA,TX,Garland,71.164.238.226,[OTHER],[OTHER],develop after treatment discontinuance for,N/A,36,110,1,51,129,TWrex-cause,814930-FS1,471   Evaluate patients who develop THROMBOCYTOPENIA or thrombosis after treatment discontinuance for HIT and HIT WITH THROMBOSIS.,THROMBOCYTOPENIA,HIT WITH THROMBOSIS
721148977,5/13/2015 13:42:29,1635740378,5/13/2015 13:42:00,false,bitcoinget,1.0,21614812,USA,PA,Erie,174.100.250.115,[CAUSES],[CAUSES],after treatment discontinuance for,N/A,36,110,1,51,129,TWrex-cause,814930-FS1,471   Evaluate patients who develop THROMBOCYTOPENIA or thrombosis after treatment discontinuance for HIT and HIT WITH THROMBOSIS.,THROMBOCYTOPENIA,HIT WITH THROMBOSIS
721148977,5/13/2015 13:52:20,1635744323,5/13/2015 13:49:55,false,neodev,1.0,24564999,GBR,H9,London,86.145.227.9,[ASSOCIATED_WITH],[ASSOCIATED_WITH],who develop after treatment,N/A,36,110,1,51,129,TWrex-cause,814930-FS1,471   Evaluate patients who develop THROMBOCYTOPENIA or thrombosis after treatment discontinuance for HIT and HIT WITH THROMBOSIS.,THROMBOCYTOPENIA,HIT WITH THROMBOSIS
721148977,5/13/2015 13:57:45,1635746506,5/13/2015 13:57:16,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[CAUSES],[CAUSES],develop after treatment,N/A,36,110,1,51,129,TWrex-cause,814930-FS1,471   Evaluate patients who develop THROMBOCYTOPENIA or thrombosis after treatment discontinuance for HIT and HIT WITH THROMBOSIS.,THROMBOCYTOPENIA,HIT WITH THROMBOSIS
721148977,5/13/2015 14:22:17,1635756733,5/13/2015 14:21:38,false,prodege,1.0,24403612,CAN,ON,Ajax,99.239.181.149,[TREATS],[TREATS],THROMBOCYTOPENIA after treatment for HIT HIT WITH THROMBOSIS.,N/a,36,110,1,51,129,TWrex-cause,814930-FS1,471   Evaluate patients who develop THROMBOCYTOPENIA or thrombosis after treatment discontinuance for HIT and HIT WITH THROMBOSIS.,THROMBOCYTOPENIA,HIT WITH THROMBOSIS
721148977,5/13/2015 14:30:24,1635760580,5/13/2015 14:29:59,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[CAUSES],[CAUSES],after discontinuance,N/A,36,110,1,51,129,TWrex-cause,814930-FS1,471   Evaluate patients who develop THROMBOCYTOPENIA or thrombosis after treatment discontinuance for HIT and HIT WITH THROMBOSIS.,THROMBOCYTOPENIA,HIT WITH THROMBOSIS
721148977,5/13/2015 15:16:23,1635794958,5/13/2015 15:15:47,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,[TREATS],[TREATS],treatment,n/a,36,110,1,51,129,TWrex-cause,814930-FS1,471   Evaluate patients who develop THROMBOCYTOPENIA or thrombosis after treatment discontinuance for HIT and HIT WITH THROMBOSIS.,THROMBOCYTOPENIA,HIT WITH THROMBOSIS
721148977,5/13/2015 15:30:39,1635806101,5/13/2015 15:29:43,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[MANIFESTATION],[MANIFESTATION],patients who develop THROMBOCYTOPENIA after treatment for HIT WITH THROMBOSIS.,N/A,36,110,1,51,129,TWrex-cause,814930-FS1,471   Evaluate patients who develop THROMBOCYTOPENIA or thrombosis after treatment discontinuance for HIT and HIT WITH THROMBOSIS.,THROMBOCYTOPENIA,HIT WITH THROMBOSIS
721148977,5/13/2015 16:03:22,1635831726,5/13/2015 16:02:37,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[SIDE_EFFECT],[SIDE_EFFECT],treatment discontinuance,none,36,110,1,51,129,TWrex-cause,814930-FS1,471   Evaluate patients who develop THROMBOCYTOPENIA or thrombosis after treatment discontinuance for HIT and HIT WITH THROMBOSIS.,THROMBOCYTOPENIA,HIT WITH THROMBOSIS
721148977,5/13/2015 16:28:47,1635848199,5/13/2015 16:27:44,false,prodege,1.0,16101132,GBR,F9,Hayes,2.223.214.149,[SYMPTOM],[SYMPTOM],after,Develop,36,110,1,51,129,TWrex-cause,814930-FS1,471   Evaluate patients who develop THROMBOCYTOPENIA or thrombosis after treatment discontinuance for HIT and HIT WITH THROMBOSIS.,THROMBOCYTOPENIA,HIT WITH THROMBOSIS
721148977,5/13/2015 16:29:51,1635849000,5/13/2015 16:28:00,false,clixsense,1.0,31579138,AUS,02,Hurstville,14.200.129.68,[SIDE_EFFECT],[SIDE_EFFECT],treatment discontinuance,N/A,36,110,1,51,129,TWrex-cause,814930-FS1,471   Evaluate patients who develop THROMBOCYTOPENIA or thrombosis after treatment discontinuance for HIT and HIT WITH THROMBOSIS.,THROMBOCYTOPENIA,HIT WITH THROMBOSIS
721148977,5/13/2015 16:49:57,1635861129,5/13/2015 16:47:36,false,gptking,1.0,31799065,USA,IL,Marion,50.45.43.154,[SYMPTOM],[SYMPTOM],THROMBOCYTOPENIA HIT WITH THROMBOSIS.,N/A,36,110,1,51,129,TWrex-cause,814930-FS1,471   Evaluate patients who develop THROMBOCYTOPENIA or thrombosis after treatment discontinuance for HIT and HIT WITH THROMBOSIS.,THROMBOCYTOPENIA,HIT WITH THROMBOSIS
721148978,5/13/2015 13:08:03,1635731223,5/13/2015 13:07:42,false,neodev,1.0,30504276,CAN,ON,Sudbury,66.103.55.12,[SYMPTOM],[SYMPTOM],pain,N/A,113,79,1,116,92,TWrex-cause,813600-FS1,C]  Specific recommendation: • Encourage patients to differentiate the pain of ENDOMETRIOSIS from other types of PAIN and its relation to their menstrual cycle and intercourse and to keep a diary of their symptoms.,PAIN,ENDOMETRIOSIS
721148978,5/13/2015 13:18:44,1635734056,5/13/2015 13:18:06,false,clixsense,1.0,24329110,USA,FL,Jacksonville,12.168.136.2,[CAUSES],[CAUSES],its relation to,n/a,113,79,1,116,92,TWrex-cause,813600-FS1,C]  Specific recommendation: • Encourage patients to differentiate the pain of ENDOMETRIOSIS from other types of PAIN and its relation to their menstrual cycle and intercourse and to keep a diary of their symptoms.,PAIN,ENDOMETRIOSIS
721148978,5/13/2015 13:20:20,1635734600,5/13/2015 13:19:50,false,clixsense,1.0,23197581,NLD,11,Den Haag,82.217.5.55,[CAUSES],[CAUSES],differentiate the pain of,N/A,113,79,1,116,92,TWrex-cause,813600-FS1,C]  Specific recommendation: • Encourage patients to differentiate the pain of ENDOMETRIOSIS from other types of PAIN and its relation to their menstrual cycle and intercourse and to keep a diary of their symptoms.,PAIN,ENDOMETRIOSIS
721148978,5/13/2015 13:44:25,1635741052,5/13/2015 13:44:04,false,bitcoinget,1.0,21614812,USA,PA,Erie,174.100.250.115,[CAUSES],[CAUSES],from other types of,N/A,113,79,1,116,92,TWrex-cause,813600-FS1,C]  Specific recommendation: • Encourage patients to differentiate the pain of ENDOMETRIOSIS from other types of PAIN and its relation to their menstrual cycle and intercourse and to keep a diary of their symptoms.,PAIN,ENDOMETRIOSIS
721148978,5/13/2015 13:57:37,1635746467,5/13/2015 13:57:11,false,neodev,1.0,24564999,GBR,H9,London,86.145.227.9,[SYMPTOM],[SYMPTOM],pain of,N/A,113,79,1,116,92,TWrex-cause,813600-FS1,C]  Specific recommendation: • Encourage patients to differentiate the pain of ENDOMETRIOSIS from other types of PAIN and its relation to their menstrual cycle and intercourse and to keep a diary of their symptoms.,PAIN,ENDOMETRIOSIS
721148978,5/13/2015 14:00:10,1635747528,5/13/2015 13:59:09,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[ASSOCIATED_WITH] [OTHER],"[ASSOCIATED_WITH]
[OTHER]",differentiate from,DIFFERS FROM,113,79,1,116,92,TWrex-cause,813600-FS1,C]  Specific recommendation: • Encourage patients to differentiate the pain of ENDOMETRIOSIS from other types of PAIN and its relation to their menstrual cycle and intercourse and to keep a diary of their symptoms.,PAIN,ENDOMETRIOSIS
721148978,5/13/2015 14:24:42,1635757724,5/13/2015 14:24:14,false,prodege,1.0,24403612,CAN,ON,Ajax,99.239.181.149,[CONTRAINDICATES],[CONTRAINDICATES],differentiate ENDOMETRIOSIS from other PAIN,N/a,113,79,1,116,92,TWrex-cause,813600-FS1,C]  Specific recommendation: • Encourage patients to differentiate the pain of ENDOMETRIOSIS from other types of PAIN and its relation to their menstrual cycle and intercourse and to keep a diary of their symptoms.,PAIN,ENDOMETRIOSIS
721148978,5/13/2015 14:35:36,1635763691,5/13/2015 14:35:12,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[SYMPTOM],[SYMPTOM],pain of,N/A,113,79,1,116,92,TWrex-cause,813600-FS1,C]  Specific recommendation: • Encourage patients to differentiate the pain of ENDOMETRIOSIS from other types of PAIN and its relation to their menstrual cycle and intercourse and to keep a diary of their symptoms.,PAIN,ENDOMETRIOSIS
721148978,5/13/2015 15:19:20,1635797588,5/13/2015 15:18:33,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,[SYMPTOM],[SYMPTOM],pain,n/a,113,79,1,116,92,TWrex-cause,813600-FS1,C]  Specific recommendation: • Encourage patients to differentiate the pain of ENDOMETRIOSIS from other types of PAIN and its relation to their menstrual cycle and intercourse and to keep a diary of their symptoms.,PAIN,ENDOMETRIOSIS
721148978,5/13/2015 16:06:31,1635834139,5/13/2015 16:05:47,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[MANIFESTATION],[MANIFESTATION],relation,none,113,79,1,116,92,TWrex-cause,813600-FS1,C]  Specific recommendation: • Encourage patients to differentiate the pain of ENDOMETRIOSIS from other types of PAIN and its relation to their menstrual cycle and intercourse and to keep a diary of their symptoms.,PAIN,ENDOMETRIOSIS
721148978,5/13/2015 16:31:50,1635850462,5/13/2015 16:31:08,false,prodege,1.0,16101132,GBR,F9,Hayes,2.223.214.149,[SYMPTOM],[SYMPTOM],symptoms.,Symptom,113,79,1,116,92,TWrex-cause,813600-FS1,C]  Specific recommendation: • Encourage patients to differentiate the pain of ENDOMETRIOSIS from other types of PAIN and its relation to their menstrual cycle and intercourse and to keep a diary of their symptoms.,PAIN,ENDOMETRIOSIS
721148978,5/13/2015 16:32:33,1635850829,5/13/2015 16:32:05,false,clixsense,1.0,31579138,AUS,02,Hurstville,14.200.129.68,[IS_A],[IS_A],types,N/A,113,79,1,116,92,TWrex-cause,813600-FS1,C]  Specific recommendation: • Encourage patients to differentiate the pain of ENDOMETRIOSIS from other types of PAIN and its relation to their menstrual cycle and intercourse and to keep a diary of their symptoms.,PAIN,ENDOMETRIOSIS
721148978,5/13/2015 17:14:14,1635874030,5/13/2015 17:12:22,false,gptking,1.0,31799065,USA,IL,Marion,50.45.43.154,[SYMPTOM],[SYMPTOM],ENDOMETRIOSIS PAIN symptoms.,N/A,113,79,1,116,92,TWrex-cause,813600-FS1,C]  Specific recommendation: • Encourage patients to differentiate the pain of ENDOMETRIOSIS from other types of PAIN and its relation to their menstrual cycle and intercourse and to keep a diary of their symptoms.,PAIN,ENDOMETRIOSIS
721148978,5/13/2015 17:14:18,1635874061,5/13/2015 17:13:41,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[PART_OF],[PART_OF],pain of ENDOMETRIOSIS from other types of PAIN,n/a,113,79,1,116,92,TWrex-cause,813600-FS1,C]  Specific recommendation: • Encourage patients to differentiate the pain of ENDOMETRIOSIS from other types of PAIN and its relation to their menstrual cycle and intercourse and to keep a diary of their symptoms.,PAIN,ENDOMETRIOSIS
721148978,5/13/2015 17:19:10,1635876789,5/13/2015 17:16:48,false,clixsense,1,7051387,USA,NY,Rego Park,98.14.64.34,[NONE] [PART_OF],"[PART_OF]
[NONE]",differentiate,particpants are asked to tell what is different about the pain -- which is part of endometriosis -- from other types of  pain.,113,79,1,116,92,TWrex-cause,813600-FS1,C]  Specific recommendation: • Encourage patients to differentiate the pain of ENDOMETRIOSIS from other types of PAIN and its relation to their menstrual cycle and intercourse and to keep a diary of their symptoms.,PAIN,ENDOMETRIOSIS
721148979,5/13/2015 10:28:58,1635685013,5/13/2015 10:28:02,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[TREATS] [DIAGNOSE_BY_TEST_OR_DRUG],"[TREATS]
[DIAGNOSE_BY_TEST_OR_DRUG]",Double blind study comparing PIROXICAM and aspirin in the treatment of OSTEOARTHRITIS,N/A,71,29,-1,84,38,TWrex-cause,804217-FS1,Double blind study comparing PIROXICAM and aspirin in the treatment of OSTEOARTHRITIS,OSTEOARTHRITIS,PIROXICAM
721148979,5/13/2015 10:42:58,1635689139,5/13/2015 10:42:33,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[TREATS],[TREATS],treatment of,n/a,71,29,-1,84,38,TWrex-cause,804217-FS1,Double blind study comparing PIROXICAM and aspirin in the treatment of OSTEOARTHRITIS,OSTEOARTHRITIS,PIROXICAM
721148979,5/13/2015 10:47:59,1635690606,5/13/2015 10:47:16,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[TREATS],[TREATS],treatment of,N/A,71,29,-1,84,38,TWrex-cause,804217-FS1,Double blind study comparing PIROXICAM and aspirin in the treatment of OSTEOARTHRITIS,OSTEOARTHRITIS,PIROXICAM
721148979,5/13/2015 10:54:48,1635692655,5/13/2015 10:54:23,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[TREATS],[TREATS],OSTEOARTHRITIS,N/A,71,29,-1,84,38,TWrex-cause,804217-FS1,Double blind study comparing PIROXICAM and aspirin in the treatment of OSTEOARTHRITIS,OSTEOARTHRITIS,PIROXICAM
721148979,5/13/2015 11:15:32,1635698102,5/13/2015 11:15:19,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[TREATS],[TREATS],treatment,n/a,71,29,-1,84,38,TWrex-cause,804217-FS1,Double blind study comparing PIROXICAM and aspirin in the treatment of OSTEOARTHRITIS,OSTEOARTHRITIS,PIROXICAM
721148979,5/13/2015 11:21:57,1635699736,5/13/2015 11:21:40,false,neodev,1.0,31706957,NLD,07,Amsterdam,145.100.72.165,[TREATS],[TREATS],in the treatment of,n/a,71,29,-1,84,38,TWrex-cause,804217-FS1,Double blind study comparing PIROXICAM and aspirin in the treatment of OSTEOARTHRITIS,OSTEOARTHRITIS,PIROXICAM
721148979,5/13/2015 11:33:18,1635702347,5/13/2015 11:33:03,false,prodege,1.0,27934334,GBR,D3,Swadlincote,109.150.228.127,[TREATS],[TREATS],treatment,N/A,71,29,-1,84,38,TWrex-cause,804217-FS1,Double blind study comparing PIROXICAM and aspirin in the treatment of OSTEOARTHRITIS,OSTEOARTHRITIS,PIROXICAM
721148979,5/13/2015 11:42:21,1635705321,5/13/2015 11:41:55,false,points4rewards,1.0,28703583,USA,"","",97.73.86.35,[TREATS],[TREATS],in the treatment of,N/A,71,29,-1,84,38,TWrex-cause,804217-FS1,Double blind study comparing PIROXICAM and aspirin in the treatment of OSTEOARTHRITIS,OSTEOARTHRITIS,PIROXICAM
721148979,5/13/2015 11:42:30,1635705329,5/13/2015 11:41:56,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[TREATS],[TREATS],PIROXICAM in treatment of OSTEOARTHRITIS,n/a,71,29,-1,84,38,TWrex-cause,804217-FS1,Double blind study comparing PIROXICAM and aspirin in the treatment of OSTEOARTHRITIS,OSTEOARTHRITIS,PIROXICAM
721148979,5/13/2015 11:47:12,1635706486,5/13/2015 11:46:47,false,neodev,1.0,31726043,GBR,"","",88.150.202.140,[LOCATION],[LOCATION],the,551,71,29,-1,84,38,TWrex-cause,804217-FS1,Double blind study comparing PIROXICAM and aspirin in the treatment of OSTEOARTHRITIS,OSTEOARTHRITIS,PIROXICAM
721148979,5/13/2015 12:21:46,1635718296,5/13/2015 12:21:29,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,[TREATS],[TREATS],treatment,n/a,71,29,-1,84,38,TWrex-cause,804217-FS1,Double blind study comparing PIROXICAM and aspirin in the treatment of OSTEOARTHRITIS,OSTEOARTHRITIS,PIROXICAM
721148979,5/13/2015 12:25:18,1635719815,5/13/2015 12:25:04,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[TREATS],[TREATS],PIROXICAM and aspirin in the treatment of OSTEOARTHRITIS,n/a,71,29,-1,84,38,TWrex-cause,804217-FS1,Double blind study comparing PIROXICAM and aspirin in the treatment of OSTEOARTHRITIS,OSTEOARTHRITIS,PIROXICAM
721148979,5/13/2015 12:36:50,1635723010,5/13/2015 12:35:39,false,neodev,1,30588889,NLD,07,Amsterdam,77.248.175.222,[TREATS],[TREATS],treatment,N/A,71,29,-1,84,38,TWrex-cause,804217-FS1,Double blind study comparing PIROXICAM and aspirin in the treatment of OSTEOARTHRITIS,OSTEOARTHRITIS,PIROXICAM
721148979,5/13/2015 12:55:08,1635727336,5/13/2015 12:54:29,false,prodege,1.0,23482077,USA,TX,Garland,71.164.238.226,[TREATS],[TREATS],in the treatment of,N/A,71,29,-1,84,38,TWrex-cause,804217-FS1,Double blind study comparing PIROXICAM and aspirin in the treatment of OSTEOARTHRITIS,OSTEOARTHRITIS,PIROXICAM
721148979,5/13/2015 13:01:02,1635728758,5/13/2015 13:00:49,false,neodev,1.0,30504276,CAN,ON,Sudbury,66.103.55.12,[TREATS],[TREATS],treatment,N/A,71,29,-1,84,38,TWrex-cause,804217-FS1,Double blind study comparing PIROXICAM and aspirin in the treatment of OSTEOARTHRITIS,OSTEOARTHRITIS,PIROXICAM
721148980,5/13/2015 10:25:19,1635683928,5/13/2015 10:24:10,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[TREATS] [DIAGNOSE_BY_TEST_OR_DRUG],"[TREATS]
[DIAGNOSE_BY_TEST_OR_DRUG]","In the SOLVD treatment trial, ENALAPRIL titrated to 20 mg/d in patients with class II AND III CHF reduced mortality by 4.5% at 3 years (NNT = 22)",N/A,85,32,-1,98,41,TWrex-cause,800379-FS1,"• In the SOLVD treatment trial, ENALAPRIL titrated to 20 mg/d in patients with class II AND III CHF reduced mortality by 4.5% at 3 years (NNT = 22) ( 143.",II AND III CHF,ENALAPRIL
721148980,5/13/2015 10:40:50,1635688418,5/13/2015 10:40:29,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[TREATS],[TREATS],"treatment trial,",n/a,85,32,-1,98,41,TWrex-cause,800379-FS1,"• In the SOLVD treatment trial, ENALAPRIL titrated to 20 mg/d in patients with class II AND III CHF reduced mortality by 4.5% at 3 years (NNT = 22) ( 143.",II AND III CHF,ENALAPRIL
721148980,5/13/2015 10:44:37,1635689714,5/13/2015 10:42:21,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[TREATS],[TREATS],"treatment trial,",N/A,85,32,-1,98,41,TWrex-cause,800379-FS1,"• In the SOLVD treatment trial, ENALAPRIL titrated to 20 mg/d in patients with class II AND III CHF reduced mortality by 4.5% at 3 years (NNT = 22) ( 143.",II AND III CHF,ENALAPRIL
721148980,5/13/2015 10:53:35,1635692409,5/13/2015 10:52:21,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[PREVENTS],[PREVENTS],mortality,N/A,85,32,-1,98,41,TWrex-cause,800379-FS1,"• In the SOLVD treatment trial, ENALAPRIL titrated to 20 mg/d in patients with class II AND III CHF reduced mortality by 4.5% at 3 years (NNT = 22) ( 143.",II AND III CHF,ENALAPRIL
721148980,5/13/2015 11:14:51,1635697898,5/13/2015 11:14:38,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[TREATS],[TREATS],treatment,n/a,85,32,-1,98,41,TWrex-cause,800379-FS1,"• In the SOLVD treatment trial, ENALAPRIL titrated to 20 mg/d in patients with class II AND III CHF reduced mortality by 4.5% at 3 years (NNT = 22) ( 143.",II AND III CHF,ENALAPRIL
721148980,5/13/2015 11:19:18,1635699276,5/13/2015 11:18:04,false,neodev,1.0,31706957,NLD,07,Amsterdam,145.100.72.165,[PREVENTS],[PREVENTS],reduced mortality,n/a,85,32,-1,98,41,TWrex-cause,800379-FS1,"• In the SOLVD treatment trial, ENALAPRIL titrated to 20 mg/d in patients with class II AND III CHF reduced mortality by 4.5% at 3 years (NNT = 22) ( 143.",II AND III CHF,ENALAPRIL
721148980,5/13/2015 11:32:08,1635702081,5/13/2015 11:31:37,false,prodege,1.0,27934334,GBR,D3,Swadlincote,109.150.228.127,[TREATS],[TREATS],treatment,N/A,85,32,-1,98,41,TWrex-cause,800379-FS1,"• In the SOLVD treatment trial, ENALAPRIL titrated to 20 mg/d in patients with class II AND III CHF reduced mortality by 4.5% at 3 years (NNT = 22) ( 143.",II AND III CHF,ENALAPRIL
721148980,5/13/2015 11:40:05,1635704834,5/13/2015 11:39:24,false,points4rewards,1.0,28703583,USA,"","",97.73.86.35,[TREATS],[TREATS],treatment,N/A,85,32,-1,98,41,TWrex-cause,800379-FS1,"• In the SOLVD treatment trial, ENALAPRIL titrated to 20 mg/d in patients with class II AND III CHF reduced mortality by 4.5% at 3 years (NNT = 22) ( 143.",II AND III CHF,ENALAPRIL
721148980,5/13/2015 11:40:51,1635704980,5/13/2015 11:40:06,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[TREATS],[TREATS],"treatment trial, ENALAPRIL in patients with class II AND III CHF",n/a,85,32,-1,98,41,TWrex-cause,800379-FS1,"• In the SOLVD treatment trial, ENALAPRIL titrated to 20 mg/d in patients with class II AND III CHF reduced mortality by 4.5% at 3 years (NNT = 22) ( 143.",II AND III CHF,ENALAPRIL
721148980,5/13/2015 11:45:51,1635705985,5/13/2015 11:45:40,false,neodev,1.0,31726043,GBR,"","",88.150.202.140,[CONTRAINDICATES],[CONTRAINDICATES],with,8548,85,32,-1,98,41,TWrex-cause,800379-FS1,"• In the SOLVD treatment trial, ENALAPRIL titrated to 20 mg/d in patients with class II AND III CHF reduced mortality by 4.5% at 3 years (NNT = 22) ( 143.",II AND III CHF,ENALAPRIL
721148980,5/13/2015 12:20:52,1635718008,5/13/2015 12:20:12,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,[TREATS],[TREATS],reduced mortality,n/a,85,32,-1,98,41,TWrex-cause,800379-FS1,"• In the SOLVD treatment trial, ENALAPRIL titrated to 20 mg/d in patients with class II AND III CHF reduced mortality by 4.5% at 3 years (NNT = 22) ( 143.",II AND III CHF,ENALAPRIL
721148980,5/13/2015 12:23:59,1635719177,5/13/2015 12:23:44,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[TREATS],[TREATS],"SOLVD treatment trial, ENALAPRIL",n/a,85,32,-1,98,41,TWrex-cause,800379-FS1,"• In the SOLVD treatment trial, ENALAPRIL titrated to 20 mg/d in patients with class II AND III CHF reduced mortality by 4.5% at 3 years (NNT = 22) ( 143.",II AND III CHF,ENALAPRIL
721148980,5/13/2015 12:32:16,1635721705,5/13/2015 12:31:48,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[TREATS],[TREATS],reduced mortality,N/A,85,32,-1,98,41,TWrex-cause,800379-FS1,"• In the SOLVD treatment trial, ENALAPRIL titrated to 20 mg/d in patients with class II AND III CHF reduced mortality by 4.5% at 3 years (NNT = 22) ( 143.",II AND III CHF,ENALAPRIL
721148980,5/13/2015 12:52:51,1635726847,5/13/2015 12:51:31,false,prodege,1.0,23482077,USA,TX,Garland,71.164.238.226,[OTHER],[OTHER],"In the treatment trial,",N/A,85,32,-1,98,41,TWrex-cause,800379-FS1,"• In the SOLVD treatment trial, ENALAPRIL titrated to 20 mg/d in patients with class II AND III CHF reduced mortality by 4.5% at 3 years (NNT = 22) ( 143.",II AND III CHF,ENALAPRIL
721148980,5/13/2015 13:00:42,1635728684,5/13/2015 13:00:13,false,clixsense,1.0,24329110,USA,FL,Jacksonville,12.168.136.2,[TREATS],[TREATS],"treatment trial,",n/a,85,32,-1,98,41,TWrex-cause,800379-FS1,"• In the SOLVD treatment trial, ENALAPRIL titrated to 20 mg/d in patients with class II AND III CHF reduced mortality by 4.5% at 3 years (NNT = 22) ( 143.",II AND III CHF,ENALAPRIL
721148981,5/13/2015 16:48:47,1635860552,5/13/2015 16:48:00,false,clixsense,1.0,31579138,AUS,02,Hurstville,14.200.129.68,[CAUSES],[CAUSES],caused,N/A,0,73,1,41,81,TWrex-cause,810459-FS1,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY and other disorders caused by JC VIRUS: clinical features and pathogenesis.,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,JC VIRUS
721148981,5/13/2015 17:29:43,1635882826,5/13/2015 17:28:32,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[CAUSES],[CAUSES],caused by,n/a,0,73,1,41,81,TWrex-cause,810459-FS1,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY and other disorders caused by JC VIRUS: clinical features and pathogenesis.,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,JC VIRUS
721148981,5/13/2015 17:38:10,1635887361,5/13/2015 17:37:48,false,gptking,1.0,31799065,USA,IL,Marion,50.45.43.154,[SYMPTOM],[SYMPTOM],PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY caused by JC VIRUS:,N/A,0,73,1,41,81,TWrex-cause,810459-FS1,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY and other disorders caused by JC VIRUS: clinical features and pathogenesis.,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,JC VIRUS
721148981,5/13/2015 18:13:18,1635904868,5/13/2015 18:12:58,false,clixsense,1.0,32549163,CAN,MB,Winnipeg,206.45.167.246,[CAUSES],[CAUSES],PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY caused by JC VIRUS:,N/A,0,73,1,41,81,TWrex-cause,810459-FS1,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY and other disorders caused by JC VIRUS: clinical features and pathogenesis.,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,JC VIRUS
721148981,5/13/2015 18:16:10,1635905948,5/13/2015 18:15:35,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[CAUSES],[CAUSES],caused by,N/A,0,73,1,41,81,TWrex-cause,810459-FS1,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY and other disorders caused by JC VIRUS: clinical features and pathogenesis.,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,JC VIRUS
721148981,5/13/2015 18:20:46,1635907847,5/13/2015 18:20:15,false,instagc,1.0,24252915,GBR,"","",80.44.146.98,[CAUSES],[CAUSES],caused by,N/a,0,73,1,41,81,TWrex-cause,810459-FS1,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY and other disorders caused by JC VIRUS: clinical features and pathogenesis.,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,JC VIRUS
721148981,5/13/2015 18:21:41,1635908435,5/13/2015 18:21:05,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[CAUSES],[CAUSES],caused by,N/A,0,73,1,41,81,TWrex-cause,810459-FS1,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY and other disorders caused by JC VIRUS: clinical features and pathogenesis.,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,JC VIRUS
721148981,5/13/2015 18:46:13,1635921286,5/13/2015 18:45:48,false,prodege,1.0,32302664,USA,IL,Geneseo,173.27.241.235,[MANIFESTATION],[MANIFESTATION],and other disorders caused by,no comment,0,73,1,41,81,TWrex-cause,810459-FS1,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY and other disorders caused by JC VIRUS: clinical features and pathogenesis.,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,JC VIRUS
721148981,5/13/2015 19:09:38,1635930701,5/13/2015 19:09:26,false,clixsense,1.0,19162475,GBR,P8,Trowbridge,82.33.126.30,[ASSOCIATED_WITH] [PREVENTS],"[PREVENTS]
[ASSOCIATED_WITH]",disorders caused,n/a,0,73,1,41,81,TWrex-cause,810459-FS1,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY and other disorders caused by JC VIRUS: clinical features and pathogenesis.,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,JC VIRUS
721148981,5/13/2015 19:12:25,1635932392,5/13/2015 19:12:00,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[CAUSES],[CAUSES],caused,N/A,0,73,1,41,81,TWrex-cause,810459-FS1,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY and other disorders caused by JC VIRUS: clinical features and pathogenesis.,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,JC VIRUS
721148981,5/13/2015 19:44:47,1635962923,5/13/2015 19:44:25,false,elite,1.0,30064988,GBR,H3,Leeds,92.22.208.245,[CAUSES],[CAUSES],caused by,N/A,0,73,1,41,81,TWrex-cause,810459-FS1,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY and other disorders caused by JC VIRUS: clinical features and pathogenesis.,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,JC VIRUS
721148981,5/13/2015 20:05:24,1635979230,5/13/2015 20:04:23,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.156.243,[CAUSES],[CAUSES],PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY caused by JC VIRUS:,N/A,0,73,1,41,81,TWrex-cause,810459-FS1,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY and other disorders caused by JC VIRUS: clinical features and pathogenesis.,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,JC VIRUS
721148981,5/13/2015 20:05:26,1635979261,5/13/2015 20:04:49,false,clixsense,1.0,27969116,NLD,"","",212.78.195.38,[IS_A],[IS_A],and other disorders caused by,caused by,0,73,1,41,81,TWrex-cause,810459-FS1,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY and other disorders caused by JC VIRUS: clinical features and pathogenesis.,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,JC VIRUS
721148981,5/13/2015 20:32:44,1635999334,5/13/2015 20:32:29,false,neodev,1.0,20961587,NLD,05,Maastricht,84.26.48.136,[CAUSES],[CAUSES],caused,N/A,0,73,1,41,81,TWrex-cause,810459-FS1,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY and other disorders caused by JC VIRUS: clinical features and pathogenesis.,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,JC VIRUS
721148981,5/13/2015 20:42:02,1636005583,5/13/2015 20:40:35,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[CAUSES],[CAUSES],PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY caused by JC VIRUS:,N/A,0,73,1,41,81,TWrex-cause,810459-FS1,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY and other disorders caused by JC VIRUS: clinical features and pathogenesis.,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,JC VIRUS
721148982,5/13/2015 13:07:21,1635731012,5/13/2015 13:07:10,false,neodev,1.0,30504276,CAN,ON,Sudbury,66.103.55.12,[TREATS],[TREATS],treatment,N/A,150,112,-1,170,119,TWrex-cause,804066-FS1,"2]  Kitabchi AE, Murphy MB, Spencer J, Matteri R, Karas J. Is a priming dose of insulin necessary in a low dose INSULIN protocol for the treatment of DIABETIC KETOACIDOSIS",DIABETIC KETOACIDOSIS,INSULIN
721148982,5/13/2015 13:17:33,1635733681,5/13/2015 13:17:09,false,clixsense,1.0,24329110,USA,FL,Jacksonville,12.168.136.2,[TREATS],[TREATS],treatment of,n/a,150,112,-1,170,119,TWrex-cause,804066-FS1,"2]  Kitabchi AE, Murphy MB, Spencer J, Matteri R, Karas J. Is a priming dose of insulin necessary in a low dose INSULIN protocol for the treatment of DIABETIC KETOACIDOSIS",DIABETIC KETOACIDOSIS,INSULIN
721148982,5/13/2015 13:19:24,1635734216,5/13/2015 13:18:59,false,clixsense,1.0,23197581,NLD,11,Den Haag,82.217.5.55,[TREATS],[TREATS],for the treatment of,N/A,150,112,-1,170,119,TWrex-cause,804066-FS1,"2]  Kitabchi AE, Murphy MB, Spencer J, Matteri R, Karas J. Is a priming dose of insulin necessary in a low dose INSULIN protocol for the treatment of DIABETIC KETOACIDOSIS",DIABETIC KETOACIDOSIS,INSULIN
721148982,5/13/2015 13:43:19,1635740661,5/13/2015 13:43:03,false,bitcoinget,1.0,21614812,USA,PA,Erie,174.100.250.115,[TREATS],[TREATS],protocol for the treatment of,N/A,150,112,-1,170,119,TWrex-cause,804066-FS1,"2]  Kitabchi AE, Murphy MB, Spencer J, Matteri R, Karas J. Is a priming dose of insulin necessary in a low dose INSULIN protocol for the treatment of DIABETIC KETOACIDOSIS",DIABETIC KETOACIDOSIS,INSULIN
721148982,5/13/2015 13:56:46,1635746109,5/13/2015 13:53:49,false,neodev,1.0,24564999,GBR,H9,London,86.145.227.9,[TREATS],[TREATS],treatment,N/A,150,112,-1,170,119,TWrex-cause,804066-FS1,"2]  Kitabchi AE, Murphy MB, Spencer J, Matteri R, Karas J. Is a priming dose of insulin necessary in a low dose INSULIN protocol for the treatment of DIABETIC KETOACIDOSIS",DIABETIC KETOACIDOSIS,INSULIN
721148982,5/13/2015 13:58:30,1635746850,5/13/2015 13:58:14,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[TREATS],[TREATS],treatment,N/A,150,112,-1,170,119,TWrex-cause,804066-FS1,"2]  Kitabchi AE, Murphy MB, Spencer J, Matteri R, Karas J. Is a priming dose of insulin necessary in a low dose INSULIN protocol for the treatment of DIABETIC KETOACIDOSIS",DIABETIC KETOACIDOSIS,INSULIN
721148982,5/13/2015 14:23:26,1635757161,5/13/2015 14:22:49,false,prodege,1.0,24403612,CAN,ON,Ajax,99.239.181.149,[TREATS],[TREATS],INSULIN protocol for treatment of DIABETIC KETOACIDOSIS,N/a,150,112,-1,170,119,TWrex-cause,804066-FS1,"2]  Kitabchi AE, Murphy MB, Spencer J, Matteri R, Karas J. Is a priming dose of insulin necessary in a low dose INSULIN protocol for the treatment of DIABETIC KETOACIDOSIS",DIABETIC KETOACIDOSIS,INSULIN
721148982,5/13/2015 14:32:32,1635761705,5/13/2015 14:30:51,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[TREATS],[TREATS],treatment of,N/A,150,112,-1,170,119,TWrex-cause,804066-FS1,"2]  Kitabchi AE, Murphy MB, Spencer J, Matteri R, Karas J. Is a priming dose of insulin necessary in a low dose INSULIN protocol for the treatment of DIABETIC KETOACIDOSIS",DIABETIC KETOACIDOSIS,INSULIN
721148982,5/13/2015 15:17:59,1635796486,5/13/2015 15:17:34,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,[TREATS],[TREATS],treatment,n/a,150,112,-1,170,119,TWrex-cause,804066-FS1,"2]  Kitabchi AE, Murphy MB, Spencer J, Matteri R, Karas J. Is a priming dose of insulin necessary in a low dose INSULIN protocol for the treatment of DIABETIC KETOACIDOSIS",DIABETIC KETOACIDOSIS,INSULIN
721148982,5/13/2015 15:34:41,1635809270,5/13/2015 15:33:19,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[TREATS],[TREATS],Is a INSULIN for treatment DIABETIC KETOACIDOSIS,N/A,150,112,-1,170,119,TWrex-cause,804066-FS1,"2]  Kitabchi AE, Murphy MB, Spencer J, Matteri R, Karas J. Is a priming dose of insulin necessary in a low dose INSULIN protocol for the treatment of DIABETIC KETOACIDOSIS",DIABETIC KETOACIDOSIS,INSULIN
721148982,5/13/2015 16:04:23,1635832557,5/13/2015 16:03:54,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[TREATS],[TREATS],treatment,none,150,112,-1,170,119,TWrex-cause,804066-FS1,"2]  Kitabchi AE, Murphy MB, Spencer J, Matteri R, Karas J. Is a priming dose of insulin necessary in a low dose INSULIN protocol for the treatment of DIABETIC KETOACIDOSIS",DIABETIC KETOACIDOSIS,INSULIN
721148982,5/13/2015 16:30:32,1635849462,5/13/2015 16:29:36,false,prodege,1.0,16101132,GBR,F9,Hayes,2.223.214.149,[PREVENTS],[PREVENTS],treatment,Treat with,150,112,-1,170,119,TWrex-cause,804066-FS1,"2]  Kitabchi AE, Murphy MB, Spencer J, Matteri R, Karas J. Is a priming dose of insulin necessary in a low dose INSULIN protocol for the treatment of DIABETIC KETOACIDOSIS",DIABETIC KETOACIDOSIS,INSULIN
721148982,5/13/2015 16:31:25,1635850093,5/13/2015 16:31:02,false,clixsense,1.0,31579138,AUS,02,Hurstville,14.200.129.68,[TREATS],[TREATS],treatment,N/A,150,112,-1,170,119,TWrex-cause,804066-FS1,"2]  Kitabchi AE, Murphy MB, Spencer J, Matteri R, Karas J. Is a priming dose of insulin necessary in a low dose INSULIN protocol for the treatment of DIABETIC KETOACIDOSIS",DIABETIC KETOACIDOSIS,INSULIN
721148982,5/13/2015 16:51:22,1635861810,5/13/2015 16:50:39,false,gptking,1.0,31799065,USA,IL,Marion,50.45.43.154,[TREATS],[TREATS],INSULIN treatment DIABETIC KETOACIDOSIS,N/A,150,112,-1,170,119,TWrex-cause,804066-FS1,"2]  Kitabchi AE, Murphy MB, Spencer J, Matteri R, Karas J. Is a priming dose of insulin necessary in a low dose INSULIN protocol for the treatment of DIABETIC KETOACIDOSIS",DIABETIC KETOACIDOSIS,INSULIN
721148982,5/13/2015 17:16:44,1635875395,5/13/2015 17:16:16,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[TREATS],[TREATS],treatment,n/a,150,112,-1,170,119,TWrex-cause,804066-FS1,"2]  Kitabchi AE, Murphy MB, Spencer J, Matteri R, Karas J. Is a priming dose of insulin necessary in a low dose INSULIN protocol for the treatment of DIABETIC KETOACIDOSIS",DIABETIC KETOACIDOSIS,INSULIN
721148983,5/13/2015 10:28:01,1635684666,5/13/2015 10:26:31,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[SIDE_EFFECT],[SIDE_EFFECT],"If MALIGNANT HYPERTHERMIA occurs, discontinue all ANESTHETIC AGENTS and initiate IV dantrolene therapy a in conjunction with supportive measures (e.g., administering oxygen, treating metabolic acidosis, instituting cooling procedures); maintain urinary output and monitor serum electrolytes.",N/A,3,50,1,24,67,TWrex-cause,812483-FS1,"If MALIGNANT HYPERTHERMIA occurs, discontinue all ANESTHETIC AGENTS and initiate IV dantrolene therapy  a   in conjunction with supportive measures (e.g., administering oxygen, treating metabolic acidosis, instituting cooling procedures); maintain urinary output and monitor serum electrolytes.",MALIGNANT HYPERTHERMIA,ANESTHETIC AGENTS
721148983,5/13/2015 10:42:32,1635688902,5/13/2015 10:42:07,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[CONTRAINDICATES],[CONTRAINDICATES],discontinue,n/a,3,50,1,24,67,TWrex-cause,812483-FS1,"If MALIGNANT HYPERTHERMIA occurs, discontinue all ANESTHETIC AGENTS and initiate IV dantrolene therapy  a   in conjunction with supportive measures (e.g., administering oxygen, treating metabolic acidosis, instituting cooling procedures); maintain urinary output and monitor serum electrolytes.",MALIGNANT HYPERTHERMIA,ANESTHETIC AGENTS
721148983,5/13/2015 10:47:12,1635690417,5/13/2015 10:45:24,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[SIDE_EFFECT],[SIDE_EFFECT],"If occurs,",N/A,3,50,1,24,67,TWrex-cause,812483-FS1,"If MALIGNANT HYPERTHERMIA occurs, discontinue all ANESTHETIC AGENTS and initiate IV dantrolene therapy  a   in conjunction with supportive measures (e.g., administering oxygen, treating metabolic acidosis, instituting cooling procedures); maintain urinary output and monitor serum electrolytes.",MALIGNANT HYPERTHERMIA,ANESTHETIC AGENTS
721148983,5/13/2015 10:54:22,1635692549,5/13/2015 10:54:01,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[TREATS],[TREATS],HYPERTHERMIA,N/A,3,50,1,24,67,TWrex-cause,812483-FS1,"If MALIGNANT HYPERTHERMIA occurs, discontinue all ANESTHETIC AGENTS and initiate IV dantrolene therapy  a   in conjunction with supportive measures (e.g., administering oxygen, treating metabolic acidosis, instituting cooling procedures); maintain urinary output and monitor serum electrolytes.",MALIGNANT HYPERTHERMIA,ANESTHETIC AGENTS
721148983,5/13/2015 11:15:18,1635698026,5/13/2015 11:15:04,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[CAUSES],[CAUSES],discontinue,n/a,3,50,1,24,67,TWrex-cause,812483-FS1,"If MALIGNANT HYPERTHERMIA occurs, discontinue all ANESTHETIC AGENTS and initiate IV dantrolene therapy  a   in conjunction with supportive measures (e.g., administering oxygen, treating metabolic acidosis, instituting cooling procedures); maintain urinary output and monitor serum electrolytes.",MALIGNANT HYPERTHERMIA,ANESTHETIC AGENTS
721148983,5/13/2015 11:21:38,1635699706,5/13/2015 11:19:44,false,neodev,1.0,31706957,NLD,07,Amsterdam,145.100.72.165,[CAUSES],[CAUSES],discontinue all,n/a,3,50,1,24,67,TWrex-cause,812483-FS1,"If MALIGNANT HYPERTHERMIA occurs, discontinue all ANESTHETIC AGENTS and initiate IV dantrolene therapy  a   in conjunction with supportive measures (e.g., administering oxygen, treating metabolic acidosis, instituting cooling procedures); maintain urinary output and monitor serum electrolytes.",MALIGNANT HYPERTHERMIA,ANESTHETIC AGENTS
721148983,5/13/2015 11:33:02,1635702300,5/13/2015 11:32:27,false,prodege,1.0,27934334,GBR,D3,Swadlincote,109.150.228.127,[CAUSES],[CAUSES],discontinue,N/A,3,50,1,24,67,TWrex-cause,812483-FS1,"If MALIGNANT HYPERTHERMIA occurs, discontinue all ANESTHETIC AGENTS and initiate IV dantrolene therapy  a   in conjunction with supportive measures (e.g., administering oxygen, treating metabolic acidosis, instituting cooling procedures); maintain urinary output and monitor serum electrolytes.",MALIGNANT HYPERTHERMIA,ANESTHETIC AGENTS
721148983,5/13/2015 11:41:50,1635705206,5/13/2015 11:40:46,false,points4rewards,1.0,28703583,USA,"","",97.73.86.35,[CONTRAINDICATES],[CONTRAINDICATES],discontinue,N/A,3,50,1,24,67,TWrex-cause,812483-FS1,"If MALIGNANT HYPERTHERMIA occurs, discontinue all ANESTHETIC AGENTS and initiate IV dantrolene therapy  a   in conjunction with supportive measures (e.g., administering oxygen, treating metabolic acidosis, instituting cooling procedures); maintain urinary output and monitor serum electrolytes.",MALIGNANT HYPERTHERMIA,ANESTHETIC AGENTS
721148983,5/13/2015 11:41:54,1635705218,5/13/2015 11:41:20,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[CONTRAINDICATES],[CONTRAINDICATES],"If MALIGNANT HYPERTHERMIA occurs, discontinue ANESTHETIC AGENTS",n/a,3,50,1,24,67,TWrex-cause,812483-FS1,"If MALIGNANT HYPERTHERMIA occurs, discontinue all ANESTHETIC AGENTS and initiate IV dantrolene therapy  a   in conjunction with supportive measures (e.g., administering oxygen, treating metabolic acidosis, instituting cooling procedures); maintain urinary output and monitor serum electrolytes.",MALIGNANT HYPERTHERMIA,ANESTHETIC AGENTS
721148983,5/13/2015 11:46:37,1635706324,5/13/2015 11:46:22,false,neodev,1.0,31726043,GBR,"","",88.150.202.140,[MANIFESTATION],[MANIFESTATION],instituting,5541,3,50,1,24,67,TWrex-cause,812483-FS1,"If MALIGNANT HYPERTHERMIA occurs, discontinue all ANESTHETIC AGENTS and initiate IV dantrolene therapy  a   in conjunction with supportive measures (e.g., administering oxygen, treating metabolic acidosis, instituting cooling procedures); maintain urinary output and monitor serum electrolytes.",MALIGNANT HYPERTHERMIA,ANESTHETIC AGENTS
721148983,5/13/2015 12:21:28,1635718239,5/13/2015 12:21:09,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,[CONTRAINDICATES],[CONTRAINDICATES],discontinue,n/a,3,50,1,24,67,TWrex-cause,812483-FS1,"If MALIGNANT HYPERTHERMIA occurs, discontinue all ANESTHETIC AGENTS and initiate IV dantrolene therapy  a   in conjunction with supportive measures (e.g., administering oxygen, treating metabolic acidosis, instituting cooling procedures); maintain urinary output and monitor serum electrolytes.",MALIGNANT HYPERTHERMIA,ANESTHETIC AGENTS
721148983,5/13/2015 12:25:04,1635719680,5/13/2015 12:24:21,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[CAUSES],[CAUSES],MALIGNANT HYPERTHERMIA ANESTHETIC AGENTS,n/a,3,50,1,24,67,TWrex-cause,812483-FS1,"If MALIGNANT HYPERTHERMIA occurs, discontinue all ANESTHETIC AGENTS and initiate IV dantrolene therapy  a   in conjunction with supportive measures (e.g., administering oxygen, treating metabolic acidosis, instituting cooling procedures); maintain urinary output and monitor serum electrolytes.",MALIGNANT HYPERTHERMIA,ANESTHETIC AGENTS
721148983,5/13/2015 12:35:38,1635722814,5/13/2015 12:33:07,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[MANIFESTATION],[MANIFESTATION],"occurs,",N/A,3,50,1,24,67,TWrex-cause,812483-FS1,"If MALIGNANT HYPERTHERMIA occurs, discontinue all ANESTHETIC AGENTS and initiate IV dantrolene therapy  a   in conjunction with supportive measures (e.g., administering oxygen, treating metabolic acidosis, instituting cooling procedures); maintain urinary output and monitor serum electrolytes.",MALIGNANT HYPERTHERMIA,ANESTHETIC AGENTS
721148983,5/13/2015 12:54:27,1635727234,5/13/2015 12:53:16,false,prodege,1.0,23482077,USA,TX,Garland,71.164.238.226,[CONTRAINDICATES],[CONTRAINDICATES],"If occurs, discontinue",N/A,3,50,1,24,67,TWrex-cause,812483-FS1,"If MALIGNANT HYPERTHERMIA occurs, discontinue all ANESTHETIC AGENTS and initiate IV dantrolene therapy  a   in conjunction with supportive measures (e.g., administering oxygen, treating metabolic acidosis, instituting cooling procedures); maintain urinary output and monitor serum electrolytes.",MALIGNANT HYPERTHERMIA,ANESTHETIC AGENTS
721148983,5/13/2015 13:01:06,1635728819,5/13/2015 13:00:43,false,clixsense,1.0,24329110,USA,FL,Jacksonville,12.168.136.2,[CONTRAINDICATES],[CONTRAINDICATES],discontinue all,n/a,3,50,1,24,67,TWrex-cause,812483-FS1,"If MALIGNANT HYPERTHERMIA occurs, discontinue all ANESTHETIC AGENTS and initiate IV dantrolene therapy  a   in conjunction with supportive measures (e.g., administering oxygen, treating metabolic acidosis, instituting cooling procedures); maintain urinary output and monitor serum electrolytes.",MALIGNANT HYPERTHERMIA,ANESTHETIC AGENTS
721148984,5/13/2015 10:18:54,1635682087,5/13/2015 10:17:36,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[TREATS] [DIAGNOSE_BY_TEST_OR_DRUG] [SYMPTOM],"[TREATS]
[DIAGNOSE_BY_TEST_OR_DRUG]
[SYMPTOM]","Treatment ORAL CANDIDIASIS can be treated with topical anti fungal drugs, such as NYSTATIN miconazole, Gentian violet or amphotericin B. Topical therapy is given as an oral suspension which is washed around the mouth and then swallowed by the patient.",N/A,11,83,-1,26,91,TWrex-cause,800142-FS1,"Treatment  ORAL CANDIDIASIS can be treated with topical anti fungal drugs, such as NYSTATIN miconazole, Gentian violet or amphotericin B. Topical therapy is given as an oral suspension which is washed around the mouth and then swallowed by the patient.",ORAL CANDIDIASIS,NYSTATIN
721148984,5/13/2015 10:36:22,1635687260,5/13/2015 10:35:11,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[TREATS],[TREATS],can be treated with,N/A,11,83,-1,26,91,TWrex-cause,800142-FS1,"Treatment  ORAL CANDIDIASIS can be treated with topical anti fungal drugs, such as NYSTATIN miconazole, Gentian violet or amphotericin B. Topical therapy is given as an oral suspension which is washed around the mouth and then swallowed by the patient.",ORAL CANDIDIASIS,NYSTATIN
721148984,5/13/2015 10:36:58,1635687482,5/13/2015 10:36:33,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[TREATS],[TREATS],can be treated with,n/a,11,83,-1,26,91,TWrex-cause,800142-FS1,"Treatment  ORAL CANDIDIASIS can be treated with topical anti fungal drugs, such as NYSTATIN miconazole, Gentian violet or amphotericin B. Topical therapy is given as an oral suspension which is washed around the mouth and then swallowed by the patient.",ORAL CANDIDIASIS,NYSTATIN
721148984,5/13/2015 10:48:37,1635690733,5/13/2015 10:47:53,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[TREATS],[TREATS],ORAL CANDIDIASIS,N/A,11,83,-1,26,91,TWrex-cause,800142-FS1,"Treatment  ORAL CANDIDIASIS can be treated with topical anti fungal drugs, such as NYSTATIN miconazole, Gentian violet or amphotericin B. Topical therapy is given as an oral suspension which is washed around the mouth and then swallowed by the patient.",ORAL CANDIDIASIS,NYSTATIN
721148984,5/13/2015 11:10:25,1635696957,5/13/2015 11:09:47,false,neodev,1.0,31706957,NLD,07,Amsterdam,145.100.72.165,[TREATS],[TREATS],can be treated with,n/a,11,83,-1,26,91,TWrex-cause,800142-FS1,"Treatment  ORAL CANDIDIASIS can be treated with topical anti fungal drugs, such as NYSTATIN miconazole, Gentian violet or amphotericin B. Topical therapy is given as an oral suspension which is washed around the mouth and then swallowed by the patient.",ORAL CANDIDIASIS,NYSTATIN
721148984,5/13/2015 11:13:10,1635697578,5/13/2015 11:12:57,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[TREATS],[TREATS],treated with,n/a,11,83,-1,26,91,TWrex-cause,800142-FS1,"Treatment  ORAL CANDIDIASIS can be treated with topical anti fungal drugs, such as NYSTATIN miconazole, Gentian violet or amphotericin B. Topical therapy is given as an oral suspension which is washed around the mouth and then swallowed by the patient.",ORAL CANDIDIASIS,NYSTATIN
721148984,5/13/2015 11:27:40,1635701340,5/13/2015 11:27:17,false,prodege,1.0,27934334,GBR,D3,Swadlincote,109.150.228.127,[TREATS],[TREATS],treated,N/A,11,83,-1,26,91,TWrex-cause,800142-FS1,"Treatment  ORAL CANDIDIASIS can be treated with topical anti fungal drugs, such as NYSTATIN miconazole, Gentian violet or amphotericin B. Topical therapy is given as an oral suspension which is washed around the mouth and then swallowed by the patient.",ORAL CANDIDIASIS,NYSTATIN
721148984,5/13/2015 11:33:27,1635702364,5/13/2015 11:32:57,false,points4rewards,1.0,28703583,USA,"","",97.73.86.35,[TREATS],[TREATS],can be treated,N/A,11,83,-1,26,91,TWrex-cause,800142-FS1,"Treatment  ORAL CANDIDIASIS can be treated with topical anti fungal drugs, such as NYSTATIN miconazole, Gentian violet or amphotericin B. Topical therapy is given as an oral suspension which is washed around the mouth and then swallowed by the patient.",ORAL CANDIDIASIS,NYSTATIN
721148984,5/13/2015 11:36:47,1635704002,5/13/2015 11:35:50,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[TREATS],[TREATS],ORAL CANDIDIASIS can be treated with NYSTATIN,n/a,11,83,-1,26,91,TWrex-cause,800142-FS1,"Treatment  ORAL CANDIDIASIS can be treated with topical anti fungal drugs, such as NYSTATIN miconazole, Gentian violet or amphotericin B. Topical therapy is given as an oral suspension which is washed around the mouth and then swallowed by the patient.",ORAL CANDIDIASIS,NYSTATIN
721148984,5/13/2015 11:43:56,1635705554,5/13/2015 11:43:41,false,neodev,1.0,31726043,GBR,"","",88.150.202.140,[LOCATION],[LOCATION],NYSTATIN,55,11,83,-1,26,91,TWrex-cause,800142-FS1,"Treatment  ORAL CANDIDIASIS can be treated with topical anti fungal drugs, such as NYSTATIN miconazole, Gentian violet or amphotericin B. Topical therapy is given as an oral suspension which is washed around the mouth and then swallowed by the patient.",ORAL CANDIDIASIS,NYSTATIN
721148984,5/13/2015 12:17:11,1635716411,5/13/2015 12:16:42,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,[TREATS],[TREATS],treated,n/a,11,83,-1,26,91,TWrex-cause,800142-FS1,"Treatment  ORAL CANDIDIASIS can be treated with topical anti fungal drugs, such as NYSTATIN miconazole, Gentian violet or amphotericin B. Topical therapy is given as an oral suspension which is washed around the mouth and then swallowed by the patient.",ORAL CANDIDIASIS,NYSTATIN
721148984,5/13/2015 12:20:34,1635717913,5/13/2015 12:20:19,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[TREATS],[TREATS],ORAL CANDIDIASIS can be treated with NYSTATIN,n/a,11,83,-1,26,91,TWrex-cause,800142-FS1,"Treatment  ORAL CANDIDIASIS can be treated with topical anti fungal drugs, such as NYSTATIN miconazole, Gentian violet or amphotericin B. Topical therapy is given as an oral suspension which is washed around the mouth and then swallowed by the patient.",ORAL CANDIDIASIS,NYSTATIN
721148984,5/13/2015 12:23:53,1635719132,5/13/2015 12:23:05,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[TREATS],[TREATS],treated,N/A,11,83,-1,26,91,TWrex-cause,800142-FS1,"Treatment  ORAL CANDIDIASIS can be treated with topical anti fungal drugs, such as NYSTATIN miconazole, Gentian violet or amphotericin B. Topical therapy is given as an oral suspension which is washed around the mouth and then swallowed by the patient.",ORAL CANDIDIASIS,NYSTATIN
721148984,5/13/2015 12:45:23,1635724995,5/13/2015 12:44:07,false,prodege,1.0,23482077,USA,TX,Garland,71.164.238.226,[TREATS],[TREATS],can be treated,N/A,11,83,-1,26,91,TWrex-cause,800142-FS1,"Treatment  ORAL CANDIDIASIS can be treated with topical anti fungal drugs, such as NYSTATIN miconazole, Gentian violet or amphotericin B. Topical therapy is given as an oral suspension which is washed around the mouth and then swallowed by the patient.",ORAL CANDIDIASIS,NYSTATIN
721148984,5/13/2015 12:58:28,1635728068,5/13/2015 12:57:45,false,clixsense,1.0,6574449,USA,"","",216.216.68.85,[OTHER],[OTHER],"Treatment ORAL CANDIDIASIS treated topical anti fungal drugs, NYSTATIN Topical therapy given oral suspension washed around mouth swallowed patient.",na,11,83,-1,26,91,TWrex-cause,800142-FS1,"Treatment  ORAL CANDIDIASIS can be treated with topical anti fungal drugs, such as NYSTATIN miconazole, Gentian violet or amphotericin B. Topical therapy is given as an oral suspension which is washed around the mouth and then swallowed by the patient.",ORAL CANDIDIASIS,NYSTATIN
721148985,5/13/2015 13:05:20,1635730529,5/13/2015 13:04:58,false,neodev,1.0,30504276,CAN,ON,Sudbury,66.103.55.12,[TREATS],[TREATS],benefit from,N/A,18,63,-1,30,81,TWrex-cause,804344-FS1,"1]  Do women with PRE ECLAMPSIA and their babies, benefit from MAGNESIUM SULPHATE",PRE ECLAMPSIA,MAGNESIUM SULPHATE
721148985,5/13/2015 13:08:18,1635731278,5/13/2015 13:07:49,false,clixsense,1.0,24329110,USA,FL,Jacksonville,12.168.136.2,[TREATS],[TREATS],benefit from,n/a,18,63,-1,30,81,TWrex-cause,804344-FS1,"1]  Do women with PRE ECLAMPSIA and their babies, benefit from MAGNESIUM SULPHATE",PRE ECLAMPSIA,MAGNESIUM SULPHATE
721148985,5/13/2015 13:14:45,1635732953,5/13/2015 13:14:18,false,clixsense,1.0,23197581,NLD,11,Den Haag,82.217.5.55,[TREATS],[TREATS],benefit from,N/A,18,63,-1,30,81,TWrex-cause,804344-FS1,"1]  Do women with PRE ECLAMPSIA and their babies, benefit from MAGNESIUM SULPHATE",PRE ECLAMPSIA,MAGNESIUM SULPHATE
721148985,5/13/2015 13:15:57,1635733325,5/13/2015 13:15:36,false,prodege,1.0,23482077,USA,TX,Garland,71.164.238.226,[TREATS],[TREATS],benefit from,N/A,18,63,-1,30,81,TWrex-cause,804344-FS1,"1]  Do women with PRE ECLAMPSIA and their babies, benefit from MAGNESIUM SULPHATE",PRE ECLAMPSIA,MAGNESIUM SULPHATE
721148985,5/13/2015 13:36:38,1635738790,5/13/2015 13:35:42,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[TREATS] [LOCATION],"[TREATS]
[LOCATION]",women with PRE ECLAMPSIA benefit from MAGNESIUM SULPHATE,N/A,18,63,-1,30,81,TWrex-cause,804344-FS1,"1]  Do women with PRE ECLAMPSIA and their babies, benefit from MAGNESIUM SULPHATE",PRE ECLAMPSIA,MAGNESIUM SULPHATE
721148985,5/13/2015 13:39:42,1635739545,5/13/2015 13:39:09,false,bitcoinget,1.0,21614812,USA,PA,Erie,174.100.250.115,[OTHER],[OTHER],benefit from,N/A,18,63,-1,30,81,TWrex-cause,804344-FS1,"1]  Do women with PRE ECLAMPSIA and their babies, benefit from MAGNESIUM SULPHATE",PRE ECLAMPSIA,MAGNESIUM SULPHATE
721148985,5/13/2015 13:46:45,1635741970,5/13/2015 13:46:31,false,neodev,1.0,24564999,GBR,H9,London,86.145.227.9,[TREATS],[TREATS],benefit from,N/A,18,63,-1,30,81,TWrex-cause,804344-FS1,"1]  Do women with PRE ECLAMPSIA and their babies, benefit from MAGNESIUM SULPHATE",PRE ECLAMPSIA,MAGNESIUM SULPHATE
721148985,5/13/2015 13:54:58,1635745399,5/13/2015 13:54:31,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[TREATS],[TREATS],benefit from,N/A,18,63,-1,30,81,TWrex-cause,804344-FS1,"1]  Do women with PRE ECLAMPSIA and their babies, benefit from MAGNESIUM SULPHATE",PRE ECLAMPSIA,MAGNESIUM SULPHATE
721148985,5/13/2015 14:16:54,1635754641,5/13/2015 14:16:07,false,prodege,1.0,24403612,CAN,ON,Ajax,99.239.181.149,[OTHER],[OTHER],PRE ECLAMPSIA benefit from MAGNESIUM SULPHATE,N/a,18,63,-1,30,81,TWrex-cause,804344-FS1,"1]  Do women with PRE ECLAMPSIA and their babies, benefit from MAGNESIUM SULPHATE",PRE ECLAMPSIA,MAGNESIUM SULPHATE
721148985,5/13/2015 14:25:37,1635758140,5/13/2015 14:25:19,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[TREATS],[TREATS],benefit from,N/A,18,63,-1,30,81,TWrex-cause,804344-FS1,"1]  Do women with PRE ECLAMPSIA and their babies, benefit from MAGNESIUM SULPHATE",PRE ECLAMPSIA,MAGNESIUM SULPHATE
721148985,5/13/2015 15:10:59,1635790291,5/13/2015 15:10:33,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],benefit,n/a,18,63,-1,30,81,TWrex-cause,804344-FS1,"1]  Do women with PRE ECLAMPSIA and their babies, benefit from MAGNESIUM SULPHATE",PRE ECLAMPSIA,MAGNESIUM SULPHATE
721148985,5/13/2015 15:40:30,1635813767,5/13/2015 15:39:52,false,clixsense,1.0,32549163,CAN,MB,Winnipeg,206.45.167.246,[OTHER],[OTHER],"Do women with PRE ECLAMPSIA and their babies, benefit from MAGNESIUM SULPHATE",N/A,18,63,-1,30,81,TWrex-cause,804344-FS1,"1]  Do women with PRE ECLAMPSIA and their babies, benefit from MAGNESIUM SULPHATE",PRE ECLAMPSIA,MAGNESIUM SULPHATE
721148985,5/13/2015 15:56:02,1635825575,5/13/2015 15:55:45,false,instagc,1.0,24252915,GBR,F2,Gosport,92.24.208.155,[PREVENTS],[PREVENTS],benefit from,N/a,18,63,-1,30,81,TWrex-cause,804344-FS1,"1]  Do women with PRE ECLAMPSIA and their babies, benefit from MAGNESIUM SULPHATE",PRE ECLAMPSIA,MAGNESIUM SULPHATE
721148985,5/13/2015 15:59:12,1635828144,5/13/2015 15:58:50,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[TREATS],[TREATS],benefit,none,18,63,-1,30,81,TWrex-cause,804344-FS1,"1]  Do women with PRE ECLAMPSIA and their babies, benefit from MAGNESIUM SULPHATE",PRE ECLAMPSIA,MAGNESIUM SULPHATE
721148985,5/13/2015 16:24:02,1635844861,5/13/2015 16:23:30,false,prodege,1.0,16101132,GBR,F9,Hayes,2.223.214.149,[OTHER],[OTHER],benefit,Benefit,18,63,-1,30,81,TWrex-cause,804344-FS1,"1]  Do women with PRE ECLAMPSIA and their babies, benefit from MAGNESIUM SULPHATE",PRE ECLAMPSIA,MAGNESIUM SULPHATE
721148986,5/13/2015 13:24:03,1635735473,5/13/2015 13:23:21,false,clixsense,1.0,23197581,NLD,11,Den Haag,82.217.5.55,[SYMPTOM] [MANIFESTATION],"[SYMPTOM]
[MANIFESTATION]",is termed when it is accompanied by,N/A,68,24,1,74,41,TWrex-cause,813212-FS1,This disorder is termed KALLMANN SYNDROME when it is accompanied by ANOSMIA and has also been termed idiopathic hypogonadotropic hypogonadism (IHH.,ANOSMIA,KALLMANN SYNDROME
721148986,5/13/2015 14:00:18,1635747582,5/13/2015 14:00:00,false,neodev,1.0,24564999,GBR,H9,London,86.145.227.9,[ASSOCIATED_WITH],[ASSOCIATED_WITH],accompanied,N/A,68,24,1,74,41,TWrex-cause,813212-FS1,This disorder is termed KALLMANN SYNDROME when it is accompanied by ANOSMIA and has also been termed idiopathic hypogonadotropic hypogonadism (IHH.,ANOSMIA,KALLMANN SYNDROME
721148986,5/13/2015 14:05:04,1635749799,5/13/2015 14:04:34,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[ASSOCIATED_WITH],[ASSOCIATED_WITH],when accompanied by,N/A,68,24,1,74,41,TWrex-cause,813212-FS1,This disorder is termed KALLMANN SYNDROME when it is accompanied by ANOSMIA and has also been termed idiopathic hypogonadotropic hypogonadism (IHH.,ANOSMIA,KALLMANN SYNDROME
721148986,5/13/2015 14:29:17,1635760179,5/13/2015 14:28:51,false,prodege,1.0,24403612,CAN,ON,Ajax,99.239.181.149,[SYMPTOM],[SYMPTOM],KALLMANN SYNDROME when accompanied by ANOSMIA,N/a,68,24,1,74,41,TWrex-cause,813212-FS1,This disorder is termed KALLMANN SYNDROME when it is accompanied by ANOSMIA and has also been termed idiopathic hypogonadotropic hypogonadism (IHH.,ANOSMIA,KALLMANN SYNDROME
721148986,5/13/2015 14:39:21,1635765977,5/13/2015 14:38:57,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[IS_A],[IS_A],when it is accompanied by,N/A,68,24,1,74,41,TWrex-cause,813212-FS1,This disorder is termed KALLMANN SYNDROME when it is accompanied by ANOSMIA and has also been termed idiopathic hypogonadotropic hypogonadism (IHH.,ANOSMIA,KALLMANN SYNDROME
721148986,5/13/2015 15:23:15,1635800280,5/13/2015 15:22:39,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,[TREATS],[TREATS],termed,n/a,68,24,1,74,41,TWrex-cause,813212-FS1,This disorder is termed KALLMANN SYNDROME when it is accompanied by ANOSMIA and has also been termed idiopathic hypogonadotropic hypogonadism (IHH.,ANOSMIA,KALLMANN SYNDROME
721148986,5/13/2015 16:16:11,1635840023,5/13/2015 16:14:45,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[MANIFESTATION],[MANIFESTATION],accompanied,none,68,24,1,74,41,TWrex-cause,813212-FS1,This disorder is termed KALLMANN SYNDROME when it is accompanied by ANOSMIA and has also been termed idiopathic hypogonadotropic hypogonadism (IHH.,ANOSMIA,KALLMANN SYNDROME
721148986,5/13/2015 16:35:59,1635852900,5/13/2015 16:35:27,false,prodege,1.0,16101132,GBR,F9,Hayes,2.223.214.149,[SIDE_EFFECT],[SIDE_EFFECT],accompanied,Associated with,68,24,1,74,41,TWrex-cause,813212-FS1,This disorder is termed KALLMANN SYNDROME when it is accompanied by ANOSMIA and has also been termed idiopathic hypogonadotropic hypogonadism (IHH.,ANOSMIA,KALLMANN SYNDROME
721148986,5/13/2015 16:38:35,1635854505,5/13/2015 16:37:52,false,clixsense,1.0,31579138,AUS,02,Hurstville,14.200.129.68,[ASSOCIATED_WITH],[ASSOCIATED_WITH],accompanied,N/A,68,24,1,74,41,TWrex-cause,813212-FS1,This disorder is termed KALLMANN SYNDROME when it is accompanied by ANOSMIA and has also been termed idiopathic hypogonadotropic hypogonadism (IHH.,ANOSMIA,KALLMANN SYNDROME
721148986,5/13/2015 17:18:48,1635876569,5/13/2015 17:17:58,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[ASSOCIATED_WITH],[ASSOCIATED_WITH],accompanied by,n/a,68,24,1,74,41,TWrex-cause,813212-FS1,This disorder is termed KALLMANN SYNDROME when it is accompanied by ANOSMIA and has also been termed idiopathic hypogonadotropic hypogonadism (IHH.,ANOSMIA,KALLMANN SYNDROME
721148986,5/13/2015 17:21:10,1635877987,5/13/2015 17:20:48,false,gptking,1.0,31799065,USA,IL,Marion,50.45.43.154,[ASSOCIATED_WITH],[ASSOCIATED_WITH],KALLMANN SYNDROME ANOSMIA,N/A,68,24,1,74,41,TWrex-cause,813212-FS1,This disorder is termed KALLMANN SYNDROME when it is accompanied by ANOSMIA and has also been termed idiopathic hypogonadotropic hypogonadism (IHH.,ANOSMIA,KALLMANN SYNDROME
721148986,5/13/2015 17:54:59,1635898095,5/13/2015 17:54:19,false,prodege,1.0,14848125,GBR,L6,Shrewsbury,86.138.223.142,[ASSOCIATED_WITH],[ASSOCIATED_WITH],accompanied by,N/A,68,24,1,74,41,TWrex-cause,813212-FS1,This disorder is termed KALLMANN SYNDROME when it is accompanied by ANOSMIA and has also been termed idiopathic hypogonadotropic hypogonadism (IHH.,ANOSMIA,KALLMANN SYNDROME
721148986,5/13/2015 18:05:40,1635901710,5/13/2015 18:04:37,false,clixsense,1.0,6574449,USA,"","",216.216.68.85,[OTHER],[OTHER],disorder KALLMANN SYNDROME accompanied ANOSMIA termed idiopathic hypogonadotropic hypogonadism,na,68,24,1,74,41,TWrex-cause,813212-FS1,This disorder is termed KALLMANN SYNDROME when it is accompanied by ANOSMIA and has also been termed idiopathic hypogonadotropic hypogonadism (IHH.,ANOSMIA,KALLMANN SYNDROME
721148986,5/13/2015 18:08:11,1635902645,5/13/2015 18:07:42,false,clixsense,1.0,32549163,CAN,MB,Winnipeg,206.45.167.246,[SYMPTOM],[SYMPTOM],termed KALLMANN SYNDROME when it is accompanied by ANOSMIA,N/A,68,24,1,74,41,TWrex-cause,813212-FS1,This disorder is termed KALLMANN SYNDROME when it is accompanied by ANOSMIA and has also been termed idiopathic hypogonadotropic hypogonadism (IHH.,ANOSMIA,KALLMANN SYNDROME
721148986,5/13/2015 18:11:47,1635904221,5/13/2015 18:11:27,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[PART_OF],[PART_OF],accompanied by,N/A,68,24,1,74,41,TWrex-cause,813212-FS1,This disorder is termed KALLMANN SYNDROME when it is accompanied by ANOSMIA and has also been termed idiopathic hypogonadotropic hypogonadism (IHH.,ANOSMIA,KALLMANN SYNDROME
721148987,5/13/2015 11:51:05,1635707339,5/13/2015 11:50:46,false,neodev,1.0,31726043,GBR,"","",88.150.202.140,[CAUSES],[CAUSES],reduces,55,113,73,-1,136,91,TWrex-cause,800421-FS1,"2]  Yoshida H, Shiratori Y, Moriyama M, Arakawa Y, Ide T, Sata M, et al. INTERFERON THERAPY reduces the risk for HEPATOCELLULAR CARCINOMA: national surveillance program of cirrhotic and noncirrhotic patients with chronic hepatitis C in Japan.",HEPATOCELLULAR CARCINOMA,INTERFERON THERAPY
721148987,5/13/2015 12:31:25,1635721496,5/13/2015 12:31:08,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[PREVENTS],[PREVENTS],INTERFERON THERAPY reduces the risk HEPATOCELLULAR CARCINOMA:,n/a,113,73,-1,136,91,TWrex-cause,800421-FS1,"2]  Yoshida H, Shiratori Y, Moriyama M, Arakawa Y, Ide T, Sata M, et al. INTERFERON THERAPY reduces the risk for HEPATOCELLULAR CARCINOMA: national surveillance program of cirrhotic and noncirrhotic patients with chronic hepatitis C in Japan.",HEPATOCELLULAR CARCINOMA,INTERFERON THERAPY
721148987,5/13/2015 13:03:55,1635729964,5/13/2015 13:03:42,false,neodev,1.0,30504276,CAN,ON,Sudbury,66.103.55.12,[PREVENTS],[PREVENTS],reduces the risk,N/A,113,73,-1,136,91,TWrex-cause,800421-FS1,"2]  Yoshida H, Shiratori Y, Moriyama M, Arakawa Y, Ide T, Sata M, et al. INTERFERON THERAPY reduces the risk for HEPATOCELLULAR CARCINOMA: national surveillance program of cirrhotic and noncirrhotic patients with chronic hepatitis C in Japan.",HEPATOCELLULAR CARCINOMA,INTERFERON THERAPY
721148987,5/13/2015 13:06:14,1635730788,5/13/2015 13:05:42,false,clixsense,1.0,24329110,USA,FL,Jacksonville,12.168.136.2,[TREATS],[TREATS],reduces the risk for,n/a,113,73,-1,136,91,TWrex-cause,800421-FS1,"2]  Yoshida H, Shiratori Y, Moriyama M, Arakawa Y, Ide T, Sata M, et al. INTERFERON THERAPY reduces the risk for HEPATOCELLULAR CARCINOMA: national surveillance program of cirrhotic and noncirrhotic patients with chronic hepatitis C in Japan.",HEPATOCELLULAR CARCINOMA,INTERFERON THERAPY
721148987,5/13/2015 13:11:27,1635731975,5/13/2015 13:10:41,false,prodege,1.0,23482077,USA,TX,Garland,71.164.238.226,[PREVENTS],[PREVENTS],reduces the risk for,N/A,113,73,-1,136,91,TWrex-cause,800421-FS1,"2]  Yoshida H, Shiratori Y, Moriyama M, Arakawa Y, Ide T, Sata M, et al. INTERFERON THERAPY reduces the risk for HEPATOCELLULAR CARCINOMA: national surveillance program of cirrhotic and noncirrhotic patients with chronic hepatitis C in Japan.",HEPATOCELLULAR CARCINOMA,INTERFERON THERAPY
721148987,5/13/2015 13:12:17,1635732231,5/13/2015 13:11:50,false,clixsense,1.0,23197581,NLD,11,Den Haag,82.217.5.55,[PREVENTS],[PREVENTS],reduces the risk,N/A,113,73,-1,136,91,TWrex-cause,800421-FS1,"2]  Yoshida H, Shiratori Y, Moriyama M, Arakawa Y, Ide T, Sata M, et al. INTERFERON THERAPY reduces the risk for HEPATOCELLULAR CARCINOMA: national surveillance program of cirrhotic and noncirrhotic patients with chronic hepatitis C in Japan.",HEPATOCELLULAR CARCINOMA,INTERFERON THERAPY
721148987,5/13/2015 13:30:19,1635737096,5/13/2015 13:29:15,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[PREVENTS],[PREVENTS],INTERFERON THERAPY reduces the risk for HEPATOCELLULAR CARCINOMA:,N/A,113,73,-1,136,91,TWrex-cause,800421-FS1,"2]  Yoshida H, Shiratori Y, Moriyama M, Arakawa Y, Ide T, Sata M, et al. INTERFERON THERAPY reduces the risk for HEPATOCELLULAR CARCINOMA: national surveillance program of cirrhotic and noncirrhotic patients with chronic hepatitis C in Japan.",HEPATOCELLULAR CARCINOMA,INTERFERON THERAPY
721148987,5/13/2015 13:38:02,1635739138,5/13/2015 13:37:29,false,bitcoinget,1.0,21614812,USA,PA,Erie,174.100.250.115,[TREATS],[TREATS],reduces the risk for,N/A,113,73,-1,136,91,TWrex-cause,800421-FS1,"2]  Yoshida H, Shiratori Y, Moriyama M, Arakawa Y, Ide T, Sata M, et al. INTERFERON THERAPY reduces the risk for HEPATOCELLULAR CARCINOMA: national surveillance program of cirrhotic and noncirrhotic patients with chronic hepatitis C in Japan.",HEPATOCELLULAR CARCINOMA,INTERFERON THERAPY
721148987,5/13/2015 13:42:54,1635740532,5/13/2015 13:42:35,false,neodev,1.0,24564999,GBR,H9,London,86.145.227.9,[PREVENTS],[PREVENTS],reduces the risk for,N/A,113,73,-1,136,91,TWrex-cause,800421-FS1,"2]  Yoshida H, Shiratori Y, Moriyama M, Arakawa Y, Ide T, Sata M, et al. INTERFERON THERAPY reduces the risk for HEPATOCELLULAR CARCINOMA: national surveillance program of cirrhotic and noncirrhotic patients with chronic hepatitis C in Japan.",HEPATOCELLULAR CARCINOMA,INTERFERON THERAPY
721148987,5/13/2015 13:52:05,1635744225,5/13/2015 13:51:43,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[PREVENTS],[PREVENTS],reduces risk,N/A,113,73,-1,136,91,TWrex-cause,800421-FS1,"2]  Yoshida H, Shiratori Y, Moriyama M, Arakawa Y, Ide T, Sata M, et al. INTERFERON THERAPY reduces the risk for HEPATOCELLULAR CARCINOMA: national surveillance program of cirrhotic and noncirrhotic patients with chronic hepatitis C in Japan.",HEPATOCELLULAR CARCINOMA,INTERFERON THERAPY
721148987,5/13/2015 14:12:39,1635753046,5/13/2015 14:11:46,false,prodege,1.0,24403612,CAN,ON,Ajax,99.239.181.149,[PREVENTS],[PREVENTS],INTERFERON THERAPY reduces risk for HEPATOCELLULAR CARCINOMA:,N/a,113,73,-1,136,91,TWrex-cause,800421-FS1,"2]  Yoshida H, Shiratori Y, Moriyama M, Arakawa Y, Ide T, Sata M, et al. INTERFERON THERAPY reduces the risk for HEPATOCELLULAR CARCINOMA: national surveillance program of cirrhotic and noncirrhotic patients with chronic hepatitis C in Japan.",HEPATOCELLULAR CARCINOMA,INTERFERON THERAPY
721148987,5/13/2015 14:23:26,1635757162,5/13/2015 14:23:08,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[PREVENTS] [TREATS],"[TREATS]
[PREVENTS]",reduces the risk,N/A,113,73,-1,136,91,TWrex-cause,800421-FS1,"2]  Yoshida H, Shiratori Y, Moriyama M, Arakawa Y, Ide T, Sata M, et al. INTERFERON THERAPY reduces the risk for HEPATOCELLULAR CARCINOMA: national surveillance program of cirrhotic and noncirrhotic patients with chronic hepatitis C in Japan.",HEPATOCELLULAR CARCINOMA,INTERFERON THERAPY
721148987,5/13/2015 15:08:34,1635787828,5/13/2015 15:07:51,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,[PREVENTS],[PREVENTS],THERAPY,n/a,113,73,-1,136,91,TWrex-cause,800421-FS1,"2]  Yoshida H, Shiratori Y, Moriyama M, Arakawa Y, Ide T, Sata M, et al. INTERFERON THERAPY reduces the risk for HEPATOCELLULAR CARCINOMA: national surveillance program of cirrhotic and noncirrhotic patients with chronic hepatitis C in Japan.",HEPATOCELLULAR CARCINOMA,INTERFERON THERAPY
721148987,5/13/2015 15:38:29,1635812126,5/13/2015 15:38:08,false,clixsense,1.0,32549163,CAN,MB,Winnipeg,206.45.167.246,[PREVENTS],[PREVENTS],INTERFERON THERAPY reduces the risk for HEPATOCELLULAR CARCINOMA:,N/A,113,73,-1,136,91,TWrex-cause,800421-FS1,"2]  Yoshida H, Shiratori Y, Moriyama M, Arakawa Y, Ide T, Sata M, et al. INTERFERON THERAPY reduces the risk for HEPATOCELLULAR CARCINOMA: national surveillance program of cirrhotic and noncirrhotic patients with chronic hepatitis C in Japan.",HEPATOCELLULAR CARCINOMA,INTERFERON THERAPY
721148987,5/13/2015 15:53:49,1635823697,5/13/2015 15:53:21,false,instagc,1.0,24252915,GBR,F2,Gosport,92.24.208.155,[PREVENTS],[PREVENTS],INTERFERON THERAPY reduces the risk for HEPATOCELLULAR CARCINOMA:,N/a,113,73,-1,136,91,TWrex-cause,800421-FS1,"2]  Yoshida H, Shiratori Y, Moriyama M, Arakawa Y, Ide T, Sata M, et al. INTERFERON THERAPY reduces the risk for HEPATOCELLULAR CARCINOMA: national surveillance program of cirrhotic and noncirrhotic patients with chronic hepatitis C in Japan.",HEPATOCELLULAR CARCINOMA,INTERFERON THERAPY
721148988,5/13/2015 16:23:46,1635844685,5/13/2015 16:23:22,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[PREVENTS],[PREVENTS],prevents,none,3,3,-1,12,33,TWrex-cause,804469-FS1,3  DIPHTHERIA TOXOID IMMUNIZATION prevents the serious complications of DIPHTHERIA alleviating the clinical manifestations of the disease by blocking the toxin's ability to enter cells.,DIPHTHERIA,DIPHTHERIA TOXOID IMMUNIZATION
721148988,5/13/2015 16:41:24,1635856212,5/13/2015 16:40:34,false,prodege,1.0,16101132,GBR,F9,Hayes,2.223.214.149,[PREVENTS],[PREVENTS],prevents,Prevented with,3,3,-1,12,33,TWrex-cause,804469-FS1,3  DIPHTHERIA TOXOID IMMUNIZATION prevents the serious complications of DIPHTHERIA alleviating the clinical manifestations of the disease by blocking the toxin's ability to enter cells.,DIPHTHERIA,DIPHTHERIA TOXOID IMMUNIZATION
721148988,5/13/2015 16:44:46,1635858239,5/13/2015 16:44:11,false,clixsense,1.0,31579138,AUS,02,Hurstville,14.200.129.68,[TREATS],[TREATS],prevents complications,N/A,3,3,-1,12,33,TWrex-cause,804469-FS1,3  DIPHTHERIA TOXOID IMMUNIZATION prevents the serious complications of DIPHTHERIA alleviating the clinical manifestations of the disease by blocking the toxin's ability to enter cells.,DIPHTHERIA,DIPHTHERIA TOXOID IMMUNIZATION
721148988,5/13/2015 17:25:56,1635880744,5/13/2015 17:25:21,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[PREVENTS],[PREVENTS],prevents,n/a,3,3,-1,12,33,TWrex-cause,804469-FS1,3  DIPHTHERIA TOXOID IMMUNIZATION prevents the serious complications of DIPHTHERIA alleviating the clinical manifestations of the disease by blocking the toxin's ability to enter cells.,DIPHTHERIA,DIPHTHERIA TOXOID IMMUNIZATION
721148988,5/13/2015 17:36:33,1635886543,5/13/2015 17:35:10,false,gptking,1.0,31799065,USA,IL,Marion,50.45.43.154,[PREVENTS],[PREVENTS],3 DIPHTHERIA TOXOID IMMUNIZATION prevents DIPHTHERIA,N/A,3,3,-1,12,33,TWrex-cause,804469-FS1,3  DIPHTHERIA TOXOID IMMUNIZATION prevents the serious complications of DIPHTHERIA alleviating the clinical manifestations of the disease by blocking the toxin's ability to enter cells.,DIPHTHERIA,DIPHTHERIA TOXOID IMMUNIZATION
721148988,5/13/2015 18:11:42,1635904194,5/13/2015 18:11:25,false,clixsense,1.0,32549163,CAN,MB,Winnipeg,206.45.167.246,[PREVENTS],[PREVENTS],DIPHTHERIA TOXOID IMMUNIZATION prevents the serious complications of DIPHTHERIA,N/A,3,3,-1,12,33,TWrex-cause,804469-FS1,3  DIPHTHERIA TOXOID IMMUNIZATION prevents the serious complications of DIPHTHERIA alleviating the clinical manifestations of the disease by blocking the toxin's ability to enter cells.,DIPHTHERIA,DIPHTHERIA TOXOID IMMUNIZATION
721148988,5/13/2015 18:14:52,1635905527,5/13/2015 18:14:32,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[PREVENTS],[PREVENTS],prevents the serious complications,N/A,3,3,-1,12,33,TWrex-cause,804469-FS1,3  DIPHTHERIA TOXOID IMMUNIZATION prevents the serious complications of DIPHTHERIA alleviating the clinical manifestations of the disease by blocking the toxin's ability to enter cells.,DIPHTHERIA,DIPHTHERIA TOXOID IMMUNIZATION
721148988,5/13/2015 18:19:07,1635907079,5/13/2015 18:18:28,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[PREVENTS],[PREVENTS],prevents,N/A,3,3,-1,12,33,TWrex-cause,804469-FS1,3  DIPHTHERIA TOXOID IMMUNIZATION prevents the serious complications of DIPHTHERIA alleviating the clinical manifestations of the disease by blocking the toxin's ability to enter cells.,DIPHTHERIA,DIPHTHERIA TOXOID IMMUNIZATION
721148988,5/13/2015 18:19:12,1635907123,5/13/2015 18:18:39,false,instagc,1.0,24252915,GBR,"","",80.44.146.98,[PREVENTS],[PREVENTS],prevents the serious complications of DIPHTHERIA,N/a,3,3,-1,12,33,TWrex-cause,804469-FS1,3  DIPHTHERIA TOXOID IMMUNIZATION prevents the serious complications of DIPHTHERIA alleviating the clinical manifestations of the disease by blocking the toxin's ability to enter cells.,DIPHTHERIA,DIPHTHERIA TOXOID IMMUNIZATION
721148988,5/13/2015 18:44:22,1635920528,5/13/2015 18:43:35,false,prodege,1.0,32302664,USA,IL,Geneseo,173.27.241.235,[ASSOCIATED_WITH],[ASSOCIATED_WITH],prevents the serious complications of,no comment,3,3,-1,12,33,TWrex-cause,804469-FS1,3  DIPHTHERIA TOXOID IMMUNIZATION prevents the serious complications of DIPHTHERIA alleviating the clinical manifestations of the disease by blocking the toxin's ability to enter cells.,DIPHTHERIA,DIPHTHERIA TOXOID IMMUNIZATION
721148988,5/13/2015 19:08:05,1635930090,5/13/2015 19:07:41,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[PREVENTS],[PREVENTS],prevents,N/A,3,3,-1,12,33,TWrex-cause,804469-FS1,3  DIPHTHERIA TOXOID IMMUNIZATION prevents the serious complications of DIPHTHERIA alleviating the clinical manifestations of the disease by blocking the toxin's ability to enter cells.,DIPHTHERIA,DIPHTHERIA TOXOID IMMUNIZATION
721148988,5/13/2015 19:08:54,1635930387,5/13/2015 19:08:40,false,clixsense,1.0,19162475,GBR,P8,Trowbridge,82.33.126.30,[SIDE_EFFECT],[SIDE_EFFECT],serious complications,n/a,3,3,-1,12,33,TWrex-cause,804469-FS1,3  DIPHTHERIA TOXOID IMMUNIZATION prevents the serious complications of DIPHTHERIA alleviating the clinical manifestations of the disease by blocking the toxin's ability to enter cells.,DIPHTHERIA,DIPHTHERIA TOXOID IMMUNIZATION
721148988,5/13/2015 19:43:12,1635961856,5/13/2015 19:42:53,false,elite,1.0,30064988,GBR,H3,Leeds,92.22.208.245,[PREVENTS],[PREVENTS],prevents,N/A,3,3,-1,12,33,TWrex-cause,804469-FS1,3  DIPHTHERIA TOXOID IMMUNIZATION prevents the serious complications of DIPHTHERIA alleviating the clinical manifestations of the disease by blocking the toxin's ability to enter cells.,DIPHTHERIA,DIPHTHERIA TOXOID IMMUNIZATION
721148988,5/13/2015 20:02:49,1635976904,5/13/2015 20:02:27,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.156.243,[PREVENTS],[PREVENTS],DIPHTHERIA TOXOID IMMUNIZATION prevents DIPHTHERIA,N/A,3,3,-1,12,33,TWrex-cause,804469-FS1,3  DIPHTHERIA TOXOID IMMUNIZATION prevents the serious complications of DIPHTHERIA alleviating the clinical manifestations of the disease by blocking the toxin's ability to enter cells.,DIPHTHERIA,DIPHTHERIA TOXOID IMMUNIZATION
721148988,5/13/2015 20:03:29,1635977544,5/13/2015 20:02:59,false,clixsense,1.0,27969116,NLD,"","",212.78.195.38,[PREVENTS],[PREVENTS],prevents,prevents the complications of,3,3,-1,12,33,TWrex-cause,804469-FS1,3  DIPHTHERIA TOXOID IMMUNIZATION prevents the serious complications of DIPHTHERIA alleviating the clinical manifestations of the disease by blocking the toxin's ability to enter cells.,DIPHTHERIA,DIPHTHERIA TOXOID IMMUNIZATION
721148989,5/13/2015 16:18:55,1635841476,5/13/2015 16:17:43,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[MANIFESTATION],[MANIFESTATION],indicators,none,22,132,1,33,149,TWrex-cause,813732-FS1,"• Clinical spells and HYPERTENSION from circulating catecholamines are insufficiently sensitive to be used as primary indicators of PHEOCHROMOCYTOMAS but, when present, may herald life threatening crises.",HYPERTENSION,PHEOCHROMOCYTOMAS
721148989,5/13/2015 16:38:08,1635854309,5/13/2015 16:37:41,false,prodege,1.0,16101132,GBR,F9,Hayes,2.223.214.149,[SYMPTOM],[SYMPTOM],indicators,Symptom,22,132,1,33,149,TWrex-cause,813732-FS1,"• Clinical spells and HYPERTENSION from circulating catecholamines are insufficiently sensitive to be used as primary indicators of PHEOCHROMOCYTOMAS but, when present, may herald life threatening crises.",HYPERTENSION,PHEOCHROMOCYTOMAS
721148989,5/13/2015 16:40:35,1635855742,5/13/2015 16:40:10,false,clixsense,1.0,31579138,AUS,02,Hurstville,14.200.129.68,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],indicators,N/A,22,132,1,33,149,TWrex-cause,813732-FS1,"• Clinical spells and HYPERTENSION from circulating catecholamines are insufficiently sensitive to be used as primary indicators of PHEOCHROMOCYTOMAS but, when present, may herald life threatening crises.",HYPERTENSION,PHEOCHROMOCYTOMAS
721148989,5/13/2015 17:21:59,1635878476,5/13/2015 17:21:25,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[MANIFESTATION],[MANIFESTATION],primary indicators,n/a,22,132,1,33,149,TWrex-cause,813732-FS1,"• Clinical spells and HYPERTENSION from circulating catecholamines are insufficiently sensitive to be used as primary indicators of PHEOCHROMOCYTOMAS but, when present, may herald life threatening crises.",HYPERTENSION,PHEOCHROMOCYTOMAS
721148989,5/13/2015 17:30:09,1635883027,5/13/2015 17:29:43,false,gptking,1.0,31799065,USA,IL,Marion,50.45.43.154,[SYMPTOM],[SYMPTOM],HYPERTENSION PHEOCHROMOCYTOMAS,N/A,22,132,1,33,149,TWrex-cause,813732-FS1,"• Clinical spells and HYPERTENSION from circulating catecholamines are insufficiently sensitive to be used as primary indicators of PHEOCHROMOCYTOMAS but, when present, may herald life threatening crises.",HYPERTENSION,PHEOCHROMOCYTOMAS
721148989,5/13/2015 17:57:04,1635898864,5/13/2015 17:56:26,false,prodege,1.0,14848125,GBR,L6,Shrewsbury,86.138.223.142,[MANIFESTATION],[MANIFESTATION],"when present,",N/A,22,132,1,33,149,TWrex-cause,813732-FS1,"• Clinical spells and HYPERTENSION from circulating catecholamines are insufficiently sensitive to be used as primary indicators of PHEOCHROMOCYTOMAS but, when present, may herald life threatening crises.",HYPERTENSION,PHEOCHROMOCYTOMAS
721148989,5/13/2015 18:09:54,1635903448,5/13/2015 18:09:39,false,clixsense,1.0,32549163,CAN,MB,Winnipeg,206.45.167.246,[SYMPTOM],[SYMPTOM],HYPERTENSION used as primary indicators of PHEOCHROMOCYTOMAS,N/A,22,132,1,33,149,TWrex-cause,813732-FS1,"• Clinical spells and HYPERTENSION from circulating catecholamines are insufficiently sensitive to be used as primary indicators of PHEOCHROMOCYTOMAS but, when present, may herald life threatening crises.",HYPERTENSION,PHEOCHROMOCYTOMAS
721148989,5/13/2015 18:11:26,1635904065,5/13/2015 18:10:56,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[SYMPTOM],[SYMPTOM],primary indicators,N/A,22,132,1,33,149,TWrex-cause,813732-FS1,"• Clinical spells and HYPERTENSION from circulating catecholamines are insufficiently sensitive to be used as primary indicators of PHEOCHROMOCYTOMAS but, when present, may herald life threatening crises.",HYPERTENSION,PHEOCHROMOCYTOMAS
721148989,5/13/2015 18:13:57,1635905163,5/13/2015 18:13:11,false,instagc,1.0,24252915,GBR,"","",80.44.146.98,[ASSOCIATED_WITH],[ASSOCIATED_WITH],as of,N/a,22,132,1,33,149,TWrex-cause,813732-FS1,"• Clinical spells and HYPERTENSION from circulating catecholamines are insufficiently sensitive to be used as primary indicators of PHEOCHROMOCYTOMAS but, when present, may herald life threatening crises.",HYPERTENSION,PHEOCHROMOCYTOMAS
721148989,5/13/2015 18:13:57,1635905169,5/13/2015 18:12:21,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[ASSOCIATED_WITH],[ASSOCIATED_WITH],insufficiently sensitive to be used as primary indicators,N/A,22,132,1,33,149,TWrex-cause,813732-FS1,"• Clinical spells and HYPERTENSION from circulating catecholamines are insufficiently sensitive to be used as primary indicators of PHEOCHROMOCYTOMAS but, when present, may herald life threatening crises.",HYPERTENSION,PHEOCHROMOCYTOMAS
721148989,5/13/2015 18:19:56,1635907393,5/13/2015 18:17:55,false,neodev,1.0,31861180,GBR,M9,Stafford,82.16.53.211,[ASSOCIATED_WITH],[ASSOCIATED_WITH],indicators of,N/A,22,132,1,33,149,TWrex-cause,813732-FS1,"• Clinical spells and HYPERTENSION from circulating catecholamines are insufficiently sensitive to be used as primary indicators of PHEOCHROMOCYTOMAS but, when present, may herald life threatening crises.",HYPERTENSION,PHEOCHROMOCYTOMAS
721148989,5/13/2015 18:40:42,1635918744,5/13/2015 18:39:35,false,prodege,1.0,32302664,USA,IL,Geneseo,173.27.241.235,[SYMPTOM],[SYMPTOM],from circulating catecholamines are insufficiently sensitive to be used as primary indicators of,no comment,22,132,1,33,149,TWrex-cause,813732-FS1,"• Clinical spells and HYPERTENSION from circulating catecholamines are insufficiently sensitive to be used as primary indicators of PHEOCHROMOCYTOMAS but, when present, may herald life threatening crises.",HYPERTENSION,PHEOCHROMOCYTOMAS
721148989,5/13/2015 18:58:18,1635926156,5/13/2015 18:57:14,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[SYMPTOM],[SYMPTOM],"primary indicators present,",N/A,22,132,1,33,149,TWrex-cause,813732-FS1,"• Clinical spells and HYPERTENSION from circulating catecholamines are insufficiently sensitive to be used as primary indicators of PHEOCHROMOCYTOMAS but, when present, may herald life threatening crises.",HYPERTENSION,PHEOCHROMOCYTOMAS
721148989,5/13/2015 19:02:18,1635927833,5/13/2015 19:02:03,false,clixsense,1.0,19162475,GBR,P8,Trowbridge,82.33.126.30,[CAUSES],[CAUSES],as primary indicators,n/a,22,132,1,33,149,TWrex-cause,813732-FS1,"• Clinical spells and HYPERTENSION from circulating catecholamines are insufficiently sensitive to be used as primary indicators of PHEOCHROMOCYTOMAS but, when present, may herald life threatening crises.",HYPERTENSION,PHEOCHROMOCYTOMAS
721148989,5/13/2015 19:40:07,1635959640,5/13/2015 19:39:14,false,elite,1.0,30064988,GBR,H3,Leeds,92.22.208.245,[SYMPTOM],[SYMPTOM],primary indicators,N/A,22,132,1,33,149,TWrex-cause,813732-FS1,"• Clinical spells and HYPERTENSION from circulating catecholamines are insufficiently sensitive to be used as primary indicators of PHEOCHROMOCYTOMAS but, when present, may herald life threatening crises.",HYPERTENSION,PHEOCHROMOCYTOMAS
721148990,5/13/2015 10:21:47,1635683218,5/13/2015 10:20:22,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[ASSOCIATED_WITH],[ASSOCIATED_WITH],"Loffler's syndrome (a subcategory of HYPEREOSINOPHILIC SYNDROME with primary cardiac involvement), which occurs in the tropics, begins as an ACUTE ARTERITIS WITH EOSINOPHILIA followed by thrombus formation on the endocardium, chordae, and atrioventricular (AV) valves, progressing to fibrosis.",N/A,141,37,1,173,63,TWrex-cause,812643-FS1,"Loffler's syndrome (a subcategory of HYPEREOSINOPHILIC SYNDROME with primary cardiac involvement), which occurs in the tropics, begins as an ACUTE ARTERITIS WITH EOSINOPHILIA followed by thrombus formation on the endocardium, chordae, and atrioventricular (AV) valves, progressing to fibrosis.",ACUTE ARTERITIS WITH EOSINOPHILIA,HYPEREOSINOPHILIC SYNDROME
721148990,5/13/2015 10:38:58,1635688079,5/13/2015 10:37:58,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[ASSOCIATED_WITH],[ASSOCIATED_WITH],begins as,n/a,141,37,1,173,63,TWrex-cause,812643-FS1,"Loffler's syndrome (a subcategory of HYPEREOSINOPHILIC SYNDROME with primary cardiac involvement), which occurs in the tropics, begins as an ACUTE ARTERITIS WITH EOSINOPHILIA followed by thrombus formation on the endocardium, chordae, and atrioventricular (AV) valves, progressing to fibrosis.",ACUTE ARTERITIS WITH EOSINOPHILIA,HYPEREOSINOPHILIC SYNDROME
721148990,5/13/2015 10:40:15,1635688332,5/13/2015 10:38:31,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[MANIFESTATION],[MANIFESTATION],begins as,N/A,141,37,1,173,63,TWrex-cause,812643-FS1,"Loffler's syndrome (a subcategory of HYPEREOSINOPHILIC SYNDROME with primary cardiac involvement), which occurs in the tropics, begins as an ACUTE ARTERITIS WITH EOSINOPHILIA followed by thrombus formation on the endocardium, chordae, and atrioventricular (AV) valves, progressing to fibrosis.",ACUTE ARTERITIS WITH EOSINOPHILIA,HYPEREOSINOPHILIC SYNDROME
721148990,5/13/2015 10:50:24,1635691359,5/13/2015 10:49:26,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[LOCATION],[LOCATION],"tropics,",N/A,141,37,1,173,63,TWrex-cause,812643-FS1,"Loffler's syndrome (a subcategory of HYPEREOSINOPHILIC SYNDROME with primary cardiac involvement), which occurs in the tropics, begins as an ACUTE ARTERITIS WITH EOSINOPHILIA followed by thrombus formation on the endocardium, chordae, and atrioventricular (AV) valves, progressing to fibrosis.",ACUTE ARTERITIS WITH EOSINOPHILIA,HYPEREOSINOPHILIC SYNDROME
721148990,5/13/2015 11:13:54,1635697661,5/13/2015 11:13:31,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[ASSOCIATED_WITH],[ASSOCIATED_WITH],begins as,n/a,141,37,1,173,63,TWrex-cause,812643-FS1,"Loffler's syndrome (a subcategory of HYPEREOSINOPHILIC SYNDROME with primary cardiac involvement), which occurs in the tropics, begins as an ACUTE ARTERITIS WITH EOSINOPHILIA followed by thrombus formation on the endocardium, chordae, and atrioventricular (AV) valves, progressing to fibrosis.",ACUTE ARTERITIS WITH EOSINOPHILIA,HYPEREOSINOPHILIC SYNDROME
721148990,5/13/2015 11:14:55,1635697911,5/13/2015 11:13:58,false,neodev,1.0,31706957,NLD,07,Amsterdam,145.100.72.165,[IS_A],[IS_A],begins as an,n/a,141,37,1,173,63,TWrex-cause,812643-FS1,"Loffler's syndrome (a subcategory of HYPEREOSINOPHILIC SYNDROME with primary cardiac involvement), which occurs in the tropics, begins as an ACUTE ARTERITIS WITH EOSINOPHILIA followed by thrombus formation on the endocardium, chordae, and atrioventricular (AV) valves, progressing to fibrosis.",ACUTE ARTERITIS WITH EOSINOPHILIA,HYPEREOSINOPHILIC SYNDROME
721148990,5/13/2015 11:29:20,1635701603,5/13/2015 11:28:38,false,prodege,1.0,27934334,GBR,D3,Swadlincote,109.150.228.127,[SYMPTOM],[SYMPTOM],begins as,N/A,141,37,1,173,63,TWrex-cause,812643-FS1,"Loffler's syndrome (a subcategory of HYPEREOSINOPHILIC SYNDROME with primary cardiac involvement), which occurs in the tropics, begins as an ACUTE ARTERITIS WITH EOSINOPHILIA followed by thrombus formation on the endocardium, chordae, and atrioventricular (AV) valves, progressing to fibrosis.",ACUTE ARTERITIS WITH EOSINOPHILIA,HYPEREOSINOPHILIC SYNDROME
721148990,5/13/2015 11:35:39,1635703375,5/13/2015 11:34:23,false,points4rewards,1.0,28703583,USA,"","",97.73.86.35,[MANIFESTATION] [SYMPTOM],"[SYMPTOM]
[MANIFESTATION]",begins as followed by thrombus formation,N/A,141,37,1,173,63,TWrex-cause,812643-FS1,"Loffler's syndrome (a subcategory of HYPEREOSINOPHILIC SYNDROME with primary cardiac involvement), which occurs in the tropics, begins as an ACUTE ARTERITIS WITH EOSINOPHILIA followed by thrombus formation on the endocardium, chordae, and atrioventricular (AV) valves, progressing to fibrosis.",ACUTE ARTERITIS WITH EOSINOPHILIA,HYPEREOSINOPHILIC SYNDROME
721148990,5/13/2015 11:38:59,1635704551,5/13/2015 11:37:49,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[SYMPTOM],[SYMPTOM],HYPEREOSINOPHILIC SYNDROME begins as ACUTE ARTERITIS WITH EOSINOPHILIA,n/a,141,37,1,173,63,TWrex-cause,812643-FS1,"Loffler's syndrome (a subcategory of HYPEREOSINOPHILIC SYNDROME with primary cardiac involvement), which occurs in the tropics, begins as an ACUTE ARTERITIS WITH EOSINOPHILIA followed by thrombus formation on the endocardium, chordae, and atrioventricular (AV) valves, progressing to fibrosis.",ACUTE ARTERITIS WITH EOSINOPHILIA,HYPEREOSINOPHILIC SYNDROME
721148990,5/13/2015 11:44:46,1635705719,5/13/2015 11:44:29,false,neodev,1.0,31726043,GBR,"","",88.150.202.140,[CAUSES],[CAUSES],formation,955,141,37,1,173,63,TWrex-cause,812643-FS1,"Loffler's syndrome (a subcategory of HYPEREOSINOPHILIC SYNDROME with primary cardiac involvement), which occurs in the tropics, begins as an ACUTE ARTERITIS WITH EOSINOPHILIA followed by thrombus formation on the endocardium, chordae, and atrioventricular (AV) valves, progressing to fibrosis.",ACUTE ARTERITIS WITH EOSINOPHILIA,HYPEREOSINOPHILIC SYNDROME
721148990,5/13/2015 12:19:16,1635717434,5/13/2015 12:18:56,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,[SYMPTOM],[SYMPTOM],begins,n/a,141,37,1,173,63,TWrex-cause,812643-FS1,"Loffler's syndrome (a subcategory of HYPEREOSINOPHILIC SYNDROME with primary cardiac involvement), which occurs in the tropics, begins as an ACUTE ARTERITIS WITH EOSINOPHILIA followed by thrombus formation on the endocardium, chordae, and atrioventricular (AV) valves, progressing to fibrosis.",ACUTE ARTERITIS WITH EOSINOPHILIA,HYPEREOSINOPHILIC SYNDROME
721148990,5/13/2015 12:21:46,1635718291,5/13/2015 12:21:28,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[SYMPTOM],[SYMPTOM],HYPEREOSINOPHILIC SYNDROME begins as an ACUTE ARTERITIS WITH EOSINOPHILIA,n/a,141,37,1,173,63,TWrex-cause,812643-FS1,"Loffler's syndrome (a subcategory of HYPEREOSINOPHILIC SYNDROME with primary cardiac involvement), which occurs in the tropics, begins as an ACUTE ARTERITIS WITH EOSINOPHILIA followed by thrombus formation on the endocardium, chordae, and atrioventricular (AV) valves, progressing to fibrosis.",ACUTE ARTERITIS WITH EOSINOPHILIA,HYPEREOSINOPHILIC SYNDROME
721148990,5/13/2015 12:26:34,1635720373,5/13/2015 12:25:01,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[SYMPTOM],[SYMPTOM],begins,N/A,141,37,1,173,63,TWrex-cause,812643-FS1,"Loffler's syndrome (a subcategory of HYPEREOSINOPHILIC SYNDROME with primary cardiac involvement), which occurs in the tropics, begins as an ACUTE ARTERITIS WITH EOSINOPHILIA followed by thrombus formation on the endocardium, chordae, and atrioventricular (AV) valves, progressing to fibrosis.",ACUTE ARTERITIS WITH EOSINOPHILIA,HYPEREOSINOPHILIC SYNDROME
721148990,5/13/2015 12:48:18,1635725744,5/13/2015 12:47:14,false,prodege,1.0,23482077,USA,TX,Garland,71.164.238.226,[SYMPTOM] [MANIFESTATION],"[SYMPTOM]
[MANIFESTATION]",begins as an,N/A,141,37,1,173,63,TWrex-cause,812643-FS1,"Loffler's syndrome (a subcategory of HYPEREOSINOPHILIC SYNDROME with primary cardiac involvement), which occurs in the tropics, begins as an ACUTE ARTERITIS WITH EOSINOPHILIA followed by thrombus formation on the endocardium, chordae, and atrioventricular (AV) valves, progressing to fibrosis.",ACUTE ARTERITIS WITH EOSINOPHILIA,HYPEREOSINOPHILIC SYNDROME
721148990,5/13/2015 13:01:10,1635728823,5/13/2015 12:58:57,false,clixsense,1.0,6574449,USA,"","",216.216.68.85,[OTHER],[OTHER],"Loffler's syndrome subcategory HYPEREOSINOPHILIC SYNDROME primary cardiac involvement), occurs tropics, begins ACUTE ARTERITIS WITH EOSINOPHILIA followed thrombus formation endocardium, chordae, atrioventricular valves, progressing fibrosis.",na,141,37,1,173,63,TWrex-cause,812643-FS1,"Loffler's syndrome (a subcategory of HYPEREOSINOPHILIC SYNDROME with primary cardiac involvement), which occurs in the tropics, begins as an ACUTE ARTERITIS WITH EOSINOPHILIA followed by thrombus formation on the endocardium, chordae, and atrioventricular (AV) valves, progressing to fibrosis.",ACUTE ARTERITIS WITH EOSINOPHILIA,HYPEREOSINOPHILIC SYNDROME
721148991,5/13/2015 13:23:19,1635735372,5/13/2015 13:22:47,false,clixsense,1.0,23197581,NLD,11,Den Haag,82.217.5.55,[TREATS],[TREATS],the treatment of,N/A,98,54,-1,136,65,TWrex-cause,800940-FS1,"Russell MD, Nolen T, Allen JM et al. Cefprozil versus AMOXICILLIN/clavulanate in the treatment of ACUTE UNCOMPLICATED MAXILLARY SINUSITIS in adults; a randomized, prospective clinical trial.",ACUTE UNCOMPLICATED MAXILLARY SINUSITIS,AMOXICILLIN
721148991,5/13/2015 13:59:59,1635747461,5/13/2015 13:59:42,false,neodev,1.0,24564999,GBR,H9,London,86.145.227.9,[TREATS],[TREATS],treatment of,N/A,98,54,-1,136,65,TWrex-cause,800940-FS1,"Russell MD, Nolen T, Allen JM et al. Cefprozil versus AMOXICILLIN/clavulanate in the treatment of ACUTE UNCOMPLICATED MAXILLARY SINUSITIS in adults; a randomized, prospective clinical trial.",ACUTE UNCOMPLICATED MAXILLARY SINUSITIS,AMOXICILLIN
721148991,5/13/2015 14:04:34,1635749537,5/13/2015 14:04:15,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[TREATS],[TREATS],treatment,N/A,98,54,-1,136,65,TWrex-cause,800940-FS1,"Russell MD, Nolen T, Allen JM et al. Cefprozil versus AMOXICILLIN/clavulanate in the treatment of ACUTE UNCOMPLICATED MAXILLARY SINUSITIS in adults; a randomized, prospective clinical trial.",ACUTE UNCOMPLICATED MAXILLARY SINUSITIS,AMOXICILLIN
721148991,5/13/2015 14:28:51,1635759888,5/13/2015 14:28:25,false,prodege,1.0,24403612,CAN,ON,Ajax,99.239.181.149,[TREATS],[TREATS],AMOXICILLIN/clavulanate in treatment of ACUTE UNCOMPLICATED MAXILLARY SINUSITIS,N/a,98,54,-1,136,65,TWrex-cause,800940-FS1,"Russell MD, Nolen T, Allen JM et al. Cefprozil versus AMOXICILLIN/clavulanate in the treatment of ACUTE UNCOMPLICATED MAXILLARY SINUSITIS in adults; a randomized, prospective clinical trial.",ACUTE UNCOMPLICATED MAXILLARY SINUSITIS,AMOXICILLIN
721148991,5/13/2015 14:38:57,1635765758,5/13/2015 14:38:37,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[TREATS],[TREATS],treatment of,N/A,98,54,-1,136,65,TWrex-cause,800940-FS1,"Russell MD, Nolen T, Allen JM et al. Cefprozil versus AMOXICILLIN/clavulanate in the treatment of ACUTE UNCOMPLICATED MAXILLARY SINUSITIS in adults; a randomized, prospective clinical trial.",ACUTE UNCOMPLICATED MAXILLARY SINUSITIS,AMOXICILLIN
721148991,5/13/2015 15:22:38,1635799892,5/13/2015 15:22:04,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,[TREATS],[TREATS],treatment,n/a,98,54,-1,136,65,TWrex-cause,800940-FS1,"Russell MD, Nolen T, Allen JM et al. Cefprozil versus AMOXICILLIN/clavulanate in the treatment of ACUTE UNCOMPLICATED MAXILLARY SINUSITIS in adults; a randomized, prospective clinical trial.",ACUTE UNCOMPLICATED MAXILLARY SINUSITIS,AMOXICILLIN
721148991,5/13/2015 16:14:45,1635839236,5/13/2015 16:13:39,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[TREATS],[TREATS],treatment,none,98,54,-1,136,65,TWrex-cause,800940-FS1,"Russell MD, Nolen T, Allen JM et al. Cefprozil versus AMOXICILLIN/clavulanate in the treatment of ACUTE UNCOMPLICATED MAXILLARY SINUSITIS in adults; a randomized, prospective clinical trial.",ACUTE UNCOMPLICATED MAXILLARY SINUSITIS,AMOXICILLIN
721148991,5/13/2015 16:35:25,1635852532,5/13/2015 16:35:04,false,prodege,1.0,16101132,GBR,F9,Hayes,2.223.214.149,[TREATS],[TREATS],treatment,Treated with,98,54,-1,136,65,TWrex-cause,800940-FS1,"Russell MD, Nolen T, Allen JM et al. Cefprozil versus AMOXICILLIN/clavulanate in the treatment of ACUTE UNCOMPLICATED MAXILLARY SINUSITIS in adults; a randomized, prospective clinical trial.",ACUTE UNCOMPLICATED MAXILLARY SINUSITIS,AMOXICILLIN
721148991,5/13/2015 16:37:50,1635854153,5/13/2015 16:37:31,false,clixsense,1.0,31579138,AUS,02,Hurstville,14.200.129.68,[TREATS],[TREATS],treatment,N/A,98,54,-1,136,65,TWrex-cause,800940-FS1,"Russell MD, Nolen T, Allen JM et al. Cefprozil versus AMOXICILLIN/clavulanate in the treatment of ACUTE UNCOMPLICATED MAXILLARY SINUSITIS in adults; a randomized, prospective clinical trial.",ACUTE UNCOMPLICATED MAXILLARY SINUSITIS,AMOXICILLIN
721148991,5/13/2015 17:17:56,1635876070,5/13/2015 17:17:11,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[TREATS],[TREATS],treatment of,n/a,98,54,-1,136,65,TWrex-cause,800940-FS1,"Russell MD, Nolen T, Allen JM et al. Cefprozil versus AMOXICILLIN/clavulanate in the treatment of ACUTE UNCOMPLICATED MAXILLARY SINUSITIS in adults; a randomized, prospective clinical trial.",ACUTE UNCOMPLICATED MAXILLARY SINUSITIS,AMOXICILLIN
721148991,5/13/2015 17:20:47,1635877757,5/13/2015 17:19:50,false,gptking,1.0,31799065,USA,IL,Marion,50.45.43.154,[TREATS],[TREATS],AMOXICILLIN/clavulanate ACUTE UNCOMPLICATED MAXILLARY SINUSITIS,N/A,98,54,-1,136,65,TWrex-cause,800940-FS1,"Russell MD, Nolen T, Allen JM et al. Cefprozil versus AMOXICILLIN/clavulanate in the treatment of ACUTE UNCOMPLICATED MAXILLARY SINUSITIS in adults; a randomized, prospective clinical trial.",ACUTE UNCOMPLICATED MAXILLARY SINUSITIS,AMOXICILLIN
721148991,5/13/2015 17:54:18,1635897860,5/13/2015 17:53:50,false,prodege,1.0,14848125,GBR,L6,Shrewsbury,86.138.223.142,[TREATS],[TREATS],in the treatment,N/A,98,54,-1,136,65,TWrex-cause,800940-FS1,"Russell MD, Nolen T, Allen JM et al. Cefprozil versus AMOXICILLIN/clavulanate in the treatment of ACUTE UNCOMPLICATED MAXILLARY SINUSITIS in adults; a randomized, prospective clinical trial.",ACUTE UNCOMPLICATED MAXILLARY SINUSITIS,AMOXICILLIN
721148991,5/13/2015 18:04:35,1635901354,5/13/2015 18:04:08,false,clixsense,1.0,6574449,USA,"","",216.216.68.85,[OTHER],[OTHER],"Cefprozil versus AMOXICILLIN/clavulanate treatment ACUTE UNCOMPLICATED MAXILLARY SINUSITIS adults; randomized, prospective clinical trial.",na,98,54,-1,136,65,TWrex-cause,800940-FS1,"Russell MD, Nolen T, Allen JM et al. Cefprozil versus AMOXICILLIN/clavulanate in the treatment of ACUTE UNCOMPLICATED MAXILLARY SINUSITIS in adults; a randomized, prospective clinical trial.",ACUTE UNCOMPLICATED MAXILLARY SINUSITIS,AMOXICILLIN
721148991,5/13/2015 18:07:40,1635902426,5/13/2015 18:07:20,false,clixsense,1.0,32549163,CAN,MB,Winnipeg,206.45.167.246,[TREATS],[TREATS],AMOXICILLIN/clavulanate in the treatment of ACUTE UNCOMPLICATED MAXILLARY SINUSITIS,N/A,98,54,-1,136,65,TWrex-cause,800940-FS1,"Russell MD, Nolen T, Allen JM et al. Cefprozil versus AMOXICILLIN/clavulanate in the treatment of ACUTE UNCOMPLICATED MAXILLARY SINUSITIS in adults; a randomized, prospective clinical trial.",ACUTE UNCOMPLICATED MAXILLARY SINUSITIS,AMOXICILLIN
721148991,5/13/2015 18:08:54,1635903010,5/13/2015 18:07:39,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[TREATS],[TREATS],treatment,N/A,98,54,-1,136,65,TWrex-cause,800940-FS1,"Russell MD, Nolen T, Allen JM et al. Cefprozil versus AMOXICILLIN/clavulanate in the treatment of ACUTE UNCOMPLICATED MAXILLARY SINUSITIS in adults; a randomized, prospective clinical trial.",ACUTE UNCOMPLICATED MAXILLARY SINUSITIS,AMOXICILLIN
721148992,5/13/2015 13:05:36,1635730595,5/13/2015 13:05:21,false,neodev,1.0,30504276,CAN,ON,Sudbury,66.103.55.12,[ASSOCIATED_WITH],[ASSOCIATED_WITH],rare complication of,N/A,9,54,1,15,60,TWrex-cause,812523-FS1,"However, HAM/TSP is a relatively rare complication of HTLV 1 with an incidence roughly comparable to that of adult T cell leukemia, another rare condition associated with HTLV 1.",HAM/TSP,HTLV 1
721148992,5/13/2015 13:08:46,1635731358,5/13/2015 13:08:19,false,clixsense,1.0,24329110,USA,FL,Jacksonville,12.168.136.2,[CAUSES],[CAUSES],rare complication of,n/a,9,54,1,15,60,TWrex-cause,812523-FS1,"However, HAM/TSP is a relatively rare complication of HTLV 1 with an incidence roughly comparable to that of adult T cell leukemia, another rare condition associated with HTLV 1.",HAM/TSP,HTLV 1
721148992,5/13/2015 13:15:33,1635733215,5/13/2015 13:14:46,false,clixsense,1.0,23197581,NLD,11,Den Haag,82.217.5.55,[MANIFESTATION],[MANIFESTATION],is a relatively rare complication of HTLV 1,N/A,9,54,1,15,60,TWrex-cause,812523-FS1,"However, HAM/TSP is a relatively rare complication of HTLV 1 with an incidence roughly comparable to that of adult T cell leukemia, another rare condition associated with HTLV 1.",HAM/TSP,HTLV 1
721148992,5/13/2015 13:17:14,1635733630,5/13/2015 13:15:58,false,prodege,1.0,23482077,USA,TX,Garland,71.164.238.226,[ASSOCIATED_WITH] [MANIFESTATION],"[MANIFESTATION]
[ASSOCIATED_WITH]",complication of,N/A,9,54,1,15,60,TWrex-cause,812523-FS1,"However, HAM/TSP is a relatively rare complication of HTLV 1 with an incidence roughly comparable to that of adult T cell leukemia, another rare condition associated with HTLV 1.",HAM/TSP,HTLV 1
721148992,5/13/2015 13:40:09,1635739712,5/13/2015 13:39:43,false,bitcoinget,1.0,21614812,USA,PA,Erie,174.100.250.115,[SIDE_EFFECT],[SIDE_EFFECT],rare complication of,N/A,9,54,1,15,60,TWrex-cause,812523-FS1,"However, HAM/TSP is a relatively rare complication of HTLV 1 with an incidence roughly comparable to that of adult T cell leukemia, another rare condition associated with HTLV 1.",HAM/TSP,HTLV 1
721148992,5/13/2015 13:47:05,1635742057,5/13/2015 13:46:46,false,neodev,1.0,24564999,GBR,H9,London,86.145.227.9,[CAUSES],[CAUSES],rare complication of,N/A,9,54,1,15,60,TWrex-cause,812523-FS1,"However, HAM/TSP is a relatively rare complication of HTLV 1 with an incidence roughly comparable to that of adult T cell leukemia, another rare condition associated with HTLV 1.",HAM/TSP,HTLV 1
721148992,5/13/2015 13:55:22,1635745511,5/13/2015 13:54:59,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[SYMPTOM],[SYMPTOM],complication of,N/A,9,54,1,15,60,TWrex-cause,812523-FS1,"However, HAM/TSP is a relatively rare complication of HTLV 1 with an incidence roughly comparable to that of adult T cell leukemia, another rare condition associated with HTLV 1.",HAM/TSP,HTLV 1
721148992,5/13/2015 14:17:48,1635754987,5/13/2015 14:16:55,false,prodege,1.0,24403612,CAN,ON,Ajax,99.239.181.149,[SYMPTOM],[SYMPTOM],HAM/TSP rare complication of HTLV 1,N/a,9,54,1,15,60,TWrex-cause,812523-FS1,"However, HAM/TSP is a relatively rare complication of HTLV 1 with an incidence roughly comparable to that of adult T cell leukemia, another rare condition associated with HTLV 1.",HAM/TSP,HTLV 1
721148992,5/13/2015 14:26:45,1635758729,5/13/2015 14:25:38,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[MANIFESTATION],[MANIFESTATION],complication of,N/A,9,54,1,15,60,TWrex-cause,812523-FS1,"However, HAM/TSP is a relatively rare complication of HTLV 1 with an incidence roughly comparable to that of adult T cell leukemia, another rare condition associated with HTLV 1.",HAM/TSP,HTLV 1
721148992,5/13/2015 15:11:27,1635790793,5/13/2015 15:11:00,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,[SYMPTOM],[SYMPTOM],complication,n/a,9,54,1,15,60,TWrex-cause,812523-FS1,"However, HAM/TSP is a relatively rare complication of HTLV 1 with an incidence roughly comparable to that of adult T cell leukemia, another rare condition associated with HTLV 1.",HAM/TSP,HTLV 1
721148992,5/13/2015 15:20:32,1635798371,5/13/2015 15:18:03,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[SYMPTOM] [ASSOCIATED_WITH],"[SYMPTOM]
[ASSOCIATED_WITH]",HAM/TSP is a rare complication HTLV 1 associated with,N/A,9,54,1,15,60,TWrex-cause,812523-FS1,"However, HAM/TSP is a relatively rare complication of HTLV 1 with an incidence roughly comparable to that of adult T cell leukemia, another rare condition associated with HTLV 1.",HAM/TSP,HTLV 1
721148992,5/13/2015 15:41:32,1635814562,5/13/2015 15:40:32,false,clixsense,1.0,32549163,CAN,MB,Winnipeg,206.45.167.246,[CAUSES],[CAUSES],HAM/TSP is a relatively rare complication of HTLV 1,N/A,9,54,1,15,60,TWrex-cause,812523-FS1,"However, HAM/TSP is a relatively rare complication of HTLV 1 with an incidence roughly comparable to that of adult T cell leukemia, another rare condition associated with HTLV 1.",HAM/TSP,HTLV 1
721148992,5/13/2015 15:56:35,1635825972,5/13/2015 15:56:04,false,instagc,1.0,24252915,GBR,F2,Gosport,92.24.208.155,[MANIFESTATION],[MANIFESTATION],is a relatively rare complication of,N/a,9,54,1,15,60,TWrex-cause,812523-FS1,"However, HAM/TSP is a relatively rare complication of HTLV 1 with an incidence roughly comparable to that of adult T cell leukemia, another rare condition associated with HTLV 1.",HAM/TSP,HTLV 1
721148992,5/13/2015 16:00:05,1635828749,5/13/2015 15:59:13,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[MANIFESTATION],[MANIFESTATION],rare complication,none,9,54,1,15,60,TWrex-cause,812523-FS1,"However, HAM/TSP is a relatively rare complication of HTLV 1 with an incidence roughly comparable to that of adult T cell leukemia, another rare condition associated with HTLV 1.",HAM/TSP,HTLV 1
721148992,5/13/2015 16:25:15,1635845733,5/13/2015 16:24:03,false,prodege,1.0,16101132,GBR,F9,Hayes,2.223.214.149,[MANIFESTATION],[MANIFESTATION],complication,Manifest,9,54,1,15,60,TWrex-cause,812523-FS1,"However, HAM/TSP is a relatively rare complication of HTLV 1 with an incidence roughly comparable to that of adult T cell leukemia, another rare condition associated with HTLV 1.",HAM/TSP,HTLV 1
721148993,5/13/2015 10:22:38,1635683403,5/13/2015 10:21:49,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[TREATS] [DIAGNOSE_BY_TEST_OR_DRUG],"[TREATS]
[DIAGNOSE_BY_TEST_OR_DRUG]",Diclofenac versus LIDOCAINE as injection therapy in MYOFASCIAL PAIN,N/A,52,18,-1,66,27,TWrex-cause,800546-FS1,Diclofenac versus LIDOCAINE as injection therapy in MYOFASCIAL PAIN,MYOFASCIAL PAIN,LIDOCAINE
721148993,5/13/2015 10:39:32,1635688224,5/13/2015 10:38:59,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[TREATS],[TREATS],therapy,n/a,52,18,-1,66,27,TWrex-cause,800546-FS1,Diclofenac versus LIDOCAINE as injection therapy in MYOFASCIAL PAIN,MYOFASCIAL PAIN,LIDOCAINE
721148993,5/13/2015 10:41:09,1635688499,5/13/2015 10:40:20,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[OTHER],[OTHER],injection therapy in,N/A,52,18,-1,66,27,TWrex-cause,800546-FS1,Diclofenac versus LIDOCAINE as injection therapy in MYOFASCIAL PAIN,MYOFASCIAL PAIN,LIDOCAINE
721148993,5/13/2015 10:51:42,1635691789,5/13/2015 10:50:25,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[PREVENTS],[PREVENTS],MYOFASCIAL PAIN,N/A,52,18,-1,66,27,TWrex-cause,800546-FS1,Diclofenac versus LIDOCAINE as injection therapy in MYOFASCIAL PAIN,MYOFASCIAL PAIN,LIDOCAINE
721148993,5/13/2015 11:14:11,1635697707,5/13/2015 11:13:55,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[TREATS],[TREATS],injection therapy,n/a,52,18,-1,66,27,TWrex-cause,800546-FS1,Diclofenac versus LIDOCAINE as injection therapy in MYOFASCIAL PAIN,MYOFASCIAL PAIN,LIDOCAINE
721148993,5/13/2015 11:15:26,1635698071,5/13/2015 11:14:56,false,neodev,1.0,31706957,NLD,07,Amsterdam,145.100.72.165,[TREATS],[TREATS],therapy in,n/a,52,18,-1,66,27,TWrex-cause,800546-FS1,Diclofenac versus LIDOCAINE as injection therapy in MYOFASCIAL PAIN,MYOFASCIAL PAIN,LIDOCAINE
721148993,5/13/2015 11:29:37,1635701624,5/13/2015 11:29:21,false,prodege,1.0,27934334,GBR,D3,Swadlincote,109.150.228.127,[TREATS],[TREATS],therapy,N/A,52,18,-1,66,27,TWrex-cause,800546-FS1,Diclofenac versus LIDOCAINE as injection therapy in MYOFASCIAL PAIN,MYOFASCIAL PAIN,LIDOCAINE
721148993,5/13/2015 11:37:13,1635704150,5/13/2015 11:35:45,false,points4rewards,1.0,28703583,USA,"","",97.73.86.35,[ASSOCIATED_WITH],[ASSOCIATED_WITH],Diclofenac versus as injection therapy,N/A,52,18,-1,66,27,TWrex-cause,800546-FS1,Diclofenac versus LIDOCAINE as injection therapy in MYOFASCIAL PAIN,MYOFASCIAL PAIN,LIDOCAINE
721148993,5/13/2015 11:39:28,1635704720,5/13/2015 11:39:02,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[TREATS],[TREATS],LIDOCAINE as therapy in MYOFASCIAL PAIN,n/a,52,18,-1,66,27,TWrex-cause,800546-FS1,Diclofenac versus LIDOCAINE as injection therapy in MYOFASCIAL PAIN,MYOFASCIAL PAIN,LIDOCAINE
721148993,5/13/2015 11:45:11,1635705791,5/13/2015 11:44:55,false,neodev,1.0,31726043,GBR,"","",88.150.202.140,[LOCATION],[LOCATION],MYOFASCIAL,55,52,18,-1,66,27,TWrex-cause,800546-FS1,Diclofenac versus LIDOCAINE as injection therapy in MYOFASCIAL PAIN,MYOFASCIAL PAIN,LIDOCAINE
721148993,5/13/2015 12:19:36,1635717534,5/13/2015 12:19:17,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,[TREATS],[TREATS],therapy,n/a,52,18,-1,66,27,TWrex-cause,800546-FS1,Diclofenac versus LIDOCAINE as injection therapy in MYOFASCIAL PAIN,MYOFASCIAL PAIN,LIDOCAINE
721148993,5/13/2015 12:22:00,1635718385,5/13/2015 12:21:47,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[TREATS],[TREATS],LIDOCAINE as injection therapy in MYOFASCIAL PAIN,n/a,52,18,-1,66,27,TWrex-cause,800546-FS1,Diclofenac versus LIDOCAINE as injection therapy in MYOFASCIAL PAIN,MYOFASCIAL PAIN,LIDOCAINE
721148993,5/13/2015 12:27:27,1635720575,5/13/2015 12:26:35,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[TREATS],[TREATS],therapy,N/A,52,18,-1,66,27,TWrex-cause,800546-FS1,Diclofenac versus LIDOCAINE as injection therapy in MYOFASCIAL PAIN,MYOFASCIAL PAIN,LIDOCAINE
721148993,5/13/2015 12:49:02,1635725926,5/13/2015 12:48:20,false,prodege,1.0,23482077,USA,TX,Garland,71.164.238.226,[TREATS],[TREATS],as therapy in,N/A,52,18,-1,66,27,TWrex-cause,800546-FS1,Diclofenac versus LIDOCAINE as injection therapy in MYOFASCIAL PAIN,MYOFASCIAL PAIN,LIDOCAINE
721148993,5/13/2015 12:59:43,1635728338,5/13/2015 12:59:13,false,clixsense,1.0,24329110,USA,FL,Jacksonville,12.168.136.2,[TREATS],[TREATS],therapy in,n/a,52,18,-1,66,27,TWrex-cause,800546-FS1,Diclofenac versus LIDOCAINE as injection therapy in MYOFASCIAL PAIN,MYOFASCIAL PAIN,LIDOCAINE
721148994,5/13/2015 13:04:15,1635730121,5/13/2015 13:03:56,false,neodev,1.0,30504276,CAN,ON,Sudbury,66.103.55.12,[NONE],[NONE],N/A,N/A,130,200,1,177,228,TWrex-cause,814549-FS1,"2]  Kay GN, Pressley JC, Packer DL, Pritchett EL, German LD, Gilbert MR. Value of the 12 lead electrocardiogram in discriminating ATRIOVENTRICULAR NODAL RECIPROCATING TACHYCARDIA from circus movement ATRIOVENTRICULAR TACHYCARDIA utilizing a retrograde accessory pathway.",ATRIOVENTRICULAR NODAL RECIPROCATING TACHYCARDIA,ATRIOVENTRICULAR TACHYCARDIA
721148994,5/13/2015 13:06:47,1635730925,5/13/2015 13:06:15,false,clixsense,1.0,24329110,USA,FL,Jacksonville,12.168.136.2,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],in discriminating,n/a,130,200,1,177,228,TWrex-cause,814549-FS1,"2]  Kay GN, Pressley JC, Packer DL, Pritchett EL, German LD, Gilbert MR. Value of the 12 lead electrocardiogram in discriminating ATRIOVENTRICULAR NODAL RECIPROCATING TACHYCARDIA from circus movement ATRIOVENTRICULAR TACHYCARDIA utilizing a retrograde accessory pathway.",ATRIOVENTRICULAR NODAL RECIPROCATING TACHYCARDIA,ATRIOVENTRICULAR TACHYCARDIA
721148994,5/13/2015 13:13:08,1635732516,5/13/2015 13:12:19,false,clixsense,1.0,23197581,NLD,11,Den Haag,82.217.5.55,[IS_A],[IS_A],discriminating from,N/A,130,200,1,177,228,TWrex-cause,814549-FS1,"2]  Kay GN, Pressley JC, Packer DL, Pritchett EL, German LD, Gilbert MR. Value of the 12 lead electrocardiogram in discriminating ATRIOVENTRICULAR NODAL RECIPROCATING TACHYCARDIA from circus movement ATRIOVENTRICULAR TACHYCARDIA utilizing a retrograde accessory pathway.",ATRIOVENTRICULAR NODAL RECIPROCATING TACHYCARDIA,ATRIOVENTRICULAR TACHYCARDIA
721148994,5/13/2015 13:13:35,1635732648,5/13/2015 13:11:32,false,prodege,1.0,23482077,USA,TX,Garland,71.164.238.226,[NONE],[NONE],N/A,Two different conditions for which a test is being used to discriminate from one another.,130,200,1,177,228,TWrex-cause,814549-FS1,"2]  Kay GN, Pressley JC, Packer DL, Pritchett EL, German LD, Gilbert MR. Value of the 12 lead electrocardiogram in discriminating ATRIOVENTRICULAR NODAL RECIPROCATING TACHYCARDIA from circus movement ATRIOVENTRICULAR TACHYCARDIA utilizing a retrograde accessory pathway.",ATRIOVENTRICULAR NODAL RECIPROCATING TACHYCARDIA,ATRIOVENTRICULAR TACHYCARDIA
721148994,5/13/2015 13:32:07,1635737517,5/13/2015 13:30:20,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],"Kay GN, Pressley JC, Packer DL, Pritchett EL, German LD, Gilbert MR. discriminating ATRIOVENTRICULAR NODAL RECIPROCATING TACHYCARDIA from ATRIOVENTRICULAR TACHYCARDIA utilizing retrograde accessory pathway.",N/A,130,200,1,177,228,TWrex-cause,814549-FS1,"2]  Kay GN, Pressley JC, Packer DL, Pritchett EL, German LD, Gilbert MR. Value of the 12 lead electrocardiogram in discriminating ATRIOVENTRICULAR NODAL RECIPROCATING TACHYCARDIA from circus movement ATRIOVENTRICULAR TACHYCARDIA utilizing a retrograde accessory pathway.",ATRIOVENTRICULAR NODAL RECIPROCATING TACHYCARDIA,ATRIOVENTRICULAR TACHYCARDIA
721148994,5/13/2015 13:38:15,1635739215,5/13/2015 13:38:02,false,bitcoinget,1.0,21614812,USA,PA,Erie,174.100.250.115,[CAUSES],[CAUSES],from circus movement,N/A,130,200,1,177,228,TWrex-cause,814549-FS1,"2]  Kay GN, Pressley JC, Packer DL, Pritchett EL, German LD, Gilbert MR. Value of the 12 lead electrocardiogram in discriminating ATRIOVENTRICULAR NODAL RECIPROCATING TACHYCARDIA from circus movement ATRIOVENTRICULAR TACHYCARDIA utilizing a retrograde accessory pathway.",ATRIOVENTRICULAR NODAL RECIPROCATING TACHYCARDIA,ATRIOVENTRICULAR TACHYCARDIA
721148994,5/13/2015 13:44:13,1635741001,5/13/2015 13:42:55,false,neodev,1.0,24564999,GBR,H9,London,86.145.227.9,[OTHER],[OTHER],discriminating from,N/A,130,200,1,177,228,TWrex-cause,814549-FS1,"2]  Kay GN, Pressley JC, Packer DL, Pritchett EL, German LD, Gilbert MR. Value of the 12 lead electrocardiogram in discriminating ATRIOVENTRICULAR NODAL RECIPROCATING TACHYCARDIA from circus movement ATRIOVENTRICULAR TACHYCARDIA utilizing a retrograde accessory pathway.",ATRIOVENTRICULAR NODAL RECIPROCATING TACHYCARDIA,ATRIOVENTRICULAR TACHYCARDIA
721148994,5/13/2015 13:52:58,1635744540,5/13/2015 13:52:07,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[OTHER],[OTHER],discriminating from,DIFFERS FROM,130,200,1,177,228,TWrex-cause,814549-FS1,"2]  Kay GN, Pressley JC, Packer DL, Pritchett EL, German LD, Gilbert MR. Value of the 12 lead electrocardiogram in discriminating ATRIOVENTRICULAR NODAL RECIPROCATING TACHYCARDIA from circus movement ATRIOVENTRICULAR TACHYCARDIA utilizing a retrograde accessory pathway.",ATRIOVENTRICULAR NODAL RECIPROCATING TACHYCARDIA,ATRIOVENTRICULAR TACHYCARDIA
721148994,5/13/2015 14:13:33,1635753408,5/13/2015 14:12:40,false,prodege,1.0,24403612,CAN,ON,Ajax,99.239.181.149,[PART_OF],[PART_OF],ATRIOVENTRICULAR NODAL RECIPROCATING TACHYCARDIA from ATRIOVENTRICULAR TACHYCARDIA,N/A,130,200,1,177,228,TWrex-cause,814549-FS1,"2]  Kay GN, Pressley JC, Packer DL, Pritchett EL, German LD, Gilbert MR. Value of the 12 lead electrocardiogram in discriminating ATRIOVENTRICULAR NODAL RECIPROCATING TACHYCARDIA from circus movement ATRIOVENTRICULAR TACHYCARDIA utilizing a retrograde accessory pathway.",ATRIOVENTRICULAR NODAL RECIPROCATING TACHYCARDIA,ATRIOVENTRICULAR TACHYCARDIA
721148994,5/13/2015 14:24:10,1635757547,5/13/2015 14:23:28,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[IS_A],[IS_A],discriminating,N/A,130,200,1,177,228,TWrex-cause,814549-FS1,"2]  Kay GN, Pressley JC, Packer DL, Pritchett EL, German LD, Gilbert MR. Value of the 12 lead electrocardiogram in discriminating ATRIOVENTRICULAR NODAL RECIPROCATING TACHYCARDIA from circus movement ATRIOVENTRICULAR TACHYCARDIA utilizing a retrograde accessory pathway.",ATRIOVENTRICULAR NODAL RECIPROCATING TACHYCARDIA,ATRIOVENTRICULAR TACHYCARDIA
721148994,5/13/2015 15:09:54,1635789309,5/13/2015 15:09:17,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,[ASSOCIATED_WITH],[ASSOCIATED_WITH],movement,n/a,130,200,1,177,228,TWrex-cause,814549-FS1,"2]  Kay GN, Pressley JC, Packer DL, Pritchett EL, German LD, Gilbert MR. Value of the 12 lead electrocardiogram in discriminating ATRIOVENTRICULAR NODAL RECIPROCATING TACHYCARDIA from circus movement ATRIOVENTRICULAR TACHYCARDIA utilizing a retrograde accessory pathway.",ATRIOVENTRICULAR NODAL RECIPROCATING TACHYCARDIA,ATRIOVENTRICULAR TACHYCARDIA
721148994,5/13/2015 15:38:58,1635812489,5/13/2015 15:38:30,false,clixsense,1.0,32549163,CAN,MB,Winnipeg,206.45.167.246,[NONE],[NONE],N/A,Different conditions,130,200,1,177,228,TWrex-cause,814549-FS1,"2]  Kay GN, Pressley JC, Packer DL, Pritchett EL, German LD, Gilbert MR. Value of the 12 lead electrocardiogram in discriminating ATRIOVENTRICULAR NODAL RECIPROCATING TACHYCARDIA from circus movement ATRIOVENTRICULAR TACHYCARDIA utilizing a retrograde accessory pathway.",ATRIOVENTRICULAR NODAL RECIPROCATING TACHYCARDIA,ATRIOVENTRICULAR TACHYCARDIA
721148994,5/13/2015 15:54:31,1635824379,5/13/2015 15:53:51,false,instagc,1.0,24252915,GBR,F2,Gosport,92.24.208.155,[IS_A],[IS_A],discriminating ATRIOVENTRICULAR NODAL RECIPROCATING TACHYCARDIA from circus movement ATRIOVENTRICULAR TACHYCARDIA,N/a,130,200,1,177,228,TWrex-cause,814549-FS1,"2]  Kay GN, Pressley JC, Packer DL, Pritchett EL, German LD, Gilbert MR. Value of the 12 lead electrocardiogram in discriminating ATRIOVENTRICULAR NODAL RECIPROCATING TACHYCARDIA from circus movement ATRIOVENTRICULAR TACHYCARDIA utilizing a retrograde accessory pathway.",ATRIOVENTRICULAR NODAL RECIPROCATING TACHYCARDIA,ATRIOVENTRICULAR TACHYCARDIA
721148994,5/13/2015 15:57:14,1635826495,5/13/2015 15:56:15,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],discriminating,none,130,200,1,177,228,TWrex-cause,814549-FS1,"2]  Kay GN, Pressley JC, Packer DL, Pritchett EL, German LD, Gilbert MR. Value of the 12 lead electrocardiogram in discriminating ATRIOVENTRICULAR NODAL RECIPROCATING TACHYCARDIA from circus movement ATRIOVENTRICULAR TACHYCARDIA utilizing a retrograde accessory pathway.",ATRIOVENTRICULAR NODAL RECIPROCATING TACHYCARDIA,ATRIOVENTRICULAR TACHYCARDIA
721148994,5/13/2015 16:02:58,1635831372,5/13/2015 16:02:03,false,clixsense,1.0,7051387,USA,NY,Rego Park,98.14.64.34,[NONE],[NONE],movement,"""circus movement"" makes no sense.",130,200,1,177,228,TWrex-cause,814549-FS1,"2]  Kay GN, Pressley JC, Packer DL, Pritchett EL, German LD, Gilbert MR. Value of the 12 lead electrocardiogram in discriminating ATRIOVENTRICULAR NODAL RECIPROCATING TACHYCARDIA from circus movement ATRIOVENTRICULAR TACHYCARDIA utilizing a retrograde accessory pathway.",ATRIOVENTRICULAR NODAL RECIPROCATING TACHYCARDIA,ATRIOVENTRICULAR TACHYCARDIA
721148995,5/13/2015 09:55:25,1635676137,5/13/2015 09:55:03,false,neodev,1.0,32103286,CAN,AB,Edmonton,208.123.223.37,[PREVENTS] [CAUSES] [LOCATION] [NONE],"[PREVENTS]
[CAUSES]
[LOCATION]
[NONE]",no,no,64,43,-1,87,45,TWrex-cause,804903-FS1,"McClung M, Clemmesen B, Daifotis A et al.: ALENDRONATE prevents POSTMENOPAUSAL BONE LOSS in women without osteoporosis: a double blind, randomized, controlled trial.",POSTMENOPAUSAL BONE LOSS,ALENDRONATE
721148995,5/13/2015 09:59:14,1635677155,5/13/2015 09:58:17,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[PREVENTS],[PREVENTS],ALENDRONATE prevents POSTMENOPAUSAL BONE LOSS in women without osteoporosis:,N/A,64,43,-1,87,45,TWrex-cause,804903-FS1,"McClung M, Clemmesen B, Daifotis A et al.: ALENDRONATE prevents POSTMENOPAUSAL BONE LOSS in women without osteoporosis: a double blind, randomized, controlled trial.",POSTMENOPAUSAL BONE LOSS,ALENDRONATE
721148995,5/13/2015 10:16:36,1635681554,5/13/2015 10:16:04,false,clixsense,1.0,26847653,NLD,03,Warnsveld,213.93.50.164,[PREVENTS],[PREVENTS],prevents,n/a,64,43,-1,87,45,TWrex-cause,804903-FS1,"McClung M, Clemmesen B, Daifotis A et al.: ALENDRONATE prevents POSTMENOPAUSAL BONE LOSS in women without osteoporosis: a double blind, randomized, controlled trial.",POSTMENOPAUSAL BONE LOSS,ALENDRONATE
721148995,5/13/2015 10:20:28,1635682698,5/13/2015 10:19:56,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[PREVENTS],[PREVENTS],prevents,n/a,64,43,-1,87,45,TWrex-cause,804903-FS1,"McClung M, Clemmesen B, Daifotis A et al.: ALENDRONATE prevents POSTMENOPAUSAL BONE LOSS in women without osteoporosis: a double blind, randomized, controlled trial.",POSTMENOPAUSAL BONE LOSS,ALENDRONATE
721148995,5/13/2015 10:21:01,1635682950,5/13/2015 10:19:51,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[PREVENTS],[PREVENTS],prevents,N/A,64,43,-1,87,45,TWrex-cause,804903-FS1,"McClung M, Clemmesen B, Daifotis A et al.: ALENDRONATE prevents POSTMENOPAUSAL BONE LOSS in women without osteoporosis: a double blind, randomized, controlled trial.",POSTMENOPAUSAL BONE LOSS,ALENDRONATE
721148995,5/13/2015 10:29:13,1635685168,5/13/2015 10:28:52,false,pocketmoneygpt,1.0,28884030,USA,WI,Minocqua,75.143.134.247,[PREVENTS],[PREVENTS],prevents,n/a,64,43,-1,87,45,TWrex-cause,804903-FS1,"McClung M, Clemmesen B, Daifotis A et al.: ALENDRONATE prevents POSTMENOPAUSAL BONE LOSS in women without osteoporosis: a double blind, randomized, controlled trial.",POSTMENOPAUSAL BONE LOSS,ALENDRONATE
721148995,5/13/2015 10:38:17,1635687888,5/13/2015 10:37:10,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[PREVENTS],[PREVENTS],POSTMENOPAUSAL BONE LOSS,N/A,64,43,-1,87,45,TWrex-cause,804903-FS1,"McClung M, Clemmesen B, Daifotis A et al.: ALENDRONATE prevents POSTMENOPAUSAL BONE LOSS in women without osteoporosis: a double blind, randomized, controlled trial.",POSTMENOPAUSAL BONE LOSS,ALENDRONATE
721148995,5/13/2015 10:50:24,1635691361,5/13/2015 10:50:01,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,[PREVENTS],[PREVENTS],prevents,n/a,64,43,-1,87,45,TWrex-cause,804903-FS1,"McClung M, Clemmesen B, Daifotis A et al.: ALENDRONATE prevents POSTMENOPAUSAL BONE LOSS in women without osteoporosis: a double blind, randomized, controlled trial.",POSTMENOPAUSAL BONE LOSS,ALENDRONATE
721148995,5/13/2015 10:53:16,1635692305,5/13/2015 10:52:47,false,neodev,1.0,29579905,GBR,"","",5.152.206.71,[CAUSES] [CONTRAINDICATES],"[CAUSES]
[CONTRAINDICATES]",ALENDRONATE women,N/A,64,43,-1,87,45,TWrex-cause,804903-FS1,"McClung M, Clemmesen B, Daifotis A et al.: ALENDRONATE prevents POSTMENOPAUSAL BONE LOSS in women without osteoporosis: a double blind, randomized, controlled trial.",POSTMENOPAUSAL BONE LOSS,ALENDRONATE
721148995,5/13/2015 10:54:59,1635692670,5/13/2015 10:54:48,false,neodev,1.0,31706957,NLD,07,Amsterdam,145.100.72.165,[PREVENTS],[PREVENTS],prevents,n/a,64,43,-1,87,45,TWrex-cause,804903-FS1,"McClung M, Clemmesen B, Daifotis A et al.: ALENDRONATE prevents POSTMENOPAUSAL BONE LOSS in women without osteoporosis: a double blind, randomized, controlled trial.",POSTMENOPAUSAL BONE LOSS,ALENDRONATE
721148995,5/13/2015 10:56:37,1635693128,5/13/2015 10:56:24,false,elite,1.0,31856422,GBR,C9,Workington,92.18.169.149,[PREVENTS],[PREVENTS],prevents,N/A,64,43,-1,87,45,TWrex-cause,804903-FS1,"McClung M, Clemmesen B, Daifotis A et al.: ALENDRONATE prevents POSTMENOPAUSAL BONE LOSS in women without osteoporosis: a double blind, randomized, controlled trial.",POSTMENOPAUSAL BONE LOSS,ALENDRONATE
721148995,5/13/2015 11:06:21,1635696067,5/13/2015 11:05:59,false,instagc,1.0,24252915,GBR,K6,Portsmouth,89.240.160.95,[PREVENTS],[PREVENTS],ALENDRONATE prevents POSTMENOPAUSAL BONE LOSS,N/a,64,43,-1,87,45,TWrex-cause,804903-FS1,"McClung M, Clemmesen B, Daifotis A et al.: ALENDRONATE prevents POSTMENOPAUSAL BONE LOSS in women without osteoporosis: a double blind, randomized, controlled trial.",POSTMENOPAUSAL BONE LOSS,ALENDRONATE
721148995,5/13/2015 11:08:36,1635696580,5/13/2015 11:08:23,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[PREVENTS],[PREVENTS],prevents,n/a,64,43,-1,87,45,TWrex-cause,804903-FS1,"McClung M, Clemmesen B, Daifotis A et al.: ALENDRONATE prevents POSTMENOPAUSAL BONE LOSS in women without osteoporosis: a double blind, randomized, controlled trial.",POSTMENOPAUSAL BONE LOSS,ALENDRONATE
721148995,5/13/2015 11:14:52,1635697906,5/13/2015 11:14:31,false,prodege,1.0,27934334,GBR,D3,Swadlincote,109.150.228.127,[PREVENTS],[PREVENTS],prevents,N/A,64,43,-1,87,45,TWrex-cause,804903-FS1,"McClung M, Clemmesen B, Daifotis A et al.: ALENDRONATE prevents POSTMENOPAUSAL BONE LOSS in women without osteoporosis: a double blind, randomized, controlled trial.",POSTMENOPAUSAL BONE LOSS,ALENDRONATE
721148995,5/13/2015 11:19:12,1635699262,5/13/2015 11:18:43,false,points4rewards,1.0,28703583,USA,"","",97.73.86.35,[PREVENTS],[PREVENTS],prevents,N/A,64,43,-1,87,45,TWrex-cause,804903-FS1,"McClung M, Clemmesen B, Daifotis A et al.: ALENDRONATE prevents POSTMENOPAUSAL BONE LOSS in women without osteoporosis: a double blind, randomized, controlled trial.",POSTMENOPAUSAL BONE LOSS,ALENDRONATE
721148996,5/13/2015 11:47:42,1635706611,5/13/2015 11:47:16,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[CAUSES],[CAUSES],HYPERTENSION may result from SECRETION (PHEOCHROMOCYTOMAS),n/a,0,69,1,11,98,TWrex-cause,813064-FS1,HYPERTENSION may result from abnormal epinephrine and norepinephrine SECRETION (PHEOCHROMOCYTOMAS) or from cortisol excess (ACTH secreting tumors.,HYPERTENSION,SECRETION (PHEOCHROMOCYTOMAS)
721148996,5/13/2015 11:50:13,1635707192,5/13/2015 11:49:59,false,neodev,1.0,31726043,GBR,"","",88.150.202.140,[PREVENTS],[PREVENTS],(PHEOCHROMOCYTOMAS),5441,0,69,1,11,98,TWrex-cause,813064-FS1,HYPERTENSION may result from abnormal epinephrine and norepinephrine SECRETION (PHEOCHROMOCYTOMAS) or from cortisol excess (ACTH secreting tumors.,HYPERTENSION,SECRETION (PHEOCHROMOCYTOMAS)
721148996,5/13/2015 12:30:50,1635721324,5/13/2015 12:30:25,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[SYMPTOM],[SYMPTOM],HYPERTENSION may result from SECRETION (PHEOCHROMOCYTOMAS),n/a,0,69,1,11,98,TWrex-cause,813064-FS1,HYPERTENSION may result from abnormal epinephrine and norepinephrine SECRETION (PHEOCHROMOCYTOMAS) or from cortisol excess (ACTH secreting tumors.,HYPERTENSION,SECRETION (PHEOCHROMOCYTOMAS)
721148996,5/13/2015 13:03:28,1635729789,5/13/2015 13:03:12,false,neodev,1.0,30504276,CAN,ON,Sudbury,66.103.55.12,[SYMPTOM],[SYMPTOM],may result from,N/A,0,69,1,11,98,TWrex-cause,813064-FS1,HYPERTENSION may result from abnormal epinephrine and norepinephrine SECRETION (PHEOCHROMOCYTOMAS) or from cortisol excess (ACTH secreting tumors.,HYPERTENSION,SECRETION (PHEOCHROMOCYTOMAS)
721148996,5/13/2015 13:05:17,1635730512,5/13/2015 13:04:14,false,clixsense,1.0,24329110,USA,FL,Jacksonville,12.168.136.2,[MANIFESTATION],[MANIFESTATION],may result from,n/a,0,69,1,11,98,TWrex-cause,813064-FS1,HYPERTENSION may result from abnormal epinephrine and norepinephrine SECRETION (PHEOCHROMOCYTOMAS) or from cortisol excess (ACTH secreting tumors.,HYPERTENSION,SECRETION (PHEOCHROMOCYTOMAS)
721148996,5/13/2015 13:10:12,1635731720,5/13/2015 13:08:45,false,prodege,1.0,23482077,USA,TX,Garland,71.164.238.226,[CAUSES] [SYMPTOM] [MANIFESTATION],"[CAUSES]
[SYMPTOM]
[MANIFESTATION]",may result from,N/A,0,69,1,11,98,TWrex-cause,813064-FS1,HYPERTENSION may result from abnormal epinephrine and norepinephrine SECRETION (PHEOCHROMOCYTOMAS) or from cortisol excess (ACTH secreting tumors.,HYPERTENSION,SECRETION (PHEOCHROMOCYTOMAS)
721148996,5/13/2015 13:11:22,1635731965,5/13/2015 13:10:51,false,clixsense,1.0,23197581,NLD,11,Den Haag,82.217.5.55,[SYMPTOM],[SYMPTOM],may result from abnormal epinephrine and norepinephrine SECRETION,N/A,0,69,1,11,98,TWrex-cause,813064-FS1,HYPERTENSION may result from abnormal epinephrine and norepinephrine SECRETION (PHEOCHROMOCYTOMAS) or from cortisol excess (ACTH secreting tumors.,HYPERTENSION,SECRETION (PHEOCHROMOCYTOMAS)
721148996,5/13/2015 13:28:18,1635736526,5/13/2015 13:27:24,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[CAUSES] [CONTRAINDICATES],"[CAUSES]
[CONTRAINDICATES]",HYPERTENSION may result from SECRETION (PHEOCHROMOCYTOMAS),N/A,0,69,1,11,98,TWrex-cause,813064-FS1,HYPERTENSION may result from abnormal epinephrine and norepinephrine SECRETION (PHEOCHROMOCYTOMAS) or from cortisol excess (ACTH secreting tumors.,HYPERTENSION,SECRETION (PHEOCHROMOCYTOMAS)
721148996,5/13/2015 13:29:01,1635736707,5/13/2015 13:28:28,false,clixsense,1.0,6574449,USA,"","",216.216.68.85,[OTHER],[OTHER],HYPERTENSION result abnormal epinephrine norepinephrine SECRETION (PHEOCHROMOCYTOMAS) cortisol excess (ACTH secreting tumors.,na,0,69,1,11,98,TWrex-cause,813064-FS1,HYPERTENSION may result from abnormal epinephrine and norepinephrine SECRETION (PHEOCHROMOCYTOMAS) or from cortisol excess (ACTH secreting tumors.,HYPERTENSION,SECRETION (PHEOCHROMOCYTOMAS)
721148996,5/13/2015 13:36:58,1635738905,5/13/2015 13:35:53,false,bitcoinget,1.0,21614812,USA,PA,Erie,174.100.250.115,[ASSOCIATED_WITH],[ASSOCIATED_WITH],may result from,N/A,0,69,1,11,98,TWrex-cause,813064-FS1,HYPERTENSION may result from abnormal epinephrine and norepinephrine SECRETION (PHEOCHROMOCYTOMAS) or from cortisol excess (ACTH secreting tumors.,HYPERTENSION,SECRETION (PHEOCHROMOCYTOMAS)
721148996,5/13/2015 13:42:09,1635740227,5/13/2015 13:41:07,false,neodev,1.0,24564999,GBR,H9,London,86.145.227.9,[CAUSES],[CAUSES],may result from,N/A,0,69,1,11,98,TWrex-cause,813064-FS1,HYPERTENSION may result from abnormal epinephrine and norepinephrine SECRETION (PHEOCHROMOCYTOMAS) or from cortisol excess (ACTH secreting tumors.,HYPERTENSION,SECRETION (PHEOCHROMOCYTOMAS)
721148996,5/13/2015 13:51:22,1635743894,5/13/2015 13:50:53,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[CAUSES],[CAUSES],may result,N/A,0,69,1,11,98,TWrex-cause,813064-FS1,HYPERTENSION may result from abnormal epinephrine and norepinephrine SECRETION (PHEOCHROMOCYTOMAS) or from cortisol excess (ACTH secreting tumors.,HYPERTENSION,SECRETION (PHEOCHROMOCYTOMAS)
721148996,5/13/2015 14:10:59,1635752313,5/13/2015 14:09:54,false,prodege,1.0,24403612,CAN,ON,Ajax,99.239.181.149,[CAUSES],[CAUSES],HYPERTENSION result from SECRETION (PHEOCHROMOCYTOMAS),N/A,0,69,1,11,98,TWrex-cause,813064-FS1,HYPERTENSION may result from abnormal epinephrine and norepinephrine SECRETION (PHEOCHROMOCYTOMAS) or from cortisol excess (ACTH secreting tumors.,HYPERTENSION,SECRETION (PHEOCHROMOCYTOMAS)
721148996,5/13/2015 14:22:50,1635756965,5/13/2015 14:22:31,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[CAUSES],[CAUSES],result from,N/A,0,69,1,11,98,TWrex-cause,813064-FS1,HYPERTENSION may result from abnormal epinephrine and norepinephrine SECRETION (PHEOCHROMOCYTOMAS) or from cortisol excess (ACTH secreting tumors.,HYPERTENSION,SECRETION (PHEOCHROMOCYTOMAS)
721148996,5/13/2015 15:07:29,1635786596,5/13/2015 15:06:52,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,[CAUSES],[CAUSES],result,n/a,0,69,1,11,98,TWrex-cause,813064-FS1,HYPERTENSION may result from abnormal epinephrine and norepinephrine SECRETION (PHEOCHROMOCYTOMAS) or from cortisol excess (ACTH secreting tumors.,HYPERTENSION,SECRETION (PHEOCHROMOCYTOMAS)
721148997,5/13/2015 10:20:21,1635682634,5/13/2015 10:18:55,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[PART_OF],[PART_OF],"The widely used World Health Organization system classifies endometrial hyperplasia according to four combinations of glandular crowding and NUCLEAR ATYPIA: simple, complex, simple atypical, or COMPLEX ATYPICAL HYPERPLASIA although the two forms of atypical hyperplasia are often collapsed into one category.",N/A,153,206,1,166,234,TWrex-cause,814550-FS1,"Comments: • The widely used World Health Organization system classifies endometrial hyperplasia according to four combinations of glandular crowding and NUCLEAR ATYPIA: simple, complex, simple atypical, or COMPLEX ATYPICAL HYPERPLASIA although the two forms of atypical hyperplasia are often collapsed into one category.",NUCLEAR ATYPIA,COMPLEX ATYPICAL HYPERPLASIA
721148997,5/13/2015 10:37:57,1635687779,5/13/2015 10:36:59,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[IS_A],[IS_A],classifies according to four combinations,n/a,153,206,1,166,234,TWrex-cause,814550-FS1,"Comments: • The widely used World Health Organization system classifies endometrial hyperplasia according to four combinations of glandular crowding and NUCLEAR ATYPIA: simple, complex, simple atypical, or COMPLEX ATYPICAL HYPERPLASIA although the two forms of atypical hyperplasia are often collapsed into one category.",NUCLEAR ATYPIA,COMPLEX ATYPICAL HYPERPLASIA
721148997,5/13/2015 10:38:27,1635687915,5/13/2015 10:36:26,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[IS_A] [PART_OF],"[IS_A]
[PART_OF]",classifies,N/A,153,206,1,166,234,TWrex-cause,814550-FS1,"Comments: • The widely used World Health Organization system classifies endometrial hyperplasia according to four combinations of glandular crowding and NUCLEAR ATYPIA: simple, complex, simple atypical, or COMPLEX ATYPICAL HYPERPLASIA although the two forms of atypical hyperplasia are often collapsed into one category.",NUCLEAR ATYPIA,COMPLEX ATYPICAL HYPERPLASIA
721148997,5/13/2015 10:49:25,1635691008,5/13/2015 10:48:38,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[TREATS],[TREATS],COMPLEX ATYPICAL HYPERPLASIA,N/A,153,206,1,166,234,TWrex-cause,814550-FS1,"Comments: • The widely used World Health Organization system classifies endometrial hyperplasia according to four combinations of glandular crowding and NUCLEAR ATYPIA: simple, complex, simple atypical, or COMPLEX ATYPICAL HYPERPLASIA although the two forms of atypical hyperplasia are often collapsed into one category.",NUCLEAR ATYPIA,COMPLEX ATYPICAL HYPERPLASIA
721148997,5/13/2015 11:13:30,1635697598,5/13/2015 11:13:11,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[ASSOCIATED_WITH],[ASSOCIATED_WITH],or,n/a,153,206,1,166,234,TWrex-cause,814550-FS1,"Comments: • The widely used World Health Organization system classifies endometrial hyperplasia according to four combinations of glandular crowding and NUCLEAR ATYPIA: simple, complex, simple atypical, or COMPLEX ATYPICAL HYPERPLASIA although the two forms of atypical hyperplasia are often collapsed into one category.",NUCLEAR ATYPIA,COMPLEX ATYPICAL HYPERPLASIA
721148997,5/13/2015 11:13:57,1635697664,5/13/2015 11:13:35,false,neodev,1.0,31706957,NLD,07,Amsterdam,145.100.72.165,[PART_OF],[PART_OF],classifies to four combinations of,n/a,153,206,1,166,234,TWrex-cause,814550-FS1,"Comments: • The widely used World Health Organization system classifies endometrial hyperplasia according to four combinations of glandular crowding and NUCLEAR ATYPIA: simple, complex, simple atypical, or COMPLEX ATYPICAL HYPERPLASIA although the two forms of atypical hyperplasia are often collapsed into one category.",NUCLEAR ATYPIA,COMPLEX ATYPICAL HYPERPLASIA
721148997,5/13/2015 11:28:37,1635701460,5/13/2015 11:27:40,false,prodege,1.0,27934334,GBR,D3,Swadlincote,109.150.228.127,[IS_A],[IS_A],classifies,N/A,153,206,1,166,234,TWrex-cause,814550-FS1,"Comments: • The widely used World Health Organization system classifies endometrial hyperplasia according to four combinations of glandular crowding and NUCLEAR ATYPIA: simple, complex, simple atypical, or COMPLEX ATYPICAL HYPERPLASIA although the two forms of atypical hyperplasia are often collapsed into one category.",NUCLEAR ATYPIA,COMPLEX ATYPICAL HYPERPLASIA
721148997,5/13/2015 11:34:16,1635702611,5/13/2015 11:33:34,false,points4rewards,1.0,28703583,USA,"","",97.73.86.35,[ASSOCIATED_WITH],[ASSOCIATED_WITH],into one category.,N/A,153,206,1,166,234,TWrex-cause,814550-FS1,"Comments: • The widely used World Health Organization system classifies endometrial hyperplasia according to four combinations of glandular crowding and NUCLEAR ATYPIA: simple, complex, simple atypical, or COMPLEX ATYPICAL HYPERPLASIA although the two forms of atypical hyperplasia are often collapsed into one category.",NUCLEAR ATYPIA,COMPLEX ATYPICAL HYPERPLASIA
721148997,5/13/2015 11:37:48,1635704286,5/13/2015 11:36:49,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[ASSOCIATED_WITH],[ASSOCIATED_WITH],classifies according to NUCLEAR ATYPIA: or COMPLEX ATYPICAL HYPERPLASIA,n/a,153,206,1,166,234,TWrex-cause,814550-FS1,"Comments: • The widely used World Health Organization system classifies endometrial hyperplasia according to four combinations of glandular crowding and NUCLEAR ATYPIA: simple, complex, simple atypical, or COMPLEX ATYPICAL HYPERPLASIA although the two forms of atypical hyperplasia are often collapsed into one category.",NUCLEAR ATYPIA,COMPLEX ATYPICAL HYPERPLASIA
721148997,5/13/2015 11:44:21,1635705621,5/13/2015 11:44:05,false,neodev,1.0,31726043,GBR,"","",88.150.202.140,[SYMPTOM],[SYMPTOM],classifies,5151,153,206,1,166,234,TWrex-cause,814550-FS1,"Comments: • The widely used World Health Organization system classifies endometrial hyperplasia according to four combinations of glandular crowding and NUCLEAR ATYPIA: simple, complex, simple atypical, or COMPLEX ATYPICAL HYPERPLASIA although the two forms of atypical hyperplasia are often collapsed into one category.",NUCLEAR ATYPIA,COMPLEX ATYPICAL HYPERPLASIA
721148997,5/13/2015 12:18:56,1635717211,5/13/2015 12:17:12,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,[NONE],[NONE],n/a,n/a,153,206,1,166,234,TWrex-cause,814550-FS1,"Comments: • The widely used World Health Organization system classifies endometrial hyperplasia according to four combinations of glandular crowding and NUCLEAR ATYPIA: simple, complex, simple atypical, or COMPLEX ATYPICAL HYPERPLASIA although the two forms of atypical hyperplasia are often collapsed into one category.",NUCLEAR ATYPIA,COMPLEX ATYPICAL HYPERPLASIA
721148997,5/13/2015 12:21:26,1635718222,5/13/2015 12:20:35,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[PART_OF],[PART_OF],NUCLEAR ATYPIA: or COMPLEX ATYPICAL HYPERPLASIA,n/a,153,206,1,166,234,TWrex-cause,814550-FS1,"Comments: • The widely used World Health Organization system classifies endometrial hyperplasia according to four combinations of glandular crowding and NUCLEAR ATYPIA: simple, complex, simple atypical, or COMPLEX ATYPICAL HYPERPLASIA although the two forms of atypical hyperplasia are often collapsed into one category.",NUCLEAR ATYPIA,COMPLEX ATYPICAL HYPERPLASIA
721148997,5/13/2015 12:24:59,1635719591,5/13/2015 12:23:54,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[IS_A],[IS_A],classifies,N/A,153,206,1,166,234,TWrex-cause,814550-FS1,"Comments: • The widely used World Health Organization system classifies endometrial hyperplasia according to four combinations of glandular crowding and NUCLEAR ATYPIA: simple, complex, simple atypical, or COMPLEX ATYPICAL HYPERPLASIA although the two forms of atypical hyperplasia are often collapsed into one category.",NUCLEAR ATYPIA,COMPLEX ATYPICAL HYPERPLASIA
721148997,5/13/2015 12:47:13,1635725483,5/13/2015 12:45:23,false,prodege,1.0,23482077,USA,TX,Garland,71.164.238.226,[SYMPTOM] [MANIFESTATION],"[SYMPTOM]
[MANIFESTATION]",classifies according to,N/A,153,206,1,166,234,TWrex-cause,814550-FS1,"Comments: • The widely used World Health Organization system classifies endometrial hyperplasia according to four combinations of glandular crowding and NUCLEAR ATYPIA: simple, complex, simple atypical, or COMPLEX ATYPICAL HYPERPLASIA although the two forms of atypical hyperplasia are often collapsed into one category.",NUCLEAR ATYPIA,COMPLEX ATYPICAL HYPERPLASIA
721148997,5/13/2015 12:58:56,1635728137,5/13/2015 12:58:29,false,clixsense,1.0,6574449,USA,"","",216.216.68.85,[OTHER],[OTHER],"widely World Health Organization system classifies endometrial hyperplasia four combinations glandular crowding NUCLEAR ATYPIA: simple, complex, simple atypical, COMPLEX ATYPICAL HYPERPLASIA two forms atypical hyperplasia collapsed one category.",na,153,206,1,166,234,TWrex-cause,814550-FS1,"Comments: • The widely used World Health Organization system classifies endometrial hyperplasia according to four combinations of glandular crowding and NUCLEAR ATYPIA: simple, complex, simple atypical, or COMPLEX ATYPICAL HYPERPLASIA although the two forms of atypical hyperplasia are often collapsed into one category.",NUCLEAR ATYPIA,COMPLEX ATYPICAL HYPERPLASIA
721148998,5/13/2015 09:55:56,1635676275,5/13/2015 09:55:46,false,neodev,1,32103286,CAN,AB,Edmonton,208.123.223.37,[CAUSES] [LOCATION] [NONE],"[CAUSES]
[LOCATION]
[NONE]",no,no,31,13,-1,54,18,TWrex-cause,805047-FS1,• The use of DDAVP may prevent PERIOPERATIVE HEMORRHAGE and minimize blood product exposure due to transfusion in low risk procedures.,PERIOPERATIVE HEMORRHAGE,DDAVP
721148998,5/13/2015 10:02:02,1635677866,5/13/2015 10:01:06,false,clixsense,1,10798016,GBR,C7,Coventry,86.24.245.191,[PREVENTS],[PREVENTS],The use of DDAVP may prevent PERIOPERATIVE HEMORRHAGE and minimize blood product exposure due to transfusion in low risk procedures.,N/A,31,13,-1,54,18,TWrex-cause,805047-FS1,• The use of DDAVP may prevent PERIOPERATIVE HEMORRHAGE and minimize blood product exposure due to transfusion in low risk procedures.,PERIOPERATIVE HEMORRHAGE,DDAVP
721148998,5/13/2015 10:18:01,1635681873,5/13/2015 10:17:44,false,clixsense,1,26847653,NLD,03,Warnsveld,213.93.50.164,[PREVENTS],[PREVENTS],may prevent,n/a,31,13,-1,54,18,TWrex-cause,805047-FS1,• The use of DDAVP may prevent PERIOPERATIVE HEMORRHAGE and minimize blood product exposure due to transfusion in low risk procedures.,PERIOPERATIVE HEMORRHAGE,DDAVP
721148998,5/13/2015 10:23:23,1635683531,5/13/2015 10:22:28,false,instagc,1,18531561,CAN,ON,Mississauga,99.229.92.227,[PREVENTS],[PREVENTS],may prevent,n/a,31,13,-1,54,18,TWrex-cause,805047-FS1,• The use of DDAVP may prevent PERIOPERATIVE HEMORRHAGE and minimize blood product exposure due to transfusion in low risk procedures.,PERIOPERATIVE HEMORRHAGE,DDAVP
721148998,5/13/2015 10:23:44,1635683608,5/13/2015 10:23:14,false,points4rewards,1,20113482,USA,OR,Portland,67.213.218.72,[PREVENTS],[PREVENTS],may prevent,N/A,31,13,-1,54,18,TWrex-cause,805047-FS1,• The use of DDAVP may prevent PERIOPERATIVE HEMORRHAGE and minimize blood product exposure due to transfusion in low risk procedures.,PERIOPERATIVE HEMORRHAGE,DDAVP
721148998,5/13/2015 10:29:44,1635685338,5/13/2015 10:29:31,false,pocketmoneygpt,1,28884030,USA,WI,Minocqua,75.143.134.247,[PREVENTS],[PREVENTS],prevent,n/a,31,13,-1,54,18,TWrex-cause,805047-FS1,• The use of DDAVP may prevent PERIOPERATIVE HEMORRHAGE and minimize blood product exposure due to transfusion in low risk procedures.,PERIOPERATIVE HEMORRHAGE,DDAVP
721148998,5/13/2015 10:40:09,1635688322,5/13/2015 10:39:04,false,clixsense,1,17950689,GBR,Y9,Tonypandy,92.2.44.79,[CAUSES],[CAUSES],transfusion,N/A,31,13,-1,54,18,TWrex-cause,805047-FS1,• The use of DDAVP may prevent PERIOPERATIVE HEMORRHAGE and minimize blood product exposure due to transfusion in low risk procedures.,PERIOPERATIVE HEMORRHAGE,DDAVP
721148998,5/13/2015 10:51:46,1635691826,5/13/2015 10:51:30,false,clixsense,1,31482589,NLD,"","",31.201.11.16,[PREVENTS],[PREVENTS],prevent,n/a,31,13,-1,54,18,TWrex-cause,805047-FS1,• The use of DDAVP may prevent PERIOPERATIVE HEMORRHAGE and minimize blood product exposure due to transfusion in low risk procedures.,PERIOPERATIVE HEMORRHAGE,DDAVP
721148998,5/13/2015 10:54:36,1635692637,5/13/2015 10:53:54,false,neodev,1,29579905,GBR,"","",5.152.206.71,[LOCATION] [CAUSES],"[CAUSES]
[LOCATION]",DDAVP PERIOPERATIVE exposure,N/A,31,13,-1,54,18,TWrex-cause,805047-FS1,• The use of DDAVP may prevent PERIOPERATIVE HEMORRHAGE and minimize blood product exposure due to transfusion in low risk procedures.,PERIOPERATIVE HEMORRHAGE,DDAVP
721148998,5/13/2015 10:55:35,1635692801,5/13/2015 10:55:21,false,neodev,1,31706957,NLD,07,Amsterdam,145.100.72.165,[PREVENTS],[PREVENTS],prevent,n/a,31,13,-1,54,18,TWrex-cause,805047-FS1,• The use of DDAVP may prevent PERIOPERATIVE HEMORRHAGE and minimize blood product exposure due to transfusion in low risk procedures.,PERIOPERATIVE HEMORRHAGE,DDAVP
721148998,5/13/2015 10:57:03,1635693281,5/13/2015 10:56:54,false,elite,1,31856422,GBR,C9,Workington,92.18.169.149,[PREVENTS],[PREVENTS],may prevent,N/A,31,13,-1,54,18,TWrex-cause,805047-FS1,• The use of DDAVP may prevent PERIOPERATIVE HEMORRHAGE and minimize blood product exposure due to transfusion in low risk procedures.,PERIOPERATIVE HEMORRHAGE,DDAVP
721148998,5/13/2015 11:07:14,1635696253,5/13/2015 11:06:59,false,instagc,1,24252915,GBR,K6,Portsmouth,89.240.160.95,[PREVENTS],[PREVENTS],DDAVP prevent PERIOPERATIVE HEMORRHAGE,N/a,31,13,-1,54,18,TWrex-cause,805047-FS1,• The use of DDAVP may prevent PERIOPERATIVE HEMORRHAGE and minimize blood product exposure due to transfusion in low risk procedures.,PERIOPERATIVE HEMORRHAGE,DDAVP
721148998,5/13/2015 11:09:14,1635696692,5/13/2015 11:09:02,false,instagc,1,13581319,USA,IL,Mount Vernon,66.232.166.86,[PREVENTS],[PREVENTS],prevent,n/a,31,13,-1,54,18,TWrex-cause,805047-FS1,• The use of DDAVP may prevent PERIOPERATIVE HEMORRHAGE and minimize blood product exposure due to transfusion in low risk procedures.,PERIOPERATIVE HEMORRHAGE,DDAVP
721148998,5/13/2015 11:16:36,1635698573,5/13/2015 11:15:30,false,prodege,1,27934334,GBR,D3,Swadlincote,109.150.228.127,[PREVENTS],[PREVENTS],may prevent,N/A,31,13,-1,54,18,TWrex-cause,805047-FS1,• The use of DDAVP may prevent PERIOPERATIVE HEMORRHAGE and minimize blood product exposure due to transfusion in low risk procedures.,PERIOPERATIVE HEMORRHAGE,DDAVP
721148998,5/13/2015 11:20:06,1635699467,5/13/2015 11:19:17,false,points4rewards,1,28703583,USA,"","",97.73.86.35,[PREVENTS],[PREVENTS],may prevent,N/A,31,13,-1,54,18,TWrex-cause,805047-FS1,• The use of DDAVP may prevent PERIOPERATIVE HEMORRHAGE and minimize blood product exposure due to transfusion in low risk procedures.,PERIOPERATIVE HEMORRHAGE,DDAVP
721148999,5/13/2015 16:51:24,1635861814,5/13/2015 16:51:04,false,clixsense,1,31579138,AUS,02,Hurstville,14.200.129.68,[TREATS],[TREATS],TREATMENT,N/A,125,100,-1,143,120,TWrex-cause,800791-FS1,"2]  Yamada M, Fukuda Y, Koyama Y, Nakano I, Urano F, Isobe K, et al. A long term follow up study of INTERFERON TREATMENT for CHRONIC HEPATITIS C in Japanese patients with congenital bleeding disorders.",CHRONIC HEPATITIS C,INTERFERON TREATMENT
721148999,5/13/2015 17:35:51,1635886136,5/13/2015 17:34:40,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[TREATS],[TREATS],for,n/a,125,100,-1,143,120,TWrex-cause,800791-FS1,"2]  Yamada M, Fukuda Y, Koyama Y, Nakano I, Urano F, Isobe K, et al. A long term follow up study of INTERFERON TREATMENT for CHRONIC HEPATITIS C in Japanese patients with congenital bleeding disorders.",CHRONIC HEPATITIS C,INTERFERON TREATMENT
721148999,5/13/2015 17:41:12,1635889337,5/13/2015 17:40:48,false,gptking,1,31799065,USA,IL,Marion,50.45.43.154,[TREATS],[TREATS],INTERFERON TREATMENT CHRONIC HEPATITIS C,N/A,125,100,-1,143,120,TWrex-cause,800791-FS1,"2]  Yamada M, Fukuda Y, Koyama Y, Nakano I, Urano F, Isobe K, et al. A long term follow up study of INTERFERON TREATMENT for CHRONIC HEPATITIS C in Japanese patients with congenital bleeding disorders.",CHRONIC HEPATITIS C,INTERFERON TREATMENT
721148999,5/13/2015 18:18:44,1635906906,5/13/2015 18:18:18,false,instagc,1,30326470,USA,CA,Santee,99.44.37.73,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],follow up study,N/A,125,100,-1,143,120,TWrex-cause,800791-FS1,"2]  Yamada M, Fukuda Y, Koyama Y, Nakano I, Urano F, Isobe K, et al. A long term follow up study of INTERFERON TREATMENT for CHRONIC HEPATITIS C in Japanese patients with congenital bleeding disorders.",CHRONIC HEPATITIS C,INTERFERON TREATMENT
721148999,5/13/2015 18:27:07,1635911630,5/13/2015 18:26:21,false,zoombucks,1,6744840,CAN,BC,Kelowna,174.4.58.160,[TREATS],[TREATS],INTERFERON TREATMENT for CHRONIC HEPATITIS C,N/A,125,100,-1,143,120,TWrex-cause,800791-FS1,"2]  Yamada M, Fukuda Y, Koyama Y, Nakano I, Urano F, Isobe K, et al. A long term follow up study of INTERFERON TREATMENT for CHRONIC HEPATITIS C in Japanese patients with congenital bleeding disorders.",CHRONIC HEPATITIS C,INTERFERON TREATMENT
721148999,5/13/2015 18:49:12,1635922447,5/13/2015 18:48:30,false,prodege,1,32302664,USA,IL,Geneseo,173.27.241.235,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],for,no comment,125,100,-1,143,120,TWrex-cause,800791-FS1,"2]  Yamada M, Fukuda Y, Koyama Y, Nakano I, Urano F, Isobe K, et al. A long term follow up study of INTERFERON TREATMENT for CHRONIC HEPATITIS C in Japanese patients with congenital bleeding disorders.",CHRONIC HEPATITIS C,INTERFERON TREATMENT
721148999,5/13/2015 19:17:19,1635939798,5/13/2015 19:14:49,false,clixsense,1,30681826,GBR,I3,Rochester,86.163.150.232,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],study for,N/A,125,100,-1,143,120,TWrex-cause,800791-FS1,"2]  Yamada M, Fukuda Y, Koyama Y, Nakano I, Urano F, Isobe K, et al. A long term follow up study of INTERFERON TREATMENT for CHRONIC HEPATITIS C in Japanese patients with congenital bleeding disorders.",CHRONIC HEPATITIS C,INTERFERON TREATMENT
721148999,5/13/2015 19:47:18,1635964961,5/13/2015 19:46:34,false,elite,1,30064988,GBR,H3,Leeds,92.22.208.245,[OTHER],[OTHER],follow up study,N/A,125,100,-1,143,120,TWrex-cause,800791-FS1,"2]  Yamada M, Fukuda Y, Koyama Y, Nakano I, Urano F, Isobe K, et al. A long term follow up study of INTERFERON TREATMENT for CHRONIC HEPATITIS C in Japanese patients with congenital bleeding disorders.",CHRONIC HEPATITIS C,INTERFERON TREATMENT
721148999,5/13/2015 20:07:29,1635981053,5/13/2015 20:07:12,false,instagc,1,20312760,GBR,I2,Manchester,90.244.156.243,[TREATS],[TREATS],INTERFERON TREATMENT for CHRONIC HEPATITIS C,N/A,125,100,-1,143,120,TWrex-cause,800791-FS1,"2]  Yamada M, Fukuda Y, Koyama Y, Nakano I, Urano F, Isobe K, et al. A long term follow up study of INTERFERON TREATMENT for CHRONIC HEPATITIS C in Japanese patients with congenital bleeding disorders.",CHRONIC HEPATITIS C,INTERFERON TREATMENT
721148999,5/13/2015 20:08:42,1635981921,5/13/2015 20:08:01,false,clixsense,1,27969116,NLD,"","",212.78.195.38,[ASSOCIATED_WITH],[ASSOCIATED_WITH],follow up,none,125,100,-1,143,120,TWrex-cause,800791-FS1,"2]  Yamada M, Fukuda Y, Koyama Y, Nakano I, Urano F, Isobe K, et al. A long term follow up study of INTERFERON TREATMENT for CHRONIC HEPATITIS C in Japanese patients with congenital bleeding disorders.",CHRONIC HEPATITIS C,INTERFERON TREATMENT
721148999,5/13/2015 20:34:48,1636000672,5/13/2015 20:34:17,false,neodev,1,20961587,NLD,05,Maastricht,84.26.48.136,[OTHER],[OTHER],study,N/A,125,100,-1,143,120,TWrex-cause,800791-FS1,"2]  Yamada M, Fukuda Y, Koyama Y, Nakano I, Urano F, Isobe K, et al. A long term follow up study of INTERFERON TREATMENT for CHRONIC HEPATITIS C in Japanese patients with congenital bleeding disorders.",CHRONIC HEPATITIS C,INTERFERON TREATMENT
721148999,5/13/2015 20:51:08,1636011819,5/13/2015 20:49:20,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[DIAGNOSE_BY_TEST_OR_DRUG] [TREATS],"[TREATS]
[DIAGNOSE_BY_TEST_OR_DRUG]",long term follow up study of INTERFERON TREATMENT for CHRONIC HEPATITIS C,N/A,125,100,-1,143,120,TWrex-cause,800791-FS1,"2]  Yamada M, Fukuda Y, Koyama Y, Nakano I, Urano F, Isobe K, et al. A long term follow up study of INTERFERON TREATMENT for CHRONIC HEPATITIS C in Japanese patients with congenital bleeding disorders.",CHRONIC HEPATITIS C,INTERFERON TREATMENT
721148999,5/13/2015 20:56:06,1636015121,5/13/2015 20:55:48,false,elite,1,32732290,GBR,A7,Birmingham,86.147.79.250,[TREATS],[TREATS],TREATMENT for,N/A,125,100,-1,143,120,TWrex-cause,800791-FS1,"2]  Yamada M, Fukuda Y, Koyama Y, Nakano I, Urano F, Isobe K, et al. A long term follow up study of INTERFERON TREATMENT for CHRONIC HEPATITIS C in Japanese patients with congenital bleeding disorders.",CHRONIC HEPATITIS C,INTERFERON TREATMENT
721148999,5/13/2015 21:10:47,1636025283,5/13/2015 21:10:03,false,clixsense,1.0,26847653,NLD,03,Warnsveld,213.93.50.164,[TREATS],[TREATS],INTERFERON TREATMENT for,n/a,125,100,-1,143,120,TWrex-cause,800791-FS1,"2]  Yamada M, Fukuda Y, Koyama Y, Nakano I, Urano F, Isobe K, et al. A long term follow up study of INTERFERON TREATMENT for CHRONIC HEPATITIS C in Japanese patients with congenital bleeding disorders.",CHRONIC HEPATITIS C,INTERFERON TREATMENT
721148999,5/13/2015 21:18:52,1636030235,5/13/2015 21:17:22,false,neodev,1,11460728,CAN,BC,Burnaby,70.79.16.165,[TREATS],[TREATS],INTERFERON TREATMENT CHRONIC HEPATITIS C,N/A,125,100,-1,143,120,TWrex-cause,800791-FS1,"2]  Yamada M, Fukuda Y, Koyama Y, Nakano I, Urano F, Isobe K, et al. A long term follow up study of INTERFERON TREATMENT for CHRONIC HEPATITIS C in Japanese patients with congenital bleeding disorders.",CHRONIC HEPATITIS C,INTERFERON TREATMENT
721149000,5/13/2015 13:06:36,1635730891,5/13/2015 13:06:26,false,neodev,1.0,30504276,CAN,ON,Sudbury,66.103.55.12,[PREVENTS],[PREVENTS],preventing,N/A,57,15,-1,67,24,TWrex-cause,805203-FS1,2007 07 18     VITAMIN C for preventing and treating the COMMON COLD,COMMON COLD,VITAMIN C
721149000,5/13/2015 13:15:51,1635733280,5/13/2015 13:15:25,false,clixsense,1.0,24329110,USA,FL,Jacksonville,12.168.136.2,[TREATS] [PREVENTS],"[TREATS]
[PREVENTS]",preventing and treating,n/a,57,15,-1,67,24,TWrex-cause,805203-FS1,2007 07 18     VITAMIN C for preventing and treating the COMMON COLD,COMMON COLD,VITAMIN C
721149000,5/13/2015 13:17:44,1635733712,5/13/2015 13:17:25,false,clixsense,1.0,23197581,NLD,11,Den Haag,82.217.5.55,[PREVENTS] [TREATS],"[TREATS]
[PREVENTS]",for preventing and treating,N/A,57,15,-1,67,24,TWrex-cause,805203-FS1,2007 07 18     VITAMIN C for preventing and treating the COMMON COLD,COMMON COLD,VITAMIN C
721149000,5/13/2015 13:19:59,1635734446,5/13/2015 13:19:40,false,prodege,1.0,23482077,USA,TX,Garland,71.164.238.226,[TREATS] [PREVENTS],"[TREATS]
[PREVENTS]",preventing treating,N/A,57,15,-1,67,24,TWrex-cause,805203-FS1,2007 07 18     VITAMIN C for preventing and treating the COMMON COLD,COMMON COLD,VITAMIN C
721149000,5/13/2015 13:41:59,1635740182,5/13/2015 13:41:46,false,bitcoinget,1.0,21614812,USA,PA,Erie,174.100.250.115,[TREATS] [PREVENTS],"[TREATS]
[PREVENTS]",preventing and treating,N/A,57,15,-1,67,24,TWrex-cause,805203-FS1,2007 07 18     VITAMIN C for preventing and treating the COMMON COLD,COMMON COLD,VITAMIN C
721149000,5/13/2015 13:49:54,1635743261,5/13/2015 13:49:37,false,neodev,1.0,24564999,GBR,H9,London,86.145.227.9,[PREVENTS] [TREATS],"[TREATS]
[PREVENTS]",preventing and treating,N/A,57,15,-1,67,24,TWrex-cause,805203-FS1,2007 07 18     VITAMIN C for preventing and treating the COMMON COLD,COMMON COLD,VITAMIN C
721149000,5/13/2015 13:57:15,1635746317,5/13/2015 13:56:56,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[PREVENTS] [TREATS],"[TREATS]
[PREVENTS]",preventing and treating,N/A,57,15,-1,67,24,TWrex-cause,805203-FS1,2007 07 18     VITAMIN C for preventing and treating the COMMON COLD,COMMON COLD,VITAMIN C
721149000,5/13/2015 14:21:37,1635756419,5/13/2015 14:21:07,false,prodege,1.0,24403612,CAN,ON,Ajax,99.239.181.149,[TREATS] [PREVENTS],"[TREATS]
[PREVENTS]",VITAMIN C for preventing and treating COMMON COLD,N/a,57,15,-1,67,24,TWrex-cause,805203-FS1,2007 07 18     VITAMIN C for preventing and treating the COMMON COLD,COMMON COLD,VITAMIN C
721149000,5/13/2015 14:29:58,1635760426,5/13/2015 14:29:06,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[PREVENTS] [TREATS],"[TREATS]
[PREVENTS]",preventing and treating,N/A,57,15,-1,67,24,TWrex-cause,805203-FS1,2007 07 18     VITAMIN C for preventing and treating the COMMON COLD,COMMON COLD,VITAMIN C
721149000,5/13/2015 15:15:46,1635794489,5/13/2015 15:15:11,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,[TREATS] [PREVENTS],"[TREATS]
[PREVENTS]",preventing treating,n/a,57,15,-1,67,24,TWrex-cause,805203-FS1,2007 07 18     VITAMIN C for preventing and treating the COMMON COLD,COMMON COLD,VITAMIN C
721149000,5/13/2015 15:25:56,1635802490,5/13/2015 15:25:09,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[PREVENTS] [TREATS],"[TREATS]
[PREVENTS]",VITAMIN C for preventing and treating COMMON COLD,N/A,57,15,-1,67,24,TWrex-cause,805203-FS1,2007 07 18     VITAMIN C for preventing and treating the COMMON COLD,COMMON COLD,VITAMIN C
721149000,5/13/2015 15:43:20,1635815948,5/13/2015 15:43:06,false,clixsense,1.0,32549163,CAN,MB,Winnipeg,206.45.167.246,[TREATS] [PREVENTS],"[TREATS]
[PREVENTS]",VITAMIN C for preventing and treating the COMMON COLD,N/A,57,15,-1,67,24,TWrex-cause,805203-FS1,2007 07 18     VITAMIN C for preventing and treating the COMMON COLD,COMMON COLD,VITAMIN C
721149000,5/13/2015 15:59:28,1635828268,5/13/2015 15:59:05,false,instagc,1.0,24252915,GBR,F2,Gosport,92.24.208.155,[TREATS] [PREVENTS],"[TREATS]
[PREVENTS]",preventing and treating,N/a,57,15,-1,67,24,TWrex-cause,805203-FS1,2007 07 18     VITAMIN C for preventing and treating the COMMON COLD,COMMON COLD,VITAMIN C
721149000,5/13/2015 16:02:37,1635831081,5/13/2015 16:02:13,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[TREATS] [PREVENTS],"[TREATS]
[PREVENTS]",preventing treating,none,57,15,-1,67,24,TWrex-cause,805203-FS1,2007 07 18     VITAMIN C for preventing and treating the COMMON COLD,COMMON COLD,VITAMIN C
721149000,5/13/2015 16:27:42,1635847334,5/13/2015 16:27:23,false,prodege,1.0,16101132,GBR,F9,Hayes,2.223.214.149,[TREATS],[TREATS],treating,Treated with,57,15,-1,67,24,TWrex-cause,805203-FS1,2007 07 18     VITAMIN C for preventing and treating the COMMON COLD,COMMON COLD,VITAMIN C
721149001,5/13/2015 16:50:30,1635861459,5/13/2015 16:49:58,false,clixsense,1.0,31579138,AUS,02,Hurstville,14.200.129.68,[TREATS],[TREATS],Treatment,N/A,22,61,1,28,78,TWrex-cause,814950-FS1,Q Fever  Treatment of Q FEVER endocarditis   +    caused by  COXIELLA BURNETII ; used in conjunction with doxycycline.,Q FEVER,COXIELLA BURNETII
721149001,5/13/2015 17:33:45,1635885004,5/13/2015 17:32:23,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[CAUSES],[CAUSES],caused by,n/a,22,61,1,28,78,TWrex-cause,814950-FS1,Q Fever  Treatment of Q FEVER endocarditis   +    caused by  COXIELLA BURNETII ; used in conjunction with doxycycline.,Q FEVER,COXIELLA BURNETII
721149001,5/13/2015 17:40:07,1635888564,5/13/2015 17:39:41,false,gptking,1.0,31799065,USA,IL,Marion,50.45.43.154,[CAUSES],[CAUSES],Q FEVER caused by COXIELLA BURNETII,N/A,22,61,1,28,78,TWrex-cause,814950-FS1,Q Fever  Treatment of Q FEVER endocarditis   +    caused by  COXIELLA BURNETII ; used in conjunction with doxycycline.,Q FEVER,COXIELLA BURNETII
721149001,5/13/2015 18:16:23,1635906009,5/13/2015 18:14:12,false,clixsense,1.0,32549163,CAN,MB,Winnipeg,206.45.167.246,[CAUSES],[CAUSES],Q FEVER caused by COXIELLA BURNETII,N/A,22,61,1,28,78,TWrex-cause,814950-FS1,Q Fever  Treatment of Q FEVER endocarditis   +    caused by  COXIELLA BURNETII ; used in conjunction with doxycycline.,Q FEVER,COXIELLA BURNETII
721149001,5/13/2015 18:17:26,1635906349,5/13/2015 18:17:06,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[TREATS],[TREATS],Treatment,N/A,22,61,1,28,78,TWrex-cause,814950-FS1,Q Fever  Treatment of Q FEVER endocarditis   +    caused by  COXIELLA BURNETII ; used in conjunction with doxycycline.,Q FEVER,COXIELLA BURNETII
721149001,5/13/2015 18:22:01,1635908626,5/13/2015 18:21:39,false,instagc,1.0,24252915,GBR,"","",80.44.146.98,[LOCATION],[LOCATION],caused by,N/a,22,61,1,28,78,TWrex-cause,814950-FS1,Q Fever  Treatment of Q FEVER endocarditis   +    caused by  COXIELLA BURNETII ; used in conjunction with doxycycline.,Q FEVER,COXIELLA BURNETII
721149001,5/13/2015 18:25:21,1635910477,5/13/2015 18:23:52,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[CAUSES],[CAUSES],caused by,N/A,22,61,1,28,78,TWrex-cause,814950-FS1,Q Fever  Treatment of Q FEVER endocarditis   +    caused by  COXIELLA BURNETII ; used in conjunction with doxycycline.,Q FEVER,COXIELLA BURNETII
721149001,5/13/2015 18:47:42,1635921766,5/13/2015 18:47:18,false,prodege,1.0,32302664,USA,IL,Geneseo,173.27.241.235,[CAUSES],[CAUSES],endocarditis + caused by,no comment,22,61,1,28,78,TWrex-cause,814950-FS1,Q Fever  Treatment of Q FEVER endocarditis   +    caused by  COXIELLA BURNETII ; used in conjunction with doxycycline.,Q FEVER,COXIELLA BURNETII
721149001,5/13/2015 19:13:35,1635933908,5/13/2015 19:13:11,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[CAUSES],[CAUSES],caused by,N/A,22,61,1,28,78,TWrex-cause,814950-FS1,Q Fever  Treatment of Q FEVER endocarditis   +    caused by  COXIELLA BURNETII ; used in conjunction with doxycycline.,Q FEVER,COXIELLA BURNETII
721149001,5/13/2015 19:45:59,1635963836,5/13/2015 19:45:37,false,elite,1.0,30064988,GBR,H3,Leeds,92.22.208.245,[CAUSES],[CAUSES],caused by,N/A,22,61,1,28,78,TWrex-cause,814950-FS1,Q Fever  Treatment of Q FEVER endocarditis   +    caused by  COXIELLA BURNETII ; used in conjunction with doxycycline.,Q FEVER,COXIELLA BURNETII
721149001,5/13/2015 20:06:30,1635980186,5/13/2015 20:06:14,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.156.243,[CAUSES],[CAUSES],Q FEVER caused by COXIELLA BURNETII,N/A,22,61,1,28,78,TWrex-cause,814950-FS1,Q Fever  Treatment of Q FEVER endocarditis   +    caused by  COXIELLA BURNETII ; used in conjunction with doxycycline.,Q FEVER,COXIELLA BURNETII
721149001,5/13/2015 20:07:10,1635980718,5/13/2015 20:06:49,false,clixsense,1.0,27969116,NLD,"","",212.78.195.38,[CAUSES],[CAUSES],caused by,is caused by,22,61,1,28,78,TWrex-cause,814950-FS1,Q Fever  Treatment of Q FEVER endocarditis   +    caused by  COXIELLA BURNETII ; used in conjunction with doxycycline.,Q FEVER,COXIELLA BURNETII
721149001,5/13/2015 20:33:26,1635999805,5/13/2015 20:33:14,false,neodev,1.0,20961587,NLD,05,Maastricht,84.26.48.136,[TREATS],[TREATS],Treatment,N/A,22,61,1,28,78,TWrex-cause,814950-FS1,Q Fever  Treatment of Q FEVER endocarditis   +    caused by  COXIELLA BURNETII ; used in conjunction with doxycycline.,Q FEVER,COXIELLA BURNETII
721149001,5/13/2015 20:47:09,1636009196,5/13/2015 20:45:50,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[CAUSES],[CAUSES],Q FEVER caused by COXIELLA BURNETII,N/A,22,61,1,28,78,TWrex-cause,814950-FS1,Q Fever  Treatment of Q FEVER endocarditis   +    caused by  COXIELLA BURNETII ; used in conjunction with doxycycline.,Q FEVER,COXIELLA BURNETII
721149001,5/13/2015 20:55:08,1636014391,5/13/2015 20:54:02,false,elite,1.0,32732290,GBR,A7,Birmingham,86.147.79.250,[CAUSES],[CAUSES],caused by,N/A,22,61,1,28,78,TWrex-cause,814950-FS1,Q Fever  Treatment of Q FEVER endocarditis   +    caused by  COXIELLA BURNETII ; used in conjunction with doxycycline.,Q FEVER,COXIELLA BURNETII
721149002,5/13/2015 11:47:14,1635706490,5/13/2015 11:46:37,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[SIDE_EFFECT],[SIDE_EFFECT],DIABETES MELLITUS reported DIABETIC KETOACIDOSIS has occurred.,n/a,172,53,1,192,70,TWrex-cause,811962-FS1,"185  Hyperglycemic Effects  Hyperglycemia, new onset DIABETES MELLITUS or exacerbation of preexisting diabetes mellitus reported with use of HIV protease inhibitors (PIs); DIABETIC KETOACIDOSIS has occurred.",DIABETIC KETOACIDOSIS,DIABETES MELLITUS
721149002,5/13/2015 11:49:56,1635707132,5/13/2015 11:49:46,false,neodev,1.0,31726043,GBR,"","",88.150.202.140,[LOCATION],[LOCATION],occurred.,44,172,53,1,192,70,TWrex-cause,811962-FS1,"185  Hyperglycemic Effects  Hyperglycemia, new onset DIABETES MELLITUS or exacerbation of preexisting diabetes mellitus reported with use of HIV protease inhibitors (PIs); DIABETIC KETOACIDOSIS has occurred.",DIABETIC KETOACIDOSIS,DIABETES MELLITUS
721149002,5/13/2015 12:30:24,1635721234,5/13/2015 12:29:57,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[SYMPTOM],[SYMPTOM],DIABETES MELLITUS DIABETIC KETOACIDOSIS has occurred.,n/a,172,53,1,192,70,TWrex-cause,811962-FS1,"185  Hyperglycemic Effects  Hyperglycemia, new onset DIABETES MELLITUS or exacerbation of preexisting diabetes mellitus reported with use of HIV protease inhibitors (PIs); DIABETIC KETOACIDOSIS has occurred.",DIABETIC KETOACIDOSIS,DIABETES MELLITUS
721149002,5/13/2015 13:03:10,1635729631,5/13/2015 13:02:48,false,neodev,1.0,30504276,CAN,ON,Sudbury,66.103.55.12,[PART_OF],[PART_OF],or,N/A,172,53,1,192,70,TWrex-cause,811962-FS1,"185  Hyperglycemic Effects  Hyperglycemia, new onset DIABETES MELLITUS or exacerbation of preexisting diabetes mellitus reported with use of HIV protease inhibitors (PIs); DIABETIC KETOACIDOSIS has occurred.",DIABETIC KETOACIDOSIS,DIABETES MELLITUS
721149002,5/13/2015 13:04:13,1635730102,5/13/2015 13:03:42,false,clixsense,1.0,24329110,USA,FL,Jacksonville,12.168.136.2,[CAUSES],[CAUSES],exacerbation of,n/a,172,53,1,192,70,TWrex-cause,811962-FS1,"185  Hyperglycemic Effects  Hyperglycemia, new onset DIABETES MELLITUS or exacerbation of preexisting diabetes mellitus reported with use of HIV protease inhibitors (PIs); DIABETIC KETOACIDOSIS has occurred.",DIABETIC KETOACIDOSIS,DIABETES MELLITUS
721149002,5/13/2015 13:08:40,1635731305,5/13/2015 13:06:04,false,prodege,1.0,23482077,USA,TX,Garland,71.164.238.226,[NONE],[NONE],N/A,Text is not clear.  May need more surrounding text to clarify what is being discussed.,172,53,1,192,70,TWrex-cause,811962-FS1,"185  Hyperglycemic Effects  Hyperglycemia, new onset DIABETES MELLITUS or exacerbation of preexisting diabetes mellitus reported with use of HIV protease inhibitors (PIs); DIABETIC KETOACIDOSIS has occurred.",DIABETIC KETOACIDOSIS,DIABETES MELLITUS
721149002,5/13/2015 13:10:50,1635731868,5/13/2015 13:10:07,false,clixsense,1.0,23197581,NLD,11,Den Haag,82.217.5.55,[SYMPTOM],[SYMPTOM],has occurred.,N/A,172,53,1,192,70,TWrex-cause,811962-FS1,"185  Hyperglycemic Effects  Hyperglycemia, new onset DIABETES MELLITUS or exacerbation of preexisting diabetes mellitus reported with use of HIV protease inhibitors (PIs); DIABETIC KETOACIDOSIS has occurred.",DIABETIC KETOACIDOSIS,DIABETES MELLITUS
721149002,5/13/2015 13:27:23,1635736237,5/13/2015 13:25:26,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[LOCATION],[LOCATION],DIABETES MELLITUS exacerbation of DIABETIC KETOACIDOSIS,N/A,172,53,1,192,70,TWrex-cause,811962-FS1,"185  Hyperglycemic Effects  Hyperglycemia, new onset DIABETES MELLITUS or exacerbation of preexisting diabetes mellitus reported with use of HIV protease inhibitors (PIs); DIABETIC KETOACIDOSIS has occurred.",DIABETIC KETOACIDOSIS,DIABETES MELLITUS
721149002,5/13/2015 13:28:27,1635736577,5/13/2015 13:28:05,false,clixsense,1,6574449,USA,"","",216.216.68.85,[OTHER],[OTHER],"Hyperglycemic Effects Hyperglycemia, onset DIABETES MELLITUS exacerbation preexisting diabetes mellitus reported use HIV protease inhibitors DIABETIC KETOACIDOSIS occurred.",na,172,53,1,192,70,TWrex-cause,811962-FS1,"185  Hyperglycemic Effects  Hyperglycemia, new onset DIABETES MELLITUS or exacerbation of preexisting diabetes mellitus reported with use of HIV protease inhibitors (PIs); DIABETIC KETOACIDOSIS has occurred.",DIABETIC KETOACIDOSIS,DIABETES MELLITUS
721149002,5/13/2015 13:35:52,1635738492,5/13/2015 13:35:32,false,bitcoinget,1.0,21614812,USA,PA,Erie,174.100.250.115,[NONE],[NONE],N/A,not directly related,172,53,1,192,70,TWrex-cause,811962-FS1,"185  Hyperglycemic Effects  Hyperglycemia, new onset DIABETES MELLITUS or exacerbation of preexisting diabetes mellitus reported with use of HIV protease inhibitors (PIs); DIABETIC KETOACIDOSIS has occurred.",DIABETIC KETOACIDOSIS,DIABETES MELLITUS
721149002,5/13/2015 13:41:05,1635739917,5/13/2015 13:39:08,false,neodev,1.0,24564999,GBR,H9,London,86.145.227.9,[CAUSES],[CAUSES],has occurred.,N/A,172,53,1,192,70,TWrex-cause,811962-FS1,"185  Hyperglycemic Effects  Hyperglycemia, new onset DIABETES MELLITUS or exacerbation of preexisting diabetes mellitus reported with use of HIV protease inhibitors (PIs); DIABETIC KETOACIDOSIS has occurred.",DIABETIC KETOACIDOSIS,DIABETES MELLITUS
721149002,5/13/2015 13:50:52,1635743645,5/13/2015 13:50:21,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[CAUSES],[CAUSES],has occurred.,N/A,172,53,1,192,70,TWrex-cause,811962-FS1,"185  Hyperglycemic Effects  Hyperglycemia, new onset DIABETES MELLITUS or exacerbation of preexisting diabetes mellitus reported with use of HIV protease inhibitors (PIs); DIABETIC KETOACIDOSIS has occurred.",DIABETIC KETOACIDOSIS,DIABETES MELLITUS
721149002,5/13/2015 14:09:52,1635751770,5/13/2015 14:08:56,false,prodege,1.0,24403612,CAN,ON,Ajax,99.239.181.149,[CAUSES],[CAUSES],DIABETES MELLITUS DIABETIC KETOACIDOSIS has occurred.,N^A,172,53,1,192,70,TWrex-cause,811962-FS1,"185  Hyperglycemic Effects  Hyperglycemia, new onset DIABETES MELLITUS or exacerbation of preexisting diabetes mellitus reported with use of HIV protease inhibitors (PIs); DIABETIC KETOACIDOSIS has occurred.",DIABETIC KETOACIDOSIS,DIABETES MELLITUS
721149002,5/13/2015 14:22:30,1635756847,5/13/2015 14:21:48,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[CAUSES],[CAUSES],reported with use,N/A,172,53,1,192,70,TWrex-cause,811962-FS1,"185  Hyperglycemic Effects  Hyperglycemia, new onset DIABETES MELLITUS or exacerbation of preexisting diabetes mellitus reported with use of HIV protease inhibitors (PIs); DIABETIC KETOACIDOSIS has occurred.",DIABETIC KETOACIDOSIS,DIABETES MELLITUS
721149002,5/13/2015 15:06:52,1635786093,5/13/2015 15:06:25,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,[ASSOCIATED_WITH],[ASSOCIATED_WITH],use,n/a,172,53,1,192,70,TWrex-cause,811962-FS1,"185  Hyperglycemic Effects  Hyperglycemia, new onset DIABETES MELLITUS or exacerbation of preexisting diabetes mellitus reported with use of HIV protease inhibitors (PIs); DIABETIC KETOACIDOSIS has occurred.",DIABETIC KETOACIDOSIS,DIABETES MELLITUS
721149003,5/13/2015 13:06:11,1635730786,5/13/2015 13:06:01,false,neodev,1.0,30504276,CAN,ON,Sudbury,66.103.55.12,[TREATS],[TREATS],treatment,N/A,124,85,-1,147,120,TWrex-cause,803669-FS1,"Broder I, Tarlo SM, Davies GM et al. Safety and efficacy of long term treatment with INHALED BECLOMETHASONE DIPROPIONATE in STEROID DEPENDENT ASTHMA",STEROID DEPENDENT ASTHMA,INHALED BECLOMETHASONE DIPROPIONATE
721149003,5/13/2015 13:11:18,1635731957,5/13/2015 13:10:59,false,clixsense,1.0,24329110,USA,FL,Jacksonville,12.168.136.2,[TREATS],[TREATS],treatment with,n/a,124,85,-1,147,120,TWrex-cause,803669-FS1,"Broder I, Tarlo SM, Davies GM et al. Safety and efficacy of long term treatment with INHALED BECLOMETHASONE DIPROPIONATE in STEROID DEPENDENT ASTHMA",STEROID DEPENDENT ASTHMA,INHALED BECLOMETHASONE DIPROPIONATE
721149003,5/13/2015 13:16:51,1635733536,5/13/2015 13:16:27,false,clixsense,1.0,23197581,NLD,11,Den Haag,82.217.5.55,[TREATS],[TREATS],long term treatment,N/A,124,85,-1,147,120,TWrex-cause,803669-FS1,"Broder I, Tarlo SM, Davies GM et al. Safety and efficacy of long term treatment with INHALED BECLOMETHASONE DIPROPIONATE in STEROID DEPENDENT ASTHMA",STEROID DEPENDENT ASTHMA,INHALED BECLOMETHASONE DIPROPIONATE
721149003,5/13/2015 13:18:49,1635734070,5/13/2015 13:18:15,false,prodege,1.0,23482077,USA,TX,Garland,71.164.238.226,[TREATS],[TREATS],treatment with,N/A,124,85,-1,147,120,TWrex-cause,803669-FS1,"Broder I, Tarlo SM, Davies GM et al. Safety and efficacy of long term treatment with INHALED BECLOMETHASONE DIPROPIONATE in STEROID DEPENDENT ASTHMA",STEROID DEPENDENT ASTHMA,INHALED BECLOMETHASONE DIPROPIONATE
721149003,5/13/2015 13:41:25,1635739955,5/13/2015 13:41:14,false,bitcoinget,1.0,21614812,USA,PA,Erie,174.100.250.115,[TREATS],[TREATS],treatment,N/A,124,85,-1,147,120,TWrex-cause,803669-FS1,"Broder I, Tarlo SM, Davies GM et al. Safety and efficacy of long term treatment with INHALED BECLOMETHASONE DIPROPIONATE in STEROID DEPENDENT ASTHMA",STEROID DEPENDENT ASTHMA,INHALED BECLOMETHASONE DIPROPIONATE
721149003,5/13/2015 13:49:08,1635742919,5/13/2015 13:48:35,false,neodev,1.0,24564999,GBR,H9,London,86.145.227.9,[TREATS],[TREATS],treatment in,N/A,124,85,-1,147,120,TWrex-cause,803669-FS1,"Broder I, Tarlo SM, Davies GM et al. Safety and efficacy of long term treatment with INHALED BECLOMETHASONE DIPROPIONATE in STEROID DEPENDENT ASTHMA",STEROID DEPENDENT ASTHMA,INHALED BECLOMETHASONE DIPROPIONATE
721149003,5/13/2015 13:56:19,1635745895,5/13/2015 13:56:03,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[TREATS],[TREATS],treatment,N/A,124,85,-1,147,120,TWrex-cause,803669-FS1,"Broder I, Tarlo SM, Davies GM et al. Safety and efficacy of long term treatment with INHALED BECLOMETHASONE DIPROPIONATE in STEROID DEPENDENT ASTHMA",STEROID DEPENDENT ASTHMA,INHALED BECLOMETHASONE DIPROPIONATE
721149003,5/13/2015 14:20:20,1635755893,5/13/2015 14:19:34,false,prodege,1.0,24403612,CAN,ON,Ajax,99.239.181.149,[TREATS],[TREATS],long term treatment INHALED BECLOMETHASONE DIPROPIONATE in STEROID DEPENDENT ASTHMA,N/a,124,85,-1,147,120,TWrex-cause,803669-FS1,"Broder I, Tarlo SM, Davies GM et al. Safety and efficacy of long term treatment with INHALED BECLOMETHASONE DIPROPIONATE in STEROID DEPENDENT ASTHMA",STEROID DEPENDENT ASTHMA,INHALED BECLOMETHASONE DIPROPIONATE
721149003,5/13/2015 14:28:41,1635759776,5/13/2015 14:28:21,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[TREATS],[TREATS],treatment,N/A,124,85,-1,147,120,TWrex-cause,803669-FS1,"Broder I, Tarlo SM, Davies GM et al. Safety and efficacy of long term treatment with INHALED BECLOMETHASONE DIPROPIONATE in STEROID DEPENDENT ASTHMA",STEROID DEPENDENT ASTHMA,INHALED BECLOMETHASONE DIPROPIONATE
721149003,5/13/2015 15:13:04,1635792293,5/13/2015 15:12:42,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,[TREATS],[TREATS],treatment,n/a,124,85,-1,147,120,TWrex-cause,803669-FS1,"Broder I, Tarlo SM, Davies GM et al. Safety and efficacy of long term treatment with INHALED BECLOMETHASONE DIPROPIONATE in STEROID DEPENDENT ASTHMA",STEROID DEPENDENT ASTHMA,INHALED BECLOMETHASONE DIPROPIONATE
721149003,5/13/2015 15:23:50,1635800743,5/13/2015 15:22:27,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[TREATS] [DIAGNOSE_BY_TEST_OR_DRUG],"[TREATS]
[DIAGNOSE_BY_TEST_OR_DRUG]",of treatment with INHALED BECLOMETHASONE DIPROPIONATE STEROID DEPENDENT ASTHMA,N/A,124,85,-1,147,120,TWrex-cause,803669-FS1,"Broder I, Tarlo SM, Davies GM et al. Safety and efficacy of long term treatment with INHALED BECLOMETHASONE DIPROPIONATE in STEROID DEPENDENT ASTHMA",STEROID DEPENDENT ASTHMA,INHALED BECLOMETHASONE DIPROPIONATE
721149003,5/13/2015 15:42:28,1635815320,5/13/2015 15:42:08,false,clixsense,1.0,32549163,CAN,MB,Winnipeg,206.45.167.246,[TREATS],[TREATS],treatment with INHALED BECLOMETHASONE DIPROPIONATE in STEROID DEPENDENT ASTHMA,N/A,124,85,-1,147,120,TWrex-cause,803669-FS1,"Broder I, Tarlo SM, Davies GM et al. Safety and efficacy of long term treatment with INHALED BECLOMETHASONE DIPROPIONATE in STEROID DEPENDENT ASTHMA",STEROID DEPENDENT ASTHMA,INHALED BECLOMETHASONE DIPROPIONATE
721149003,5/13/2015 15:58:12,1635827332,5/13/2015 15:57:31,false,instagc,1.0,24252915,GBR,F2,Gosport,92.24.208.155,[TREATS],[TREATS],treatment with,N/a,124,85,-1,147,120,TWrex-cause,803669-FS1,"Broder I, Tarlo SM, Davies GM et al. Safety and efficacy of long term treatment with INHALED BECLOMETHASONE DIPROPIONATE in STEROID DEPENDENT ASTHMA",STEROID DEPENDENT ASTHMA,INHALED BECLOMETHASONE DIPROPIONATE
721149003,5/13/2015 16:01:29,1635830075,5/13/2015 16:01:07,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[TREATS],[TREATS],treatment,none,124,85,-1,147,120,TWrex-cause,803669-FS1,"Broder I, Tarlo SM, Davies GM et al. Safety and efficacy of long term treatment with INHALED BECLOMETHASONE DIPROPIONATE in STEROID DEPENDENT ASTHMA",STEROID DEPENDENT ASTHMA,INHALED BECLOMETHASONE DIPROPIONATE
721149003,5/13/2015 16:27:58,1635847537,5/13/2015 16:26:39,false,clixsense,1.0,31579138,AUS,02,Hurstville,14.200.129.68,[TREATS],[TREATS],treatment with,N/A,124,85,-1,147,120,TWrex-cause,803669-FS1,"Broder I, Tarlo SM, Davies GM et al. Safety and efficacy of long term treatment with INHALED BECLOMETHASONE DIPROPIONATE in STEROID DEPENDENT ASTHMA",STEROID DEPENDENT ASTHMA,INHALED BECLOMETHASONE DIPROPIONATE
721149004,5/13/2015 11:45:43,1635705969,5/13/2015 11:45:09,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[SYMPTOM],[SYMPTOM],PELVIC PAIN with ENDOMETRIOSIS,n/a,134,180,1,144,193,TWrex-cause,813901-FS1,• Note that the differential diagnosis and work up may be slightly different for a patient with suspected endometriosis and primarily PELVIC PAIN than for a patient with suspected ENDOMETRIOSIS and primarily fertility concerns.,PELVIC PAIN,ENDOMETRIOSIS
721149004,5/13/2015 11:49:11,1635707002,5/13/2015 11:48:57,false,neodev,1.0,31726043,GBR,"","",88.150.202.140,[CAUSES],[CAUSES],suspected,8484,134,180,1,144,193,TWrex-cause,813901-FS1,• Note that the differential diagnosis and work up may be slightly different for a patient with suspected endometriosis and primarily PELVIC PAIN than for a patient with suspected ENDOMETRIOSIS and primarily fertility concerns.,PELVIC PAIN,ENDOMETRIOSIS
721149004,5/13/2015 12:29:19,1635720972,5/13/2015 12:28:53,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[SYMPTOM],[SYMPTOM],PELVIC PAIN ENDOMETRIOSIS,n/a,134,180,1,144,193,TWrex-cause,813901-FS1,• Note that the differential diagnosis and work up may be slightly different for a patient with suspected endometriosis and primarily PELVIC PAIN than for a patient with suspected ENDOMETRIOSIS and primarily fertility concerns.,PELVIC PAIN,ENDOMETRIOSIS
721149004,5/13/2015 13:02:25,1635729290,5/13/2015 13:02:12,false,neodev,1.0,30504276,CAN,ON,Sudbury,66.103.55.12,[NONE],[NONE],N/A,N/A,134,180,1,144,193,TWrex-cause,813901-FS1,• Note that the differential diagnosis and work up may be slightly different for a patient with suspected endometriosis and primarily PELVIC PAIN than for a patient with suspected ENDOMETRIOSIS and primarily fertility concerns.,PELVIC PAIN,ENDOMETRIOSIS
721149004,5/13/2015 13:03:17,1635729693,5/13/2015 13:02:32,false,clixsense,1.0,24329110,USA,FL,Jacksonville,12.168.136.2,[CAUSES],[CAUSES],primarily for a patient with suspected,n/a,134,180,1,144,193,TWrex-cause,813901-FS1,• Note that the differential diagnosis and work up may be slightly different for a patient with suspected endometriosis and primarily PELVIC PAIN than for a patient with suspected ENDOMETRIOSIS and primarily fertility concerns.,PELVIC PAIN,ENDOMETRIOSIS
721149004,5/13/2015 13:03:55,1635729975,5/13/2015 13:03:27,false,clixsense,1.0,6574449,USA,"","",216.216.68.85,[OTHER],[OTHER],Note differential diagnosis slightly different patient suspected endometriosis primarily PELVIC PAIN than patient suspected ENDOMETRIOSIS primarily fertility concerns.,na,134,180,1,144,193,TWrex-cause,813901-FS1,• Note that the differential diagnosis and work up may be slightly different for a patient with suspected endometriosis and primarily PELVIC PAIN than for a patient with suspected ENDOMETRIOSIS and primarily fertility concerns.,PELVIC PAIN,ENDOMETRIOSIS
721149004,5/13/2015 13:04:39,1635730237,5/13/2015 13:02:04,false,prodege,1.0,23482077,USA,TX,Garland,71.164.238.226,[NONE],[NONE],N/A,"The highlighted ""PELVIC PAIN"" is related to an unhighlighted use of ""endometriosis.""",134,180,1,144,193,TWrex-cause,813901-FS1,• Note that the differential diagnosis and work up may be slightly different for a patient with suspected endometriosis and primarily PELVIC PAIN than for a patient with suspected ENDOMETRIOSIS and primarily fertility concerns.,PELVIC PAIN,ENDOMETRIOSIS
721149004,5/13/2015 13:09:22,1635731499,5/13/2015 13:08:28,false,clixsense,1.0,23197581,NLD,11,Den Haag,82.217.5.55,[SYMPTOM],[SYMPTOM],suspected endometriosis and primarily PELVIC PAIN,N/A,134,180,1,144,193,TWrex-cause,813901-FS1,• Note that the differential diagnosis and work up may be slightly different for a patient with suspected endometriosis and primarily PELVIC PAIN than for a patient with suspected ENDOMETRIOSIS and primarily fertility concerns.,PELVIC PAIN,ENDOMETRIOSIS
721149004,5/13/2015 13:24:10,1635735520,5/13/2015 13:22:11,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[DIAGNOSE_BY_TEST_OR_DRUG] [SYMPTOM],"[DIAGNOSE_BY_TEST_OR_DRUG]
[SYMPTOM]",diagnosis may be for a patient with PELVIC PAIN ENDOMETRIOSIS,N/A,134,180,1,144,193,TWrex-cause,813901-FS1,• Note that the differential diagnosis and work up may be slightly different for a patient with suspected endometriosis and primarily PELVIC PAIN than for a patient with suspected ENDOMETRIOSIS and primarily fertility concerns.,PELVIC PAIN,ENDOMETRIOSIS
721149004,5/13/2015 13:34:43,1635738093,5/13/2015 13:32:29,false,bitcoinget,1.0,21614812,USA,PA,Erie,174.100.250.115,[ASSOCIATED_WITH],[ASSOCIATED_WITH],suspected,N/A,134,180,1,144,193,TWrex-cause,813901-FS1,• Note that the differential diagnosis and work up may be slightly different for a patient with suspected endometriosis and primarily PELVIC PAIN than for a patient with suspected ENDOMETRIOSIS and primarily fertility concerns.,PELVIC PAIN,ENDOMETRIOSIS
721149004,5/13/2015 13:38:20,1635739231,5/13/2015 13:36:53,false,neodev,1.0,24564999,GBR,H9,London,86.145.227.9,[SYMPTOM],[SYMPTOM],differential diagnosis,N/A,134,180,1,144,193,TWrex-cause,813901-FS1,• Note that the differential diagnosis and work up may be slightly different for a patient with suspected endometriosis and primarily PELVIC PAIN than for a patient with suspected ENDOMETRIOSIS and primarily fertility concerns.,PELVIC PAIN,ENDOMETRIOSIS
721149004,5/13/2015 13:49:44,1635743172,5/13/2015 13:48:22,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[SYMPTOM],[SYMPTOM],differential diagnosis,N/A,134,180,1,144,193,TWrex-cause,813901-FS1,• Note that the differential diagnosis and work up may be slightly different for a patient with suspected endometriosis and primarily PELVIC PAIN than for a patient with suspected ENDOMETRIOSIS and primarily fertility concerns.,PELVIC PAIN,ENDOMETRIOSIS
721149004,5/13/2015 14:08:17,1635751134,5/13/2015 14:07:13,false,prodege,1.0,24403612,CAN,ON,Ajax,99.239.181.149,[OTHER],[OTHER],PELVIC PAIN than with ENDOMETRIOSIS,N/A,134,180,1,144,193,TWrex-cause,813901-FS1,• Note that the differential diagnosis and work up may be slightly different for a patient with suspected endometriosis and primarily PELVIC PAIN than for a patient with suspected ENDOMETRIOSIS and primarily fertility concerns.,PELVIC PAIN,ENDOMETRIOSIS
721149004,5/13/2015 14:21:14,1635756220,5/13/2015 14:20:03,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[SYMPTOM],[SYMPTOM],suspected,N/A,134,180,1,144,193,TWrex-cause,813901-FS1,• Note that the differential diagnosis and work up may be slightly different for a patient with suspected endometriosis and primarily PELVIC PAIN than for a patient with suspected ENDOMETRIOSIS and primarily fertility concerns.,PELVIC PAIN,ENDOMETRIOSIS
721149004,5/13/2015 15:09:16,1635788505,5/13/2015 15:08:36,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,[CAUSES],[CAUSES],suspected,n/a,134,180,1,144,193,TWrex-cause,813901-FS1,• Note that the differential diagnosis and work up may be slightly different for a patient with suspected endometriosis and primarily PELVIC PAIN than for a patient with suspected ENDOMETRIOSIS and primarily fertility concerns.,PELVIC PAIN,ENDOMETRIOSIS
721149005,5/13/2015 18:20:21,1635907691,5/13/2015 18:19:58,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[PREVENTS],[PREVENTS],long term prevention,N/A,83,139,-1,85,178,TWrex-cause,805059-FS1,"PubMed ID: 12917299  QUESTION  In patients with unprovoked venous thromboembolism (VTE), is low intensity warfarin therapy as effective as CONVENTIONAL INTENSITY WARFARIN THERAPY for the long term prevention of recurrent VTE",VTE,CONVENTIONAL INTENSITY WARFARIN THERAPY
721149005,5/13/2015 18:30:49,1635913686,5/13/2015 18:29:44,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[TREATS],[TREATS],as effective,N/A,83,139,-1,85,178,TWrex-cause,805059-FS1,"PubMed ID: 12917299  QUESTION  In patients with unprovoked venous thromboembolism (VTE), is low intensity warfarin therapy as effective as CONVENTIONAL INTENSITY WARFARIN THERAPY for the long term prevention of recurrent VTE",VTE,CONVENTIONAL INTENSITY WARFARIN THERAPY
721149005,5/13/2015 18:51:28,1635923485,5/13/2015 18:50:40,false,prodege,1.0,32302664,USA,IL,Geneseo,173.27.241.235,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],for the long term prevention of recurrent,no comment,83,139,-1,85,178,TWrex-cause,805059-FS1,"PubMed ID: 12917299  QUESTION  In patients with unprovoked venous thromboembolism (VTE), is low intensity warfarin therapy as effective as CONVENTIONAL INTENSITY WARFARIN THERAPY for the long term prevention of recurrent VTE",VTE,CONVENTIONAL INTENSITY WARFARIN THERAPY
721149005,5/13/2015 19:23:15,1635949111,5/13/2015 19:22:16,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[PREVENTS],[PREVENTS],prevention,N/A,83,139,-1,85,178,TWrex-cause,805059-FS1,"PubMed ID: 12917299  QUESTION  In patients with unprovoked venous thromboembolism (VTE), is low intensity warfarin therapy as effective as CONVENTIONAL INTENSITY WARFARIN THERAPY for the long term prevention of recurrent VTE",VTE,CONVENTIONAL INTENSITY WARFARIN THERAPY
721149005,5/13/2015 19:49:15,1635966483,5/13/2015 19:48:54,false,elite,1.0,30064988,GBR,H3,Leeds,92.22.208.245,[PREVENTS],[PREVENTS],long term prevention,N/A,83,139,-1,85,178,TWrex-cause,805059-FS1,"PubMed ID: 12917299  QUESTION  In patients with unprovoked venous thromboembolism (VTE), is low intensity warfarin therapy as effective as CONVENTIONAL INTENSITY WARFARIN THERAPY for the long term prevention of recurrent VTE",VTE,CONVENTIONAL INTENSITY WARFARIN THERAPY
721149005,5/13/2015 20:09:13,1635982226,5/13/2015 20:08:52,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.156.243,[PREVENTS],[PREVENTS],CONVENTIONAL INTENSITY WARFARIN THERAPY for prevention of VTE,N/A,83,139,-1,85,178,TWrex-cause,805059-FS1,"PubMed ID: 12917299  QUESTION  In patients with unprovoked venous thromboembolism (VTE), is low intensity warfarin therapy as effective as CONVENTIONAL INTENSITY WARFARIN THERAPY for the long term prevention of recurrent VTE",VTE,CONVENTIONAL INTENSITY WARFARIN THERAPY
721149005,5/13/2015 20:36:35,1636001840,5/13/2015 20:36:18,false,neodev,1.0,20961587,NLD,05,Maastricht,84.26.48.136,[TREATS],[TREATS],therapy,N/A,83,139,-1,85,178,TWrex-cause,805059-FS1,"PubMed ID: 12917299  QUESTION  In patients with unprovoked venous thromboembolism (VTE), is low intensity warfarin therapy as effective as CONVENTIONAL INTENSITY WARFARIN THERAPY for the long term prevention of recurrent VTE",VTE,CONVENTIONAL INTENSITY WARFARIN THERAPY
721149005,5/13/2015 20:57:37,1636016082,5/13/2015 20:55:11,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[TREATS],[TREATS],In patients with effective CONVENTIONAL INTENSITY WARFARIN THERAPY VTE,N/A,83,139,-1,85,178,TWrex-cause,805059-FS1,"PubMed ID: 12917299  QUESTION  In patients with unprovoked venous thromboembolism (VTE), is low intensity warfarin therapy as effective as CONVENTIONAL INTENSITY WARFARIN THERAPY for the long term prevention of recurrent VTE",VTE,CONVENTIONAL INTENSITY WARFARIN THERAPY
721149005,5/13/2015 20:58:03,1636016354,5/13/2015 20:57:27,false,elite,1.0,32732290,GBR,A7,Birmingham,86.147.79.250,[TREATS] [PREVENTS],"[TREATS]
[PREVENTS]",therapy for prevention of,N/A,83,139,-1,85,178,TWrex-cause,805059-FS1,"PubMed ID: 12917299  QUESTION  In patients with unprovoked venous thromboembolism (VTE), is low intensity warfarin therapy as effective as CONVENTIONAL INTENSITY WARFARIN THERAPY for the long term prevention of recurrent VTE",VTE,CONVENTIONAL INTENSITY WARFARIN THERAPY
721149005,5/13/2015 21:15:31,1636028260,5/13/2015 21:14:53,false,clixsense,1.0,26847653,NLD,03,Warnsveld,213.93.50.164,[PREVENTS],[PREVENTS],long term prevention,n/a,83,139,-1,85,178,TWrex-cause,805059-FS1,"PubMed ID: 12917299  QUESTION  In patients with unprovoked venous thromboembolism (VTE), is low intensity warfarin therapy as effective as CONVENTIONAL INTENSITY WARFARIN THERAPY for the long term prevention of recurrent VTE",VTE,CONVENTIONAL INTENSITY WARFARIN THERAPY
721149005,5/13/2015 21:22:03,1636032354,5/13/2015 21:21:05,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[TREATS],[TREATS],CONVENTIONAL INTENSITY WARFARIN THERAPY VTE,N/A,83,139,-1,85,178,TWrex-cause,805059-FS1,"PubMed ID: 12917299  QUESTION  In patients with unprovoked venous thromboembolism (VTE), is low intensity warfarin therapy as effective as CONVENTIONAL INTENSITY WARFARIN THERAPY for the long term prevention of recurrent VTE",VTE,CONVENTIONAL INTENSITY WARFARIN THERAPY
721149005,5/13/2015 21:37:02,1636042472,5/13/2015 21:36:46,false,neodev,1.0,30749660,USA,NC,Durham,24.211.188.217,[PREVENTS] [DIAGNOSE_BY_TEST_OR_DRUG],"[PREVENTS]
[DIAGNOSE_BY_TEST_OR_DRUG]",is low intensity warfarin therapy as effective as CONVENTIONAL,n/a,83,139,-1,85,178,TWrex-cause,805059-FS1,"PubMed ID: 12917299  QUESTION  In patients with unprovoked venous thromboembolism (VTE), is low intensity warfarin therapy as effective as CONVENTIONAL INTENSITY WARFARIN THERAPY for the long term prevention of recurrent VTE",VTE,CONVENTIONAL INTENSITY WARFARIN THERAPY
721149005,5/13/2015 21:46:35,1636048762,5/13/2015 21:46:00,false,instagc,1.0,13763729,USA,NC,Apex,75.182.91.110,[TREATS],[TREATS],long term prevention of,N/A,83,139,-1,85,178,TWrex-cause,805059-FS1,"PubMed ID: 12917299  QUESTION  In patients with unprovoked venous thromboembolism (VTE), is low intensity warfarin therapy as effective as CONVENTIONAL INTENSITY WARFARIN THERAPY for the long term prevention of recurrent VTE",VTE,CONVENTIONAL INTENSITY WARFARIN THERAPY
721149005,5/13/2015 21:49:16,1636050245,5/13/2015 21:48:47,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,75.147.181.53,[TREATS],[TREATS],THERAPY,N/A,83,139,-1,85,178,TWrex-cause,805059-FS1,"PubMed ID: 12917299  QUESTION  In patients with unprovoked venous thromboembolism (VTE), is low intensity warfarin therapy as effective as CONVENTIONAL INTENSITY WARFARIN THERAPY for the long term prevention of recurrent VTE",VTE,CONVENTIONAL INTENSITY WARFARIN THERAPY
721149005,5/13/2015 21:52:42,1636052211,5/13/2015 21:51:44,false,neodev,1,31861180,GBR,M9,Stafford,82.16.53.211,[PREVENTS],[PREVENTS],prevention,n/a,83,139,-1,85,178,TWrex-cause,805059-FS1,"PubMed ID: 12917299  QUESTION  In patients with unprovoked venous thromboembolism (VTE), is low intensity warfarin therapy as effective as CONVENTIONAL INTENSITY WARFARIN THERAPY for the long term prevention of recurrent VTE",VTE,CONVENTIONAL INTENSITY WARFARIN THERAPY
721149006,5/13/2015 17:38:30,1635887581,5/13/2015 17:37:02,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[SYMPTOM],[SYMPTOM],in the,n/a,39,51,-1,42,78,TWrex-cause,803399-FS1,There was a significant alleviation of PAIN in the CHONDROITIN SULFATE TREATED groups compared to placebo.,PAIN,CHONDROITIN SULFATE TREATED
721149006,5/13/2015 18:19:57,1635907409,5/13/2015 18:19:37,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[SYMPTOM],[SYMPTOM],was a significant,N/A,39,51,-1,42,78,TWrex-cause,803399-FS1,There was a significant alleviation of PAIN in the CHONDROITIN SULFATE TREATED groups compared to placebo.,PAIN,CHONDROITIN SULFATE TREATED
721149006,5/13/2015 18:29:42,1635913045,5/13/2015 18:28:35,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[TREATS],[TREATS],TREATED,N/A,39,51,-1,42,78,TWrex-cause,803399-FS1,There was a significant alleviation of PAIN in the CHONDROITIN SULFATE TREATED groups compared to placebo.,PAIN,CHONDROITIN SULFATE TREATED
721149006,5/13/2015 18:50:39,1635923125,5/13/2015 18:50:14,false,prodege,1.0,32302664,USA,IL,Geneseo,173.27.241.235,[SIDE_EFFECT],[SIDE_EFFECT],in the,no comment,39,51,-1,42,78,TWrex-cause,803399-FS1,There was a significant alleviation of PAIN in the CHONDROITIN SULFATE TREATED groups compared to placebo.,PAIN,CHONDROITIN SULFATE TREATED
721149006,5/13/2015 19:22:15,1635948336,5/13/2015 19:20:21,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[TREATS],[TREATS],alleviation,N/A,39,51,-1,42,78,TWrex-cause,803399-FS1,There was a significant alleviation of PAIN in the CHONDROITIN SULFATE TREATED groups compared to placebo.,PAIN,CHONDROITIN SULFATE TREATED
721149006,5/13/2015 19:48:52,1635966057,5/13/2015 19:48:16,false,elite,1.0,30064988,GBR,H3,Leeds,92.22.208.245,[SYMPTOM],[SYMPTOM],in CHONDROITIN SULFATE TREATED groups,N/A,39,51,-1,42,78,TWrex-cause,803399-FS1,There was a significant alleviation of PAIN in the CHONDROITIN SULFATE TREATED groups compared to placebo.,PAIN,CHONDROITIN SULFATE TREATED
721149006,5/13/2015 20:08:50,1635982033,5/13/2015 20:08:12,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.156.243,[TREATS],[TREATS],alleviation of PAIN in the CHONDROITIN SULFATE TREATED groups,N/A,39,51,-1,42,78,TWrex-cause,803399-FS1,There was a significant alleviation of PAIN in the CHONDROITIN SULFATE TREATED groups compared to placebo.,PAIN,CHONDROITIN SULFATE TREATED
721149006,5/13/2015 20:36:16,1636001667,5/13/2015 20:35:41,false,neodev,1.0,20961587,NLD,05,Maastricht,84.26.48.136,[TREATS],[TREATS],TREATED,N/A,39,51,-1,42,78,TWrex-cause,803399-FS1,There was a significant alleviation of PAIN in the CHONDROITIN SULFATE TREATED groups compared to placebo.,PAIN,CHONDROITIN SULFATE TREATED
721149006,5/13/2015 20:55:09,1636014423,5/13/2015 20:53:45,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[TREATS],[TREATS],alleviation of PAIN in CHONDROITIN SULFATE TREATED groups,N/A,39,51,-1,42,78,TWrex-cause,803399-FS1,There was a significant alleviation of PAIN in the CHONDROITIN SULFATE TREATED groups compared to placebo.,PAIN,CHONDROITIN SULFATE TREATED
721149006,5/13/2015 20:57:27,1636015909,5/13/2015 20:56:48,false,elite,1.0,32732290,GBR,A7,Birmingham,86.147.79.250,[SYMPTOM] [MANIFESTATION] [ASSOCIATED_WITH],"[SYMPTOM]
[MANIFESTATION]
[ASSOCIATED_WITH]",in the,N/A,39,51,-1,42,78,TWrex-cause,803399-FS1,There was a significant alleviation of PAIN in the CHONDROITIN SULFATE TREATED groups compared to placebo.,PAIN,CHONDROITIN SULFATE TREATED
721149006,5/13/2015 21:14:52,1636027953,5/13/2015 21:14:04,false,clixsense,1.0,26847653,NLD,03,Warnsveld,213.93.50.164,[TREATS],[TREATS],in the TREATED groups,n/a,39,51,-1,42,78,TWrex-cause,803399-FS1,There was a significant alleviation of PAIN in the CHONDROITIN SULFATE TREATED groups compared to placebo.,PAIN,CHONDROITIN SULFATE TREATED
721149006,5/13/2015 21:21:04,1636031684,5/13/2015 21:20:07,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[TREATS],[TREATS],alleviation PAIN in the CHONDROITIN SULFATE TREATED,N/A,39,51,-1,42,78,TWrex-cause,803399-FS1,There was a significant alleviation of PAIN in the CHONDROITIN SULFATE TREATED groups compared to placebo.,PAIN,CHONDROITIN SULFATE TREATED
721149006,5/13/2015 21:36:45,1636042266,5/13/2015 21:34:10,false,neodev,1.0,30749660,USA,NC,Durham,24.211.188.217,[DIAGNOSE_BY_TEST_OR_DRUG] [PREVENTS],"[PREVENTS]
[DIAGNOSE_BY_TEST_OR_DRUG]",groups compared to placebo.,n/a,39,51,-1,42,78,TWrex-cause,803399-FS1,There was a significant alleviation of PAIN in the CHONDROITIN SULFATE TREATED groups compared to placebo.,PAIN,CHONDROITIN SULFATE TREATED
721149006,5/13/2015 21:46:00,1636048423,5/13/2015 21:45:29,false,instagc,1.0,13763729,USA,NC,Apex,75.182.91.110,[TREATS],[TREATS],in the TREATED groups,N/A,39,51,-1,42,78,TWrex-cause,803399-FS1,There was a significant alleviation of PAIN in the CHONDROITIN SULFATE TREATED groups compared to placebo.,PAIN,CHONDROITIN SULFATE TREATED
721149006,5/13/2015 21:48:46,1636049973,5/13/2015 21:48:08,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,75.147.181.53,[TREATS],[TREATS],TREATED groups,N/A,39,51,-1,42,78,TWrex-cause,803399-FS1,There was a significant alleviation of PAIN in the CHONDROITIN SULFATE TREATED groups compared to placebo.,PAIN,CHONDROITIN SULFATE TREATED
721149007,5/13/2015 16:51:50,1635862100,5/13/2015 16:51:25,false,clixsense,1.0,31579138,AUS,02,Hurstville,14.200.129.68,[TREATS],[TREATS],THERAPY,N/A,93,51,-1,116,88,TWrex-cause,803830-FS1,"Aoki F, Tyring S, Diaz Mitoma F et al. Single day, PATIENT INITIATED FAMCICLOVIR THERAPY for RECURRENT GENITAL HERPES: a randomized, double blind, placebo controlled trial.",RECURRENT GENITAL HERPES,PATIENT INITIATED FAMCICLOVIR THERAPY
721149007,5/13/2015 17:36:16,1635886326,5/13/2015 17:35:54,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[TREATS],[TREATS],THERAPY for,n/a,93,51,-1,116,88,TWrex-cause,803830-FS1,"Aoki F, Tyring S, Diaz Mitoma F et al. Single day, PATIENT INITIATED FAMCICLOVIR THERAPY for RECURRENT GENITAL HERPES: a randomized, double blind, placebo controlled trial.",RECURRENT GENITAL HERPES,PATIENT INITIATED FAMCICLOVIR THERAPY
721149007,5/13/2015 17:41:42,1635889703,5/13/2015 17:41:13,false,gptking,1.0,31799065,USA,IL,Marion,50.45.43.154,[TREATS],[TREATS],PATIENT INITIATED FAMCICLOVIR THERAPY for RECURRENT GENITAL HERPES:,N/A,93,51,-1,116,88,TWrex-cause,803830-FS1,"Aoki F, Tyring S, Diaz Mitoma F et al. Single day, PATIENT INITIATED FAMCICLOVIR THERAPY for RECURRENT GENITAL HERPES: a randomized, double blind, placebo controlled trial.",RECURRENT GENITAL HERPES,PATIENT INITIATED FAMCICLOVIR THERAPY
721149007,5/13/2015 18:19:09,1635907097,5/13/2015 18:18:47,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[TREATS],[TREATS],controlled trial.,N/A,93,51,-1,116,88,TWrex-cause,803830-FS1,"Aoki F, Tyring S, Diaz Mitoma F et al. Single day, PATIENT INITIATED FAMCICLOVIR THERAPY for RECURRENT GENITAL HERPES: a randomized, double blind, placebo controlled trial.",RECURRENT GENITAL HERPES,PATIENT INITIATED FAMCICLOVIR THERAPY
721149007,5/13/2015 18:27:56,1635912069,5/13/2015 18:27:08,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[TREATS],[TREATS],THERAPY for,N/A,93,51,-1,116,88,TWrex-cause,803830-FS1,"Aoki F, Tyring S, Diaz Mitoma F et al. Single day, PATIENT INITIATED FAMCICLOVIR THERAPY for RECURRENT GENITAL HERPES: a randomized, double blind, placebo controlled trial.",RECURRENT GENITAL HERPES,PATIENT INITIATED FAMCICLOVIR THERAPY
721149007,5/13/2015 18:49:43,1635922744,5/13/2015 18:49:14,false,prodege,1.0,32302664,USA,IL,Geneseo,173.27.241.235,[TREATS],[TREATS],for,no comment,93,51,-1,116,88,TWrex-cause,803830-FS1,"Aoki F, Tyring S, Diaz Mitoma F et al. Single day, PATIENT INITIATED FAMCICLOVIR THERAPY for RECURRENT GENITAL HERPES: a randomized, double blind, placebo controlled trial.",RECURRENT GENITAL HERPES,PATIENT INITIATED FAMCICLOVIR THERAPY
721149007,5/13/2015 19:18:58,1635942670,5/13/2015 19:17:20,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[DIAGNOSE_BY_TEST_OR_DRUG] [TREATS],"[TREATS]
[DIAGNOSE_BY_TEST_OR_DRUG]","randomized, double blind, placebo controlled trial.",N/A,93,51,-1,116,88,TWrex-cause,803830-FS1,"Aoki F, Tyring S, Diaz Mitoma F et al. Single day, PATIENT INITIATED FAMCICLOVIR THERAPY for RECURRENT GENITAL HERPES: a randomized, double blind, placebo controlled trial.",RECURRENT GENITAL HERPES,PATIENT INITIATED FAMCICLOVIR THERAPY
721149007,5/13/2015 19:47:55,1635965325,5/13/2015 19:47:20,false,elite,1.0,30064988,GBR,H3,Leeds,92.22.208.245,[OTHER],[OTHER],placebo controlled trial.,N/A,93,51,-1,116,88,TWrex-cause,803830-FS1,"Aoki F, Tyring S, Diaz Mitoma F et al. Single day, PATIENT INITIATED FAMCICLOVIR THERAPY for RECURRENT GENITAL HERPES: a randomized, double blind, placebo controlled trial.",RECURRENT GENITAL HERPES,PATIENT INITIATED FAMCICLOVIR THERAPY
721149007,5/13/2015 20:07:50,1635981330,5/13/2015 20:07:30,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.156.243,[TREATS],[TREATS],PATIENT INITIATED FAMCICLOVIR THERAPY for RECURRENT GENITAL HERPES:,N/A,93,51,-1,116,88,TWrex-cause,803830-FS1,"Aoki F, Tyring S, Diaz Mitoma F et al. Single day, PATIENT INITIATED FAMCICLOVIR THERAPY for RECURRENT GENITAL HERPES: a randomized, double blind, placebo controlled trial.",RECURRENT GENITAL HERPES,PATIENT INITIATED FAMCICLOVIR THERAPY
721149007,5/13/2015 20:09:16,1635982273,5/13/2015 20:08:44,false,clixsense,1.0,27969116,NLD,"","",212.78.195.38,[OTHER],[OTHER],placebo controlled trial.,it was a trail.,93,51,-1,116,88,TWrex-cause,803830-FS1,"Aoki F, Tyring S, Diaz Mitoma F et al. Single day, PATIENT INITIATED FAMCICLOVIR THERAPY for RECURRENT GENITAL HERPES: a randomized, double blind, placebo controlled trial.",RECURRENT GENITAL HERPES,PATIENT INITIATED FAMCICLOVIR THERAPY
721149007,5/13/2015 20:35:24,1636001067,5/13/2015 20:34:49,false,neodev,1.0,20961587,NLD,05,Maastricht,84.26.48.136,[ASSOCIATED_WITH],[ASSOCIATED_WITH],trial.,N/A,93,51,-1,116,88,TWrex-cause,803830-FS1,"Aoki F, Tyring S, Diaz Mitoma F et al. Single day, PATIENT INITIATED FAMCICLOVIR THERAPY for RECURRENT GENITAL HERPES: a randomized, double blind, placebo controlled trial.",RECURRENT GENITAL HERPES,PATIENT INITIATED FAMCICLOVIR THERAPY
721149007,5/13/2015 20:53:00,1636013000,5/13/2015 20:51:09,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[TREATS] [DIAGNOSE_BY_TEST_OR_DRUG],"[TREATS]
[DIAGNOSE_BY_TEST_OR_DRUG]","PATIENT INITIATED FAMCICLOVIR THERAPY for RECURRENT GENITAL HERPES: a randomized, double blind, placebo controlled trial.",N/A,93,51,-1,116,88,TWrex-cause,803830-FS1,"Aoki F, Tyring S, Diaz Mitoma F et al. Single day, PATIENT INITIATED FAMCICLOVIR THERAPY for RECURRENT GENITAL HERPES: a randomized, double blind, placebo controlled trial.",RECURRENT GENITAL HERPES,PATIENT INITIATED FAMCICLOVIR THERAPY
721149007,5/13/2015 20:56:22,1636015273,5/13/2015 20:56:08,false,elite,1.0,32732290,GBR,A7,Birmingham,86.147.79.250,[TREATS],[TREATS],THERAPY for,N/A,93,51,-1,116,88,TWrex-cause,803830-FS1,"Aoki F, Tyring S, Diaz Mitoma F et al. Single day, PATIENT INITIATED FAMCICLOVIR THERAPY for RECURRENT GENITAL HERPES: a randomized, double blind, placebo controlled trial.",RECURRENT GENITAL HERPES,PATIENT INITIATED FAMCICLOVIR THERAPY
721149007,5/13/2015 21:13:21,1636026885,5/13/2015 21:10:49,false,clixsense,1.0,26847653,NLD,03,Warnsveld,213.93.50.164,[OTHER],[OTHER],for,n/a,93,51,-1,116,88,TWrex-cause,803830-FS1,"Aoki F, Tyring S, Diaz Mitoma F et al. Single day, PATIENT INITIATED FAMCICLOVIR THERAPY for RECURRENT GENITAL HERPES: a randomized, double blind, placebo controlled trial.",RECURRENT GENITAL HERPES,PATIENT INITIATED FAMCICLOVIR THERAPY
721149007,5/13/2015 21:19:35,1636030644,5/13/2015 21:18:53,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[TREATS],[TREATS],PATIENT INITIATED FAMCICLOVIR THERAPY for RECURRENT GENITAL HERPES:,N/A,93,51,-1,116,88,TWrex-cause,803830-FS1,"Aoki F, Tyring S, Diaz Mitoma F et al. Single day, PATIENT INITIATED FAMCICLOVIR THERAPY for RECURRENT GENITAL HERPES: a randomized, double blind, placebo controlled trial.",RECURRENT GENITAL HERPES,PATIENT INITIATED FAMCICLOVIR THERAPY
721149008,5/13/2015 18:21:19,1635908207,5/13/2015 18:20:22,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[ASSOCIATED_WITH],[ASSOCIATED_WITH],"(e.g.,",N/A,28,77,1,59,90,TWrex-cause,811454-FS1,"1   Viral infections (e.g., CYTOMEGALOVIRUS [CMV] INFECTIONS herpes simplex, HERPES ZOSTER reported more frequently in cardiac transplant recipients receiving mycophenolate than in those receiving azathioprine.",CYTOMEGALOVIRUS [CMV] INFECTIONS,HERPES ZOSTER
721149008,5/13/2015 18:32:56,1635914888,5/13/2015 18:30:49,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[OTHER],[OTHER],reported more frequently in,reported in similar diseases but not the same,28,77,1,59,90,TWrex-cause,811454-FS1,"1   Viral infections (e.g., CYTOMEGALOVIRUS [CMV] INFECTIONS herpes simplex, HERPES ZOSTER reported more frequently in cardiac transplant recipients receiving mycophenolate than in those receiving azathioprine.",CYTOMEGALOVIRUS [CMV] INFECTIONS,HERPES ZOSTER
721149008,5/13/2015 18:52:43,1635924064,5/13/2015 18:51:29,false,prodege,1.0,32302664,USA,IL,Geneseo,173.27.241.235,[ASSOCIATED_WITH],[ASSOCIATED_WITH],"herpes simplex,",no comment,28,77,1,59,90,TWrex-cause,811454-FS1,"1   Viral infections (e.g., CYTOMEGALOVIRUS [CMV] INFECTIONS herpes simplex, HERPES ZOSTER reported more frequently in cardiac transplant recipients receiving mycophenolate than in those receiving azathioprine.",CYTOMEGALOVIRUS [CMV] INFECTIONS,HERPES ZOSTER
721149008,5/13/2015 19:25:42,1635950620,5/13/2015 19:23:17,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[MANIFESTATION],[MANIFESTATION],reported more frequently,N/A,28,77,1,59,90,TWrex-cause,811454-FS1,"1   Viral infections (e.g., CYTOMEGALOVIRUS [CMV] INFECTIONS herpes simplex, HERPES ZOSTER reported more frequently in cardiac transplant recipients receiving mycophenolate than in those receiving azathioprine.",CYTOMEGALOVIRUS [CMV] INFECTIONS,HERPES ZOSTER
721149008,5/13/2015 19:50:00,1635967011,5/13/2015 19:49:17,false,elite,1.0,30064988,GBR,H3,Leeds,92.22.208.245,[IS_A],[IS_A],Viral infections,N/A,28,77,1,59,90,TWrex-cause,811454-FS1,"1   Viral infections (e.g., CYTOMEGALOVIRUS [CMV] INFECTIONS herpes simplex, HERPES ZOSTER reported more frequently in cardiac transplant recipients receiving mycophenolate than in those receiving azathioprine.",CYTOMEGALOVIRUS [CMV] INFECTIONS,HERPES ZOSTER
721149008,5/13/2015 20:09:56,1635982896,5/13/2015 20:09:14,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.156.243,[ASSOCIATED_WITH],[ASSOCIATED_WITH],"CYTOMEGALOVIRUS [CMV] INFECTIONS herpes simplex, HERPES ZOSTER",N/A,28,77,1,59,90,TWrex-cause,811454-FS1,"1   Viral infections (e.g., CYTOMEGALOVIRUS [CMV] INFECTIONS herpes simplex, HERPES ZOSTER reported more frequently in cardiac transplant recipients receiving mycophenolate than in those receiving azathioprine.",CYTOMEGALOVIRUS [CMV] INFECTIONS,HERPES ZOSTER
721149008,5/13/2015 20:37:11,1636002158,5/13/2015 20:36:36,false,neodev,1.0,20961587,NLD,05,Maastricht,84.26.48.136,[MANIFESTATION],[MANIFESTATION],receiving,N/A,28,77,1,59,90,TWrex-cause,811454-FS1,"1   Viral infections (e.g., CYTOMEGALOVIRUS [CMV] INFECTIONS herpes simplex, HERPES ZOSTER reported more frequently in cardiac transplant recipients receiving mycophenolate than in those receiving azathioprine.",CYTOMEGALOVIRUS [CMV] INFECTIONS,HERPES ZOSTER
721149008,5/13/2015 20:59:45,1636017464,5/13/2015 20:58:04,false,elite,1.0,32732290,GBR,A7,Birmingham,86.147.79.250,[ASSOCIATED_WITH] [SIDE_EFFECT] [MANIFESTATION] [NONE],"[MANIFESTATION]
[ASSOCIATED_WITH]
[SIDE_EFFECT]
[NONE]",N/A,Both terms are side effects of the same treatment.,28,77,1,59,90,TWrex-cause,811454-FS1,"1   Viral infections (e.g., CYTOMEGALOVIRUS [CMV] INFECTIONS herpes simplex, HERPES ZOSTER reported more frequently in cardiac transplant recipients receiving mycophenolate than in those receiving azathioprine.",CYTOMEGALOVIRUS [CMV] INFECTIONS,HERPES ZOSTER
721149008,5/13/2015 21:18:06,1636029757,5/13/2015 21:15:32,false,clixsense,1.0,26847653,NLD,03,Warnsveld,213.93.50.164,[OTHER],[OTHER],"Viral infections (e.g.,",n/a,28,77,1,59,90,TWrex-cause,811454-FS1,"1   Viral infections (e.g., CYTOMEGALOVIRUS [CMV] INFECTIONS herpes simplex, HERPES ZOSTER reported more frequently in cardiac transplant recipients receiving mycophenolate than in those receiving azathioprine.",CYTOMEGALOVIRUS [CMV] INFECTIONS,HERPES ZOSTER
721149008,5/13/2015 21:22:58,1636033137,5/13/2015 21:22:04,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[ASSOCIATED_WITH],[ASSOCIATED_WITH],CYTOMEGALOVIRUS [CMV] INFECTIONS HERPES ZOSTER reported more frequently,N/A,28,77,1,59,90,TWrex-cause,811454-FS1,"1   Viral infections (e.g., CYTOMEGALOVIRUS [CMV] INFECTIONS herpes simplex, HERPES ZOSTER reported more frequently in cardiac transplant recipients receiving mycophenolate than in those receiving azathioprine.",CYTOMEGALOVIRUS [CMV] INFECTIONS,HERPES ZOSTER
721149008,5/13/2015 21:37:36,1636042909,5/13/2015 21:37:03,false,neodev,1.0,30749660,USA,NC,Durham,24.211.188.217,[DIAGNOSE_BY_TEST_OR_DRUG] [PREVENTS],"[PREVENTS]
[DIAGNOSE_BY_TEST_OR_DRUG]","herpes simplex, more frequently in cardiac transplant",n/a,28,77,1,59,90,TWrex-cause,811454-FS1,"1   Viral infections (e.g., CYTOMEGALOVIRUS [CMV] INFECTIONS herpes simplex, HERPES ZOSTER reported more frequently in cardiac transplant recipients receiving mycophenolate than in those receiving azathioprine.",CYTOMEGALOVIRUS [CMV] INFECTIONS,HERPES ZOSTER
721149008,5/13/2015 21:47:30,1636049256,5/13/2015 21:46:36,false,instagc,1.0,13763729,USA,NC,Apex,75.182.91.110,[IS_A],[IS_A],"Viral infections (e.g.,",N/A,28,77,1,59,90,TWrex-cause,811454-FS1,"1   Viral infections (e.g., CYTOMEGALOVIRUS [CMV] INFECTIONS herpes simplex, HERPES ZOSTER reported more frequently in cardiac transplant recipients receiving mycophenolate than in those receiving azathioprine.",CYTOMEGALOVIRUS [CMV] INFECTIONS,HERPES ZOSTER
721149008,5/13/2015 21:49:50,1636050588,5/13/2015 21:49:19,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,75.147.181.53,[ASSOCIATED_WITH],[ASSOCIATED_WITH],"Viral infections (e.g.,",N/A,28,77,1,59,90,TWrex-cause,811454-FS1,"1   Viral infections (e.g., CYTOMEGALOVIRUS [CMV] INFECTIONS herpes simplex, HERPES ZOSTER reported more frequently in cardiac transplant recipients receiving mycophenolate than in those receiving azathioprine.",CYTOMEGALOVIRUS [CMV] INFECTIONS,HERPES ZOSTER
721149008,5/13/2015 22:18:46,1636066086,5/13/2015 22:18:16,false,clixsense,1.0,19294877,USA,MA,Cambridge,71.174.188.109,[ASSOCIATED_WITH],[ASSOCIATED_WITH],"Viral infections (e.g., CYTOMEGALOVIRUS INFECTIONS HERPES ZOSTER reported more frequently in cardiac transplant recipients",n/a,28,77,1,59,90,TWrex-cause,811454-FS1,"1   Viral infections (e.g., CYTOMEGALOVIRUS [CMV] INFECTIONS herpes simplex, HERPES ZOSTER reported more frequently in cardiac transplant recipients receiving mycophenolate than in those receiving azathioprine.",CYTOMEGALOVIRUS [CMV] INFECTIONS,HERPES ZOSTER
721149008,5/13/2015 22:19:05,1636066324,5/13/2015 22:17:51,false,clixsense,1.0,8888883,USA,"","",73.21.180.112,[NONE],[NONE],N?A,Those are just type of viral infections,28,77,1,59,90,TWrex-cause,811454-FS1,"1   Viral infections (e.g., CYTOMEGALOVIRUS [CMV] INFECTIONS herpes simplex, HERPES ZOSTER reported more frequently in cardiac transplant recipients receiving mycophenolate than in those receiving azathioprine.",CYTOMEGALOVIRUS [CMV] INFECTIONS,HERPES ZOSTER
721149009,5/13/2015 09:58:03,1635676807,5/13/2015 09:57:54,false,neodev,1.0,32103286,CAN,AB,Edmonton,208.123.223.37,[CAUSES] [LOCATION] [NONE],"[CAUSES]
[LOCATION]
[NONE]",no,no,49,66,1,53,86,TWrex-cause,811179-FS1,"i ,   l  Relapsing Fever  Treatment of relapsing FEVER caused by  BORRELIA RECURRENTIS.",FEVER,BORRELIA RECURRENTIS
721149009,5/13/2015 10:13:34,1635680808,5/13/2015 10:12:47,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[CAUSES],[CAUSES],Relapsing Fever Treatment of relapsing FEVER caused by BORRELIA RECURRENTIS.,N/A,49,66,1,53,86,TWrex-cause,811179-FS1,"i ,   l  Relapsing Fever  Treatment of relapsing FEVER caused by  BORRELIA RECURRENTIS.",FEVER,BORRELIA RECURRENTIS
721149009,5/13/2015 10:29:46,1635685349,5/13/2015 10:28:13,false,clixsense,1.0,26847653,NLD,03,Warnsveld,213.93.50.164,[TREATS] [CAUSES],"[TREATS]
[CAUSES]",Treatment of relapsing caused by,n/a,49,66,1,53,86,TWrex-cause,811179-FS1,"i ,   l  Relapsing Fever  Treatment of relapsing FEVER caused by  BORRELIA RECURRENTIS.",FEVER,BORRELIA RECURRENTIS
721149009,5/13/2015 10:31:10,1635685834,5/13/2015 10:30:31,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[CAUSES],[CAUSES],caused by,N/A,49,66,1,53,86,TWrex-cause,811179-FS1,"i ,   l  Relapsing Fever  Treatment of relapsing FEVER caused by  BORRELIA RECURRENTIS.",FEVER,BORRELIA RECURRENTIS
721149009,5/13/2015 10:33:06,1635686333,5/13/2015 10:32:21,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[CAUSES],[CAUSES],caused by,n/a,49,66,1,53,86,TWrex-cause,811179-FS1,"i ,   l  Relapsing Fever  Treatment of relapsing FEVER caused by  BORRELIA RECURRENTIS.",FEVER,BORRELIA RECURRENTIS
721149009,5/13/2015 10:44:09,1635689549,5/13/2015 10:43:58,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[TREATS],[TREATS],relapsing FEVER,N/A,49,66,1,53,86,TWrex-cause,811179-FS1,"i ,   l  Relapsing Fever  Treatment of relapsing FEVER caused by  BORRELIA RECURRENTIS.",FEVER,BORRELIA RECURRENTIS
721149009,5/13/2015 11:05:24,1635695923,5/13/2015 11:05:05,false,neodev,1.0,31706957,NLD,07,Amsterdam,145.100.72.165,[CAUSES],[CAUSES],caused by,n/a,49,66,1,53,86,TWrex-cause,811179-FS1,"i ,   l  Relapsing Fever  Treatment of relapsing FEVER caused by  BORRELIA RECURRENTIS.",FEVER,BORRELIA RECURRENTIS
721149009,5/13/2015 11:11:53,1635697296,5/13/2015 11:11:39,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[CAUSES],[CAUSES],caused by,n/a,49,66,1,53,86,TWrex-cause,811179-FS1,"i ,   l  Relapsing Fever  Treatment of relapsing FEVER caused by  BORRELIA RECURRENTIS.",FEVER,BORRELIA RECURRENTIS
721149009,5/13/2015 11:21:25,1635699660,5/13/2015 11:21:05,false,prodege,1.0,27934334,GBR,D3,Swadlincote,109.150.228.127,[CAUSES],[CAUSES],caused by,N/A,49,66,1,53,86,TWrex-cause,811179-FS1,"i ,   l  Relapsing Fever  Treatment of relapsing FEVER caused by  BORRELIA RECURRENTIS.",FEVER,BORRELIA RECURRENTIS
721149009,5/13/2015 11:29:11,1635701573,5/13/2015 11:28:34,false,points4rewards,1.0,28703583,USA,"","",97.73.86.35,[CAUSES],[CAUSES],caused by,N/A,49,66,1,53,86,TWrex-cause,811179-FS1,"i ,   l  Relapsing Fever  Treatment of relapsing FEVER caused by  BORRELIA RECURRENTIS.",FEVER,BORRELIA RECURRENTIS
721149009,5/13/2015 11:33:12,1635702336,5/13/2015 11:31:42,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[CAUSES],[CAUSES],FEVER caused by BORRELIA RECURRENTIS.,n/a,49,66,1,53,86,TWrex-cause,811179-FS1,"i ,   l  Relapsing Fever  Treatment of relapsing FEVER caused by  BORRELIA RECURRENTIS.",FEVER,BORRELIA RECURRENTIS
721149009,5/13/2015 11:41:43,1635705191,5/13/2015 11:41:24,false,neodev,1.0,31726043,GBR,"","",88.150.202.140,[LOCATION],[LOCATION],BORRELIA,561,49,66,1,53,86,TWrex-cause,811179-FS1,"i ,   l  Relapsing Fever  Treatment of relapsing FEVER caused by  BORRELIA RECURRENTIS.",FEVER,BORRELIA RECURRENTIS
721149009,5/13/2015 12:14:48,1635715584,5/13/2015 12:14:18,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,[CAUSES],[CAUSES],caused,n/a,49,66,1,53,86,TWrex-cause,811179-FS1,"i ,   l  Relapsing Fever  Treatment of relapsing FEVER caused by  BORRELIA RECURRENTIS.",FEVER,BORRELIA RECURRENTIS
721149009,5/13/2015 12:18:18,1635716942,5/13/2015 12:17:56,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[CAUSES],[CAUSES],FEVER caused by BORRELIA RECURRENTIS.,n/a,49,66,1,53,86,TWrex-cause,811179-FS1,"i ,   l  Relapsing Fever  Treatment of relapsing FEVER caused by  BORRELIA RECURRENTIS.",FEVER,BORRELIA RECURRENTIS
721149009,5/13/2015 12:18:48,1635717150,5/13/2015 12:18:36,false,clixsense,1.0,28457001,CAN,ON,North Bay,24.204.202.220,[CAUSES],[CAUSES],caused,n/a,49,66,1,53,86,TWrex-cause,811179-FS1,"i ,   l  Relapsing Fever  Treatment of relapsing FEVER caused by  BORRELIA RECURRENTIS.",FEVER,BORRELIA RECURRENTIS
721149010,5/13/2015 09:57:52,1635676761,5/13/2015 09:57:36,false,neodev,1.0,32103286,CAN,AB,Edmonton,208.123.223.37,[CAUSES] [PREVENTS] [LOCATION] [NONE],"[PREVENTS]
[CAUSES]
[LOCATION]
[NONE]",no,no,156,175,-1,161,188,TWrex-cause,802468-FS1,"Reflux of infected urine into the renal pelvis or presence of infected urine behind an obstruction can lead to chronic pyelonephritis, renal scarring, poor KIDNEY growth, and RENAL FAILURE",KIDNEY,RENAL FAILURE
721149010,5/13/2015 10:12:46,1635680642,5/13/2015 10:10:24,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[ASSOCIATED_WITH],[ASSOCIATED_WITH],"Reflux of infected urine into the renal pelvis or presence of infected urine behind an obstruction can lead to chronic pyelonephritis, renal scarring, poor KIDNEY growth, and RENAL FAILURE",N/A,156,175,-1,161,188,TWrex-cause,802468-FS1,"Reflux of infected urine into the renal pelvis or presence of infected urine behind an obstruction can lead to chronic pyelonephritis, renal scarring, poor KIDNEY growth, and RENAL FAILURE",KIDNEY,RENAL FAILURE
721149010,5/13/2015 10:28:12,1635684761,5/13/2015 10:27:04,false,clixsense,1.0,26847653,NLD,03,Warnsveld,213.93.50.164,[ASSOCIATED_WITH],[ASSOCIATED_WITH],can lead to and,n/a,156,175,-1,161,188,TWrex-cause,802468-FS1,"Reflux of infected urine into the renal pelvis or presence of infected urine behind an obstruction can lead to chronic pyelonephritis, renal scarring, poor KIDNEY growth, and RENAL FAILURE",KIDNEY,RENAL FAILURE
721149010,5/13/2015 10:30:28,1635685631,5/13/2015 10:29:56,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[ASSOCIATED_WITH],[ASSOCIATED_WITH],and,N/A,156,175,-1,161,188,TWrex-cause,802468-FS1,"Reflux of infected urine into the renal pelvis or presence of infected urine behind an obstruction can lead to chronic pyelonephritis, renal scarring, poor KIDNEY growth, and RENAL FAILURE",KIDNEY,RENAL FAILURE
721149010,5/13/2015 10:32:20,1635686145,5/13/2015 10:30:13,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[NONE],[NONE],n/a,different conditions that can result,156,175,-1,161,188,TWrex-cause,802468-FS1,"Reflux of infected urine into the renal pelvis or presence of infected urine behind an obstruction can lead to chronic pyelonephritis, renal scarring, poor KIDNEY growth, and RENAL FAILURE",KIDNEY,RENAL FAILURE
721149010,5/13/2015 10:43:58,1635689490,5/13/2015 10:43:47,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[CAUSES],[CAUSES],"pyelonephritis,",N/A,156,175,-1,161,188,TWrex-cause,802468-FS1,"Reflux of infected urine into the renal pelvis or presence of infected urine behind an obstruction can lead to chronic pyelonephritis, renal scarring, poor KIDNEY growth, and RENAL FAILURE",KIDNEY,RENAL FAILURE
721149010,5/13/2015 11:05:03,1635695837,5/13/2015 11:02:43,false,neodev,1.0,31706957,NLD,07,Amsterdam,145.100.72.165,[IS_A],[IS_A],"poor KIDNEY growth, and RENAL FAILURE",n/a,156,175,-1,161,188,TWrex-cause,802468-FS1,"Reflux of infected urine into the renal pelvis or presence of infected urine behind an obstruction can lead to chronic pyelonephritis, renal scarring, poor KIDNEY growth, and RENAL FAILURE",KIDNEY,RENAL FAILURE
721149010,5/13/2015 11:11:38,1635697229,5/13/2015 11:11:17,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[ASSOCIATED_WITH],[ASSOCIATED_WITH],and,n/a,156,175,-1,161,188,TWrex-cause,802468-FS1,"Reflux of infected urine into the renal pelvis or presence of infected urine behind an obstruction can lead to chronic pyelonephritis, renal scarring, poor KIDNEY growth, and RENAL FAILURE",KIDNEY,RENAL FAILURE
721149010,5/13/2015 11:21:04,1635699620,5/13/2015 11:20:15,false,prodege,1.0,27934334,GBR,D3,Swadlincote,109.150.228.127,[LOCATION],[LOCATION],KIDNEY RENAL,N/A,156,175,-1,161,188,TWrex-cause,802468-FS1,"Reflux of infected urine into the renal pelvis or presence of infected urine behind an obstruction can lead to chronic pyelonephritis, renal scarring, poor KIDNEY growth, and RENAL FAILURE",KIDNEY,RENAL FAILURE
721149010,5/13/2015 11:28:22,1635701426,5/13/2015 11:26:57,false,points4rewards,1.0,28703583,USA,"","",97.73.86.35,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],"Reflux of infected urine can lead to chronic pyelonephritis,",N/A,156,175,-1,161,188,TWrex-cause,802468-FS1,"Reflux of infected urine into the renal pelvis or presence of infected urine behind an obstruction can lead to chronic pyelonephritis, renal scarring, poor KIDNEY growth, and RENAL FAILURE",KIDNEY,RENAL FAILURE
721149010,5/13/2015 11:31:39,1635701970,5/13/2015 11:31:00,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[ASSOCIATED_WITH],[ASSOCIATED_WITH],"can lead to KIDNEY growth, and RENAL FAILURE",n/a,156,175,-1,161,188,TWrex-cause,802468-FS1,"Reflux of infected urine into the renal pelvis or presence of infected urine behind an obstruction can lead to chronic pyelonephritis, renal scarring, poor KIDNEY growth, and RENAL FAILURE",KIDNEY,RENAL FAILURE
721149010,5/13/2015 11:41:17,1635705072,5/13/2015 11:41:02,false,neodev,1.0,31726043,GBR,"","",88.150.202.140,[SYMPTOM],[SYMPTOM],behind,854,156,175,-1,161,188,TWrex-cause,802468-FS1,"Reflux of infected urine into the renal pelvis or presence of infected urine behind an obstruction can lead to chronic pyelonephritis, renal scarring, poor KIDNEY growth, and RENAL FAILURE",KIDNEY,RENAL FAILURE
721149010,5/13/2015 12:14:17,1635715323,5/13/2015 12:12:48,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,[ASSOCIATED_WITH],[ASSOCIATED_WITH],behind,n/a,156,175,-1,161,188,TWrex-cause,802468-FS1,"Reflux of infected urine into the renal pelvis or presence of infected urine behind an obstruction can lead to chronic pyelonephritis, renal scarring, poor KIDNEY growth, and RENAL FAILURE",KIDNEY,RENAL FAILURE
721149010,5/13/2015 12:17:54,1635716757,5/13/2015 12:17:31,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[SYMPTOM],[SYMPTOM],"poor KIDNEY growth, and RENAL FAILURE",n/a,156,175,-1,161,188,TWrex-cause,802468-FS1,"Reflux of infected urine into the renal pelvis or presence of infected urine behind an obstruction can lead to chronic pyelonephritis, renal scarring, poor KIDNEY growth, and RENAL FAILURE",KIDNEY,RENAL FAILURE
721149010,5/13/2015 12:18:35,1635717048,5/13/2015 12:18:00,false,clixsense,1.0,28457001,CAN,ON,North Bay,24.204.202.220,[NONE],[NONE],none,no relationship,156,175,-1,161,188,TWrex-cause,802468-FS1,"Reflux of infected urine into the renal pelvis or presence of infected urine behind an obstruction can lead to chronic pyelonephritis, renal scarring, poor KIDNEY growth, and RENAL FAILURE",KIDNEY,RENAL FAILURE
721149011,5/13/2015 10:24:09,1635683681,5/13/2015 10:22:40,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],A culture for HAEMOPHILUS DUCREYI if CHANCROID is prevalent in your area and if your lab can do a culture (which requires special media and is frequently not available),N/A,41,17,1,49,36,TWrex-cause,810888-FS1,◊ A culture for  HAEMOPHILUS DUCREYI  if CHANCROID is prevalent in your area and if your lab can do a culture (which requires special media and is frequently not available) • Obtain a serologic test for syphilis for all patients with genital lesions.,CHANCROID,HAEMOPHILUS DUCREYI
721149011,5/13/2015 10:40:28,1635688351,5/13/2015 10:39:33,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[ASSOCIATED_WITH],[ASSOCIATED_WITH],if CHANCROID is prevalent,n/a,41,17,1,49,36,TWrex-cause,810888-FS1,◊ A culture for  HAEMOPHILUS DUCREYI  if CHANCROID is prevalent in your area and if your lab can do a culture (which requires special media and is frequently not available) • Obtain a serologic test for syphilis for all patients with genital lesions.,CHANCROID,HAEMOPHILUS DUCREYI
721149011,5/13/2015 10:42:17,1635688808,5/13/2015 10:41:13,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[OTHER],[OTHER],if is prevalent,N/A,41,17,1,49,36,TWrex-cause,810888-FS1,◊ A culture for  HAEMOPHILUS DUCREYI  if CHANCROID is prevalent in your area and if your lab can do a culture (which requires special media and is frequently not available) • Obtain a serologic test for syphilis for all patients with genital lesions.,CHANCROID,HAEMOPHILUS DUCREYI
721149011,5/13/2015 10:52:19,1635692037,5/13/2015 10:51:43,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],HAEMOPHILUS,N/A,41,17,1,49,36,TWrex-cause,810888-FS1,◊ A culture for  HAEMOPHILUS DUCREYI  if CHANCROID is prevalent in your area and if your lab can do a culture (which requires special media and is frequently not available) • Obtain a serologic test for syphilis for all patients with genital lesions.,CHANCROID,HAEMOPHILUS DUCREYI
721149011,5/13/2015 11:14:37,1635697844,5/13/2015 11:14:12,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[ASSOCIATED_WITH],[ASSOCIATED_WITH],culture,n/a,41,17,1,49,36,TWrex-cause,810888-FS1,◊ A culture for  HAEMOPHILUS DUCREYI  if CHANCROID is prevalent in your area and if your lab can do a culture (which requires special media and is frequently not available) • Obtain a serologic test for syphilis for all patients with genital lesions.,CHANCROID,HAEMOPHILUS DUCREYI
721149011,5/13/2015 11:18:03,1635699005,5/13/2015 11:15:27,false,neodev,1.0,31706957,NLD,07,Amsterdam,145.100.72.165,[IS_A],[IS_A],A culture if,n/a,41,17,1,49,36,TWrex-cause,810888-FS1,◊ A culture for  HAEMOPHILUS DUCREYI  if CHANCROID is prevalent in your area and if your lab can do a culture (which requires special media and is frequently not available) • Obtain a serologic test for syphilis for all patients with genital lesions.,CHANCROID,HAEMOPHILUS DUCREYI
721149011,5/13/2015 11:31:37,1635701967,5/13/2015 11:29:39,false,prodege,1.0,27934334,GBR,D3,Swadlincote,109.150.228.127,[ASSOCIATED_WITH],[ASSOCIATED_WITH],culture if CHANCROID prevalent,N/A,41,17,1,49,36,TWrex-cause,810888-FS1,◊ A culture for  HAEMOPHILUS DUCREYI  if CHANCROID is prevalent in your area and if your lab can do a culture (which requires special media and is frequently not available) • Obtain a serologic test for syphilis for all patients with genital lesions.,CHANCROID,HAEMOPHILUS DUCREYI
721149011,5/13/2015 11:39:18,1635704706,5/13/2015 11:37:20,false,points4rewards,1.0,28703583,USA,"","",97.73.86.35,[ASSOCIATED_WITH],[ASSOCIATED_WITH],is prevalent if your lab can do a culture,N/A,41,17,1,49,36,TWrex-cause,810888-FS1,◊ A culture for  HAEMOPHILUS DUCREYI  if CHANCROID is prevalent in your area and if your lab can do a culture (which requires special media and is frequently not available) • Obtain a serologic test for syphilis for all patients with genital lesions.,CHANCROID,HAEMOPHILUS DUCREYI
721149011,5/13/2015 11:40:03,1635704831,5/13/2015 11:39:29,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],A culture for HAEMOPHILUS DUCREYI if CHANCROID is prevalent,n/a,41,17,1,49,36,TWrex-cause,810888-FS1,◊ A culture for  HAEMOPHILUS DUCREYI  if CHANCROID is prevalent in your area and if your lab can do a culture (which requires special media and is frequently not available) • Obtain a serologic test for syphilis for all patients with genital lesions.,CHANCROID,HAEMOPHILUS DUCREYI
721149011,5/13/2015 11:45:32,1635705895,5/13/2015 11:45:18,false,neodev,1.0,31726043,GBR,"","",88.150.202.140,[LOCATION],[LOCATION],your,554,41,17,1,49,36,TWrex-cause,810888-FS1,◊ A culture for  HAEMOPHILUS DUCREYI  if CHANCROID is prevalent in your area and if your lab can do a culture (which requires special media and is frequently not available) • Obtain a serologic test for syphilis for all patients with genital lesions.,CHANCROID,HAEMOPHILUS DUCREYI
721149011,5/13/2015 12:20:10,1635717761,5/13/2015 12:19:37,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,[NONE],[NONE],n/a,n/a,41,17,1,49,36,TWrex-cause,810888-FS1,◊ A culture for  HAEMOPHILUS DUCREYI  if CHANCROID is prevalent in your area and if your lab can do a culture (which requires special media and is frequently not available) • Obtain a serologic test for syphilis for all patients with genital lesions.,CHANCROID,HAEMOPHILUS DUCREYI
721149011,5/13/2015 12:23:43,1635719106,5/13/2015 12:22:02,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[SYMPTOM],[SYMPTOM],HAEMOPHILUS DUCREYI if CHANCROID is prevalent,n/a,41,17,1,49,36,TWrex-cause,810888-FS1,◊ A culture for  HAEMOPHILUS DUCREYI  if CHANCROID is prevalent in your area and if your lab can do a culture (which requires special media and is frequently not available) • Obtain a serologic test for syphilis for all patients with genital lesions.,CHANCROID,HAEMOPHILUS DUCREYI
721149011,5/13/2015 12:28:38,1635720877,5/13/2015 12:27:28,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[OTHER],[OTHER],culture,N/A,41,17,1,49,36,TWrex-cause,810888-FS1,◊ A culture for  HAEMOPHILUS DUCREYI  if CHANCROID is prevalent in your area and if your lab can do a culture (which requires special media and is frequently not available) • Obtain a serologic test for syphilis for all patients with genital lesions.,CHANCROID,HAEMOPHILUS DUCREYI
721149011,5/13/2015 12:51:29,1635726455,5/13/2015 12:49:03,false,prodege,1.0,23482077,USA,TX,Garland,71.164.238.226,[DIAGNOSE_BY_TEST_OR_DRUG] [ASSOCIATED_WITH],"[DIAGNOSE_BY_TEST_OR_DRUG]
[ASSOCIATED_WITH]",culture for if prevalent in your area,N/A,41,17,1,49,36,TWrex-cause,810888-FS1,◊ A culture for  HAEMOPHILUS DUCREYI  if CHANCROID is prevalent in your area and if your lab can do a culture (which requires special media and is frequently not available) • Obtain a serologic test for syphilis for all patients with genital lesions.,CHANCROID,HAEMOPHILUS DUCREYI
721149011,5/13/2015 13:00:12,1635728543,5/13/2015 12:59:44,false,clixsense,1.0,24329110,USA,FL,Jacksonville,12.168.136.2,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],culture for,n/a,41,17,1,49,36,TWrex-cause,810888-FS1,◊ A culture for  HAEMOPHILUS DUCREYI  if CHANCROID is prevalent in your area and if your lab can do a culture (which requires special media and is frequently not available) • Obtain a serologic test for syphilis for all patients with genital lesions.,CHANCROID,HAEMOPHILUS DUCREYI
721149012,5/13/2015 16:42:34,1635856869,5/13/2015 16:41:56,false,prodege,1.0,16101132,GBR,F9,Hayes,2.223.214.149,[SYMPTOM],[SYMPTOM],presence,Symptom,24,124,-1,36,136,TWrex-cause,802906-FS1,"• Consider aspirating a SWOLLEN JOINT to document the presence of CPPD crystals or document an arthritic process other than CPPD DISEASE e.g., septic arthritis or gout.",SWOLLEN JOINT,CPPD DISEASE
721149012,5/13/2015 16:47:58,1635860103,5/13/2015 16:46:59,false,clixsense,1.0,31579138,AUS,02,Hurstville,14.200.129.68,[CONTRAINDICATES],[CONTRAINDICATES],other than,N/A,24,124,-1,36,136,TWrex-cause,802906-FS1,"• Consider aspirating a SWOLLEN JOINT to document the presence of CPPD crystals or document an arthritic process other than CPPD DISEASE e.g., septic arthritis or gout.",SWOLLEN JOINT,CPPD DISEASE
721149012,5/13/2015 17:28:30,1635882113,5/13/2015 17:27:05,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[SYMPTOM],[SYMPTOM],presence of,n/a,24,124,-1,36,136,TWrex-cause,802906-FS1,"• Consider aspirating a SWOLLEN JOINT to document the presence of CPPD crystals or document an arthritic process other than CPPD DISEASE e.g., septic arthritis or gout.",SWOLLEN JOINT,CPPD DISEASE
721149012,5/13/2015 17:37:47,1635887133,5/13/2015 17:37:14,false,gptking,1.0,31799065,USA,IL,Marion,50.45.43.154,[SYMPTOM],[SYMPTOM],SWOLLEN JOINT presence CPPD,N/A,24,124,-1,36,136,TWrex-cause,802906-FS1,"• Consider aspirating a SWOLLEN JOINT to document the presence of CPPD crystals or document an arthritic process other than CPPD DISEASE e.g., septic arthritis or gout.",SWOLLEN JOINT,CPPD DISEASE
721149012,5/13/2015 18:12:57,1635904680,5/13/2015 18:12:30,false,clixsense,1.0,32549163,CAN,MB,Winnipeg,206.45.167.246,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],Consider aspirating a SWOLLEN JOINT to document the presence of CPPD crystals or document other than CPPD DISEASE,N/A,24,124,-1,36,136,TWrex-cause,802906-FS1,"• Consider aspirating a SWOLLEN JOINT to document the presence of CPPD crystals or document an arthritic process other than CPPD DISEASE e.g., septic arthritis or gout.",SWOLLEN JOINT,CPPD DISEASE
721149012,5/13/2015 18:15:33,1635905728,5/13/2015 18:15:17,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],to document,N/A,24,124,-1,36,136,TWrex-cause,802906-FS1,"• Consider aspirating a SWOLLEN JOINT to document the presence of CPPD crystals or document an arthritic process other than CPPD DISEASE e.g., septic arthritis or gout.",SWOLLEN JOINT,CPPD DISEASE
721149012,5/13/2015 18:20:13,1635907623,5/13/2015 18:19:41,false,instagc,1.0,24252915,GBR,"","",80.44.146.98,[LOCATION],[LOCATION],to document the presence of,N/a,24,124,-1,36,136,TWrex-cause,802906-FS1,"• Consider aspirating a SWOLLEN JOINT to document the presence of CPPD crystals or document an arthritic process other than CPPD DISEASE e.g., septic arthritis or gout.",SWOLLEN JOINT,CPPD DISEASE
721149012,5/13/2015 18:21:03,1635908017,5/13/2015 18:19:56,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],document the presence,N/A,24,124,-1,36,136,TWrex-cause,802906-FS1,"• Consider aspirating a SWOLLEN JOINT to document the presence of CPPD crystals or document an arthritic process other than CPPD DISEASE e.g., septic arthritis or gout.",SWOLLEN JOINT,CPPD DISEASE
721149012,5/13/2015 18:45:47,1635921113,5/13/2015 18:45:10,false,prodege,1.0,32302664,USA,IL,Geneseo,173.27.241.235,[SIDE_EFFECT],[SIDE_EFFECT],to document the presence of,no comment,24,124,-1,36,136,TWrex-cause,802906-FS1,"• Consider aspirating a SWOLLEN JOINT to document the presence of CPPD crystals or document an arthritic process other than CPPD DISEASE e.g., septic arthritis or gout.",SWOLLEN JOINT,CPPD DISEASE
721149012,5/13/2015 19:09:24,1635930602,5/13/2015 19:09:11,false,clixsense,1.0,19162475,GBR,P8,Trowbridge,82.33.126.30,[ASSOCIATED_WITH] [SYMPTOM],"[SYMPTOM]
[ASSOCIATED_WITH]",presence of,n/a,24,124,-1,36,136,TWrex-cause,802906-FS1,"• Consider aspirating a SWOLLEN JOINT to document the presence of CPPD crystals or document an arthritic process other than CPPD DISEASE e.g., septic arthritis or gout.",SWOLLEN JOINT,CPPD DISEASE
721149012,5/13/2015 19:12:00,1635931919,5/13/2015 19:09:28,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[MANIFESTATION],[MANIFESTATION],presence,N/A,24,124,-1,36,136,TWrex-cause,802906-FS1,"• Consider aspirating a SWOLLEN JOINT to document the presence of CPPD crystals or document an arthritic process other than CPPD DISEASE e.g., septic arthritis or gout.",SWOLLEN JOINT,CPPD DISEASE
721149012,5/13/2015 19:44:23,1635962648,5/13/2015 19:43:44,false,elite,1.0,30064988,GBR,H3,Leeds,92.22.208.245,[OTHER],[OTHER],arthritic process other than,N/A,24,124,-1,36,136,TWrex-cause,802906-FS1,"• Consider aspirating a SWOLLEN JOINT to document the presence of CPPD crystals or document an arthritic process other than CPPD DISEASE e.g., septic arthritis or gout.",SWOLLEN JOINT,CPPD DISEASE
721149012,5/13/2015 20:04:21,1635978361,5/13/2015 20:03:42,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.156.243,[SYMPTOM],[SYMPTOM],SWOLLEN JOINT presence of CPPD DISEASE,N/A,24,124,-1,36,136,TWrex-cause,802906-FS1,"• Consider aspirating a SWOLLEN JOINT to document the presence of CPPD crystals or document an arthritic process other than CPPD DISEASE e.g., septic arthritis or gout.",SWOLLEN JOINT,CPPD DISEASE
721149012,5/13/2015 20:04:48,1635978743,5/13/2015 20:04:02,false,clixsense,1.0,27969116,NLD,"","",212.78.195.38,[OTHER],[OTHER],other than,is something else,24,124,-1,36,136,TWrex-cause,802906-FS1,"• Consider aspirating a SWOLLEN JOINT to document the presence of CPPD crystals or document an arthritic process other than CPPD DISEASE e.g., septic arthritis or gout.",SWOLLEN JOINT,CPPD DISEASE
721149012,5/13/2015 20:32:28,1635999098,5/13/2015 20:31:19,false,neodev,1.0,20961587,NLD,05,Maastricht,84.26.48.136,[DIAGNOSE_BY_TEST_OR_DRUG] [LOCATION],"[DIAGNOSE_BY_TEST_OR_DRUG]
[LOCATION]",presence,N/A,24,124,-1,36,136,TWrex-cause,802906-FS1,"• Consider aspirating a SWOLLEN JOINT to document the presence of CPPD crystals or document an arthritic process other than CPPD DISEASE e.g., septic arthritis or gout.",SWOLLEN JOINT,CPPD DISEASE
721149013,5/13/2015 13:24:29,1635735585,5/13/2015 13:24:05,false,clixsense,1.0,23197581,NLD,11,Den Haag,82.217.5.55,[CONTRAINDICATES],[CONTRAINDICATES],must be discontinued and substituted,N/A,119,13,-1,127,21,TWrex-cause,803160-FS1,Rationale: • WARFARIN is teratogenic and embryopathic and must be discontinued and substituted with heparin as soon as PREGNANCY is diagnosed.,PREGNANCY,WARFARIN
721149013,5/13/2015 14:02:30,1635748630,5/13/2015 14:00:18,false,neodev,1.0,24564999,GBR,H9,London,86.145.227.9,[CONTRAINDICATES],[CONTRAINDICATES],teratogenic and embryopathic,N/A,119,13,-1,127,21,TWrex-cause,803160-FS1,Rationale: • WARFARIN is teratogenic and embryopathic and must be discontinued and substituted with heparin as soon as PREGNANCY is diagnosed.,PREGNANCY,WARFARIN
721149013,5/13/2015 14:05:38,1635750086,5/13/2015 14:05:11,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[CONTRAINDICATES],[CONTRAINDICATES],must be discontinued,N/A,119,13,-1,127,21,TWrex-cause,803160-FS1,Rationale: • WARFARIN is teratogenic and embryopathic and must be discontinued and substituted with heparin as soon as PREGNANCY is diagnosed.,PREGNANCY,WARFARIN
721149013,5/13/2015 14:30:05,1635760476,5/13/2015 14:29:19,false,prodege,1.0,24403612,CAN,ON,Ajax,99.239.181.149,[OTHER],[OTHER],WARFARIN must be discontinued and substituted with as soon as PREGNANCY is diagnosed.,N/a,119,13,-1,127,21,TWrex-cause,803160-FS1,Rationale: • WARFARIN is teratogenic and embryopathic and must be discontinued and substituted with heparin as soon as PREGNANCY is diagnosed.,PREGNANCY,WARFARIN
721149013,5/13/2015 14:39:42,1635766215,5/13/2015 14:39:22,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[CONTRAINDICATES],[CONTRAINDICATES],discontinued and substituted,N/A,119,13,-1,127,21,TWrex-cause,803160-FS1,Rationale: • WARFARIN is teratogenic and embryopathic and must be discontinued and substituted with heparin as soon as PREGNANCY is diagnosed.,PREGNANCY,WARFARIN
721149013,5/13/2015 15:23:44,1635800695,5/13/2015 15:23:16,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],discontinued,n/a,119,13,-1,127,21,TWrex-cause,803160-FS1,Rationale: • WARFARIN is teratogenic and embryopathic and must be discontinued and substituted with heparin as soon as PREGNANCY is diagnosed.,PREGNANCY,WARFARIN
721149013,5/13/2015 16:16:53,1635840474,5/13/2015 16:16:18,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[CONTRAINDICATES],[CONTRAINDICATES],discontinued,none,119,13,-1,127,21,TWrex-cause,803160-FS1,Rationale: • WARFARIN is teratogenic and embryopathic and must be discontinued and substituted with heparin as soon as PREGNANCY is diagnosed.,PREGNANCY,WARFARIN
721149013,5/13/2015 16:36:40,1635853393,5/13/2015 16:36:00,false,prodege,1.0,16101132,GBR,F9,Hayes,2.223.214.149,[CONTRAINDICATES],[CONTRAINDICATES],discontinued,Discontinue,119,13,-1,127,21,TWrex-cause,803160-FS1,Rationale: • WARFARIN is teratogenic and embryopathic and must be discontinued and substituted with heparin as soon as PREGNANCY is diagnosed.,PREGNANCY,WARFARIN
721149013,5/13/2015 16:39:03,1635854777,5/13/2015 16:38:38,false,clixsense,1.0,31579138,AUS,02,Hurstville,14.200.129.68,[CONTRAINDICATES],[CONTRAINDICATES],discontinued,N/A,119,13,-1,127,21,TWrex-cause,803160-FS1,Rationale: • WARFARIN is teratogenic and embryopathic and must be discontinued and substituted with heparin as soon as PREGNANCY is diagnosed.,PREGNANCY,WARFARIN
721149013,5/13/2015 17:20:19,1635877466,5/13/2015 17:18:49,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[CONTRAINDICATES],[CONTRAINDICATES],must be discontinued and substituted,n/a,119,13,-1,127,21,TWrex-cause,803160-FS1,Rationale: • WARFARIN is teratogenic and embryopathic and must be discontinued and substituted with heparin as soon as PREGNANCY is diagnosed.,PREGNANCY,WARFARIN
721149013,5/13/2015 17:28:11,1635881901,5/13/2015 17:27:41,false,gptking,1.0,31799065,USA,IL,Marion,50.45.43.154,[CONTRAINDICATES],[CONTRAINDICATES],WARFARIN PREGNANCY,N/A,119,13,-1,127,21,TWrex-cause,803160-FS1,Rationale: • WARFARIN is teratogenic and embryopathic and must be discontinued and substituted with heparin as soon as PREGNANCY is diagnosed.,PREGNANCY,WARFARIN
721149013,5/13/2015 17:55:23,1635898214,5/13/2015 17:55:01,false,prodege,1.0,14848125,GBR,L6,Shrewsbury,86.138.223.142,[CONTRAINDICATES],[CONTRAINDICATES],must be discontinued,N/A,119,13,-1,127,21,TWrex-cause,803160-FS1,Rationale: • WARFARIN is teratogenic and embryopathic and must be discontinued and substituted with heparin as soon as PREGNANCY is diagnosed.,PREGNANCY,WARFARIN
721149013,5/13/2015 18:06:20,1635901950,5/13/2015 18:05:41,false,clixsense,1.0,6574449,USA,"","",216.216.68.85,[OTHER],[OTHER],WARFARIN teratogenic embryopathic discontinued substituted heparin PREGNANCY diagnosed.,na,119,13,-1,127,21,TWrex-cause,803160-FS1,Rationale: • WARFARIN is teratogenic and embryopathic and must be discontinued and substituted with heparin as soon as PREGNANCY is diagnosed.,PREGNANCY,WARFARIN
721149013,5/13/2015 18:08:51,1635902994,5/13/2015 18:08:13,false,clixsense,1.0,32549163,CAN,MB,Winnipeg,206.45.167.246,[CONTRAINDICATES],[CONTRAINDICATES],WARFARIN is teratogenic and embryopathic and must be discontinued as soon as PREGNANCY is diagnosed.,N/A,119,13,-1,127,21,TWrex-cause,803160-FS1,Rationale: • WARFARIN is teratogenic and embryopathic and must be discontinued and substituted with heparin as soon as PREGNANCY is diagnosed.,PREGNANCY,WARFARIN
721149013,5/13/2015 18:10:06,1635903541,5/13/2015 18:08:55,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[CONTRAINDICATES],[CONTRAINDICATES],must be discontinued,N/A,119,13,-1,127,21,TWrex-cause,803160-FS1,Rationale: • WARFARIN is teratogenic and embryopathic and must be discontinued and substituted with heparin as soon as PREGNANCY is diagnosed.,PREGNANCY,WARFARIN
721149014,5/13/2015 13:07:41,1635731122,5/13/2015 13:07:22,false,neodev,1.0,30504276,CAN,ON,Sudbury,66.103.55.12,[TREATS],[TREATS],therapy,N/A,11,60,-1,28,63,TWrex-cause,805064-FS1,"107 , 108  ULCERATIVE COLITIS   Both controlled trials with AZA and uncontrolled series with 6 MP have supported the role of purine analogues for the long term (maintenance) therapy of UC.",ULCERATIVE COLITIS,AZA
721149014,5/13/2015 13:18:05,1635733836,5/13/2015 13:17:33,false,clixsense,1.0,24329110,USA,FL,Jacksonville,12.168.136.2,[TREATS],[TREATS],long term (maintenance) therapy,n/a,11,60,-1,28,63,TWrex-cause,805064-FS1,"107 , 108  ULCERATIVE COLITIS   Both controlled trials with AZA and uncontrolled series with 6 MP have supported the role of purine analogues for the long term (maintenance) therapy of UC.",ULCERATIVE COLITIS,AZA
721149014,5/13/2015 13:19:49,1635734338,5/13/2015 13:19:26,false,clixsense,1.0,23197581,NLD,11,Den Haag,82.217.5.55,[TREATS],[TREATS],controlled trials,N/A,11,60,-1,28,63,TWrex-cause,805064-FS1,"107 , 108  ULCERATIVE COLITIS   Both controlled trials with AZA and uncontrolled series with 6 MP have supported the role of purine analogues for the long term (maintenance) therapy of UC.",ULCERATIVE COLITIS,AZA
721149014,5/13/2015 13:44:04,1635740929,5/13/2015 13:43:20,false,bitcoinget,1.0,21614812,USA,PA,Erie,174.100.250.115,[OTHER],[OTHER],controlled trials with,N/A,11,60,-1,28,63,TWrex-cause,805064-FS1,"107 , 108  ULCERATIVE COLITIS   Both controlled trials with AZA and uncontrolled series with 6 MP have supported the role of purine analogues for the long term (maintenance) therapy of UC.",ULCERATIVE COLITIS,AZA
721149014,5/13/2015 13:57:09,1635746265,5/13/2015 13:56:47,false,neodev,1.0,24564999,GBR,H9,London,86.145.227.9,[TREATS],[TREATS],long term therapy,N/A,11,60,-1,28,63,TWrex-cause,805064-FS1,"107 , 108  ULCERATIVE COLITIS   Both controlled trials with AZA and uncontrolled series with 6 MP have supported the role of purine analogues for the long term (maintenance) therapy of UC.",ULCERATIVE COLITIS,AZA
721149014,5/13/2015 13:59:03,1635747006,5/13/2015 13:58:32,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[TREATS],[TREATS],therapy,N/A,11,60,-1,28,63,TWrex-cause,805064-FS1,"107 , 108  ULCERATIVE COLITIS   Both controlled trials with AZA and uncontrolled series with 6 MP have supported the role of purine analogues for the long term (maintenance) therapy of UC.",ULCERATIVE COLITIS,AZA
721149014,5/13/2015 14:24:13,1635757549,5/13/2015 14:23:27,false,prodege,1.0,24403612,CAN,ON,Ajax,99.239.181.149,[OTHER],[OTHER],ULCERATIVE COLITIS controlled trials with AZA,N/a,11,60,-1,28,63,TWrex-cause,805064-FS1,"107 , 108  ULCERATIVE COLITIS   Both controlled trials with AZA and uncontrolled series with 6 MP have supported the role of purine analogues for the long term (maintenance) therapy of UC.",ULCERATIVE COLITIS,AZA
721149014,5/13/2015 14:35:11,1635763470,5/13/2015 14:32:33,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[TREATS],[TREATS],(maintenance) therapy,N/A,11,60,-1,28,63,TWrex-cause,805064-FS1,"107 , 108  ULCERATIVE COLITIS   Both controlled trials with AZA and uncontrolled series with 6 MP have supported the role of purine analogues for the long term (maintenance) therapy of UC.",ULCERATIVE COLITIS,AZA
721149014,5/13/2015 15:18:32,1635796910,5/13/2015 15:18:00,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,[PREVENTS],[PREVENTS],therapy,n/a,11,60,-1,28,63,TWrex-cause,805064-FS1,"107 , 108  ULCERATIVE COLITIS   Both controlled trials with AZA and uncontrolled series with 6 MP have supported the role of purine analogues for the long term (maintenance) therapy of UC.",ULCERATIVE COLITIS,AZA
721149014,5/13/2015 15:36:04,1635810403,5/13/2015 15:34:42,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],ULCERATIVE COLITIS Both controlled trials with AZA and uncontrolled series,N/A,11,60,-1,28,63,TWrex-cause,805064-FS1,"107 , 108  ULCERATIVE COLITIS   Both controlled trials with AZA and uncontrolled series with 6 MP have supported the role of purine analogues for the long term (maintenance) therapy of UC.",ULCERATIVE COLITIS,AZA
721149014,5/13/2015 16:05:46,1635833426,5/13/2015 16:04:23,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[TREATS],[TREATS],therapy,none,11,60,-1,28,63,TWrex-cause,805064-FS1,"107 , 108  ULCERATIVE COLITIS   Both controlled trials with AZA and uncontrolled series with 6 MP have supported the role of purine analogues for the long term (maintenance) therapy of UC.",ULCERATIVE COLITIS,AZA
721149014,5/13/2015 16:31:07,1635849813,5/13/2015 16:30:32,false,prodege,1.0,16101132,GBR,F9,Hayes,2.223.214.149,[OTHER],[OTHER],trials,Trial,11,60,-1,28,63,TWrex-cause,805064-FS1,"107 , 108  ULCERATIVE COLITIS   Both controlled trials with AZA and uncontrolled series with 6 MP have supported the role of purine analogues for the long term (maintenance) therapy of UC.",ULCERATIVE COLITIS,AZA
721149014,5/13/2015 16:32:03,1635850583,5/13/2015 16:31:27,false,clixsense,1.0,31579138,AUS,02,Hurstville,14.200.129.68,[TREATS],[TREATS],therapy,N/A,11,60,-1,28,63,TWrex-cause,805064-FS1,"107 , 108  ULCERATIVE COLITIS   Both controlled trials with AZA and uncontrolled series with 6 MP have supported the role of purine analogues for the long term (maintenance) therapy of UC.",ULCERATIVE COLITIS,AZA
721149014,5/13/2015 17:12:21,1635872978,5/13/2015 17:11:38,false,gptking,1.0,31799065,USA,IL,Marion,50.45.43.154,[TREATS],[TREATS],ULCERATIVE COLITIS AZA therapy,N/A,11,60,-1,28,63,TWrex-cause,805064-FS1,"107 , 108  ULCERATIVE COLITIS   Both controlled trials with AZA and uncontrolled series with 6 MP have supported the role of purine analogues for the long term (maintenance) therapy of UC.",ULCERATIVE COLITIS,AZA
721149014,5/13/2015 17:13:40,1635873706,5/13/2015 17:12:34,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[TREATS],[TREATS],trials with,n/a,11,60,-1,28,63,TWrex-cause,805064-FS1,"107 , 108  ULCERATIVE COLITIS   Both controlled trials with AZA and uncontrolled series with 6 MP have supported the role of purine analogues for the long term (maintenance) therapy of UC.",ULCERATIVE COLITIS,AZA
721149015,5/13/2015 13:08:48,1635731387,5/13/2015 13:08:37,false,neodev,1.0,30504276,CAN,ON,Sudbury,66.103.55.12,[NONE],[NONE],N/A,N/A,87,26,-1,105,64,TWrex-cause,804496-FS1,2008 10 01  The effect of GLUCOSAMINE AND/OR CHONDROITIN SULFATE on the progression of KNEE OSTEOARTHRITIS: a report from the glucosamine/chondroitin arthritis intervention trial.,KNEE OSTEOARTHRITIS,GLUCOSAMINE AND/OR CHONDROITIN SULFATE
721149015,5/13/2015 13:21:55,1635734917,5/13/2015 13:21:27,false,clixsense,1.0,23197581,NLD,11,Den Haag,82.217.5.55,[TREATS],[TREATS],The effect on the progression,N/A,87,26,-1,105,64,TWrex-cause,804496-FS1,2008 10 01  The effect of GLUCOSAMINE AND/OR CHONDROITIN SULFATE on the progression of KNEE OSTEOARTHRITIS: a report from the glucosamine/chondroitin arthritis intervention trial.,KNEE OSTEOARTHRITIS,GLUCOSAMINE AND/OR CHONDROITIN SULFATE
721149015,5/13/2015 13:45:14,1635741365,5/13/2015 13:44:57,false,bitcoinget,1.0,21614812,USA,PA,Erie,174.100.250.115,[ASSOCIATED_WITH] [TREATS],"[TREATS]
[ASSOCIATED_WITH]",on the progression of,N/A,87,26,-1,105,64,TWrex-cause,804496-FS1,2008 10 01  The effect of GLUCOSAMINE AND/OR CHONDROITIN SULFATE on the progression of KNEE OSTEOARTHRITIS: a report from the glucosamine/chondroitin arthritis intervention trial.,KNEE OSTEOARTHRITIS,GLUCOSAMINE AND/OR CHONDROITIN SULFATE
721149015,5/13/2015 13:58:59,1635746979,5/13/2015 13:58:35,false,neodev,1.0,24564999,GBR,H9,London,86.145.227.9,[TREATS],[TREATS],effect of on the progression of,N/A,87,26,-1,105,64,TWrex-cause,804496-FS1,2008 10 01  The effect of GLUCOSAMINE AND/OR CHONDROITIN SULFATE on the progression of KNEE OSTEOARTHRITIS: a report from the glucosamine/chondroitin arthritis intervention trial.,KNEE OSTEOARTHRITIS,GLUCOSAMINE AND/OR CHONDROITIN SULFATE
721149015,5/13/2015 14:02:38,1635748658,5/13/2015 14:01:55,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[PREVENTS],[PREVENTS],effect on progression,N/A,87,26,-1,105,64,TWrex-cause,804496-FS1,2008 10 01  The effect of GLUCOSAMINE AND/OR CHONDROITIN SULFATE on the progression of KNEE OSTEOARTHRITIS: a report from the glucosamine/chondroitin arthritis intervention trial.,KNEE OSTEOARTHRITIS,GLUCOSAMINE AND/OR CHONDROITIN SULFATE
721149015,5/13/2015 14:27:00,1635758832,5/13/2015 14:26:30,false,prodege,1.0,24403612,CAN,ON,Ajax,99.239.181.149,[MANIFESTATION],[MANIFESTATION],GLUCOSAMINE AND/OR CHONDROITIN SULFATE on progression of KNEE OSTEOARTHRITIS:,N/a,87,26,-1,105,64,TWrex-cause,804496-FS1,2008 10 01  The effect of GLUCOSAMINE AND/OR CHONDROITIN SULFATE on the progression of KNEE OSTEOARTHRITIS: a report from the glucosamine/chondroitin arthritis intervention trial.,KNEE OSTEOARTHRITIS,GLUCOSAMINE AND/OR CHONDROITIN SULFATE
721149015,5/13/2015 14:37:44,1635765113,5/13/2015 14:36:31,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[TREATS],[TREATS],effect of,N/A,87,26,-1,105,64,TWrex-cause,804496-FS1,2008 10 01  The effect of GLUCOSAMINE AND/OR CHONDROITIN SULFATE on the progression of KNEE OSTEOARTHRITIS: a report from the glucosamine/chondroitin arthritis intervention trial.,KNEE OSTEOARTHRITIS,GLUCOSAMINE AND/OR CHONDROITIN SULFATE
721149015,5/13/2015 15:20:41,1635798505,5/13/2015 15:20:13,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,[CAUSES],[CAUSES],effect,n/a,87,26,-1,105,64,TWrex-cause,804496-FS1,2008 10 01  The effect of GLUCOSAMINE AND/OR CHONDROITIN SULFATE on the progression of KNEE OSTEOARTHRITIS: a report from the glucosamine/chondroitin arthritis intervention trial.,KNEE OSTEOARTHRITIS,GLUCOSAMINE AND/OR CHONDROITIN SULFATE
721149015,5/13/2015 16:12:13,1635837540,5/13/2015 16:10:17,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[TREATS],[TREATS],progression,none,87,26,-1,105,64,TWrex-cause,804496-FS1,2008 10 01  The effect of GLUCOSAMINE AND/OR CHONDROITIN SULFATE on the progression of KNEE OSTEOARTHRITIS: a report from the glucosamine/chondroitin arthritis intervention trial.,KNEE OSTEOARTHRITIS,GLUCOSAMINE AND/OR CHONDROITIN SULFATE
721149015,5/13/2015 16:33:57,1635851720,5/13/2015 16:33:30,false,prodege,1.0,16101132,GBR,F9,Hayes,2.223.214.149,[OTHER],[OTHER],progression,Progression,87,26,-1,105,64,TWrex-cause,804496-FS1,2008 10 01  The effect of GLUCOSAMINE AND/OR CHONDROITIN SULFATE on the progression of KNEE OSTEOARTHRITIS: a report from the glucosamine/chondroitin arthritis intervention trial.,KNEE OSTEOARTHRITIS,GLUCOSAMINE AND/OR CHONDROITIN SULFATE
721149015,5/13/2015 16:36:12,1635853072,5/13/2015 16:34:26,false,clixsense,1.0,31579138,AUS,02,Hurstville,14.200.129.68,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],progression,N/A,87,26,-1,105,64,TWrex-cause,804496-FS1,2008 10 01  The effect of GLUCOSAMINE AND/OR CHONDROITIN SULFATE on the progression of KNEE OSTEOARTHRITIS: a report from the glucosamine/chondroitin arthritis intervention trial.,KNEE OSTEOARTHRITIS,GLUCOSAMINE AND/OR CHONDROITIN SULFATE
721149015,5/13/2015 17:15:30,1635874782,5/13/2015 17:15:06,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[TREATS],[TREATS],effect on the progression of,n/a,87,26,-1,105,64,TWrex-cause,804496-FS1,2008 10 01  The effect of GLUCOSAMINE AND/OR CHONDROITIN SULFATE on the progression of KNEE OSTEOARTHRITIS: a report from the glucosamine/chondroitin arthritis intervention trial.,KNEE OSTEOARTHRITIS,GLUCOSAMINE AND/OR CHONDROITIN SULFATE
721149015,5/13/2015 17:18:12,1635876224,5/13/2015 17:17:04,false,gptking,1.0,31799065,USA,IL,Marion,50.45.43.154,[TREATS],[TREATS],GLUCOSAMINE AND/OR CHONDROITIN SULFATE KNEE OSTEOARTHRITIS:,N/A,87,26,-1,105,64,TWrex-cause,804496-FS1,2008 10 01  The effect of GLUCOSAMINE AND/OR CHONDROITIN SULFATE on the progression of KNEE OSTEOARTHRITIS: a report from the glucosamine/chondroitin arthritis intervention trial.,KNEE OSTEOARTHRITIS,GLUCOSAMINE AND/OR CHONDROITIN SULFATE
721149015,5/13/2015 17:52:53,1635897289,5/13/2015 17:52:19,false,prodege,1.0,14848125,GBR,L6,Shrewsbury,86.138.223.142,[TREATS],[TREATS],intervention trial.,N/A,87,26,-1,105,64,TWrex-cause,804496-FS1,2008 10 01  The effect of GLUCOSAMINE AND/OR CHONDROITIN SULFATE on the progression of KNEE OSTEOARTHRITIS: a report from the glucosamine/chondroitin arthritis intervention trial.,KNEE OSTEOARTHRITIS,GLUCOSAMINE AND/OR CHONDROITIN SULFATE
721149015,5/13/2015 18:01:01,1635900286,5/13/2015 17:59:38,false,clixsense,1.0,6574449,USA,"","",216.216.68.85,[OTHER],[OTHER],effect GLUCOSAMINE CHONDROITIN SULFATE progression KNEE OSTEOARTHRITIS: report glucosamine/chondroitin arthritis intervention trial.,na,87,26,-1,105,64,TWrex-cause,804496-FS1,2008 10 01  The effect of GLUCOSAMINE AND/OR CHONDROITIN SULFATE on the progression of KNEE OSTEOARTHRITIS: a report from the glucosamine/chondroitin arthritis intervention trial.,KNEE OSTEOARTHRITIS,GLUCOSAMINE AND/OR CHONDROITIN SULFATE
721149016,5/13/2015 10:32:35,1635686227,5/13/2015 10:31:39,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[OTHER],[OTHER],Predictors of EPILEPSY in children who have experienced FEBRILE SEIZURES,N/A,56,14,1,71,22,TWrex-cause,815023-FS1,Predictors of EPILEPSY in children who have experienced FEBRILE SEIZURES,FEBRILE SEIZURES,EPILEPSY
721149016,5/13/2015 10:47:34,1635690510,5/13/2015 10:46:39,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[ASSOCIATED_WITH],[ASSOCIATED_WITH],Predictors of EPILEPSY,n/a,56,14,1,71,22,TWrex-cause,815023-FS1,Predictors of EPILEPSY in children who have experienced FEBRILE SEIZURES,FEBRILE SEIZURES,EPILEPSY
721149016,5/13/2015 10:50:16,1635691305,5/13/2015 10:49:48,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[SYMPTOM] [MANIFESTATION],"[SYMPTOM]
[MANIFESTATION]",in,N/A,56,14,1,71,22,TWrex-cause,815023-FS1,Predictors of EPILEPSY in children who have experienced FEBRILE SEIZURES,FEBRILE SEIZURES,EPILEPSY
721149016,5/13/2015 10:55:58,1635692923,5/13/2015 10:55:43,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],EPILEPSY,N/A,56,14,1,71,22,TWrex-cause,815023-FS1,Predictors of EPILEPSY in children who have experienced FEBRILE SEIZURES,FEBRILE SEIZURES,EPILEPSY
721149016,5/13/2015 11:16:27,1635698502,5/13/2015 11:16:13,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[MANIFESTATION],[MANIFESTATION],Predictors,n/a,56,14,1,71,22,TWrex-cause,815023-FS1,Predictors of EPILEPSY in children who have experienced FEBRILE SEIZURES,FEBRILE SEIZURES,EPILEPSY
721149016,5/13/2015 11:26:46,1635701079,5/13/2015 11:24:56,false,neodev,1.0,31706957,NLD,07,Amsterdam,145.100.72.165,[SYMPTOM],[SYMPTOM],Predictors of,n/a,56,14,1,71,22,TWrex-cause,815023-FS1,Predictors of EPILEPSY in children who have experienced FEBRILE SEIZURES,FEBRILE SEIZURES,EPILEPSY
721149016,5/13/2015 11:35:24,1635703198,5/13/2015 11:34:58,false,prodege,1.0,27934334,GBR,D3,Swadlincote,109.150.228.127,[SYMPTOM] [PREVENTS],"[PREVENTS]
[SYMPTOM]",experienced,N/A,56,14,1,71,22,TWrex-cause,815023-FS1,Predictors of EPILEPSY in children who have experienced FEBRILE SEIZURES,FEBRILE SEIZURES,EPILEPSY
721149016,5/13/2015 11:44:27,1635705622,5/13/2015 11:43:58,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[ASSOCIATED_WITH],[ASSOCIATED_WITH],EPILEPSY in children who experienced FEBRILE SEIZURES,n/a,56,14,1,71,22,TWrex-cause,815023-FS1,Predictors of EPILEPSY in children who have experienced FEBRILE SEIZURES,FEBRILE SEIZURES,EPILEPSY
721149016,5/13/2015 11:45:05,1635705778,5/13/2015 11:44:36,false,points4rewards,1.0,28703583,USA,"","",97.73.86.35,[MANIFESTATION],[MANIFESTATION],Predictors of,N/A,56,14,1,71,22,TWrex-cause,815023-FS1,Predictors of EPILEPSY in children who have experienced FEBRILE SEIZURES,FEBRILE SEIZURES,EPILEPSY
721149016,5/13/2015 11:48:33,1635706834,5/13/2015 11:48:11,false,neodev,1.0,31726043,GBR,"","",88.150.202.140,[SYMPTOM],[SYMPTOM],experienced,55,56,14,1,71,22,TWrex-cause,815023-FS1,Predictors of EPILEPSY in children who have experienced FEBRILE SEIZURES,FEBRILE SEIZURES,EPILEPSY
721149016,5/13/2015 12:23:29,1635718976,5/13/2015 12:23:03,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,[MANIFESTATION],[MANIFESTATION],experienced,n/a,56,14,1,71,22,TWrex-cause,815023-FS1,Predictors of EPILEPSY in children who have experienced FEBRILE SEIZURES,FEBRILE SEIZURES,EPILEPSY
721149016,5/13/2015 12:27:18,1635720539,5/13/2015 12:27:03,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[SYMPTOM],[SYMPTOM],EPILEPSY in children who experienced FEBRILE SEIZURES,n/a,56,14,1,71,22,TWrex-cause,815023-FS1,Predictors of EPILEPSY in children who have experienced FEBRILE SEIZURES,FEBRILE SEIZURES,EPILEPSY
721149016,5/13/2015 13:01:33,1635728972,5/13/2015 13:01:18,false,neodev,1.0,30504276,CAN,ON,Sudbury,66.103.55.12,[PART_OF],[PART_OF],Predictors,N/A,56,14,1,71,22,TWrex-cause,815023-FS1,Predictors of EPILEPSY in children who have experienced FEBRILE SEIZURES,FEBRILE SEIZURES,EPILEPSY
721149016,5/13/2015 13:01:56,1635729072,5/13/2015 13:01:33,false,clixsense,1.0,24329110,USA,FL,Jacksonville,12.168.136.2,[ASSOCIATED_WITH],[ASSOCIATED_WITH],Predictors of,n/a,56,14,1,71,22,TWrex-cause,815023-FS1,Predictors of EPILEPSY in children who have experienced FEBRILE SEIZURES,FEBRILE SEIZURES,EPILEPSY
721149016,5/13/2015 13:02:00,1635729103,5/13/2015 13:01:46,false,clixsense,1.0,6574449,USA,"","",216.216.68.85,[OTHER],[OTHER],Predictors EPILEPSY children experienced FEBRILE SEIZURES,na,56,14,1,71,22,TWrex-cause,815023-FS1,Predictors of EPILEPSY in children who have experienced FEBRILE SEIZURES,FEBRILE SEIZURES,EPILEPSY
721149017,5/13/2015 16:49:56,1635861123,5/13/2015 16:49:37,false,clixsense,1.0,31579138,AUS,02,Hurstville,14.200.129.68,[CAUSES],[CAUSES],caused by,N/A,148,194,1,169,220,TWrex-cause,810098-FS1,"14  ATS, CDC, and IDSA state that rifapentine can be used in conjunction with isoniazid in the continuation phase in HIV seronegative patients with NONCAVITY PULMONARY TB caused by susceptible  MYCOBACTERIUM TUBERCULOSIS ; rifapentine is an alternative to rifampin for use in conjunction with isoniazid in the continuation phase.",NONCAVITY PULMONARY TB,MYCOBACTERIUM TUBERCULOSIS
721149017,5/13/2015 17:32:21,1635884242,5/13/2015 17:31:08,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[CAUSES],[CAUSES],caused by,n/a,148,194,1,169,220,TWrex-cause,810098-FS1,"14  ATS, CDC, and IDSA state that rifapentine can be used in conjunction with isoniazid in the continuation phase in HIV seronegative patients with NONCAVITY PULMONARY TB caused by susceptible  MYCOBACTERIUM TUBERCULOSIS ; rifapentine is an alternative to rifampin for use in conjunction with isoniazid in the continuation phase.",NONCAVITY PULMONARY TB,MYCOBACTERIUM TUBERCULOSIS
721149017,5/13/2015 17:39:39,1635888281,5/13/2015 17:39:01,false,gptking,1.0,31799065,USA,IL,Marion,50.45.43.154,[CAUSES],[CAUSES],NONCAVITY PULMONARY TB caused by MYCOBACTERIUM TUBERCULOSIS,N/A,148,194,1,169,220,TWrex-cause,810098-FS1,"14  ATS, CDC, and IDSA state that rifapentine can be used in conjunction with isoniazid in the continuation phase in HIV seronegative patients with NONCAVITY PULMONARY TB caused by susceptible  MYCOBACTERIUM TUBERCULOSIS ; rifapentine is an alternative to rifampin for use in conjunction with isoniazid in the continuation phase.",NONCAVITY PULMONARY TB,MYCOBACTERIUM TUBERCULOSIS
721149017,5/13/2015 18:14:11,1635905255,5/13/2015 18:13:57,false,clixsense,1.0,32549163,CAN,MB,Winnipeg,206.45.167.246,[CAUSES],[CAUSES],NONCAVITY PULMONARY TB caused by susceptible MYCOBACTERIUM TUBERCULOSIS,N/A,148,194,1,169,220,TWrex-cause,810098-FS1,"14  ATS, CDC, and IDSA state that rifapentine can be used in conjunction with isoniazid in the continuation phase in HIV seronegative patients with NONCAVITY PULMONARY TB caused by susceptible  MYCOBACTERIUM TUBERCULOSIS ; rifapentine is an alternative to rifampin for use in conjunction with isoniazid in the continuation phase.",NONCAVITY PULMONARY TB,MYCOBACTERIUM TUBERCULOSIS
721149017,5/13/2015 18:17:05,1635906238,5/13/2015 18:16:44,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[TREATS],[TREATS],can be used,N/A,148,194,1,169,220,TWrex-cause,810098-FS1,"14  ATS, CDC, and IDSA state that rifapentine can be used in conjunction with isoniazid in the continuation phase in HIV seronegative patients with NONCAVITY PULMONARY TB caused by susceptible  MYCOBACTERIUM TUBERCULOSIS ; rifapentine is an alternative to rifampin for use in conjunction with isoniazid in the continuation phase.",NONCAVITY PULMONARY TB,MYCOBACTERIUM TUBERCULOSIS
721149017,5/13/2015 18:21:37,1635908376,5/13/2015 18:21:17,false,instagc,1.0,24252915,GBR,"","",80.44.146.98,[CAUSES],[CAUSES],caused by,N/a,148,194,1,169,220,TWrex-cause,810098-FS1,"14  ATS, CDC, and IDSA state that rifapentine can be used in conjunction with isoniazid in the continuation phase in HIV seronegative patients with NONCAVITY PULMONARY TB caused by susceptible  MYCOBACTERIUM TUBERCULOSIS ; rifapentine is an alternative to rifampin for use in conjunction with isoniazid in the continuation phase.",NONCAVITY PULMONARY TB,MYCOBACTERIUM TUBERCULOSIS
721149017,5/13/2015 18:23:51,1635909702,5/13/2015 18:23:15,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[CAUSES],[CAUSES],caused by,N/A,148,194,1,169,220,TWrex-cause,810098-FS1,"14  ATS, CDC, and IDSA state that rifapentine can be used in conjunction with isoniazid in the continuation phase in HIV seronegative patients with NONCAVITY PULMONARY TB caused by susceptible  MYCOBACTERIUM TUBERCULOSIS ; rifapentine is an alternative to rifampin for use in conjunction with isoniazid in the continuation phase.",NONCAVITY PULMONARY TB,MYCOBACTERIUM TUBERCULOSIS
721149017,5/13/2015 18:47:17,1635921629,5/13/2015 18:46:48,false,prodege,1.0,32302664,USA,IL,Geneseo,173.27.241.235,[CAUSES],[CAUSES],caused by susceptible,no comment,148,194,1,169,220,TWrex-cause,810098-FS1,"14  ATS, CDC, and IDSA state that rifapentine can be used in conjunction with isoniazid in the continuation phase in HIV seronegative patients with NONCAVITY PULMONARY TB caused by susceptible  MYCOBACTERIUM TUBERCULOSIS ; rifapentine is an alternative to rifampin for use in conjunction with isoniazid in the continuation phase.",NONCAVITY PULMONARY TB,MYCOBACTERIUM TUBERCULOSIS
721149017,5/13/2015 19:12:49,1635932832,5/13/2015 19:09:53,false,clixsense,1.0,19162475,GBR,P8,Trowbridge,82.33.126.30,[ASSOCIATED_WITH],[ASSOCIATED_WITH],susceptible,n/a,148,194,1,169,220,TWrex-cause,810098-FS1,"14  ATS, CDC, and IDSA state that rifapentine can be used in conjunction with isoniazid in the continuation phase in HIV seronegative patients with NONCAVITY PULMONARY TB caused by susceptible  MYCOBACTERIUM TUBERCULOSIS ; rifapentine is an alternative to rifampin for use in conjunction with isoniazid in the continuation phase.",NONCAVITY PULMONARY TB,MYCOBACTERIUM TUBERCULOSIS
721149017,5/13/2015 19:13:09,1635933285,5/13/2015 19:12:47,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[CAUSES],[CAUSES],caused,N/A,148,194,1,169,220,TWrex-cause,810098-FS1,"14  ATS, CDC, and IDSA state that rifapentine can be used in conjunction with isoniazid in the continuation phase in HIV seronegative patients with NONCAVITY PULMONARY TB caused by susceptible  MYCOBACTERIUM TUBERCULOSIS ; rifapentine is an alternative to rifampin for use in conjunction with isoniazid in the continuation phase.",NONCAVITY PULMONARY TB,MYCOBACTERIUM TUBERCULOSIS
721149017,5/13/2015 19:45:36,1635963538,5/13/2015 19:45:15,false,elite,1.0,30064988,GBR,H3,Leeds,92.22.208.245,[CAUSES],[CAUSES],caused by,N/A,148,194,1,169,220,TWrex-cause,810098-FS1,"14  ATS, CDC, and IDSA state that rifapentine can be used in conjunction with isoniazid in the continuation phase in HIV seronegative patients with NONCAVITY PULMONARY TB caused by susceptible  MYCOBACTERIUM TUBERCULOSIS ; rifapentine is an alternative to rifampin for use in conjunction with isoniazid in the continuation phase.",NONCAVITY PULMONARY TB,MYCOBACTERIUM TUBERCULOSIS
721149017,5/13/2015 20:06:12,1635979845,5/13/2015 20:05:50,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.156.243,[CAUSES],[CAUSES],NONCAVITY PULMONARY TB caused by MYCOBACTERIUM TUBERCULOSIS,N/A,148,194,1,169,220,TWrex-cause,810098-FS1,"14  ATS, CDC, and IDSA state that rifapentine can be used in conjunction with isoniazid in the continuation phase in HIV seronegative patients with NONCAVITY PULMONARY TB caused by susceptible  MYCOBACTERIUM TUBERCULOSIS ; rifapentine is an alternative to rifampin for use in conjunction with isoniazid in the continuation phase.",NONCAVITY PULMONARY TB,MYCOBACTERIUM TUBERCULOSIS
721149017,5/13/2015 20:06:48,1635980419,5/13/2015 20:05:57,false,clixsense,1.0,27969116,NLD,"","",212.78.195.38,[SYMPTOM],[SYMPTOM],caused by,is caused by,148,194,1,169,220,TWrex-cause,810098-FS1,"14  ATS, CDC, and IDSA state that rifapentine can be used in conjunction with isoniazid in the continuation phase in HIV seronegative patients with NONCAVITY PULMONARY TB caused by susceptible  MYCOBACTERIUM TUBERCULOSIS ; rifapentine is an alternative to rifampin for use in conjunction with isoniazid in the continuation phase.",NONCAVITY PULMONARY TB,MYCOBACTERIUM TUBERCULOSIS
721149017,5/13/2015 20:33:13,1635999635,5/13/2015 20:32:58,false,neodev,1.0,20961587,NLD,05,Maastricht,84.26.48.136,[CAUSES],[CAUSES],caused,N/A,148,194,1,169,220,TWrex-cause,810098-FS1,"14  ATS, CDC, and IDSA state that rifapentine can be used in conjunction with isoniazid in the continuation phase in HIV seronegative patients with NONCAVITY PULMONARY TB caused by susceptible  MYCOBACTERIUM TUBERCULOSIS ; rifapentine is an alternative to rifampin for use in conjunction with isoniazid in the continuation phase.",NONCAVITY PULMONARY TB,MYCOBACTERIUM TUBERCULOSIS
721149017,5/13/2015 20:45:48,1636008192,5/13/2015 20:44:25,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[CAUSES],[CAUSES],NONCAVITY PULMONARY TB caused by MYCOBACTERIUM TUBERCULOSIS,N/A,148,194,1,169,220,TWrex-cause,810098-FS1,"14  ATS, CDC, and IDSA state that rifapentine can be used in conjunction with isoniazid in the continuation phase in HIV seronegative patients with NONCAVITY PULMONARY TB caused by susceptible  MYCOBACTERIUM TUBERCULOSIS ; rifapentine is an alternative to rifampin for use in conjunction with isoniazid in the continuation phase.",NONCAVITY PULMONARY TB,MYCOBACTERIUM TUBERCULOSIS
721149018,5/13/2015 10:14:23,1635681018,5/13/2015 10:13:35,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[CAUSES],[CAUSES],Included are infections caused by the pathogenic organism RICKETTSIA RICKETTSII which causes ROCKY MOUNTAIN SPOTTED FEVER,N/A,96,59,1,123,80,TWrex-cause,810530-FS1,"Included are infections caused by the pathogenic organism  RICKETTSIA RICKETTSII , which causes ROCKY MOUNTAIN SPOTTED FEVER",ROCKY MOUNTAIN SPOTTED FEVER,RICKETTSIA RICKETTSII
721149018,5/13/2015 10:30:22,1635685590,5/13/2015 10:29:48,false,clixsense,1.0,26847653,NLD,03,Warnsveld,213.93.50.164,[CAUSES],[CAUSES],caused by the pathogenic organism which causes,n/a,96,59,1,123,80,TWrex-cause,810530-FS1,"Included are infections caused by the pathogenic organism  RICKETTSIA RICKETTSII , which causes ROCKY MOUNTAIN SPOTTED FEVER",ROCKY MOUNTAIN SPOTTED FEVER,RICKETTSIA RICKETTSII
721149018,5/13/2015 10:31:59,1635686081,5/13/2015 10:31:14,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[CAUSES],[CAUSES],causes,N/A,96,59,1,123,80,TWrex-cause,810530-FS1,"Included are infections caused by the pathogenic organism  RICKETTSIA RICKETTSII , which causes ROCKY MOUNTAIN SPOTTED FEVER",ROCKY MOUNTAIN SPOTTED FEVER,RICKETTSIA RICKETTSII
721149018,5/13/2015 10:33:27,1635686451,5/13/2015 10:33:07,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[CAUSES],[CAUSES],which causes,n/a,96,59,1,123,80,TWrex-cause,810530-FS1,"Included are infections caused by the pathogenic organism  RICKETTSIA RICKETTSII , which causes ROCKY MOUNTAIN SPOTTED FEVER",ROCKY MOUNTAIN SPOTTED FEVER,RICKETTSIA RICKETTSII
721149018,5/13/2015 10:45:39,1635689955,5/13/2015 10:44:10,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[CAUSES],[CAUSES],pathogenic organism,N/A,96,59,1,123,80,TWrex-cause,810530-FS1,"Included are infections caused by the pathogenic organism  RICKETTSIA RICKETTSII , which causes ROCKY MOUNTAIN SPOTTED FEVER",ROCKY MOUNTAIN SPOTTED FEVER,RICKETTSIA RICKETTSII
721149018,5/13/2015 11:05:52,1635695986,5/13/2015 11:05:25,false,neodev,1.0,31706957,NLD,07,Amsterdam,145.100.72.165,[CAUSES],[CAUSES],which causes,n/a,96,59,1,123,80,TWrex-cause,810530-FS1,"Included are infections caused by the pathogenic organism  RICKETTSIA RICKETTSII , which causes ROCKY MOUNTAIN SPOTTED FEVER",ROCKY MOUNTAIN SPOTTED FEVER,RICKETTSIA RICKETTSII
721149018,5/13/2015 11:12:08,1635697344,5/13/2015 11:11:54,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[CAUSES],[CAUSES],causes,n/a,96,59,1,123,80,TWrex-cause,810530-FS1,"Included are infections caused by the pathogenic organism  RICKETTSIA RICKETTSII , which causes ROCKY MOUNTAIN SPOTTED FEVER",ROCKY MOUNTAIN SPOTTED FEVER,RICKETTSIA RICKETTSII
721149018,5/13/2015 11:21:42,1635699708,5/13/2015 11:21:26,false,prodege,1.0,27934334,GBR,D3,Swadlincote,109.150.228.127,[CAUSES],[CAUSES],causes,N/A,96,59,1,123,80,TWrex-cause,810530-FS1,"Included are infections caused by the pathogenic organism  RICKETTSIA RICKETTSII , which causes ROCKY MOUNTAIN SPOTTED FEVER",ROCKY MOUNTAIN SPOTTED FEVER,RICKETTSIA RICKETTSII
721149018,5/13/2015 11:30:03,1635701701,5/13/2015 11:29:19,false,points4rewards,1.0,28703583,USA,"","",97.73.86.35,[CAUSES],[CAUSES],caused by which causes,N/A,96,59,1,123,80,TWrex-cause,810530-FS1,"Included are infections caused by the pathogenic organism  RICKETTSIA RICKETTSII , which causes ROCKY MOUNTAIN SPOTTED FEVER",ROCKY MOUNTAIN SPOTTED FEVER,RICKETTSIA RICKETTSII
721149018,5/13/2015 11:33:58,1635702533,5/13/2015 11:33:13,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[CAUSES],[CAUSES],RICKETTSIA RICKETTSII causes ROCKY MOUNTAIN SPOTTED FEVER,n/a,96,59,1,123,80,TWrex-cause,810530-FS1,"Included are infections caused by the pathogenic organism  RICKETTSIA RICKETTSII , which causes ROCKY MOUNTAIN SPOTTED FEVER",ROCKY MOUNTAIN SPOTTED FEVER,RICKETTSIA RICKETTSII
721149018,5/13/2015 11:42:14,1635705303,5/13/2015 11:41:51,false,neodev,1.0,31726043,GBR,"","",88.150.202.140,[MANIFESTATION] [ASSOCIATED_WITH],"[MANIFESTATION]
[ASSOCIATED_WITH]",are,541,96,59,1,123,80,TWrex-cause,810530-FS1,"Included are infections caused by the pathogenic organism  RICKETTSIA RICKETTSII , which causes ROCKY MOUNTAIN SPOTTED FEVER",ROCKY MOUNTAIN SPOTTED FEVER,RICKETTSIA RICKETTSII
721149018,5/13/2015 12:15:21,1635715816,5/13/2015 12:14:49,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,[PREVENTS],[PREVENTS],causes,n/a,96,59,1,123,80,TWrex-cause,810530-FS1,"Included are infections caused by the pathogenic organism  RICKETTSIA RICKETTSII , which causes ROCKY MOUNTAIN SPOTTED FEVER",ROCKY MOUNTAIN SPOTTED FEVER,RICKETTSIA RICKETTSII
721149018,5/13/2015 12:19:00,1635717253,5/13/2015 12:18:49,false,clixsense,1.0,28457001,CAN,ON,North Bay,24.204.202.220,[CAUSES],[CAUSES],causes,n/a,96,59,1,123,80,TWrex-cause,810530-FS1,"Included are infections caused by the pathogenic organism  RICKETTSIA RICKETTSII , which causes ROCKY MOUNTAIN SPOTTED FEVER",ROCKY MOUNTAIN SPOTTED FEVER,RICKETTSIA RICKETTSII
721149018,5/13/2015 12:19:06,1635717271,5/13/2015 12:18:20,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[CAUSES],[CAUSES],RICKETTSIA RICKETTSII which causes ROCKY MOUNTAIN SPOTTED FEVER,n/a,96,59,1,123,80,TWrex-cause,810530-FS1,"Included are infections caused by the pathogenic organism  RICKETTSIA RICKETTSII , which causes ROCKY MOUNTAIN SPOTTED FEVER",ROCKY MOUNTAIN SPOTTED FEVER,RICKETTSIA RICKETTSII
721149018,5/13/2015 12:20:18,1635717825,5/13/2015 12:19:21,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[CAUSES],[CAUSES],causes,N/A,96,59,1,123,80,TWrex-cause,810530-FS1,"Included are infections caused by the pathogenic organism  RICKETTSIA RICKETTSII , which causes ROCKY MOUNTAIN SPOTTED FEVER",ROCKY MOUNTAIN SPOTTED FEVER,RICKETTSIA RICKETTSII
721149019,5/13/2015 13:05:48,1635730718,5/13/2015 13:05:37,false,neodev,1.0,30504276,CAN,ON,Sudbury,66.103.55.12,[TREATS],[TREATS],treatment,N/A,82,47,-1,85,61,TWrex-cause,803723-FS1,"Richman DD, Fischl MA, Nusinoff Lehrman S et alAZIDOTHYMIDINE in the treatment of AIDS",AIDS,AZIDOTHYMIDINE
721149019,5/13/2015 13:09:12,1635731467,5/13/2015 13:08:46,false,clixsense,1.0,24329110,USA,FL,Jacksonville,12.168.136.2,[TREATS],[TREATS],in the treatment of,n/a,82,47,-1,85,61,TWrex-cause,803723-FS1,"Richman DD, Fischl MA, Nusinoff Lehrman S et alAZIDOTHYMIDINE in the treatment of AIDS",AIDS,AZIDOTHYMIDINE
721149019,5/13/2015 13:16:05,1635733357,5/13/2015 13:15:34,false,clixsense,1.0,23197581,NLD,11,Den Haag,82.217.5.55,[TREATS],[TREATS],in the treatment of,N/A,82,47,-1,85,61,TWrex-cause,803723-FS1,"Richman DD, Fischl MA, Nusinoff Lehrman S et alAZIDOTHYMIDINE in the treatment of AIDS",AIDS,AZIDOTHYMIDINE
721149019,5/13/2015 13:17:49,1635733723,5/13/2015 13:17:14,false,prodege,1.0,23482077,USA,TX,Garland,71.164.238.226,[TREATS],[TREATS],treatment of,N/A,82,47,-1,85,61,TWrex-cause,803723-FS1,"Richman DD, Fischl MA, Nusinoff Lehrman S et alAZIDOTHYMIDINE in the treatment of AIDS",AIDS,AZIDOTHYMIDINE
721149019,5/13/2015 13:40:36,1635739815,5/13/2015 13:40:10,false,bitcoinget,1.0,21614812,USA,PA,Erie,174.100.250.115,[TREATS],[TREATS],in the treatment of,N/A,82,47,-1,85,61,TWrex-cause,803723-FS1,"Richman DD, Fischl MA, Nusinoff Lehrman S et alAZIDOTHYMIDINE in the treatment of AIDS",AIDS,AZIDOTHYMIDINE
721149019,5/13/2015 13:48:19,1635742568,5/13/2015 13:47:06,false,neodev,1.0,24564999,GBR,H9,London,86.145.227.9,[TREATS],[TREATS],treatment of,N/A,82,47,-1,85,61,TWrex-cause,803723-FS1,"Richman DD, Fischl MA, Nusinoff Lehrman S et alAZIDOTHYMIDINE in the treatment of AIDS",AIDS,AZIDOTHYMIDINE
721149019,5/13/2015 13:55:42,1635745683,5/13/2015 13:55:22,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[TREATS],[TREATS],treatment,N/A,82,47,-1,85,61,TWrex-cause,803723-FS1,"Richman DD, Fischl MA, Nusinoff Lehrman S et alAZIDOTHYMIDINE in the treatment of AIDS",AIDS,AZIDOTHYMIDINE
721149019,5/13/2015 14:18:22,1635755198,5/13/2015 14:17:49,false,prodege,1.0,24403612,CAN,ON,Ajax,99.239.181.149,[TREATS],[TREATS],alAZIDOTHYMIDINE in treatment of AIDS,N/a,82,47,-1,85,61,TWrex-cause,803723-FS1,"Richman DD, Fischl MA, Nusinoff Lehrman S et alAZIDOTHYMIDINE in the treatment of AIDS",AIDS,AZIDOTHYMIDINE
721149019,5/13/2015 14:26:56,1635758815,5/13/2015 14:26:46,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[TREATS],[TREATS],treatment of,N/A,82,47,-1,85,61,TWrex-cause,803723-FS1,"Richman DD, Fischl MA, Nusinoff Lehrman S et alAZIDOTHYMIDINE in the treatment of AIDS",AIDS,AZIDOTHYMIDINE
721149019,5/13/2015 15:12:23,1635791776,5/13/2015 15:11:29,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,[TREATS],[TREATS],treatment,n/a,82,47,-1,85,61,TWrex-cause,803723-FS1,"Richman DD, Fischl MA, Nusinoff Lehrman S et alAZIDOTHYMIDINE in the treatment of AIDS",AIDS,AZIDOTHYMIDINE
721149019,5/13/2015 15:21:28,1635798913,5/13/2015 15:20:33,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[TREATS],[TREATS],alAZIDOTHYMIDINE in treatment of AIDS,N/A,82,47,-1,85,61,TWrex-cause,803723-FS1,"Richman DD, Fischl MA, Nusinoff Lehrman S et alAZIDOTHYMIDINE in the treatment of AIDS",AIDS,AZIDOTHYMIDINE
721149019,5/13/2015 15:41:48,1635814790,5/13/2015 15:41:37,false,clixsense,1.0,32549163,CAN,MB,Winnipeg,206.45.167.246,[TREATS],[TREATS],alAZIDOTHYMIDINE in the treatment of AIDS,N/A,82,47,-1,85,61,TWrex-cause,803723-FS1,"Richman DD, Fischl MA, Nusinoff Lehrman S et alAZIDOTHYMIDINE in the treatment of AIDS",AIDS,AZIDOTHYMIDINE
721149019,5/13/2015 15:57:05,1635826431,5/13/2015 15:56:37,false,instagc,1.0,24252915,GBR,F2,Gosport,92.24.208.155,[TREATS],[TREATS],in the treatment of,N/a,82,47,-1,85,61,TWrex-cause,803723-FS1,"Richman DD, Fischl MA, Nusinoff Lehrman S et alAZIDOTHYMIDINE in the treatment of AIDS",AIDS,AZIDOTHYMIDINE
721149019,5/13/2015 16:00:41,1635829263,5/13/2015 16:00:05,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[TREATS],[TREATS],treatment,none,82,47,-1,85,61,TWrex-cause,803723-FS1,"Richman DD, Fischl MA, Nusinoff Lehrman S et alAZIDOTHYMIDINE in the treatment of AIDS",AIDS,AZIDOTHYMIDINE
721149019,5/13/2015 16:25:42,1635846068,5/13/2015 16:25:17,false,prodege,1.0,16101132,GBR,F9,Hayes,2.223.214.149,[TREATS],[TREATS],treatment,Treated with,82,47,-1,85,61,TWrex-cause,803723-FS1,"Richman DD, Fischl MA, Nusinoff Lehrman S et alAZIDOTHYMIDINE in the treatment of AIDS",AIDS,AZIDOTHYMIDINE
721149020,5/13/2015 13:06:00,1635730751,5/13/2015 13:05:49,false,neodev,1.0,30504276,CAN,ON,Sudbury,66.103.55.12,[TREATS],[TREATS],treatment,N/A,69,13,-1,88,30,TWrex-cause,800216-FS1,"436 ,   448  IV AMPHOTERICIN B is preferred for initial treatment of SEVERE BLASTOMYCOSIS especially infections involving the CNS,  146 ,   269 ,   288 ,   319 ,   320 ,   321 ,   322 ,   424 ,   436 ,   448   and for initial treatment of presumptive blastomycosis in immunocompromised patients, including HIV infected individuals.",SEVERE BLASTOMYCOSIS,IV AMPHOTERICIN B
721149020,5/13/2015 13:10:58,1635731877,5/13/2015 13:09:13,false,clixsense,1.0,24329110,USA,FL,Jacksonville,12.168.136.2,[TREATS],[TREATS],treatment of,n/a,69,13,-1,88,30,TWrex-cause,800216-FS1,"436 ,   448  IV AMPHOTERICIN B is preferred for initial treatment of SEVERE BLASTOMYCOSIS especially infections involving the CNS,  146 ,   269 ,   288 ,   319 ,   320 ,   321 ,   322 ,   424 ,   436 ,   448   and for initial treatment of presumptive blastomycosis in immunocompromised patients, including HIV infected individuals.",SEVERE BLASTOMYCOSIS,IV AMPHOTERICIN B
721149020,5/13/2015 13:16:26,1635733406,5/13/2015 13:16:06,false,clixsense,1.0,23197581,NLD,11,Den Haag,82.217.5.55,[TREATS],[TREATS],is preferred for initial treatment of,N/A,69,13,-1,88,30,TWrex-cause,800216-FS1,"436 ,   448  IV AMPHOTERICIN B is preferred for initial treatment of SEVERE BLASTOMYCOSIS especially infections involving the CNS,  146 ,   269 ,   288 ,   319 ,   320 ,   321 ,   322 ,   424 ,   436 ,   448   and for initial treatment of presumptive blastomycosis in immunocompromised patients, including HIV infected individuals.",SEVERE BLASTOMYCOSIS,IV AMPHOTERICIN B
721149020,5/13/2015 13:18:13,1635733865,5/13/2015 13:17:52,false,prodege,1.0,23482077,USA,TX,Garland,71.164.238.226,[TREATS],[TREATS],treatment of,N/A,69,13,-1,88,30,TWrex-cause,800216-FS1,"436 ,   448  IV AMPHOTERICIN B is preferred for initial treatment of SEVERE BLASTOMYCOSIS especially infections involving the CNS,  146 ,   269 ,   288 ,   319 ,   320 ,   321 ,   322 ,   424 ,   436 ,   448   and for initial treatment of presumptive blastomycosis in immunocompromised patients, including HIV infected individuals.",SEVERE BLASTOMYCOSIS,IV AMPHOTERICIN B
721149020,5/13/2015 13:41:14,1635739939,5/13/2015 13:40:37,false,bitcoinget,1.0,21614812,USA,PA,Erie,174.100.250.115,[TREATS],[TREATS],initial treatment,N/A,69,13,-1,88,30,TWrex-cause,800216-FS1,"436 ,   448  IV AMPHOTERICIN B is preferred for initial treatment of SEVERE BLASTOMYCOSIS especially infections involving the CNS,  146 ,   269 ,   288 ,   319 ,   320 ,   321 ,   322 ,   424 ,   436 ,   448   and for initial treatment of presumptive blastomycosis in immunocompromised patients, including HIV infected individuals.",SEVERE BLASTOMYCOSIS,IV AMPHOTERICIN B
721149020,5/13/2015 13:48:34,1635742691,5/13/2015 13:48:20,false,neodev,1.0,24564999,GBR,H9,London,86.145.227.9,[TREATS],[TREATS],initial treatment,N/A,69,13,-1,88,30,TWrex-cause,800216-FS1,"436 ,   448  IV AMPHOTERICIN B is preferred for initial treatment of SEVERE BLASTOMYCOSIS especially infections involving the CNS,  146 ,   269 ,   288 ,   319 ,   320 ,   321 ,   322 ,   424 ,   436 ,   448   and for initial treatment of presumptive blastomycosis in immunocompromised patients, including HIV infected individuals.",SEVERE BLASTOMYCOSIS,IV AMPHOTERICIN B
721149020,5/13/2015 13:56:01,1635745801,5/13/2015 13:55:43,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[TREATS],[TREATS],treatment,N/A,69,13,-1,88,30,TWrex-cause,800216-FS1,"436 ,   448  IV AMPHOTERICIN B is preferred for initial treatment of SEVERE BLASTOMYCOSIS especially infections involving the CNS,  146 ,   269 ,   288 ,   319 ,   320 ,   321 ,   322 ,   424 ,   436 ,   448   and for initial treatment of presumptive blastomycosis in immunocompromised patients, including HIV infected individuals.",SEVERE BLASTOMYCOSIS,IV AMPHOTERICIN B
721149020,5/13/2015 14:19:33,1635755567,5/13/2015 14:18:23,false,prodege,1.0,24403612,CAN,ON,Ajax,99.239.181.149,[TREATS],[TREATS],IV AMPHOTERICIN B is preferred treatment of SEVERE BLASTOMYCOSIS,N/a,69,13,-1,88,30,TWrex-cause,800216-FS1,"436 ,   448  IV AMPHOTERICIN B is preferred for initial treatment of SEVERE BLASTOMYCOSIS especially infections involving the CNS,  146 ,   269 ,   288 ,   319 ,   320 ,   321 ,   322 ,   424 ,   436 ,   448   and for initial treatment of presumptive blastomycosis in immunocompromised patients, including HIV infected individuals.",SEVERE BLASTOMYCOSIS,IV AMPHOTERICIN B
721149020,5/13/2015 14:28:20,1635759573,5/13/2015 14:26:57,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[TREATS],[TREATS],treatment of,N/A,69,13,-1,88,30,TWrex-cause,800216-FS1,"436 ,   448  IV AMPHOTERICIN B is preferred for initial treatment of SEVERE BLASTOMYCOSIS especially infections involving the CNS,  146 ,   269 ,   288 ,   319 ,   320 ,   321 ,   322 ,   424 ,   436 ,   448   and for initial treatment of presumptive blastomycosis in immunocompromised patients, including HIV infected individuals.",SEVERE BLASTOMYCOSIS,IV AMPHOTERICIN B
721149020,5/13/2015 15:12:40,1635792021,5/13/2015 15:12:24,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,[TREATS],[TREATS],treatment,n/a,69,13,-1,88,30,TWrex-cause,800216-FS1,"436 ,   448  IV AMPHOTERICIN B is preferred for initial treatment of SEVERE BLASTOMYCOSIS especially infections involving the CNS,  146 ,   269 ,   288 ,   319 ,   320 ,   321 ,   322 ,   424 ,   436 ,   448   and for initial treatment of presumptive blastomycosis in immunocompromised patients, including HIV infected individuals.",SEVERE BLASTOMYCOSIS,IV AMPHOTERICIN B
721149020,5/13/2015 15:22:26,1635799715,5/13/2015 15:21:29,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[TREATS],[TREATS],IV AMPHOTERICIN is preferred for initial treatment of SEVERE BLASTOMYCOSIS,N/A,69,13,-1,88,30,TWrex-cause,800216-FS1,"436 ,   448  IV AMPHOTERICIN B is preferred for initial treatment of SEVERE BLASTOMYCOSIS especially infections involving the CNS,  146 ,   269 ,   288 ,   319 ,   320 ,   321 ,   322 ,   424 ,   436 ,   448   and for initial treatment of presumptive blastomycosis in immunocompromised patients, including HIV infected individuals.",SEVERE BLASTOMYCOSIS,IV AMPHOTERICIN B
721149020,5/13/2015 15:42:07,1635815110,5/13/2015 15:41:49,false,clixsense,1.0,32549163,CAN,MB,Winnipeg,206.45.167.246,[TREATS],[TREATS],IV AMPHOTERICIN B is preferred for initial treatment of SEVERE BLASTOMYCOSIS,N/A,69,13,-1,88,30,TWrex-cause,800216-FS1,"436 ,   448  IV AMPHOTERICIN B is preferred for initial treatment of SEVERE BLASTOMYCOSIS especially infections involving the CNS,  146 ,   269 ,   288 ,   319 ,   320 ,   321 ,   322 ,   424 ,   436 ,   448   and for initial treatment of presumptive blastomycosis in immunocompromised patients, including HIV infected individuals.",SEVERE BLASTOMYCOSIS,IV AMPHOTERICIN B
721149020,5/13/2015 15:57:29,1635826758,5/13/2015 15:57:06,false,instagc,1.0,24252915,GBR,F2,Gosport,92.24.208.155,[TREATS],[TREATS],for initial treatment of,N/a,69,13,-1,88,30,TWrex-cause,800216-FS1,"436 ,   448  IV AMPHOTERICIN B is preferred for initial treatment of SEVERE BLASTOMYCOSIS especially infections involving the CNS,  146 ,   269 ,   288 ,   319 ,   320 ,   321 ,   322 ,   424 ,   436 ,   448   and for initial treatment of presumptive blastomycosis in immunocompromised patients, including HIV infected individuals.",SEVERE BLASTOMYCOSIS,IV AMPHOTERICIN B
721149020,5/13/2015 16:01:07,1635829782,5/13/2015 16:00:42,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[TREATS],[TREATS],treatment,none,69,13,-1,88,30,TWrex-cause,800216-FS1,"436 ,   448  IV AMPHOTERICIN B is preferred for initial treatment of SEVERE BLASTOMYCOSIS especially infections involving the CNS,  146 ,   269 ,   288 ,   319 ,   320 ,   321 ,   322 ,   424 ,   436 ,   448   and for initial treatment of presumptive blastomycosis in immunocompromised patients, including HIV infected individuals.",SEVERE BLASTOMYCOSIS,IV AMPHOTERICIN B
721149020,5/13/2015 16:26:50,1635846788,5/13/2015 16:26:22,false,prodege,1.0,16101132,GBR,F9,Hayes,2.223.214.149,[TREATS],[TREATS],treatment,Treated with,69,13,-1,88,30,TWrex-cause,800216-FS1,"436 ,   448  IV AMPHOTERICIN B is preferred for initial treatment of SEVERE BLASTOMYCOSIS especially infections involving the CNS,  146 ,   269 ,   288 ,   319 ,   320 ,   321 ,   322 ,   424 ,   436 ,   448   and for initial treatment of presumptive blastomycosis in immunocompromised patients, including HIV infected individuals.",SEVERE BLASTOMYCOSIS,IV AMPHOTERICIN B
721149021,5/13/2015 10:31:38,1635685978,5/13/2015 10:30:24,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[ASSOCIATED_WITH],[ASSOCIATED_WITH],EBV INFECTION in the Immunocompromised Host Immunocompromised hosts are susceptible to overwhelming EBV LYMPHOPROLIFERATIVE SYNDROMES.,N/A,4,105,1,16,138,TWrex-cause,810656-FS1,69  EBV INFECTION in the Immunocompromised Host  Immunocompromised hosts are susceptible to overwhelming EBV LYMPHOPROLIFERATIVE SYNDROMES.,EBV INFECTION,EBV LYMPHOPROLIFERATIVE SYNDROMES
721149021,5/13/2015 10:46:38,1635690250,5/13/2015 10:45:46,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[IS_A],[IS_A],hosts are susceptible to,n/a,4,105,1,16,138,TWrex-cause,810656-FS1,69  EBV INFECTION in the Immunocompromised Host  Immunocompromised hosts are susceptible to overwhelming EBV LYMPHOPROLIFERATIVE SYNDROMES.,EBV INFECTION,EBV LYMPHOPROLIFERATIVE SYNDROMES
721149021,5/13/2015 10:49:43,1635691114,5/13/2015 10:48:43,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[CAUSES] [SYMPTOM],"[CAUSES]
[SYMPTOM]",are susceptible to,N/A,4,105,1,16,138,TWrex-cause,810656-FS1,69  EBV INFECTION in the Immunocompromised Host  Immunocompromised hosts are susceptible to overwhelming EBV LYMPHOPROLIFERATIVE SYNDROMES.,EBV INFECTION,EBV LYMPHOPROLIFERATIVE SYNDROMES
721149021,5/13/2015 10:55:41,1635692812,5/13/2015 10:55:27,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[SYMPTOM],[SYMPTOM],LYMPHOPROLIFERATIVE,N/A,4,105,1,16,138,TWrex-cause,810656-FS1,69  EBV INFECTION in the Immunocompromised Host  Immunocompromised hosts are susceptible to overwhelming EBV LYMPHOPROLIFERATIVE SYNDROMES.,EBV INFECTION,EBV LYMPHOPROLIFERATIVE SYNDROMES
721149021,5/13/2015 11:16:13,1635698429,5/13/2015 11:15:55,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[CAUSES],[CAUSES],susceptible to,n/a,4,105,1,16,138,TWrex-cause,810656-FS1,69  EBV INFECTION in the Immunocompromised Host  Immunocompromised hosts are susceptible to overwhelming EBV LYMPHOPROLIFERATIVE SYNDROMES.,EBV INFECTION,EBV LYMPHOPROLIFERATIVE SYNDROMES
721149021,5/13/2015 11:24:55,1635700456,5/13/2015 11:23:27,false,neodev,1.0,31706957,NLD,07,Amsterdam,145.100.72.165,[OTHER],[OTHER],are susceptible to overwhelming,n/a,4,105,1,16,138,TWrex-cause,810656-FS1,69  EBV INFECTION in the Immunocompromised Host  Immunocompromised hosts are susceptible to overwhelming EBV LYMPHOPROLIFERATIVE SYNDROMES.,EBV INFECTION,EBV LYMPHOPROLIFERATIVE SYNDROMES
721149021,5/13/2015 11:34:57,1635702993,5/13/2015 11:34:06,false,prodege,1.0,27934334,GBR,D3,Swadlincote,109.150.228.127,[ASSOCIATED_WITH],[ASSOCIATED_WITH],are susceptible to,N/A,4,105,1,16,138,TWrex-cause,810656-FS1,69  EBV INFECTION in the Immunocompromised Host  Immunocompromised hosts are susceptible to overwhelming EBV LYMPHOPROLIFERATIVE SYNDROMES.,EBV INFECTION,EBV LYMPHOPROLIFERATIVE SYNDROMES
721149021,5/13/2015 11:43:56,1635705553,5/13/2015 11:43:20,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[ASSOCIATED_WITH],[ASSOCIATED_WITH],EBV INFECTION susceptible to EBV LYMPHOPROLIFERATIVE SYNDROMES.,n/a,4,105,1,16,138,TWrex-cause,810656-FS1,69  EBV INFECTION in the Immunocompromised Host  Immunocompromised hosts are susceptible to overwhelming EBV LYMPHOPROLIFERATIVE SYNDROMES.,EBV INFECTION,EBV LYMPHOPROLIFERATIVE SYNDROMES
721149021,5/13/2015 11:44:30,1635705648,5/13/2015 11:43:37,false,points4rewards,1.0,28703583,USA,"","",97.73.86.35,[MANIFESTATION],[MANIFESTATION],are susceptible to,N/A,4,105,1,16,138,TWrex-cause,810656-FS1,69  EBV INFECTION in the Immunocompromised Host  Immunocompromised hosts are susceptible to overwhelming EBV LYMPHOPROLIFERATIVE SYNDROMES.,EBV INFECTION,EBV LYMPHOPROLIFERATIVE SYNDROMES
721149021,5/13/2015 11:48:04,1635706754,5/13/2015 11:47:47,false,neodev,1.0,31726043,GBR,"","",88.150.202.140,[CONTRAINDICATES],[CONTRAINDICATES],hosts,5151,4,105,1,16,138,TWrex-cause,810656-FS1,69  EBV INFECTION in the Immunocompromised Host  Immunocompromised hosts are susceptible to overwhelming EBV LYMPHOPROLIFERATIVE SYNDROMES.,EBV INFECTION,EBV LYMPHOPROLIFERATIVE SYNDROMES
721149021,5/13/2015 12:23:02,1635718826,5/13/2015 12:22:42,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,[CAUSES],[CAUSES],susceptible,n/a,4,105,1,16,138,TWrex-cause,810656-FS1,69  EBV INFECTION in the Immunocompromised Host  Immunocompromised hosts are susceptible to overwhelming EBV LYMPHOPROLIFERATIVE SYNDROMES.,EBV INFECTION,EBV LYMPHOPROLIFERATIVE SYNDROMES
721149021,5/13/2015 12:27:02,1635720476,5/13/2015 12:26:43,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[SYMPTOM],[SYMPTOM],EBV INFECTION susceptible to EBV LYMPHOPROLIFERATIVE SYNDROMES.,n/a,4,105,1,16,138,TWrex-cause,810656-FS1,69  EBV INFECTION in the Immunocompromised Host  Immunocompromised hosts are susceptible to overwhelming EBV LYMPHOPROLIFERATIVE SYNDROMES.,EBV INFECTION,EBV LYMPHOPROLIFERATIVE SYNDROMES
721149021,5/13/2015 13:01:32,1635728956,5/13/2015 13:01:07,false,clixsense,1.0,24329110,USA,FL,Jacksonville,12.168.136.2,[MANIFESTATION],[MANIFESTATION],susceptible to,n/a,4,105,1,16,138,TWrex-cause,810656-FS1,69  EBV INFECTION in the Immunocompromised Host  Immunocompromised hosts are susceptible to overwhelming EBV LYMPHOPROLIFERATIVE SYNDROMES.,EBV INFECTION,EBV LYMPHOPROLIFERATIVE SYNDROMES
721149021,5/13/2015 13:01:44,1635729054,5/13/2015 13:01:12,false,clixsense,1.0,6574449,USA,"","",216.216.68.85,[OTHER],[OTHER],EBV INFECTION Immunocompromised Host Immunocompromised hosts susceptible EBV LYMPHOPROLIFERATIVE SYNDROMES.,na,4,105,1,16,138,TWrex-cause,810656-FS1,69  EBV INFECTION in the Immunocompromised Host  Immunocompromised hosts are susceptible to overwhelming EBV LYMPHOPROLIFERATIVE SYNDROMES.,EBV INFECTION,EBV LYMPHOPROLIFERATIVE SYNDROMES
721149021,5/13/2015 13:02:02,1635729119,5/13/2015 13:00:17,false,prodege,1.0,23482077,USA,TX,Garland,71.164.238.226,[NONE],[NONE],N/A,"The text is unclear due to missing word(s) or punctuation.  ""EBV INECTION in the Immunocompromised Host"" appears to possibly be a section header or title or the end of a previous sentence.",4,105,1,16,138,TWrex-cause,810656-FS1,69  EBV INFECTION in the Immunocompromised Host  Immunocompromised hosts are susceptible to overwhelming EBV LYMPHOPROLIFERATIVE SYNDROMES.,EBV INFECTION,EBV LYMPHOPROLIFERATIVE SYNDROMES
721149022,5/13/2015 10:33:40,1635686545,5/13/2015 10:32:35,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[TREATS],[TREATS],"MOPP vs. MOPP alternating with streptozotocin, CCNU, adriamycin and BLEOMYCIN (SCAB) for advanced HODGKIN'S DISEASE",N/A,136,106,-1,152,115,TWrex-cause,800855-FS1,"Wiernik PH, Longo D, Duffey PL et al. MOPP vs. MOPP alternating with streptozotocin, CCNU, adriamycin and BLEOMYCIN (SCAB) for advanced HODGKIN'S DISEASE",HODGKIN'S DISEASE,BLEOMYCIN
721149022,5/13/2015 10:47:56,1635690586,5/13/2015 10:47:35,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[TREATS],[TREATS],for,n/a,136,106,-1,152,115,TWrex-cause,800855-FS1,"Wiernik PH, Longo D, Duffey PL et al. MOPP vs. MOPP alternating with streptozotocin, CCNU, adriamycin and BLEOMYCIN (SCAB) for advanced HODGKIN'S DISEASE",HODGKIN'S DISEASE,BLEOMYCIN
721149022,5/13/2015 10:51:28,1635691740,5/13/2015 10:50:21,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[TREATS],[TREATS],for,N/A,136,106,-1,152,115,TWrex-cause,800855-FS1,"Wiernik PH, Longo D, Duffey PL et al. MOPP vs. MOPP alternating with streptozotocin, CCNU, adriamycin and BLEOMYCIN (SCAB) for advanced HODGKIN'S DISEASE",HODGKIN'S DISEASE,BLEOMYCIN
721149022,5/13/2015 10:56:24,1635693035,5/13/2015 10:55:59,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[PREVENTS],[PREVENTS],HODGKIN'S DISEASE,N/A,136,106,-1,152,115,TWrex-cause,800855-FS1,"Wiernik PH, Longo D, Duffey PL et al. MOPP vs. MOPP alternating with streptozotocin, CCNU, adriamycin and BLEOMYCIN (SCAB) for advanced HODGKIN'S DISEASE",HODGKIN'S DISEASE,BLEOMYCIN
721149022,5/13/2015 11:16:44,1635698644,5/13/2015 11:16:28,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[TREATS],[TREATS],for,n/a,136,106,-1,152,115,TWrex-cause,800855-FS1,"Wiernik PH, Longo D, Duffey PL et al. MOPP vs. MOPP alternating with streptozotocin, CCNU, adriamycin and BLEOMYCIN (SCAB) for advanced HODGKIN'S DISEASE",HODGKIN'S DISEASE,BLEOMYCIN
721149022,5/13/2015 11:29:10,1635701568,5/13/2015 11:26:48,false,neodev,1.0,31706957,NLD,07,Amsterdam,145.100.72.165,[TREATS],[TREATS],for advanced,n/a,136,106,-1,152,115,TWrex-cause,800855-FS1,"Wiernik PH, Longo D, Duffey PL et al. MOPP vs. MOPP alternating with streptozotocin, CCNU, adriamycin and BLEOMYCIN (SCAB) for advanced HODGKIN'S DISEASE",HODGKIN'S DISEASE,BLEOMYCIN
721149022,5/13/2015 11:35:51,1635703556,5/13/2015 11:35:25,false,prodege,1.0,27934334,GBR,D3,Swadlincote,109.150.228.127,[TREATS],[TREATS],for,N/A,136,106,-1,152,115,TWrex-cause,800855-FS1,"Wiernik PH, Longo D, Duffey PL et al. MOPP vs. MOPP alternating with streptozotocin, CCNU, adriamycin and BLEOMYCIN (SCAB) for advanced HODGKIN'S DISEASE",HODGKIN'S DISEASE,BLEOMYCIN
721149022,5/13/2015 11:45:07,1635705779,5/13/2015 11:44:28,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[TREATS],[TREATS],BLEOMYCIN for HODGKIN'S DISEASE,n/a,136,106,-1,152,115,TWrex-cause,800855-FS1,"Wiernik PH, Longo D, Duffey PL et al. MOPP vs. MOPP alternating with streptozotocin, CCNU, adriamycin and BLEOMYCIN (SCAB) for advanced HODGKIN'S DISEASE",HODGKIN'S DISEASE,BLEOMYCIN
721149022,5/13/2015 11:46:01,1635706030,5/13/2015 11:45:10,false,points4rewards,1.0,28703583,USA,"","",97.73.86.35,[TREATS],[TREATS],alternating with,N/A,136,106,-1,152,115,TWrex-cause,800855-FS1,"Wiernik PH, Longo D, Duffey PL et al. MOPP vs. MOPP alternating with streptozotocin, CCNU, adriamycin and BLEOMYCIN (SCAB) for advanced HODGKIN'S DISEASE",HODGKIN'S DISEASE,BLEOMYCIN
721149022,5/13/2015 11:48:53,1635706913,5/13/2015 11:48:41,false,neodev,1.0,31726043,GBR,"","",88.150.202.140,[LOCATION],[LOCATION],with,54,136,106,-1,152,115,TWrex-cause,800855-FS1,"Wiernik PH, Longo D, Duffey PL et al. MOPP vs. MOPP alternating with streptozotocin, CCNU, adriamycin and BLEOMYCIN (SCAB) for advanced HODGKIN'S DISEASE",HODGKIN'S DISEASE,BLEOMYCIN
721149022,5/13/2015 12:23:57,1635719155,5/13/2015 12:23:30,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,[TREATS],[TREATS],for,n/a,136,106,-1,152,115,TWrex-cause,800855-FS1,"Wiernik PH, Longo D, Duffey PL et al. MOPP vs. MOPP alternating with streptozotocin, CCNU, adriamycin and BLEOMYCIN (SCAB) for advanced HODGKIN'S DISEASE",HODGKIN'S DISEASE,BLEOMYCIN
721149022,5/13/2015 12:28:51,1635720894,5/13/2015 12:27:19,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[TREATS],[TREATS],BLEOMYCIN for advanced HODGKIN'S DISEASE,n/a,136,106,-1,152,115,TWrex-cause,800855-FS1,"Wiernik PH, Longo D, Duffey PL et al. MOPP vs. MOPP alternating with streptozotocin, CCNU, adriamycin and BLEOMYCIN (SCAB) for advanced HODGKIN'S DISEASE",HODGKIN'S DISEASE,BLEOMYCIN
721149022,5/13/2015 13:02:12,1635729211,5/13/2015 13:01:34,false,neodev,1.0,30504276,CAN,ON,Sudbury,66.103.55.12,[NONE],[NONE],N/A,N/A,136,106,-1,152,115,TWrex-cause,800855-FS1,"Wiernik PH, Longo D, Duffey PL et al. MOPP vs. MOPP alternating with streptozotocin, CCNU, adriamycin and BLEOMYCIN (SCAB) for advanced HODGKIN'S DISEASE",HODGKIN'S DISEASE,BLEOMYCIN
721149022,5/13/2015 13:02:31,1635729348,5/13/2015 13:01:57,false,clixsense,1.0,24329110,USA,FL,Jacksonville,12.168.136.2,[TREATS],[TREATS],alternating for advanced,n/a,136,106,-1,152,115,TWrex-cause,800855-FS1,"Wiernik PH, Longo D, Duffey PL et al. MOPP vs. MOPP alternating with streptozotocin, CCNU, adriamycin and BLEOMYCIN (SCAB) for advanced HODGKIN'S DISEASE",HODGKIN'S DISEASE,BLEOMYCIN
721149022,5/13/2015 13:03:26,1635729769,5/13/2015 13:02:02,false,clixsense,1.0,6574449,USA,"","",216.216.68.85,[OTHER],[OTHER],"MOPP MOPP alternating streptozotocin, CCNU, adriamycin BLEOMYCIN (SCAB) advanced HODGKIN'S DISEASE",na,136,106,-1,152,115,TWrex-cause,800855-FS1,"Wiernik PH, Longo D, Duffey PL et al. MOPP vs. MOPP alternating with streptozotocin, CCNU, adriamycin and BLEOMYCIN (SCAB) for advanced HODGKIN'S DISEASE",HODGKIN'S DISEASE,BLEOMYCIN
721149023,5/13/2015 11:50:38,1635707280,5/13/2015 11:50:22,false,neodev,1,31726043,GBR,"","",88.150.202.140,[SYMPTOM],[SYMPTOM],URETHRITIS,5145,44,0,-1,68,12,TWrex-cause,800218-FS1,"AZITHROMYCIN as the first line treatment of NON GONOCOCCAL URETHRITIS (NGU): a study of follow up rates, contact attendance and patients' treatment preference.",NON GONOCOCCAL URETHRITIS,AZITHROMYCIN
721149023,5/13/2015 12:31:07,1635721382,5/13/2015 12:30:51,false,instagc,1,31184650,USA,IA,Mason City,173.26.27.82,[TREATS],[TREATS],AZITHROMYCIN as the first line treatment of NON GONOCOCCAL URETHRITIS,n/a,44,0,-1,68,12,TWrex-cause,800218-FS1,"AZITHROMYCIN as the first line treatment of NON GONOCOCCAL URETHRITIS (NGU): a study of follow up rates, contact attendance and patients' treatment preference.",NON GONOCOCCAL URETHRITIS,AZITHROMYCIN
721149023,5/13/2015 13:03:41,1635729817,5/13/2015 13:03:29,false,neodev,1,30504276,CAN,ON,Sudbury,66.103.55.12,[TREATS],[TREATS],treatment,N/A,44,0,-1,68,12,TWrex-cause,800218-FS1,"AZITHROMYCIN as the first line treatment of NON GONOCOCCAL URETHRITIS (NGU): a study of follow up rates, contact attendance and patients' treatment preference.",NON GONOCOCCAL URETHRITIS,AZITHROMYCIN
721149023,5/13/2015 13:05:42,1635730668,5/13/2015 13:05:18,false,clixsense,1,24329110,USA,FL,Jacksonville,12.168.136.2,[TREATS],[TREATS],first line treatment,n/a,44,0,-1,68,12,TWrex-cause,800218-FS1,"AZITHROMYCIN as the first line treatment of NON GONOCOCCAL URETHRITIS (NGU): a study of follow up rates, contact attendance and patients' treatment preference.",NON GONOCOCCAL URETHRITIS,AZITHROMYCIN
721149023,5/13/2015 13:10:40,1635731806,5/13/2015 13:10:14,false,prodege,1,23482077,USA,TX,Garland,71.164.238.226,[TREATS],[TREATS],treatment of,N/A,44,0,-1,68,12,TWrex-cause,800218-FS1,"AZITHROMYCIN as the first line treatment of NON GONOCOCCAL URETHRITIS (NGU): a study of follow up rates, contact attendance and patients' treatment preference.",NON GONOCOCCAL URETHRITIS,AZITHROMYCIN
721149023,5/13/2015 13:11:48,1635732078,5/13/2015 13:11:23,false,clixsense,1,23197581,NLD,11,Den Haag,82.217.5.55,[TREATS],[TREATS],first line treatment,N/A,44,0,-1,68,12,TWrex-cause,800218-FS1,"AZITHROMYCIN as the first line treatment of NON GONOCOCCAL URETHRITIS (NGU): a study of follow up rates, contact attendance and patients' treatment preference.",NON GONOCOCCAL URETHRITIS,AZITHROMYCIN
721149023,5/13/2015 13:29:14,1635736815,5/13/2015 13:28:18,false,gifthulk,1,18666417,USA,PA,Meadville,24.101.97.237,[TREATS],[TREATS],AZITHROMYCIN as treatment of NON GONOCOCCAL URETHRITIS,N/A,44,0,-1,68,12,TWrex-cause,800218-FS1,"AZITHROMYCIN as the first line treatment of NON GONOCOCCAL URETHRITIS (NGU): a study of follow up rates, contact attendance and patients' treatment preference.",NON GONOCOCCAL URETHRITIS,AZITHROMYCIN
721149023,5/13/2015 13:37:28,1635738995,5/13/2015 13:36:59,false,bitcoinget,1,21614812,USA,PA,Erie,174.100.250.115,[TREATS],[TREATS],first line treatment,N/A,44,0,-1,68,12,TWrex-cause,800218-FS1,"AZITHROMYCIN as the first line treatment of NON GONOCOCCAL URETHRITIS (NGU): a study of follow up rates, contact attendance and patients' treatment preference.",NON GONOCOCCAL URETHRITIS,AZITHROMYCIN
721149023,5/13/2015 13:42:33,1635740386,5/13/2015 13:42:09,false,neodev,1,24564999,GBR,H9,London,86.145.227.9,[TREATS],[TREATS],first line treatment of,N/A,44,0,-1,68,12,TWrex-cause,800218-FS1,"AZITHROMYCIN as the first line treatment of NON GONOCOCCAL URETHRITIS (NGU): a study of follow up rates, contact attendance and patients' treatment preference.",NON GONOCOCCAL URETHRITIS,AZITHROMYCIN
721149023,5/13/2015 13:51:42,1635744023,5/13/2015 13:51:24,false,prodege,1,29849805,GBR,Z1,Swansea,82.1.37.235,[TREATS],[TREATS],treatment,N/A,44,0,-1,68,12,TWrex-cause,800218-FS1,"AZITHROMYCIN as the first line treatment of NON GONOCOCCAL URETHRITIS (NGU): a study of follow up rates, contact attendance and patients' treatment preference.",NON GONOCOCCAL URETHRITIS,AZITHROMYCIN
721149023,5/13/2015 14:11:45,1635752597,5/13/2015 14:11:00,false,prodege,1,24403612,CAN,ON,Ajax,99.239.181.149,[TREATS],[TREATS],AZITHROMYCIN first line treatment of NON GONOCOCCAL URETHRITIS,N/a,44,0,-1,68,12,TWrex-cause,800218-FS1,"AZITHROMYCIN as the first line treatment of NON GONOCOCCAL URETHRITIS (NGU): a study of follow up rates, contact attendance and patients' treatment preference.",NON GONOCOCCAL URETHRITIS,AZITHROMYCIN
721149023,5/13/2015 14:23:07,1635757067,5/13/2015 14:22:50,false,onestopgpt,1,21275875,CAN,ON,Hamilton,24.36.121.10,[TREATS],[TREATS],treatment of,N/A,44,0,-1,68,12,TWrex-cause,800218-FS1,"AZITHROMYCIN as the first line treatment of NON GONOCOCCAL URETHRITIS (NGU): a study of follow up rates, contact attendance and patients' treatment preference.",NON GONOCOCCAL URETHRITIS,AZITHROMYCIN
721149023,5/13/2015 15:07:50,1635787028,5/13/2015 15:07:29,false,points4rewards,1,20306700,USA,WA,Bothell,50.125.145.37,[TREATS],[TREATS],treatment,n/a,44,0,-1,68,12,TWrex-cause,800218-FS1,"AZITHROMYCIN as the first line treatment of NON GONOCOCCAL URETHRITIS (NGU): a study of follow up rates, contact attendance and patients' treatment preference.",NON GONOCOCCAL URETHRITIS,AZITHROMYCIN
721149023,5/13/2015 15:38:07,1635811817,5/13/2015 15:37:30,false,clixsense,1.0,32549163,CAN,MB,Winnipeg,206.45.167.246,[TREATS],[TREATS],AZITHROMYCIN as the first line treatment of NON GONOCOCCAL URETHRITIS,N/A,44,0,-1,68,12,TWrex-cause,800218-FS1,"AZITHROMYCIN as the first line treatment of NON GONOCOCCAL URETHRITIS (NGU): a study of follow up rates, contact attendance and patients' treatment preference.",NON GONOCOCCAL URETHRITIS,AZITHROMYCIN
721149023,5/13/2015 15:53:19,1635823335,5/13/2015 15:52:53,false,instagc,1.0,24252915,GBR,F2,Gosport,92.24.208.155,[TREATS],[TREATS],AZITHROMYCIN as the treatment of NON GONOCOCCAL URETHRITIS,N/a,44,0,-1,68,12,TWrex-cause,800218-FS1,"AZITHROMYCIN as the first line treatment of NON GONOCOCCAL URETHRITIS (NGU): a study of follow up rates, contact attendance and patients' treatment preference.",NON GONOCOCCAL URETHRITIS,AZITHROMYCIN
721149024,5/13/2015 09:55:44,1635676223,5/13/2015 09:55:26,false,neodev,1.0,32103286,CAN,AB,Edmonton,208.123.223.37,[LOCATION] [CAUSES] [SYMPTOM] [NONE],"[CAUSES]
[LOCATION]
[SYMPTOM]
[NONE]",no,no,235,196,-1,255,205,TWrex-cause,804142-FS1,"Commonly used but unproven approaches involve avoiding topical irritants and using systemic drugs (eg, tricyclic antidepressants, anticonvulsants) or topical drugs (eg, 2% cromoglycate or 2 or 5% LIDOCAINE in glaxal base) to interrupt CHRONIC PAIN CIRCUITS.",CHRONIC PAIN CIRCUITS,LIDOCAINE
721149024,5/13/2015 10:01:05,1635677713,5/13/2015 09:59:15,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[TREATS] [DIAGNOSE_BY_TEST_OR_DRUG],"[TREATS]
[DIAGNOSE_BY_TEST_OR_DRUG]","Commonly used but unproven approaches involve avoiding topical irritants and using systemic drugs (eg, tricyclic antidepressants, anticonvulsants) or topical drugs (eg, 2% cromoglycate or 2 or 5% LIDOCAINE in glaxal base) to interrupt CHRONIC PAIN CIRCUITS.",N/A,235,196,-1,255,205,TWrex-cause,804142-FS1,"Commonly used but unproven approaches involve avoiding topical irritants and using systemic drugs (eg, tricyclic antidepressants, anticonvulsants) or topical drugs (eg, 2% cromoglycate or 2 or 5% LIDOCAINE in glaxal base) to interrupt CHRONIC PAIN CIRCUITS.",CHRONIC PAIN CIRCUITS,LIDOCAINE
721149024,5/13/2015 10:17:42,1635681801,5/13/2015 10:16:38,false,clixsense,1.0,26847653,NLD,03,Warnsveld,213.93.50.164,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],using systemic drugs or topical drugs to interrupt,n/a,235,196,-1,255,205,TWrex-cause,804142-FS1,"Commonly used but unproven approaches involve avoiding topical irritants and using systemic drugs (eg, tricyclic antidepressants, anticonvulsants) or topical drugs (eg, 2% cromoglycate or 2 or 5% LIDOCAINE in glaxal base) to interrupt CHRONIC PAIN CIRCUITS.",CHRONIC PAIN CIRCUITS,LIDOCAINE
721149024,5/13/2015 10:22:27,1635683359,5/13/2015 10:20:29,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[TREATS],[TREATS],to interrupt,n/a,235,196,-1,255,205,TWrex-cause,804142-FS1,"Commonly used but unproven approaches involve avoiding topical irritants and using systemic drugs (eg, tricyclic antidepressants, anticonvulsants) or topical drugs (eg, 2% cromoglycate or 2 or 5% LIDOCAINE in glaxal base) to interrupt CHRONIC PAIN CIRCUITS.",CHRONIC PAIN CIRCUITS,LIDOCAINE
721149024,5/13/2015 10:23:10,1635683498,5/13/2015 10:21:04,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[TREATS],[TREATS],to interrupt,N/A,235,196,-1,255,205,TWrex-cause,804142-FS1,"Commonly used but unproven approaches involve avoiding topical irritants and using systemic drugs (eg, tricyclic antidepressants, anticonvulsants) or topical drugs (eg, 2% cromoglycate or 2 or 5% LIDOCAINE in glaxal base) to interrupt CHRONIC PAIN CIRCUITS.",CHRONIC PAIN CIRCUITS,LIDOCAINE
721149024,5/13/2015 10:29:31,1635685253,5/13/2015 10:29:14,false,pocketmoneygpt,1.0,28884030,USA,WI,Minocqua,75.143.134.247,[PREVENTS],[PREVENTS],interrupt,n/a,235,196,-1,255,205,TWrex-cause,804142-FS1,"Commonly used but unproven approaches involve avoiding topical irritants and using systemic drugs (eg, tricyclic antidepressants, anticonvulsants) or topical drugs (eg, 2% cromoglycate or 2 or 5% LIDOCAINE in glaxal base) to interrupt CHRONIC PAIN CIRCUITS.",CHRONIC PAIN CIRCUITS,LIDOCAINE
721149024,5/13/2015 10:39:02,1635688115,5/13/2015 10:38:18,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[TREATS],[TREATS],"tricyclic antidepressants,",N/A,235,196,-1,255,205,TWrex-cause,804142-FS1,"Commonly used but unproven approaches involve avoiding topical irritants and using systemic drugs (eg, tricyclic antidepressants, anticonvulsants) or topical drugs (eg, 2% cromoglycate or 2 or 5% LIDOCAINE in glaxal base) to interrupt CHRONIC PAIN CIRCUITS.",CHRONIC PAIN CIRCUITS,LIDOCAINE
721149024,5/13/2015 10:51:29,1635691738,5/13/2015 10:50:25,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,[TREATS],[TREATS],interrupt,n/a,235,196,-1,255,205,TWrex-cause,804142-FS1,"Commonly used but unproven approaches involve avoiding topical irritants and using systemic drugs (eg, tricyclic antidepressants, anticonvulsants) or topical drugs (eg, 2% cromoglycate or 2 or 5% LIDOCAINE in glaxal base) to interrupt CHRONIC PAIN CIRCUITS.",CHRONIC PAIN CIRCUITS,LIDOCAINE
721149024,5/13/2015 10:53:52,1635692477,5/13/2015 10:53:19,false,neodev,1.0,29579905,GBR,"","",5.152.206.71,[DIAGNOSE_BY_TEST_OR_DRUG] [SIDE_EFFECT],"[DIAGNOSE_BY_TEST_OR_DRUG]
[SIDE_EFFECT]",unproven PAIN,N/A,235,196,-1,255,205,TWrex-cause,804142-FS1,"Commonly used but unproven approaches involve avoiding topical irritants and using systemic drugs (eg, tricyclic antidepressants, anticonvulsants) or topical drugs (eg, 2% cromoglycate or 2 or 5% LIDOCAINE in glaxal base) to interrupt CHRONIC PAIN CIRCUITS.",CHRONIC PAIN CIRCUITS,LIDOCAINE
721149024,5/13/2015 10:55:20,1635692726,5/13/2015 10:55:00,false,neodev,1.0,31706957,NLD,07,Amsterdam,145.100.72.165,[PREVENTS],[PREVENTS],to interrupt,n/a,235,196,-1,255,205,TWrex-cause,804142-FS1,"Commonly used but unproven approaches involve avoiding topical irritants and using systemic drugs (eg, tricyclic antidepressants, anticonvulsants) or topical drugs (eg, 2% cromoglycate or 2 or 5% LIDOCAINE in glaxal base) to interrupt CHRONIC PAIN CIRCUITS.",CHRONIC PAIN CIRCUITS,LIDOCAINE
721149024,5/13/2015 10:56:53,1635693224,5/13/2015 10:56:38,false,elite,1.0,31856422,GBR,C9,Workington,92.18.169.149,[TREATS],[TREATS],to interrupt,N/A,235,196,-1,255,205,TWrex-cause,804142-FS1,"Commonly used but unproven approaches involve avoiding topical irritants and using systemic drugs (eg, tricyclic antidepressants, anticonvulsants) or topical drugs (eg, 2% cromoglycate or 2 or 5% LIDOCAINE in glaxal base) to interrupt CHRONIC PAIN CIRCUITS.",CHRONIC PAIN CIRCUITS,LIDOCAINE
721149024,5/13/2015 11:06:58,1635696204,5/13/2015 11:06:23,false,instagc,1.0,24252915,GBR,K6,Portsmouth,89.240.160.95,[TREATS],[TREATS],LIDOCAINE interrupt CHRONIC PAIN CIRCUITS.,N/a,235,196,-1,255,205,TWrex-cause,804142-FS1,"Commonly used but unproven approaches involve avoiding topical irritants and using systemic drugs (eg, tricyclic antidepressants, anticonvulsants) or topical drugs (eg, 2% cromoglycate or 2 or 5% LIDOCAINE in glaxal base) to interrupt CHRONIC PAIN CIRCUITS.",CHRONIC PAIN CIRCUITS,LIDOCAINE
721149024,5/13/2015 11:09:00,1635696659,5/13/2015 11:08:37,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[TREATS],[TREATS],interrupt,n/a,235,196,-1,255,205,TWrex-cause,804142-FS1,"Commonly used but unproven approaches involve avoiding topical irritants and using systemic drugs (eg, tricyclic antidepressants, anticonvulsants) or topical drugs (eg, 2% cromoglycate or 2 or 5% LIDOCAINE in glaxal base) to interrupt CHRONIC PAIN CIRCUITS.",CHRONIC PAIN CIRCUITS,LIDOCAINE
721149024,5/13/2015 11:15:28,1635698090,5/13/2015 11:14:53,false,prodege,1.0,27934334,GBR,D3,Swadlincote,109.150.228.127,[TREATS],[TREATS],interrupt,N/A,235,196,-1,255,205,TWrex-cause,804142-FS1,"Commonly used but unproven approaches involve avoiding topical irritants and using systemic drugs (eg, tricyclic antidepressants, anticonvulsants) or topical drugs (eg, 2% cromoglycate or 2 or 5% LIDOCAINE in glaxal base) to interrupt CHRONIC PAIN CIRCUITS.",CHRONIC PAIN CIRCUITS,LIDOCAINE
721149024,5/13/2015 11:18:37,1635699172,5/13/2015 11:17:15,false,points4rewards,1.0,28703583,USA,"","",97.73.86.35,[TREATS],[TREATS],to interrupt,N/A,235,196,-1,255,205,TWrex-cause,804142-FS1,"Commonly used but unproven approaches involve avoiding topical irritants and using systemic drugs (eg, tricyclic antidepressants, anticonvulsants) or topical drugs (eg, 2% cromoglycate or 2 or 5% LIDOCAINE in glaxal base) to interrupt CHRONIC PAIN CIRCUITS.",CHRONIC PAIN CIRCUITS,LIDOCAINE
721149025,5/13/2015 13:06:25,1635730833,5/13/2015 13:06:12,false,neodev,1.0,30504276,CAN,ON,Sudbury,66.103.55.12,[NONE],[NONE],N/A,N/A,135,158,-1,143,168,TWrex-cause,804783-FS1,Lansoprazole provided more effective and faster relief for heartburn than did omeprazole in erosive esophagitis  Keywords: Esophagitis HEARTBURN Lansoprazole OMEPRAZOLE  ACP Journal Club.,HEARTBURN,OMEPRAZOLE
721149025,5/13/2015 13:15:24,1635733173,5/13/2015 13:15:08,false,clixsense,1.0,24329110,USA,FL,Jacksonville,12.168.136.2,[TREATS],[TREATS],effective and faster relief,n/a,135,158,-1,143,168,TWrex-cause,804783-FS1,Lansoprazole provided more effective and faster relief for heartburn than did omeprazole in erosive esophagitis  Keywords: Esophagitis HEARTBURN Lansoprazole OMEPRAZOLE  ACP Journal Club.,HEARTBURN,OMEPRAZOLE
721149025,5/13/2015 13:17:24,1635733642,5/13/2015 13:16:53,false,clixsense,1.0,23197581,NLD,11,Den Haag,82.217.5.55,[TREATS],[TREATS],more effective and faster relief,N/A,135,158,-1,143,168,TWrex-cause,804783-FS1,Lansoprazole provided more effective and faster relief for heartburn than did omeprazole in erosive esophagitis  Keywords: Esophagitis HEARTBURN Lansoprazole OMEPRAZOLE  ACP Journal Club.,HEARTBURN,OMEPRAZOLE
721149025,5/13/2015 13:19:39,1635734294,5/13/2015 13:18:50,false,prodege,1.0,23482077,USA,TX,Garland,71.164.238.226,[NONE],[NONE],N/A,Highlighted words are just keywords.,135,158,-1,143,168,TWrex-cause,804783-FS1,Lansoprazole provided more effective and faster relief for heartburn than did omeprazole in erosive esophagitis  Keywords: Esophagitis HEARTBURN Lansoprazole OMEPRAZOLE  ACP Journal Club.,HEARTBURN,OMEPRAZOLE
721149025,5/13/2015 13:41:45,1635740071,5/13/2015 13:41:26,false,bitcoinget,1.0,21614812,USA,PA,Erie,174.100.250.115,[NONE],[NONE],N/A,N/A,135,158,-1,143,168,TWrex-cause,804783-FS1,Lansoprazole provided more effective and faster relief for heartburn than did omeprazole in erosive esophagitis  Keywords: Esophagitis HEARTBURN Lansoprazole OMEPRAZOLE  ACP Journal Club.,HEARTBURN,OMEPRAZOLE
721149025,5/13/2015 13:49:36,1635743122,5/13/2015 13:49:10,false,neodev,1.0,24564999,GBR,H9,London,86.145.227.9,[TREATS],[TREATS],relief for,N/A,135,158,-1,143,168,TWrex-cause,804783-FS1,Lansoprazole provided more effective and faster relief for heartburn than did omeprazole in erosive esophagitis  Keywords: Esophagitis HEARTBURN Lansoprazole OMEPRAZOLE  ACP Journal Club.,HEARTBURN,OMEPRAZOLE
721149025,5/13/2015 13:56:55,1635746159,5/13/2015 13:56:20,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[TREATS],[TREATS],relief for,N/A,135,158,-1,143,168,TWrex-cause,804783-FS1,Lansoprazole provided more effective and faster relief for heartburn than did omeprazole in erosive esophagitis  Keywords: Esophagitis HEARTBURN Lansoprazole OMEPRAZOLE  ACP Journal Club.,HEARTBURN,OMEPRAZOLE
721149025,5/13/2015 14:21:05,1635756167,5/13/2015 14:20:20,false,prodege,1.0,24403612,CAN,ON,Ajax,99.239.181.149,[PART_OF],[PART_OF],HEARTBURN Lansoprazole OMEPRAZOLE ACP Journal Club.,N/a,135,158,-1,143,168,TWrex-cause,804783-FS1,Lansoprazole provided more effective and faster relief for heartburn than did omeprazole in erosive esophagitis  Keywords: Esophagitis HEARTBURN Lansoprazole OMEPRAZOLE  ACP Journal Club.,HEARTBURN,OMEPRAZOLE
721149025,5/13/2015 14:29:05,1635760050,5/13/2015 14:28:42,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[TREATS],[TREATS],relief for,N/A,135,158,-1,143,168,TWrex-cause,804783-FS1,Lansoprazole provided more effective and faster relief for heartburn than did omeprazole in erosive esophagitis  Keywords: Esophagitis HEARTBURN Lansoprazole OMEPRAZOLE  ACP Journal Club.,HEARTBURN,OMEPRAZOLE
721149025,5/13/2015 15:15:10,1635794014,5/13/2015 15:13:05,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,[TREATS],[TREATS],relief,n/a,135,158,-1,143,168,TWrex-cause,804783-FS1,Lansoprazole provided more effective and faster relief for heartburn than did omeprazole in erosive esophagitis  Keywords: Esophagitis HEARTBURN Lansoprazole OMEPRAZOLE  ACP Journal Club.,HEARTBURN,OMEPRAZOLE
721149025,5/13/2015 15:25:07,1635801810,5/13/2015 15:23:50,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[TREATS],[TREATS],provided relief for heartburn OMEPRAZOLE,N/A,135,158,-1,143,168,TWrex-cause,804783-FS1,Lansoprazole provided more effective and faster relief for heartburn than did omeprazole in erosive esophagitis  Keywords: Esophagitis HEARTBURN Lansoprazole OMEPRAZOLE  ACP Journal Club.,HEARTBURN,OMEPRAZOLE
721149025,5/13/2015 15:43:05,1635815775,5/13/2015 15:42:29,false,clixsense,1.0,32549163,CAN,MB,Winnipeg,206.45.167.246,[TREATS],[TREATS],Lansoprazole provided more effective and faster relief for heartburn than did omeprazole,N/A,135,158,-1,143,168,TWrex-cause,804783-FS1,Lansoprazole provided more effective and faster relief for heartburn than did omeprazole in erosive esophagitis  Keywords: Esophagitis HEARTBURN Lansoprazole OMEPRAZOLE  ACP Journal Club.,HEARTBURN,OMEPRAZOLE
721149025,5/13/2015 15:59:03,1635828015,5/13/2015 15:58:13,false,instagc,1.0,24252915,GBR,F2,Gosport,92.24.208.155,[TREATS],[TREATS],faster relief for,N/a,135,158,-1,143,168,TWrex-cause,804783-FS1,Lansoprazole provided more effective and faster relief for heartburn than did omeprazole in erosive esophagitis  Keywords: Esophagitis HEARTBURN Lansoprazole OMEPRAZOLE  ACP Journal Club.,HEARTBURN,OMEPRAZOLE
721149025,5/13/2015 16:02:12,1635830620,5/13/2015 16:01:30,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[TREATS],[TREATS],relief,none,135,158,-1,143,168,TWrex-cause,804783-FS1,Lansoprazole provided more effective and faster relief for heartburn than did omeprazole in erosive esophagitis  Keywords: Esophagitis HEARTBURN Lansoprazole OMEPRAZOLE  ACP Journal Club.,HEARTBURN,OMEPRAZOLE
721149025,5/13/2015 16:27:21,1635847173,5/13/2015 16:26:52,false,prodege,1.0,16101132,GBR,F9,Hayes,2.223.214.149,[TREATS],[TREATS],relief,Treated with,135,158,-1,143,168,TWrex-cause,804783-FS1,Lansoprazole provided more effective and faster relief for heartburn than did omeprazole in erosive esophagitis  Keywords: Esophagitis HEARTBURN Lansoprazole OMEPRAZOLE  ACP Journal Club.,HEARTBURN,OMEPRAZOLE
721149026,5/13/2015 17:37:01,1635886721,5/13/2015 17:36:18,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[CAUSES],[CAUSES],can result from,n/a,8,40,1,22,64,TWrex-cause,813256-FS1,"Similar LYMPHADENOPATHY can result from INFECTIOUS MONONUCLEOSIS toxoplasmosis, cytomegalovirus, non Hodgkin lymphoma, or leukemia.",LYMPHADENOPATHY,INFECTIOUS MONONUCLEOSIS
721149026,5/13/2015 17:42:06,1635890056,5/13/2015 17:41:43,false,gptking,1.0,31799065,USA,IL,Marion,50.45.43.154,[SYMPTOM],[SYMPTOM],LYMPHADENOPATHY can result from INFECTIOUS MONONUCLEOSIS,N/A,8,40,1,22,64,TWrex-cause,813256-FS1,"Similar LYMPHADENOPATHY can result from INFECTIOUS MONONUCLEOSIS toxoplasmosis, cytomegalovirus, non Hodgkin lymphoma, or leukemia.",LYMPHADENOPATHY,INFECTIOUS MONONUCLEOSIS
721149026,5/13/2015 18:19:36,1635907268,5/13/2015 18:19:10,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[MANIFESTATION],[MANIFESTATION],can result from,N/A,8,40,1,22,64,TWrex-cause,813256-FS1,"Similar LYMPHADENOPATHY can result from INFECTIOUS MONONUCLEOSIS toxoplasmosis, cytomegalovirus, non Hodgkin lymphoma, or leukemia.",LYMPHADENOPATHY,INFECTIOUS MONONUCLEOSIS
721149026,5/13/2015 18:28:33,1635912399,5/13/2015 18:27:57,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[CAUSES],[CAUSES],can result from,N/A,8,40,1,22,64,TWrex-cause,813256-FS1,"Similar LYMPHADENOPATHY can result from INFECTIOUS MONONUCLEOSIS toxoplasmosis, cytomegalovirus, non Hodgkin lymphoma, or leukemia.",LYMPHADENOPATHY,INFECTIOUS MONONUCLEOSIS
721149026,5/13/2015 18:50:13,1635922932,5/13/2015 18:49:45,false,prodege,1.0,32302664,USA,IL,Geneseo,173.27.241.235,[MANIFESTATION],[MANIFESTATION],can result from,no comment,8,40,1,22,64,TWrex-cause,813256-FS1,"Similar LYMPHADENOPATHY can result from INFECTIOUS MONONUCLEOSIS toxoplasmosis, cytomegalovirus, non Hodgkin lymphoma, or leukemia.",LYMPHADENOPATHY,INFECTIOUS MONONUCLEOSIS
721149026,5/13/2015 19:20:20,1635945075,5/13/2015 19:19:00,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[ASSOCIATED_WITH],[ASSOCIATED_WITH],can result,N/A,8,40,1,22,64,TWrex-cause,813256-FS1,"Similar LYMPHADENOPATHY can result from INFECTIOUS MONONUCLEOSIS toxoplasmosis, cytomegalovirus, non Hodgkin lymphoma, or leukemia.",LYMPHADENOPATHY,INFECTIOUS MONONUCLEOSIS
721149026,5/13/2015 19:48:14,1635965573,5/13/2015 19:47:57,false,elite,1.0,30064988,GBR,H3,Leeds,92.22.208.245,[CAUSES],[CAUSES],result from,N/A,8,40,1,22,64,TWrex-cause,813256-FS1,"Similar LYMPHADENOPATHY can result from INFECTIOUS MONONUCLEOSIS toxoplasmosis, cytomegalovirus, non Hodgkin lymphoma, or leukemia.",LYMPHADENOPATHY,INFECTIOUS MONONUCLEOSIS
721149026,5/13/2015 20:08:10,1635981535,5/13/2015 20:07:53,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.156.243,[CAUSES],[CAUSES],LYMPHADENOPATHY can result from INFECTIOUS MONONUCLEOSIS,N/A,8,40,1,22,64,TWrex-cause,813256-FS1,"Similar LYMPHADENOPATHY can result from INFECTIOUS MONONUCLEOSIS toxoplasmosis, cytomegalovirus, non Hodgkin lymphoma, or leukemia.",LYMPHADENOPATHY,INFECTIOUS MONONUCLEOSIS
721149026,5/13/2015 20:35:39,1636001238,5/13/2015 20:35:25,false,neodev,1.0,20961587,NLD,05,Maastricht,84.26.48.136,[CAUSES],[CAUSES],result,N/A,8,40,1,22,64,TWrex-cause,813256-FS1,"Similar LYMPHADENOPATHY can result from INFECTIOUS MONONUCLEOSIS toxoplasmosis, cytomegalovirus, non Hodgkin lymphoma, or leukemia.",LYMPHADENOPATHY,INFECTIOUS MONONUCLEOSIS
721149026,5/13/2015 20:53:44,1636013464,5/13/2015 20:53:01,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[CAUSES] [PREVENTS],"[PREVENTS]
[CAUSES]",LYMPHADENOPATHY can result from INFECTIOUS MONONUCLEOSIS,N/A,8,40,1,22,64,TWrex-cause,813256-FS1,"Similar LYMPHADENOPATHY can result from INFECTIOUS MONONUCLEOSIS toxoplasmosis, cytomegalovirus, non Hodgkin lymphoma, or leukemia.",LYMPHADENOPATHY,INFECTIOUS MONONUCLEOSIS
721149026,5/13/2015 20:56:47,1636015505,5/13/2015 20:56:23,false,elite,1.0,32732290,GBR,A7,Birmingham,86.147.79.250,[CAUSES],[CAUSES],result from,N/A,8,40,1,22,64,TWrex-cause,813256-FS1,"Similar LYMPHADENOPATHY can result from INFECTIOUS MONONUCLEOSIS toxoplasmosis, cytomegalovirus, non Hodgkin lymphoma, or leukemia.",LYMPHADENOPATHY,INFECTIOUS MONONUCLEOSIS
721149026,5/13/2015 21:14:03,1636027335,5/13/2015 21:13:23,false,clixsense,1.0,26847653,NLD,03,Warnsveld,213.93.50.164,[CAUSES],[CAUSES],can result from,n/a,8,40,1,22,64,TWrex-cause,813256-FS1,"Similar LYMPHADENOPATHY can result from INFECTIOUS MONONUCLEOSIS toxoplasmosis, cytomegalovirus, non Hodgkin lymphoma, or leukemia.",LYMPHADENOPATHY,INFECTIOUS MONONUCLEOSIS
721149026,5/13/2015 21:20:06,1636031003,5/13/2015 21:19:36,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[CAUSES],[CAUSES],LYMPHADENOPATHY can result from INFECTIOUS MONONUCLEOSIS,N/A,8,40,1,22,64,TWrex-cause,813256-FS1,"Similar LYMPHADENOPATHY can result from INFECTIOUS MONONUCLEOSIS toxoplasmosis, cytomegalovirus, non Hodgkin lymphoma, or leukemia.",LYMPHADENOPATHY,INFECTIOUS MONONUCLEOSIS
721149026,5/13/2015 21:34:10,1636040366,5/13/2015 21:31:43,false,neodev,1.0,30749660,USA,NC,Durham,24.211.188.217,[DIAGNOSE_BY_TEST_OR_DRUG] [PREVENTS],"[PREVENTS]
[DIAGNOSE_BY_TEST_OR_DRUG]","cytomegalovirus, non Hodgkin lymphoma,",n/a,8,40,1,22,64,TWrex-cause,813256-FS1,"Similar LYMPHADENOPATHY can result from INFECTIOUS MONONUCLEOSIS toxoplasmosis, cytomegalovirus, non Hodgkin lymphoma, or leukemia.",LYMPHADENOPATHY,INFECTIOUS MONONUCLEOSIS
721149026,5/13/2015 21:45:28,1636048099,5/13/2015 21:44:36,false,instagc,1.0,13763729,USA,NC,Apex,75.182.91.110,[CAUSES],[CAUSES],can result from,N/A,8,40,1,22,64,TWrex-cause,813256-FS1,"Similar LYMPHADENOPATHY can result from INFECTIOUS MONONUCLEOSIS toxoplasmosis, cytomegalovirus, non Hodgkin lymphoma, or leukemia.",LYMPHADENOPATHY,INFECTIOUS MONONUCLEOSIS
721149027,5/13/2015 13:08:18,1635731277,5/13/2015 13:08:04,false,neodev,1.0,30504276,CAN,ON,Sudbury,66.103.55.12,[NONE],[NONE],N/A,N/A,86,0,1,99,21,TWrex-cause,812289-FS1,"BISMUTH SUBSALICYLATE which should not be taken by persons with peptic ulcer disease, COAGULOPATHIES or allergies to salicylates, is not as completely effective as quinolone antibiotics but has fewer side effects and enables the use of quinolone antibiotics, if they are needed for therapy.",COAGULOPATHIES,BISMUTH SUBSALICYLATE
721149027,5/13/2015 13:19:10,1635734142,5/13/2015 13:18:45,false,clixsense,1.0,24329110,USA,FL,Jacksonville,12.168.136.2,[CONTRAINDICATES],[CONTRAINDICATES],should not be taken,n/a,86,0,1,99,21,TWrex-cause,812289-FS1,"BISMUTH SUBSALICYLATE which should not be taken by persons with peptic ulcer disease, COAGULOPATHIES or allergies to salicylates, is not as completely effective as quinolone antibiotics but has fewer side effects and enables the use of quinolone antibiotics, if they are needed for therapy.",COAGULOPATHIES,BISMUTH SUBSALICYLATE
721149027,5/13/2015 13:20:52,1635734716,5/13/2015 13:20:22,false,clixsense,1.0,23197581,NLD,11,Den Haag,82.217.5.55,[CONTRAINDICATES],[CONTRAINDICATES],which should not be taken by persons with COAGULOPATHIES,N/A,86,0,1,99,21,TWrex-cause,812289-FS1,"BISMUTH SUBSALICYLATE which should not be taken by persons with peptic ulcer disease, COAGULOPATHIES or allergies to salicylates, is not as completely effective as quinolone antibiotics but has fewer side effects and enables the use of quinolone antibiotics, if they are needed for therapy.",COAGULOPATHIES,BISMUTH SUBSALICYLATE
721149027,5/13/2015 13:44:39,1635741126,5/13/2015 13:44:25,false,bitcoinget,1.0,21614812,USA,PA,Erie,174.100.250.115,[CONTRAINDICATES],[CONTRAINDICATES],which should not be taken by,N/A,86,0,1,99,21,TWrex-cause,812289-FS1,"BISMUTH SUBSALICYLATE which should not be taken by persons with peptic ulcer disease, COAGULOPATHIES or allergies to salicylates, is not as completely effective as quinolone antibiotics but has fewer side effects and enables the use of quinolone antibiotics, if they are needed for therapy.",COAGULOPATHIES,BISMUTH SUBSALICYLATE
721149027,5/13/2015 13:58:17,1635746752,5/13/2015 13:57:38,false,neodev,1.0,24564999,GBR,H9,London,86.145.227.9,[CONTRAINDICATES],[CONTRAINDICATES],should not be taken by persons with,N/A,86,0,1,99,21,TWrex-cause,812289-FS1,"BISMUTH SUBSALICYLATE which should not be taken by persons with peptic ulcer disease, COAGULOPATHIES or allergies to salicylates, is not as completely effective as quinolone antibiotics but has fewer side effects and enables the use of quinolone antibiotics, if they are needed for therapy.",COAGULOPATHIES,BISMUTH SUBSALICYLATE
721149027,5/13/2015 14:01:21,1635748099,5/13/2015 14:00:12,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[CONTRAINDICATES],[CONTRAINDICATES],not as effective,N/A,86,0,1,99,21,TWrex-cause,812289-FS1,"BISMUTH SUBSALICYLATE which should not be taken by persons with peptic ulcer disease, COAGULOPATHIES or allergies to salicylates, is not as completely effective as quinolone antibiotics but has fewer side effects and enables the use of quinolone antibiotics, if they are needed for therapy.",COAGULOPATHIES,BISMUTH SUBSALICYLATE
721149027,5/13/2015 14:25:46,1635758236,5/13/2015 14:24:43,false,prodege,1.0,24403612,CAN,ON,Ajax,99.239.181.149,[OTHER],[OTHER],BISMUTH SUBSALICYLATE should not be taken by persons with COAGULOPATHIES,N/a,86,0,1,99,21,TWrex-cause,812289-FS1,"BISMUTH SUBSALICYLATE which should not be taken by persons with peptic ulcer disease, COAGULOPATHIES or allergies to salicylates, is not as completely effective as quinolone antibiotics but has fewer side effects and enables the use of quinolone antibiotics, if they are needed for therapy.",COAGULOPATHIES,BISMUTH SUBSALICYLATE
721149027,5/13/2015 14:36:04,1635764024,5/13/2015 14:35:37,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[CONTRAINDICATES],[CONTRAINDICATES],should not be taken,N/A,86,0,1,99,21,TWrex-cause,812289-FS1,"BISMUTH SUBSALICYLATE which should not be taken by persons with peptic ulcer disease, COAGULOPATHIES or allergies to salicylates, is not as completely effective as quinolone antibiotics but has fewer side effects and enables the use of quinolone antibiotics, if they are needed for therapy.",COAGULOPATHIES,BISMUTH SUBSALICYLATE
721149027,5/13/2015 15:19:52,1635797954,5/13/2015 15:19:21,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,[PREVENTS],[PREVENTS],therapy.,n/a,86,0,1,99,21,TWrex-cause,812289-FS1,"BISMUTH SUBSALICYLATE which should not be taken by persons with peptic ulcer disease, COAGULOPATHIES or allergies to salicylates, is not as completely effective as quinolone antibiotics but has fewer side effects and enables the use of quinolone antibiotics, if they are needed for therapy.",COAGULOPATHIES,BISMUTH SUBSALICYLATE
721149027,5/13/2015 16:08:17,1635835178,5/13/2015 16:06:32,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[CONTRAINDICATES],[CONTRAINDICATES],not be taken,none,86,0,1,99,21,TWrex-cause,812289-FS1,"BISMUTH SUBSALICYLATE which should not be taken by persons with peptic ulcer disease, COAGULOPATHIES or allergies to salicylates, is not as completely effective as quinolone antibiotics but has fewer side effects and enables the use of quinolone antibiotics, if they are needed for therapy.",COAGULOPATHIES,BISMUTH SUBSALICYLATE
721149027,5/13/2015 16:32:37,1635850887,5/13/2015 16:31:51,false,prodege,1.0,16101132,GBR,F9,Hayes,2.223.214.149,[CONTRAINDICATES],[CONTRAINDICATES],not,Contraindicated,86,0,1,99,21,TWrex-cause,812289-FS1,"BISMUTH SUBSALICYLATE which should not be taken by persons with peptic ulcer disease, COAGULOPATHIES or allergies to salicylates, is not as completely effective as quinolone antibiotics but has fewer side effects and enables the use of quinolone antibiotics, if they are needed for therapy.",COAGULOPATHIES,BISMUTH SUBSALICYLATE
721149027,5/13/2015 16:33:10,1635851232,5/13/2015 16:32:34,false,clixsense,1.0,31579138,AUS,02,Hurstville,14.200.129.68,[CONTRAINDICATES],[CONTRAINDICATES],should not be taken,N/A,86,0,1,99,21,TWrex-cause,812289-FS1,"BISMUTH SUBSALICYLATE which should not be taken by persons with peptic ulcer disease, COAGULOPATHIES or allergies to salicylates, is not as completely effective as quinolone antibiotics but has fewer side effects and enables the use of quinolone antibiotics, if they are needed for therapy.",COAGULOPATHIES,BISMUTH SUBSALICYLATE
721149027,5/13/2015 17:14:42,1635874269,5/13/2015 17:14:20,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[CONTRAINDICATES],[CONTRAINDICATES],should not be taken by persons with,n/a,86,0,1,99,21,TWrex-cause,812289-FS1,"BISMUTH SUBSALICYLATE which should not be taken by persons with peptic ulcer disease, COAGULOPATHIES or allergies to salicylates, is not as completely effective as quinolone antibiotics but has fewer side effects and enables the use of quinolone antibiotics, if they are needed for therapy.",COAGULOPATHIES,BISMUTH SUBSALICYLATE
721149027,5/13/2015 17:15:58,1635874985,5/13/2015 17:14:15,false,gptking,1.0,31799065,USA,IL,Marion,50.45.43.154,[NONE],[NONE],COAGULOPATHIES  should not take BISMUTH SUBSALICYLATE,COAGULOPATHIES should not take BISMUTH SUBSALICYLATE,86,0,1,99,21,TWrex-cause,812289-FS1,"BISMUTH SUBSALICYLATE which should not be taken by persons with peptic ulcer disease, COAGULOPATHIES or allergies to salicylates, is not as completely effective as quinolone antibiotics but has fewer side effects and enables the use of quinolone antibiotics, if they are needed for therapy.",COAGULOPATHIES,BISMUTH SUBSALICYLATE
721149027,5/13/2015 17:52:18,1635896984,5/13/2015 17:51:38,false,prodege,1.0,14848125,GBR,L6,Shrewsbury,86.138.223.142,[CONTRAINDICATES],[CONTRAINDICATES],should not be taken,N/A,86,0,1,99,21,TWrex-cause,812289-FS1,"BISMUTH SUBSALICYLATE which should not be taken by persons with peptic ulcer disease, COAGULOPATHIES or allergies to salicylates, is not as completely effective as quinolone antibiotics but has fewer side effects and enables the use of quinolone antibiotics, if they are needed for therapy.",COAGULOPATHIES,BISMUTH SUBSALICYLATE
721149028,5/13/2015 13:09:17,1635731480,5/13/2015 13:08:49,false,neodev,1.0,30504276,CAN,ON,Sudbury,66.103.55.12,[SYMPTOM],[SYMPTOM],present,N/A,100,0,1,114,24,TWrex-cause,813015-FS1,"INFECTIOUS MONONUCLEOSIS  Clinical features   Patients usually present with fever, pharyngitis, and LYMPHADENOPATHY",LYMPHADENOPATHY,INFECTIOUS MONONUCLEOSIS
721149028,5/13/2015 13:22:16,1635735083,5/13/2015 13:21:57,false,clixsense,1.0,23197581,NLD,11,Den Haag,82.217.5.55,[SYMPTOM],[SYMPTOM],usually present with,N/A,100,0,1,114,24,TWrex-cause,813015-FS1,"INFECTIOUS MONONUCLEOSIS  Clinical features   Patients usually present with fever, pharyngitis, and LYMPHADENOPATHY",LYMPHADENOPATHY,INFECTIOUS MONONUCLEOSIS
721149028,5/13/2015 13:45:24,1635741456,5/13/2015 13:45:15,false,bitcoinget,1.0,21614812,USA,PA,Erie,174.100.250.115,[ASSOCIATED_WITH],[ASSOCIATED_WITH],features,N/A,100,0,1,114,24,TWrex-cause,813015-FS1,"INFECTIOUS MONONUCLEOSIS  Clinical features   Patients usually present with fever, pharyngitis, and LYMPHADENOPATHY",LYMPHADENOPATHY,INFECTIOUS MONONUCLEOSIS
721149028,5/13/2015 13:59:16,1635747154,5/13/2015 13:59:01,false,neodev,1.0,24564999,GBR,H9,London,86.145.227.9,[SYMPTOM],[SYMPTOM],Patients usually present with,N/A,100,0,1,114,24,TWrex-cause,813015-FS1,"INFECTIOUS MONONUCLEOSIS  Clinical features   Patients usually present with fever, pharyngitis, and LYMPHADENOPATHY",LYMPHADENOPATHY,INFECTIOUS MONONUCLEOSIS
721149028,5/13/2015 14:03:08,1635748950,5/13/2015 14:02:39,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[SYMPTOM],[SYMPTOM],usually present with,N/A,100,0,1,114,24,TWrex-cause,813015-FS1,"INFECTIOUS MONONUCLEOSIS  Clinical features   Patients usually present with fever, pharyngitis, and LYMPHADENOPATHY",LYMPHADENOPATHY,INFECTIOUS MONONUCLEOSIS
721149028,5/13/2015 14:27:29,1635759115,5/13/2015 14:27:01,false,prodege,1.0,24403612,CAN,ON,Ajax,99.239.181.149,[SYMPTOM],[SYMPTOM],INFECTIOUS MONONUCLEOSIS present with LYMPHADENOPATHY,N/a,100,0,1,114,24,TWrex-cause,813015-FS1,"INFECTIOUS MONONUCLEOSIS  Clinical features   Patients usually present with fever, pharyngitis, and LYMPHADENOPATHY",LYMPHADENOPATHY,INFECTIOUS MONONUCLEOSIS
721149028,5/13/2015 14:38:07,1635765347,5/13/2015 14:37:44,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[SYMPTOM],[SYMPTOM],present with,N/A,100,0,1,114,24,TWrex-cause,813015-FS1,"INFECTIOUS MONONUCLEOSIS  Clinical features   Patients usually present with fever, pharyngitis, and LYMPHADENOPATHY",LYMPHADENOPATHY,INFECTIOUS MONONUCLEOSIS
721149028,5/13/2015 15:21:29,1635798936,5/13/2015 15:20:42,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,[SYMPTOM],[SYMPTOM],present,n/a,100,0,1,114,24,TWrex-cause,813015-FS1,"INFECTIOUS MONONUCLEOSIS  Clinical features   Patients usually present with fever, pharyngitis, and LYMPHADENOPATHY",LYMPHADENOPATHY,INFECTIOUS MONONUCLEOSIS
721149028,5/13/2015 16:12:42,1635837763,5/13/2015 16:12:14,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[SYMPTOM],[SYMPTOM],present,none,100,0,1,114,24,TWrex-cause,813015-FS1,"INFECTIOUS MONONUCLEOSIS  Clinical features   Patients usually present with fever, pharyngitis, and LYMPHADENOPATHY",LYMPHADENOPATHY,INFECTIOUS MONONUCLEOSIS
721149028,5/13/2015 16:34:21,1635851981,5/13/2015 16:33:58,false,prodege,1.0,16101132,GBR,F9,Hayes,2.223.214.149,[SYMPTOM],[SYMPTOM],present,Symptom,100,0,1,114,24,TWrex-cause,813015-FS1,"INFECTIOUS MONONUCLEOSIS  Clinical features   Patients usually present with fever, pharyngitis, and LYMPHADENOPATHY",LYMPHADENOPATHY,INFECTIOUS MONONUCLEOSIS
721149028,5/13/2015 16:36:49,1635853469,5/13/2015 16:36:14,false,clixsense,1.0,31579138,AUS,02,Hurstville,14.200.129.68,[SYMPTOM],[SYMPTOM],present with,N/A,100,0,1,114,24,TWrex-cause,813015-FS1,"INFECTIOUS MONONUCLEOSIS  Clinical features   Patients usually present with fever, pharyngitis, and LYMPHADENOPATHY",LYMPHADENOPATHY,INFECTIOUS MONONUCLEOSIS
721149028,5/13/2015 17:16:14,1635875135,5/13/2015 17:15:32,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[MANIFESTATION],[MANIFESTATION],Clinical features,n/a,100,0,1,114,24,TWrex-cause,813015-FS1,"INFECTIOUS MONONUCLEOSIS  Clinical features   Patients usually present with fever, pharyngitis, and LYMPHADENOPATHY",LYMPHADENOPATHY,INFECTIOUS MONONUCLEOSIS
721149028,5/13/2015 17:18:51,1635876582,5/13/2015 17:18:14,false,gptking,1.0,31799065,USA,IL,Marion,50.45.43.154,[SYMPTOM],[SYMPTOM],INFECTIOUS MONONUCLEOSIS LYMPHADENOPATHY,N/A,100,0,1,114,24,TWrex-cause,813015-FS1,"INFECTIOUS MONONUCLEOSIS  Clinical features   Patients usually present with fever, pharyngitis, and LYMPHADENOPATHY",LYMPHADENOPATHY,INFECTIOUS MONONUCLEOSIS
721149028,5/13/2015 17:53:14,1635897409,5/13/2015 17:52:54,false,prodege,1.0,14848125,GBR,L6,Shrewsbury,86.138.223.142,[SYMPTOM],[SYMPTOM],present with,N/A,100,0,1,114,24,TWrex-cause,813015-FS1,"INFECTIOUS MONONUCLEOSIS  Clinical features   Patients usually present with fever, pharyngitis, and LYMPHADENOPATHY",LYMPHADENOPATHY,INFECTIOUS MONONUCLEOSIS
721149028,5/13/2015 18:02:11,1635900616,5/13/2015 18:01:11,false,clixsense,1.0,6574449,USA,"","",216.216.68.85,[SYMPTOM],[SYMPTOM],"INFECTIOUS MONONUCLEOSIS Patients present fever, pharyngitis, LYMPHADENOPATHY",na,100,0,1,114,24,TWrex-cause,813015-FS1,"INFECTIOUS MONONUCLEOSIS  Clinical features   Patients usually present with fever, pharyngitis, and LYMPHADENOPATHY",LYMPHADENOPATHY,INFECTIOUS MONONUCLEOSIS
721149029,5/13/2015 13:25:02,1635735683,5/13/2015 13:24:30,false,clixsense,1.0,23197581,NLD,11,Den Haag,82.217.5.55,[TREATS] [CONTRAINDICATES],"[TREATS]
[CONTRAINDICATES]",be used as the initial vasopressor,N/A,196,244,-1,200,252,TWrex-cause,804304-FS1,Current guidelines recommend that norepinephrine or dopamine be used as the initial vasopressor in patients with septic shock and that epinephrine be used as the first chosen alternative agent if SHOCK is poorly responsive to norepinephrine or DOPAMINE ( 39.,SHOCK,DOPAMINE
721149029,5/13/2015 14:03:11,1635748982,5/13/2015 14:02:32,false,neodev,1.0,24564999,GBR,H9,London,86.145.227.9,[OTHER],[OTHER],if SHOCK is poorly responsive to DOPAMINE,N/A,196,244,-1,200,252,TWrex-cause,804304-FS1,Current guidelines recommend that norepinephrine or dopamine be used as the initial vasopressor in patients with septic shock and that epinephrine be used as the first chosen alternative agent if SHOCK is poorly responsive to norepinephrine or DOPAMINE ( 39.,SHOCK,DOPAMINE
721149029,5/13/2015 14:06:12,1635750345,5/13/2015 14:05:39,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[TREATS],[TREATS],responsive to,N/A,196,244,-1,200,252,TWrex-cause,804304-FS1,Current guidelines recommend that norepinephrine or dopamine be used as the initial vasopressor in patients with septic shock and that epinephrine be used as the first chosen alternative agent if SHOCK is poorly responsive to norepinephrine or DOPAMINE ( 39.,SHOCK,DOPAMINE
721149029,5/13/2015 14:30:45,1635760714,5/13/2015 14:30:05,false,prodege,1.0,24403612,CAN,ON,Ajax,99.239.181.149,[OTHER],[OTHER],SHOCK is poorly responsive to DOPAMINE,N/a,196,244,-1,200,252,TWrex-cause,804304-FS1,Current guidelines recommend that norepinephrine or dopamine be used as the initial vasopressor in patients with septic shock and that epinephrine be used as the first chosen alternative agent if SHOCK is poorly responsive to norepinephrine or DOPAMINE ( 39.,SHOCK,DOPAMINE
721149029,5/13/2015 14:40:28,1635766510,5/13/2015 14:39:43,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[TREATS],[TREATS],be used,N/A,196,244,-1,200,252,TWrex-cause,804304-FS1,Current guidelines recommend that norepinephrine or dopamine be used as the initial vasopressor in patients with septic shock and that epinephrine be used as the first chosen alternative agent if SHOCK is poorly responsive to norepinephrine or DOPAMINE ( 39.,SHOCK,DOPAMINE
721149029,5/13/2015 15:24:24,1635801165,5/13/2015 15:23:45,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],recommend,n/a,196,244,-1,200,252,TWrex-cause,804304-FS1,Current guidelines recommend that norepinephrine or dopamine be used as the initial vasopressor in patients with septic shock and that epinephrine be used as the first chosen alternative agent if SHOCK is poorly responsive to norepinephrine or DOPAMINE ( 39.,SHOCK,DOPAMINE
721149029,5/13/2015 16:17:42,1635840837,5/13/2015 16:16:54,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[TREATS],[TREATS],responsive,none,196,244,-1,200,252,TWrex-cause,804304-FS1,Current guidelines recommend that norepinephrine or dopamine be used as the initial vasopressor in patients with septic shock and that epinephrine be used as the first chosen alternative agent if SHOCK is poorly responsive to norepinephrine or DOPAMINE ( 39.,SHOCK,DOPAMINE
721149029,5/13/2015 16:37:40,1635853990,5/13/2015 16:36:41,false,prodege,1.0,16101132,GBR,F9,Hayes,2.223.214.149,[TREATS],[TREATS],used,Treats,196,244,-1,200,252,TWrex-cause,804304-FS1,Current guidelines recommend that norepinephrine or dopamine be used as the initial vasopressor in patients with septic shock and that epinephrine be used as the first chosen alternative agent if SHOCK is poorly responsive to norepinephrine or DOPAMINE ( 39.,SHOCK,DOPAMINE
721149029,5/13/2015 16:40:08,1635855484,5/13/2015 16:39:05,false,clixsense,1.0,31579138,AUS,02,Hurstville,14.200.129.68,[TREATS],[TREATS],vasopressor,N/A,196,244,-1,200,252,TWrex-cause,804304-FS1,Current guidelines recommend that norepinephrine or dopamine be used as the initial vasopressor in patients with septic shock and that epinephrine be used as the first chosen alternative agent if SHOCK is poorly responsive to norepinephrine or DOPAMINE ( 39.,SHOCK,DOPAMINE
721149029,5/13/2015 17:21:24,1635878126,5/13/2015 17:20:21,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[TREATS],[TREATS],agent responsive,n/a,196,244,-1,200,252,TWrex-cause,804304-FS1,Current guidelines recommend that norepinephrine or dopamine be used as the initial vasopressor in patients with septic shock and that epinephrine be used as the first chosen alternative agent if SHOCK is poorly responsive to norepinephrine or DOPAMINE ( 39.,SHOCK,DOPAMINE
721149029,5/13/2015 17:29:42,1635882814,5/13/2015 17:28:12,false,gptking,1.0,31799065,USA,IL,Marion,50.45.43.154,[TREATS],[TREATS],SHOCK DOPAMINE,N/A,196,244,-1,200,252,TWrex-cause,804304-FS1,Current guidelines recommend that norepinephrine or dopamine be used as the initial vasopressor in patients with septic shock and that epinephrine be used as the first chosen alternative agent if SHOCK is poorly responsive to norepinephrine or DOPAMINE ( 39.,SHOCK,DOPAMINE
721149029,5/13/2015 17:56:24,1635898595,5/13/2015 17:55:24,false,prodege,1.0,14848125,GBR,L6,Shrewsbury,86.138.223.142,[TREATS],[TREATS],used as the initial vasopressor,N/A,196,244,-1,200,252,TWrex-cause,804304-FS1,Current guidelines recommend that norepinephrine or dopamine be used as the initial vasopressor in patients with septic shock and that epinephrine be used as the first chosen alternative agent if SHOCK is poorly responsive to norepinephrine or DOPAMINE ( 39.,SHOCK,DOPAMINE
721149029,5/13/2015 18:07:26,1635902338,5/13/2015 18:06:22,false,clixsense,1.0,6574449,USA,"","",216.216.68.85,[OTHER],[OTHER],Current guidelines recommend norepinephrine dopamine used initial vasopressor patients septic shock epinephrine used first chosen alternative agent SHOCK poorly responsive norepinephrine DOPAMINE,na,196,244,-1,200,252,TWrex-cause,804304-FS1,Current guidelines recommend that norepinephrine or dopamine be used as the initial vasopressor in patients with septic shock and that epinephrine be used as the first chosen alternative agent if SHOCK is poorly responsive to norepinephrine or DOPAMINE ( 39.,SHOCK,DOPAMINE
721149029,5/13/2015 18:09:38,1635903284,5/13/2015 18:08:53,false,clixsense,1.0,32549163,CAN,MB,Winnipeg,206.45.167.246,[TREATS],[TREATS],if SHOCK is poorly responsive to DOPAMINE,N/A,196,244,-1,200,252,TWrex-cause,804304-FS1,Current guidelines recommend that norepinephrine or dopamine be used as the initial vasopressor in patients with septic shock and that epinephrine be used as the first chosen alternative agent if SHOCK is poorly responsive to norepinephrine or DOPAMINE ( 39.,SHOCK,DOPAMINE
721149029,5/13/2015 18:12:19,1635904442,5/13/2015 18:11:10,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[TREATS],[TREATS],be used as the initial,N/A,196,244,-1,200,252,TWrex-cause,804304-FS1,Current guidelines recommend that norepinephrine or dopamine be used as the initial vasopressor in patients with septic shock and that epinephrine be used as the first chosen alternative agent if SHOCK is poorly responsive to norepinephrine or DOPAMINE ( 39.,SHOCK,DOPAMINE
721149030,5/13/2015 11:46:36,1635706294,5/13/2015 11:45:44,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[ASSOCIATED_WITH],[ASSOCIATED_WITH],PREGNANCY in countries where PROPYLTHIOURACIL not available,n/a,46,80,-1,54,96,TWrex-cause,803215-FS1,• Methimazole and carbimazole are used during PREGNANCY in many countries where PROPYLTHIOURACIL is not commercially available ( 25.,PREGNANCY,PROPYLTHIOURACIL
721149030,5/13/2015 11:49:37,1635707056,5/13/2015 11:49:20,false,neodev,1.0,31726043,GBR,"","",88.150.202.140,[LOCATION],[LOCATION],PROPYLTHIOURACIL,511,46,80,-1,54,96,TWrex-cause,803215-FS1,• Methimazole and carbimazole are used during PREGNANCY in many countries where PROPYLTHIOURACIL is not commercially available ( 25.,PREGNANCY,PROPYLTHIOURACIL
721149030,5/13/2015 12:29:56,1635721083,5/13/2015 12:29:21,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[TREATS],[TREATS],PREGNANCY PROPYLTHIOURACIL,n/a,46,80,-1,54,96,TWrex-cause,803215-FS1,• Methimazole and carbimazole are used during PREGNANCY in many countries where PROPYLTHIOURACIL is not commercially available ( 25.,PREGNANCY,PROPYLTHIOURACIL
721149030,5/13/2015 13:02:46,1635729488,5/13/2015 13:02:26,false,neodev,1.0,30504276,CAN,ON,Sudbury,66.103.55.12,[NONE],[NONE],N/A,N/A,46,80,-1,54,96,TWrex-cause,803215-FS1,• Methimazole and carbimazole are used during PREGNANCY in many countries where PROPYLTHIOURACIL is not commercially available ( 25.,PREGNANCY,PROPYLTHIOURACIL
721149030,5/13/2015 13:03:40,1635729816,5/13/2015 13:03:18,false,clixsense,1.0,24329110,USA,FL,Jacksonville,12.168.136.2,[TREATS],[TREATS],used during,m/a,46,80,-1,54,96,TWrex-cause,803215-FS1,• Methimazole and carbimazole are used during PREGNANCY in many countries where PROPYLTHIOURACIL is not commercially available ( 25.,PREGNANCY,PROPYLTHIOURACIL
721149030,5/13/2015 13:06:03,1635730768,5/13/2015 13:04:41,false,prodege,1.0,23482077,USA,TX,Garland,71.164.238.226,[OTHER],[OTHER],used during PREGNANCY where not commercially available,N/A,46,80,-1,54,96,TWrex-cause,803215-FS1,• Methimazole and carbimazole are used during PREGNANCY in many countries where PROPYLTHIOURACIL is not commercially available ( 25.,PREGNANCY,PROPYLTHIOURACIL
721149030,5/13/2015 13:10:06,1635731675,5/13/2015 13:09:23,false,clixsense,1.0,23197581,NLD,11,Den Haag,82.217.5.55,[OTHER],[OTHER],are used during PREGNANCY,N/A,46,80,-1,54,96,TWrex-cause,803215-FS1,• Methimazole and carbimazole are used during PREGNANCY in many countries where PROPYLTHIOURACIL is not commercially available ( 25.,PREGNANCY,PROPYLTHIOURACIL
721149030,5/13/2015 13:25:25,1635735775,5/13/2015 13:24:11,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[TREATS],[TREATS],used during PREGNANCY PROPYLTHIOURACIL is,N/A,46,80,-1,54,96,TWrex-cause,803215-FS1,• Methimazole and carbimazole are used during PREGNANCY in many countries where PROPYLTHIOURACIL is not commercially available ( 25.,PREGNANCY,PROPYLTHIOURACIL
721149030,5/13/2015 13:28:02,1635736409,5/13/2015 13:27:13,false,clixsense,1.0,6574449,USA,"","",216.216.68.85,[OTHER],[OTHER],Methimazole carbimazole used during PREGNANCY PROPYLTHIOURACIL not available,na,46,80,-1,54,96,TWrex-cause,803215-FS1,• Methimazole and carbimazole are used during PREGNANCY in many countries where PROPYLTHIOURACIL is not commercially available ( 25.,PREGNANCY,PROPYLTHIOURACIL
721149030,5/13/2015 13:35:31,1635738386,5/13/2015 13:34:44,false,bitcoinget,1.0,21614812,USA,PA,Erie,174.100.250.115,[NONE],[NONE],N/A,unrelated directly,46,80,-1,54,96,TWrex-cause,803215-FS1,• Methimazole and carbimazole are used during PREGNANCY in many countries where PROPYLTHIOURACIL is not commercially available ( 25.,PREGNANCY,PROPYLTHIOURACIL
721149030,5/13/2015 13:39:07,1635739454,5/13/2015 13:38:21,false,neodev,1.0,24564999,GBR,H9,London,86.145.227.9,[OTHER],[OTHER],used where PROPYLTHIOURACIL is not available,N/A,46,80,-1,54,96,TWrex-cause,803215-FS1,• Methimazole and carbimazole are used during PREGNANCY in many countries where PROPYLTHIOURACIL is not commercially available ( 25.,PREGNANCY,PROPYLTHIOURACIL
721149030,5/13/2015 13:50:20,1635743444,5/13/2015 13:49:45,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[TREATS],[TREATS],used during PREGNANCY,N/A,46,80,-1,54,96,TWrex-cause,803215-FS1,• Methimazole and carbimazole are used during PREGNANCY in many countries where PROPYLTHIOURACIL is not commercially available ( 25.,PREGNANCY,PROPYLTHIOURACIL
721149030,5/13/2015 14:08:55,1635751364,5/13/2015 14:08:18,false,prodege,1.0,24403612,CAN,ON,Ajax,99.239.181.149,[ASSOCIATED_WITH],[ASSOCIATED_WITH],PREGNANCY where PROPYLTHIOURACIL,N/A,46,80,-1,54,96,TWrex-cause,803215-FS1,• Methimazole and carbimazole are used during PREGNANCY in many countries where PROPYLTHIOURACIL is not commercially available ( 25.,PREGNANCY,PROPYLTHIOURACIL
721149030,5/13/2015 14:21:47,1635756476,5/13/2015 14:21:14,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[TREATS],[TREATS],are used during,N/A,46,80,-1,54,96,TWrex-cause,803215-FS1,• Methimazole and carbimazole are used during PREGNANCY in many countries where PROPYLTHIOURACIL is not commercially available ( 25.,PREGNANCY,PROPYLTHIOURACIL
721149030,5/13/2015 15:06:24,1635785772,5/13/2015 15:05:58,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,[IS_A],[IS_A],available,n/a,46,80,-1,54,96,TWrex-cause,803215-FS1,• Methimazole and carbimazole are used during PREGNANCY in many countries where PROPYLTHIOURACIL is not commercially available ( 25.,PREGNANCY,PROPYLTHIOURACIL
721149031,5/13/2015 13:07:09,1635730989,5/13/2015 13:06:53,false,neodev,1.0,30504276,CAN,ON,Sudbury,66.103.55.12,[NONE],[NONE],N/A,N/A,0,49,1,32,52,TWrex-cause,813018-FS1,"CHRONIC PAIN FROM BRACHIAL PLEXUS injury becomes RSD once additional, RSD defining symptoms develop.",CHRONIC PAIN FROM BRACHIAL PLEXUS,RSD
721149031,5/13/2015 13:17:09,1635733605,5/13/2015 13:16:46,false,clixsense,1.0,24329110,USA,FL,Jacksonville,12.168.136.2,[PART_OF],[PART_OF],becomes,n/a,0,49,1,32,52,TWrex-cause,813018-FS1,"CHRONIC PAIN FROM BRACHIAL PLEXUS injury becomes RSD once additional, RSD defining symptoms develop.",CHRONIC PAIN FROM BRACHIAL PLEXUS,RSD
721149031,5/13/2015 13:18:59,1635734079,5/13/2015 13:18:31,false,clixsense,1.0,23197581,NLD,11,Den Haag,82.217.5.55,[IS_A],[IS_A],"becomes RSD once additional, RSD defining symptoms develop.",N/A,0,49,1,32,52,TWrex-cause,813018-FS1,"CHRONIC PAIN FROM BRACHIAL PLEXUS injury becomes RSD once additional, RSD defining symptoms develop.",CHRONIC PAIN FROM BRACHIAL PLEXUS,RSD
721149031,5/13/2015 13:43:01,1635740581,5/13/2015 13:42:30,false,bitcoinget,1.0,21614812,USA,PA,Erie,174.100.250.115,[OTHER],[OTHER],injury becomes,N/A,0,49,1,32,52,TWrex-cause,813018-FS1,"CHRONIC PAIN FROM BRACHIAL PLEXUS injury becomes RSD once additional, RSD defining symptoms develop.",CHRONIC PAIN FROM BRACHIAL PLEXUS,RSD
721149031,5/13/2015 13:53:48,1635744856,5/13/2015 13:52:21,false,neodev,1.0,24564999,GBR,H9,London,86.145.227.9,[ASSOCIATED_WITH],[ASSOCIATED_WITH],"becomes once additional, symptoms develop.",N/A,0,49,1,32,52,TWrex-cause,813018-FS1,"CHRONIC PAIN FROM BRACHIAL PLEXUS injury becomes RSD once additional, RSD defining symptoms develop.",CHRONIC PAIN FROM BRACHIAL PLEXUS,RSD
721149031,5/13/2015 13:58:13,1635746722,5/13/2015 13:57:46,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[CAUSES],[CAUSES],becomes RSD,N/A,0,49,1,32,52,TWrex-cause,813018-FS1,"CHRONIC PAIN FROM BRACHIAL PLEXUS injury becomes RSD once additional, RSD defining symptoms develop.",CHRONIC PAIN FROM BRACHIAL PLEXUS,RSD
721149031,5/13/2015 14:22:48,1635756952,5/13/2015 14:22:19,false,prodege,1.0,24403612,CAN,ON,Ajax,99.239.181.149,[MANIFESTATION],[MANIFESTATION],CHRONIC PAIN FROM BRACHIAL PLEXUS becomes RSD,N/a,0,49,1,32,52,TWrex-cause,813018-FS1,"CHRONIC PAIN FROM BRACHIAL PLEXUS injury becomes RSD once additional, RSD defining symptoms develop.",CHRONIC PAIN FROM BRACHIAL PLEXUS,RSD
721149031,5/13/2015 14:30:49,1635760756,5/13/2015 14:30:24,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[IS_A] [MANIFESTATION],"[MANIFESTATION]
[IS_A]",becomes,N/A,0,49,1,32,52,TWrex-cause,813018-FS1,"CHRONIC PAIN FROM BRACHIAL PLEXUS injury becomes RSD once additional, RSD defining symptoms develop.",CHRONIC PAIN FROM BRACHIAL PLEXUS,RSD
721149031,5/13/2015 15:17:33,1635796058,5/13/2015 15:16:24,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,[SYMPTOM],[SYMPTOM],symptoms,n/a,0,49,1,32,52,TWrex-cause,813018-FS1,"CHRONIC PAIN FROM BRACHIAL PLEXUS injury becomes RSD once additional, RSD defining symptoms develop.",CHRONIC PAIN FROM BRACHIAL PLEXUS,RSD
721149031,5/13/2015 15:33:18,1635808233,5/13/2015 15:30:41,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[SYMPTOM] [MANIFESTATION],"[SYMPTOM]
[MANIFESTATION]",CHRONIC PAIN FROM BRACHIAL PLEXUS becomes RSD once defining symptoms develop.,N/A,0,49,1,32,52,TWrex-cause,813018-FS1,"CHRONIC PAIN FROM BRACHIAL PLEXUS injury becomes RSD once additional, RSD defining symptoms develop.",CHRONIC PAIN FROM BRACHIAL PLEXUS,RSD
721149031,5/13/2015 16:03:52,1635832193,5/13/2015 16:03:24,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[MANIFESTATION],[MANIFESTATION],becomes,none,0,49,1,32,52,TWrex-cause,813018-FS1,"CHRONIC PAIN FROM BRACHIAL PLEXUS injury becomes RSD once additional, RSD defining symptoms develop.",CHRONIC PAIN FROM BRACHIAL PLEXUS,RSD
721149031,5/13/2015 16:29:34,1635848819,5/13/2015 16:28:48,false,prodege,1.0,16101132,GBR,F9,Hayes,2.223.214.149,[ASSOCIATED_WITH],[ASSOCIATED_WITH],becomes,Associated with,0,49,1,32,52,TWrex-cause,813018-FS1,"CHRONIC PAIN FROM BRACHIAL PLEXUS injury becomes RSD once additional, RSD defining symptoms develop.",CHRONIC PAIN FROM BRACHIAL PLEXUS,RSD
721149031,5/13/2015 16:31:00,1635849778,5/13/2015 16:29:53,false,clixsense,1.0,31579138,AUS,02,Hurstville,14.200.129.68,[MANIFESTATION],[MANIFESTATION],becomes,N/A,0,49,1,32,52,TWrex-cause,813018-FS1,"CHRONIC PAIN FROM BRACHIAL PLEXUS injury becomes RSD once additional, RSD defining symptoms develop.",CHRONIC PAIN FROM BRACHIAL PLEXUS,RSD
721149031,5/13/2015 16:50:38,1635861487,5/13/2015 16:49:59,false,gptking,1.0,31799065,USA,IL,Marion,50.45.43.154,[MANIFESTATION],[MANIFESTATION],CHRONIC PAIN FROM BRACHIAL PLEXUS becomes RSD,N/A,0,49,1,32,52,TWrex-cause,813018-FS1,"CHRONIC PAIN FROM BRACHIAL PLEXUS injury becomes RSD once additional, RSD defining symptoms develop.",CHRONIC PAIN FROM BRACHIAL PLEXUS,RSD
721149031,5/13/2015 17:13:23,1635873565,5/13/2015 17:11:17,false,clixsense,1.0,7051387,USA,NY,Rego Park,98.14.64.34,[OTHER],[OTHER],becomes,turns into and changes into RSD,0,49,1,32,52,TWrex-cause,813018-FS1,"CHRONIC PAIN FROM BRACHIAL PLEXUS injury becomes RSD once additional, RSD defining symptoms develop.",CHRONIC PAIN FROM BRACHIAL PLEXUS,RSD
721149032,5/13/2015 09:57:06,1635676575,5/13/2015 09:56:54,false,neodev,1.0,32103286,CAN,AB,Edmonton,208.123.223.37,[SYMPTOM] [LOCATION] [NONE],"[LOCATION]
[SYMPTOM]
[NONE]",no,no,30,0,1,41,9,TWrex-cause,812206-FS1,ECLAMPSIA is the most serious COMPLICATION of pregnancy induced hypertension (PIH.,COMPLICATION,ECLAMPSIA
721149032,5/13/2015 10:07:47,1635679222,5/13/2015 10:06:33,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[ASSOCIATED_WITH],[ASSOCIATED_WITH],ECLAMPSIA is the most serious COMPLICATION of pregnancy induced hypertension,N/A,30,0,1,41,9,TWrex-cause,812206-FS1,ECLAMPSIA is the most serious COMPLICATION of pregnancy induced hypertension (PIH.,COMPLICATION,ECLAMPSIA
721149032,5/13/2015 10:25:12,1635683918,5/13/2015 10:23:30,false,clixsense,1.0,26847653,NLD,03,Warnsveld,213.93.50.164,[SIDE_EFFECT],[SIDE_EFFECT],is the most serious,n/a,30,0,1,41,9,TWrex-cause,812206-FS1,ECLAMPSIA is the most serious COMPLICATION of pregnancy induced hypertension (PIH.,COMPLICATION,ECLAMPSIA
721149032,5/13/2015 10:27:17,1635684390,5/13/2015 10:25:37,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[IS_A],[IS_A],is the most serious,n/a,30,0,1,41,9,TWrex-cause,812206-FS1,ECLAMPSIA is the most serious COMPLICATION of pregnancy induced hypertension (PIH.,COMPLICATION,ECLAMPSIA
721149032,5/13/2015 10:27:49,1635684617,5/13/2015 10:27:14,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[IS_A],[IS_A],is,N/A,30,0,1,41,9,TWrex-cause,812206-FS1,ECLAMPSIA is the most serious COMPLICATION of pregnancy induced hypertension (PIH.,COMPLICATION,ECLAMPSIA
721149032,5/13/2015 10:42:18,1635688811,5/13/2015 10:42:02,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[LOCATION],[LOCATION],pregnancy,N/A,30,0,1,41,9,TWrex-cause,812206-FS1,ECLAMPSIA is the most serious COMPLICATION of pregnancy induced hypertension (PIH.,COMPLICATION,ECLAMPSIA
721149032,5/13/2015 10:58:49,1635693834,5/13/2015 10:58:23,false,neodev,1.0,29579905,GBR,"","",5.152.206.71,[MANIFESTATION] [PART_OF],"[MANIFESTATION]
[PART_OF]",ECLAMPSIA COMPLICATION,N/A,30,0,1,41,9,TWrex-cause,812206-FS1,ECLAMPSIA is the most serious COMPLICATION of pregnancy induced hypertension (PIH.,COMPLICATION,ECLAMPSIA
721149032,5/13/2015 11:01:39,1635694725,5/13/2015 11:00:26,false,neodev,1.0,31706957,NLD,07,Amsterdam,145.100.72.165,[ASSOCIATED_WITH],[ASSOCIATED_WITH],ECLAMPSIA is COMPLICATION,n/a,30,0,1,41,9,TWrex-cause,812206-FS1,ECLAMPSIA is the most serious COMPLICATION of pregnancy induced hypertension (PIH.,COMPLICATION,ECLAMPSIA
721149032,5/13/2015 11:10:46,1635697070,5/13/2015 11:10:29,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[ASSOCIATED_WITH],[ASSOCIATED_WITH],most serious,n/a,30,0,1,41,9,TWrex-cause,812206-FS1,ECLAMPSIA is the most serious COMPLICATION of pregnancy induced hypertension (PIH.,COMPLICATION,ECLAMPSIA
721149032,5/13/2015 11:19:25,1635699303,5/13/2015 11:18:47,false,prodege,1.0,27934334,GBR,D3,Swadlincote,109.150.228.127,[IS_A],[IS_A],is,N/A,30,0,1,41,9,TWrex-cause,812206-FS1,ECLAMPSIA is the most serious COMPLICATION of pregnancy induced hypertension (PIH.,COMPLICATION,ECLAMPSIA
721149032,5/13/2015 11:25:07,1635700557,5/13/2015 11:24:05,false,points4rewards,1.0,28703583,USA,"","",97.73.86.35,[MANIFESTATION] [SYMPTOM],"[SYMPTOM]
[MANIFESTATION]",is the most serious COMPLICATION,N/A,30,0,1,41,9,TWrex-cause,812206-FS1,ECLAMPSIA is the most serious COMPLICATION of pregnancy induced hypertension (PIH.,COMPLICATION,ECLAMPSIA
721149032,5/13/2015 11:29:05,1635701536,5/13/2015 11:28:16,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[IS_A],[IS_A],ECLAMPSIA is COMPLICATION of,n/a,30,0,1,41,9,TWrex-cause,812206-FS1,ECLAMPSIA is the most serious COMPLICATION of pregnancy induced hypertension (PIH.,COMPLICATION,ECLAMPSIA
721149032,5/13/2015 11:40:04,1635704838,5/13/2015 11:39:42,false,neodev,1.0,31726043,GBR,"","",88.150.202.140,[LOCATION] [SYMPTOM],"[LOCATION]
[SYMPTOM]",pregnancy,515,30,0,1,41,9,TWrex-cause,812206-FS1,ECLAMPSIA is the most serious COMPLICATION of pregnancy induced hypertension (PIH.,COMPLICATION,ECLAMPSIA
721149032,5/13/2015 12:10:54,1635713736,5/13/2015 12:09:51,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,[OTHER],[OTHER],COMPLICATION,n/a,30,0,1,41,9,TWrex-cause,812206-FS1,ECLAMPSIA is the most serious COMPLICATION of pregnancy induced hypertension (PIH.,COMPLICATION,ECLAMPSIA
721149032,5/13/2015 12:16:30,1635716177,5/13/2015 12:16:09,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[SYMPTOM],[SYMPTOM],ECLAMPSIA is the most serious COMPLICATION,n/a,30,0,1,41,9,TWrex-cause,812206-FS1,ECLAMPSIA is the most serious COMPLICATION of pregnancy induced hypertension (PIH.,COMPLICATION,ECLAMPSIA
721149033,5/13/2015 09:57:35,1635676696,5/13/2015 09:57:23,false,neodev,1.0,32103286,CAN,AB,Edmonton,208.123.223.37,[CAUSES] [LOCATION] [SYMPTOM] [NONE],"[CAUSES]
[LOCATION]
[SYMPTOM]
[NONE]",no,no,144,186,1,162,219,TWrex-cause,810943-FS1,"302 ,   321  Data are limited regarding safety of repeated use of co trimoxazole in pediatric patients   186 ,   a  GI Infections  Treatment of TRAVELERS' DIARRHEA caused by susceptible ENTEROTOXIGENIC  ESCHERICHIA COLI",TRAVELERS' DIARRHEA,ENTEROTOXIGENIC  ESCHERICHIA COLI
721149033,5/13/2015 10:10:23,1635680032,5/13/2015 10:09:09,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[TREATS] [CAUSES],"[TREATS]
[CAUSES]",Data are limited regarding safety of repeated use of co trimoxazole in pediatric patients a GI Infections Treatment of TRAVELERS' DIARRHEA caused by susceptible ENTEROTOXIGENIC ESCHERICHIA COLI,N/A,144,186,1,162,219,TWrex-cause,810943-FS1,"302 ,   321  Data are limited regarding safety of repeated use of co trimoxazole in pediatric patients   186 ,   a  GI Infections  Treatment of TRAVELERS' DIARRHEA caused by susceptible ENTEROTOXIGENIC  ESCHERICHIA COLI",TRAVELERS' DIARRHEA,ENTEROTOXIGENIC  ESCHERICHIA COLI
721149033,5/13/2015 10:27:03,1635684308,5/13/2015 10:26:22,false,clixsense,1.0,26847653,NLD,03,Warnsveld,213.93.50.164,[TREATS] [CAUSES],"[TREATS]
[CAUSES]",Treatment of caused by,n/a,144,186,1,162,219,TWrex-cause,810943-FS1,"302 ,   321  Data are limited regarding safety of repeated use of co trimoxazole in pediatric patients   186 ,   a  GI Infections  Treatment of TRAVELERS' DIARRHEA caused by susceptible ENTEROTOXIGENIC  ESCHERICHIA COLI",TRAVELERS' DIARRHEA,ENTEROTOXIGENIC  ESCHERICHIA COLI
721149033,5/13/2015 10:29:53,1635685374,5/13/2015 10:28:57,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[CAUSES],[CAUSES],caused by,N/A,144,186,1,162,219,TWrex-cause,810943-FS1,"302 ,   321  Data are limited regarding safety of repeated use of co trimoxazole in pediatric patients   186 ,   a  GI Infections  Treatment of TRAVELERS' DIARRHEA caused by susceptible ENTEROTOXIGENIC  ESCHERICHIA COLI",TRAVELERS' DIARRHEA,ENTEROTOXIGENIC  ESCHERICHIA COLI
721149033,5/13/2015 10:30:12,1635685557,5/13/2015 10:28:51,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[CAUSES],[CAUSES],caused by,n/a,144,186,1,162,219,TWrex-cause,810943-FS1,"302 ,   321  Data are limited regarding safety of repeated use of co trimoxazole in pediatric patients   186 ,   a  GI Infections  Treatment of TRAVELERS' DIARRHEA caused by susceptible ENTEROTOXIGENIC  ESCHERICHIA COLI",TRAVELERS' DIARRHEA,ENTEROTOXIGENIC  ESCHERICHIA COLI
721149033,5/13/2015 10:43:46,1635689471,5/13/2015 10:43:19,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[TREATS],[TREATS],DIARRHEA,N/A,144,186,1,162,219,TWrex-cause,810943-FS1,"302 ,   321  Data are limited regarding safety of repeated use of co trimoxazole in pediatric patients   186 ,   a  GI Infections  Treatment of TRAVELERS' DIARRHEA caused by susceptible ENTEROTOXIGENIC  ESCHERICHIA COLI",TRAVELERS' DIARRHEA,ENTEROTOXIGENIC  ESCHERICHIA COLI
721149033,5/13/2015 11:02:42,1635695157,5/13/2015 11:02:15,false,neodev,1.0,31706957,NLD,07,Amsterdam,145.100.72.165,[CAUSES],[CAUSES],caused by,n/a,144,186,1,162,219,TWrex-cause,810943-FS1,"302 ,   321  Data are limited regarding safety of repeated use of co trimoxazole in pediatric patients   186 ,   a  GI Infections  Treatment of TRAVELERS' DIARRHEA caused by susceptible ENTEROTOXIGENIC  ESCHERICHIA COLI",TRAVELERS' DIARRHEA,ENTEROTOXIGENIC  ESCHERICHIA COLI
721149033,5/13/2015 11:11:16,1635697145,5/13/2015 11:11:02,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[TREATS],[TREATS],Treatment,n/a,144,186,1,162,219,TWrex-cause,810943-FS1,"302 ,   321  Data are limited regarding safety of repeated use of co trimoxazole in pediatric patients   186 ,   a  GI Infections  Treatment of TRAVELERS' DIARRHEA caused by susceptible ENTEROTOXIGENIC  ESCHERICHIA COLI",TRAVELERS' DIARRHEA,ENTEROTOXIGENIC  ESCHERICHIA COLI
721149033,5/13/2015 11:20:14,1635699481,5/13/2015 11:19:46,false,prodege,1.0,27934334,GBR,D3,Swadlincote,109.150.228.127,[CAUSES],[CAUSES],caused by,N/A,144,186,1,162,219,TWrex-cause,810943-FS1,"302 ,   321  Data are limited regarding safety of repeated use of co trimoxazole in pediatric patients   186 ,   a  GI Infections  Treatment of TRAVELERS' DIARRHEA caused by susceptible ENTEROTOXIGENIC  ESCHERICHIA COLI",TRAVELERS' DIARRHEA,ENTEROTOXIGENIC  ESCHERICHIA COLI
721149033,5/13/2015 11:26:51,1635701101,5/13/2015 11:25:52,false,points4rewards,1.0,28703583,USA,"","",97.73.86.35,[SYMPTOM] [CONTRAINDICATES],"[SYMPTOM]
[CONTRAINDICATES]",regarding safety of caused,N/A,144,186,1,162,219,TWrex-cause,810943-FS1,"302 ,   321  Data are limited regarding safety of repeated use of co trimoxazole in pediatric patients   186 ,   a  GI Infections  Treatment of TRAVELERS' DIARRHEA caused by susceptible ENTEROTOXIGENIC  ESCHERICHIA COLI",TRAVELERS' DIARRHEA,ENTEROTOXIGENIC  ESCHERICHIA COLI
721149033,5/13/2015 11:30:58,1635701856,5/13/2015 11:29:37,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[CAUSES],[CAUSES],TRAVELERS' DIARRHEA caused by ENTEROTOXIGENIC ESCHERICHIA COLI,n/a,144,186,1,162,219,TWrex-cause,810943-FS1,"302 ,   321  Data are limited regarding safety of repeated use of co trimoxazole in pediatric patients   186 ,   a  GI Infections  Treatment of TRAVELERS' DIARRHEA caused by susceptible ENTEROTOXIGENIC  ESCHERICHIA COLI",TRAVELERS' DIARRHEA,ENTEROTOXIGENIC  ESCHERICHIA COLI
721149033,5/13/2015 11:40:52,1635704981,5/13/2015 11:40:37,false,neodev,1.0,31726043,GBR,"","",88.150.202.140,[SYMPTOM],[SYMPTOM],pediatric,85451,144,186,1,162,219,TWrex-cause,810943-FS1,"302 ,   321  Data are limited regarding safety of repeated use of co trimoxazole in pediatric patients   186 ,   a  GI Infections  Treatment of TRAVELERS' DIARRHEA caused by susceptible ENTEROTOXIGENIC  ESCHERICHIA COLI",TRAVELERS' DIARRHEA,ENTEROTOXIGENIC  ESCHERICHIA COLI
721149033,5/13/2015 12:12:47,1635714574,5/13/2015 12:11:54,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,[CAUSES],[CAUSES],caused,n/a,144,186,1,162,219,TWrex-cause,810943-FS1,"302 ,   321  Data are limited regarding safety of repeated use of co trimoxazole in pediatric patients   186 ,   a  GI Infections  Treatment of TRAVELERS' DIARRHEA caused by susceptible ENTEROTOXIGENIC  ESCHERICHIA COLI",TRAVELERS' DIARRHEA,ENTEROTOXIGENIC  ESCHERICHIA COLI
721149033,5/13/2015 12:17:29,1635716564,5/13/2015 12:16:49,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[CAUSES],[CAUSES],Treatment of TRAVELERS' DIARRHEA caused by susceptible ENTEROTOXIGENIC ESCHERICHIA COLI,n/a,144,186,1,162,219,TWrex-cause,810943-FS1,"302 ,   321  Data are limited regarding safety of repeated use of co trimoxazole in pediatric patients   186 ,   a  GI Infections  Treatment of TRAVELERS' DIARRHEA caused by susceptible ENTEROTOXIGENIC  ESCHERICHIA COLI",TRAVELERS' DIARRHEA,ENTEROTOXIGENIC  ESCHERICHIA COLI
721149033,5/13/2015 12:17:59,1635716769,5/13/2015 12:17:40,false,clixsense,1,28457001,CAN,ON,North Bay,24.204.202.220,[CAUSES],[CAUSES],caused,n/a,144,186,1,162,219,TWrex-cause,810943-FS1,"302 ,   321  Data are limited regarding safety of repeated use of co trimoxazole in pediatric patients   186 ,   a  GI Infections  Treatment of TRAVELERS' DIARRHEA caused by susceptible ENTEROTOXIGENIC  ESCHERICHIA COLI",TRAVELERS' DIARRHEA,ENTEROTOXIGENIC  ESCHERICHIA COLI
721149034,5/13/2015 10:26:30,1635684142,5/13/2015 10:25:21,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[TREATS] [DIAGNOSE_BY_TEST_OR_DRUG],"[TREATS]
[DIAGNOSE_BY_TEST_OR_DRUG]",Pramipexole vs LEVODOPA as initial treatment for PARKINSON DISEASE:,N/A,49,15,-1,65,23,TWrex-cause,800747-FS1,Pramipexole vs LEVODOPA as initial treatment for PARKINSON DISEASE: a randomized controlled trial.,PARKINSON DISEASE,LEVODOPA
721149034,5/13/2015 10:42:06,1635688736,5/13/2015 10:40:51,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[TREATS],[TREATS],treatment for,n/a,49,15,-1,65,23,TWrex-cause,800747-FS1,Pramipexole vs LEVODOPA as initial treatment for PARKINSON DISEASE: a randomized controlled trial.,PARKINSON DISEASE,LEVODOPA
721149034,5/13/2015 10:45:20,1635689898,5/13/2015 10:44:42,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[TREATS],[TREATS],treatment for,N/A,49,15,-1,65,23,TWrex-cause,800747-FS1,Pramipexole vs LEVODOPA as initial treatment for PARKINSON DISEASE: a randomized controlled trial.,PARKINSON DISEASE,LEVODOPA
721149034,5/13/2015 10:54:00,1635692488,5/13/2015 10:53:36,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[TREATS],[TREATS],PARKINSON DISEASE:,N/A,49,15,-1,65,23,TWrex-cause,800747-FS1,Pramipexole vs LEVODOPA as initial treatment for PARKINSON DISEASE: a randomized controlled trial.,PARKINSON DISEASE,LEVODOPA
721149034,5/13/2015 11:15:02,1635697981,5/13/2015 11:14:52,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[TREATS],[TREATS],treatment,n/a,49,15,-1,65,23,TWrex-cause,800747-FS1,Pramipexole vs LEVODOPA as initial treatment for PARKINSON DISEASE: a randomized controlled trial.,PARKINSON DISEASE,LEVODOPA
721149034,5/13/2015 11:19:43,1635699359,5/13/2015 11:19:19,false,neodev,1.0,31706957,NLD,07,Amsterdam,145.100.72.165,[TREATS],[TREATS],as initial treatment for,n/a,49,15,-1,65,23,TWrex-cause,800747-FS1,Pramipexole vs LEVODOPA as initial treatment for PARKINSON DISEASE: a randomized controlled trial.,PARKINSON DISEASE,LEVODOPA
721149034,5/13/2015 11:32:26,1635702153,5/13/2015 11:32:09,false,prodege,1.0,27934334,GBR,D3,Swadlincote,109.150.228.127,[TREATS],[TREATS],treatment,N/A,49,15,-1,65,23,TWrex-cause,800747-FS1,Pramipexole vs LEVODOPA as initial treatment for PARKINSON DISEASE: a randomized controlled trial.,PARKINSON DISEASE,LEVODOPA
721149034,5/13/2015 11:40:41,1635704956,5/13/2015 11:40:14,false,points4rewards,1.0,28703583,USA,"","",97.73.86.35,[TREATS],[TREATS],as initial treatment,N/A,49,15,-1,65,23,TWrex-cause,800747-FS1,Pramipexole vs LEVODOPA as initial treatment for PARKINSON DISEASE: a randomized controlled trial.,PARKINSON DISEASE,LEVODOPA
721149034,5/13/2015 11:41:19,1635705076,5/13/2015 11:40:55,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[TREATS],[TREATS],LEVODOPA initial treatment for PARKINSON DISEASE:,n/a,49,15,-1,65,23,TWrex-cause,800747-FS1,Pramipexole vs LEVODOPA as initial treatment for PARKINSON DISEASE: a randomized controlled trial.,PARKINSON DISEASE,LEVODOPA
721149034,5/13/2015 11:46:15,1635706133,5/13/2015 11:45:59,false,neodev,1.0,31726043,GBR,"","",88.150.202.140,[SYMPTOM],[SYMPTOM],randomized,5844,49,15,-1,65,23,TWrex-cause,800747-FS1,Pramipexole vs LEVODOPA as initial treatment for PARKINSON DISEASE: a randomized controlled trial.,PARKINSON DISEASE,LEVODOPA
721149034,5/13/2015 12:21:08,1635718103,5/13/2015 12:20:53,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,[TREATS],[TREATS],treatment,n/a,49,15,-1,65,23,TWrex-cause,800747-FS1,Pramipexole vs LEVODOPA as initial treatment for PARKINSON DISEASE: a randomized controlled trial.,PARKINSON DISEASE,LEVODOPA
721149034,5/13/2015 12:24:20,1635719326,5/13/2015 12:24:00,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[TREATS],[TREATS],LEVODOPA as initial treatment for PARKINSON DISEASE:,n/a,49,15,-1,65,23,TWrex-cause,800747-FS1,Pramipexole vs LEVODOPA as initial treatment for PARKINSON DISEASE: a randomized controlled trial.,PARKINSON DISEASE,LEVODOPA
721149034,5/13/2015 12:33:05,1635722078,5/13/2015 12:32:17,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[TREATS],[TREATS],treatment,N/A,49,15,-1,65,23,TWrex-cause,800747-FS1,Pramipexole vs LEVODOPA as initial treatment for PARKINSON DISEASE: a randomized controlled trial.,PARKINSON DISEASE,LEVODOPA
721149034,5/13/2015 12:53:15,1635726956,5/13/2015 12:52:54,false,prodege,1.0,23482077,USA,TX,Garland,71.164.238.226,[TREATS],[TREATS],as initial treatment for,N/A,49,15,-1,65,23,TWrex-cause,800747-FS1,Pramipexole vs LEVODOPA as initial treatment for PARKINSON DISEASE: a randomized controlled trial.,PARKINSON DISEASE,LEVODOPA
721149034,5/13/2015 13:00:48,1635728686,5/13/2015 13:00:32,false,neodev,1.0,30504276,CAN,ON,Sudbury,66.103.55.12,[TREATS],[TREATS],treatment,N/A,49,15,-1,65,23,TWrex-cause,800747-FS1,Pramipexole vs LEVODOPA as initial treatment for PARKINSON DISEASE: a randomized controlled trial.,PARKINSON DISEASE,LEVODOPA
721149035,5/13/2015 10:30:23,1635685617,5/13/2015 10:28:59,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[PREVENTS] [DIAGNOSE_BY_TEST_OR_DRUG] [CAUSES],"[PREVENTS]
[DIAGNOSE_BY_TEST_OR_DRUG]
[CAUSES]",placebo controlled trial Failure of DOXYCYCLINE as a causal prophylactic agent against PLASMODIUM FALCIPARUM MALARIA in healthy nonimmune volunteers Primaquine prophylaxis against malaria in nonimmune Colombian soldiers:,N/A,116,65,-1,144,76,TWrex-cause,804391-FS1,"A randomized, double blind, placebo controlled trial  Failure of DOXYCYCLINE as a causal prophylactic agent against PLASMODIUM FALCIPARUM MALARIA in healthy nonimmune volunteers  Primaquine prophylaxis against malaria in nonimmune Colombian soldiers: efficacy and toxicity.",PLASMODIUM FALCIPARUM MALARIA,DOXYCYCLINE
721149035,5/13/2015 10:45:45,1635689968,5/13/2015 10:42:59,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[TREATS],[TREATS],causal prophylactic agent,n/a,116,65,-1,144,76,TWrex-cause,804391-FS1,"A randomized, double blind, placebo controlled trial  Failure of DOXYCYCLINE as a causal prophylactic agent against PLASMODIUM FALCIPARUM MALARIA in healthy nonimmune volunteers  Primaquine prophylaxis against malaria in nonimmune Colombian soldiers: efficacy and toxicity.",PLASMODIUM FALCIPARUM MALARIA,DOXYCYCLINE
721149035,5/13/2015 10:48:39,1635690735,5/13/2015 10:48:04,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[TREATS],[TREATS],agent against,N/A,116,65,-1,144,76,TWrex-cause,804391-FS1,"A randomized, double blind, placebo controlled trial  Failure of DOXYCYCLINE as a causal prophylactic agent against PLASMODIUM FALCIPARUM MALARIA in healthy nonimmune volunteers  Primaquine prophylaxis against malaria in nonimmune Colombian soldiers: efficacy and toxicity.",PLASMODIUM FALCIPARUM MALARIA,DOXYCYCLINE
721149035,5/13/2015 10:55:26,1635692742,5/13/2015 10:54:49,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[TREATS],[TREATS],PLASMODIUM FALCIPARUM MALARIA,N/A,116,65,-1,144,76,TWrex-cause,804391-FS1,"A randomized, double blind, placebo controlled trial  Failure of DOXYCYCLINE as a causal prophylactic agent against PLASMODIUM FALCIPARUM MALARIA in healthy nonimmune volunteers  Primaquine prophylaxis against malaria in nonimmune Colombian soldiers: efficacy and toxicity.",PLASMODIUM FALCIPARUM MALARIA,DOXYCYCLINE
721149035,5/13/2015 11:15:54,1635698323,5/13/2015 11:15:33,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[TREATS],[TREATS],agent against,n/a,116,65,-1,144,76,TWrex-cause,804391-FS1,"A randomized, double blind, placebo controlled trial  Failure of DOXYCYCLINE as a causal prophylactic agent against PLASMODIUM FALCIPARUM MALARIA in healthy nonimmune volunteers  Primaquine prophylaxis against malaria in nonimmune Colombian soldiers: efficacy and toxicity.",PLASMODIUM FALCIPARUM MALARIA,DOXYCYCLINE
721149035,5/13/2015 11:23:26,1635700044,5/13/2015 11:21:58,false,neodev,1.0,31706957,NLD,07,Amsterdam,145.100.72.165,[TREATS],[TREATS],a causal prophylactic agent against,n/a,116,65,-1,144,76,TWrex-cause,804391-FS1,"A randomized, double blind, placebo controlled trial  Failure of DOXYCYCLINE as a causal prophylactic agent against PLASMODIUM FALCIPARUM MALARIA in healthy nonimmune volunteers  Primaquine prophylaxis against malaria in nonimmune Colombian soldiers: efficacy and toxicity.",PLASMODIUM FALCIPARUM MALARIA,DOXYCYCLINE
721149035,5/13/2015 11:34:05,1635702552,5/13/2015 11:33:19,false,prodege,1.0,27934334,GBR,D3,Swadlincote,109.150.228.127,[OTHER],[OTHER],Failure as prophylactic agent,N/A,116,65,-1,144,76,TWrex-cause,804391-FS1,"A randomized, double blind, placebo controlled trial  Failure of DOXYCYCLINE as a causal prophylactic agent against PLASMODIUM FALCIPARUM MALARIA in healthy nonimmune volunteers  Primaquine prophylaxis against malaria in nonimmune Colombian soldiers: efficacy and toxicity.",PLASMODIUM FALCIPARUM MALARIA,DOXYCYCLINE
721149035,5/13/2015 11:43:19,1635705478,5/13/2015 11:42:31,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[CONTRAINDICATES],[CONTRAINDICATES],Failure of DOXYCYCLINE as prophylactic agent against PLASMODIUM FALCIPARUM MALARIA,n/a,116,65,-1,144,76,TWrex-cause,804391-FS1,"A randomized, double blind, placebo controlled trial  Failure of DOXYCYCLINE as a causal prophylactic agent against PLASMODIUM FALCIPARUM MALARIA in healthy nonimmune volunteers  Primaquine prophylaxis against malaria in nonimmune Colombian soldiers: efficacy and toxicity.",PLASMODIUM FALCIPARUM MALARIA,DOXYCYCLINE
721149035,5/13/2015 11:43:33,1635705496,5/13/2015 11:42:27,false,points4rewards,1.0,28703583,USA,"","",97.73.86.35,[SIDE_EFFECT],[SIDE_EFFECT],Failure of,N/A,116,65,-1,144,76,TWrex-cause,804391-FS1,"A randomized, double blind, placebo controlled trial  Failure of DOXYCYCLINE as a causal prophylactic agent against PLASMODIUM FALCIPARUM MALARIA in healthy nonimmune volunteers  Primaquine prophylaxis against malaria in nonimmune Colombian soldiers: efficacy and toxicity.",PLASMODIUM FALCIPARUM MALARIA,DOXYCYCLINE
721149035,5/13/2015 11:47:39,1635706610,5/13/2015 11:47:21,false,neodev,1.0,31726043,GBR,"","",88.150.202.140,[CONTRAINDICATES],[CONTRAINDICATES],prophylaxis,844,116,65,-1,144,76,TWrex-cause,804391-FS1,"A randomized, double blind, placebo controlled trial  Failure of DOXYCYCLINE as a causal prophylactic agent against PLASMODIUM FALCIPARUM MALARIA in healthy nonimmune volunteers  Primaquine prophylaxis against malaria in nonimmune Colombian soldiers: efficacy and toxicity.",PLASMODIUM FALCIPARUM MALARIA,DOXYCYCLINE
721149035,5/13/2015 12:22:41,1635718685,5/13/2015 12:21:47,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,[TREATS],[TREATS],against,n/a,116,65,-1,144,76,TWrex-cause,804391-FS1,"A randomized, double blind, placebo controlled trial  Failure of DOXYCYCLINE as a causal prophylactic agent against PLASMODIUM FALCIPARUM MALARIA in healthy nonimmune volunteers  Primaquine prophylaxis against malaria in nonimmune Colombian soldiers: efficacy and toxicity.",PLASMODIUM FALCIPARUM MALARIA,DOXYCYCLINE
721149035,5/13/2015 12:26:41,1635720392,5/13/2015 12:25:19,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[TREATS],[TREATS],DOXYCYCLINE against PLASMODIUM FALCIPARUM MALARIA,n/a,116,65,-1,144,76,TWrex-cause,804391-FS1,"A randomized, double blind, placebo controlled trial  Failure of DOXYCYCLINE as a causal prophylactic agent against PLASMODIUM FALCIPARUM MALARIA in healthy nonimmune volunteers  Primaquine prophylaxis against malaria in nonimmune Colombian soldiers: efficacy and toxicity.",PLASMODIUM FALCIPARUM MALARIA,DOXYCYCLINE
721149035,5/13/2015 12:38:51,1635723459,5/13/2015 12:36:51,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[DIAGNOSE_BY_TEST_OR_DRUG] [ASSOCIATED_WITH],"[DIAGNOSE_BY_TEST_OR_DRUG]
[ASSOCIATED_WITH]",trial,N/A,116,65,-1,144,76,TWrex-cause,804391-FS1,"A randomized, double blind, placebo controlled trial  Failure of DOXYCYCLINE as a causal prophylactic agent against PLASMODIUM FALCIPARUM MALARIA in healthy nonimmune volunteers  Primaquine prophylaxis against malaria in nonimmune Colombian soldiers: efficacy and toxicity.",PLASMODIUM FALCIPARUM MALARIA,DOXYCYCLINE
721149035,5/13/2015 12:56:53,1635727717,5/13/2015 12:55:11,false,prodege,1.0,23482077,USA,TX,Garland,71.164.238.226,[PREVENTS],[PREVENTS],causal prophylactic agent against,N/A,116,65,-1,144,76,TWrex-cause,804391-FS1,"A randomized, double blind, placebo controlled trial  Failure of DOXYCYCLINE as a causal prophylactic agent against PLASMODIUM FALCIPARUM MALARIA in healthy nonimmune volunteers  Primaquine prophylaxis against malaria in nonimmune Colombian soldiers: efficacy and toxicity.",PLASMODIUM FALCIPARUM MALARIA,DOXYCYCLINE
721149035,5/13/2015 13:01:18,1635728859,5/13/2015 13:01:03,false,neodev,1.0,30504276,CAN,ON,Sudbury,66.103.55.12,[CAUSES],[CAUSES],causal,N/A,116,65,-1,144,76,TWrex-cause,804391-FS1,"A randomized, double blind, placebo controlled trial  Failure of DOXYCYCLINE as a causal prophylactic agent against PLASMODIUM FALCIPARUM MALARIA in healthy nonimmune volunteers  Primaquine prophylaxis against malaria in nonimmune Colombian soldiers: efficacy and toxicity.",PLASMODIUM FALCIPARUM MALARIA,DOXYCYCLINE
721149036,5/13/2015 16:23:21,1635844388,5/13/2015 16:22:12,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[TREATS],[TREATS],tolerated,none,59,247,-1,75,261,TWrex-cause,804398-FS1,Caspofungin was noninferior to amphotericin B for invasive FUNGAL INFECTIONS in persistent fever and neutropenia and was better tolerated  Hospitalists Hematology/Thrombosis Infectious Disease Critical Care Oncology  About Star Ratings  Keywords: AMPHOTERICIN B Antifungal agents Mycoses Peptides  ACP Journal Club.,FUNGAL INFECTIONS,AMPHOTERICIN B
721149036,5/13/2015 16:40:32,1635855732,5/13/2015 16:39:50,false,prodege,1.0,16101132,GBR,F9,Hayes,2.223.214.149,[TREATS],[TREATS],tolerated,Treats,59,247,-1,75,261,TWrex-cause,804398-FS1,Caspofungin was noninferior to amphotericin B for invasive FUNGAL INFECTIONS in persistent fever and neutropenia and was better tolerated  Hospitalists Hematology/Thrombosis Infectious Disease Critical Care Oncology  About Star Ratings  Keywords: AMPHOTERICIN B Antifungal agents Mycoses Peptides  ACP Journal Club.,FUNGAL INFECTIONS,AMPHOTERICIN B
721149036,5/13/2015 16:44:09,1635857925,5/13/2015 16:43:12,false,clixsense,1.0,31579138,AUS,02,Hurstville,14.200.129.68,[TREATS],[TREATS],Antifungal,N/A,59,247,-1,75,261,TWrex-cause,804398-FS1,Caspofungin was noninferior to amphotericin B for invasive FUNGAL INFECTIONS in persistent fever and neutropenia and was better tolerated  Hospitalists Hematology/Thrombosis Infectious Disease Critical Care Oncology  About Star Ratings  Keywords: AMPHOTERICIN B Antifungal agents Mycoses Peptides  ACP Journal Club.,FUNGAL INFECTIONS,AMPHOTERICIN B
721149036,5/13/2015 17:25:19,1635880408,5/13/2015 17:24:24,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[TREATS],[TREATS],for,n/a,59,247,-1,75,261,TWrex-cause,804398-FS1,Caspofungin was noninferior to amphotericin B for invasive FUNGAL INFECTIONS in persistent fever and neutropenia and was better tolerated  Hospitalists Hematology/Thrombosis Infectious Disease Critical Care Oncology  About Star Ratings  Keywords: AMPHOTERICIN B Antifungal agents Mycoses Peptides  ACP Journal Club.,FUNGAL INFECTIONS,AMPHOTERICIN B
721149036,5/13/2015 17:35:09,1635885788,5/13/2015 17:34:27,false,gptking,1.0,31799065,USA,IL,Marion,50.45.43.154,[TREATS],[TREATS],FUNGAL INFECTIONS AMPHOTERICIN B,N/A,59,247,-1,75,261,TWrex-cause,804398-FS1,Caspofungin was noninferior to amphotericin B for invasive FUNGAL INFECTIONS in persistent fever and neutropenia and was better tolerated  Hospitalists Hematology/Thrombosis Infectious Disease Critical Care Oncology  About Star Ratings  Keywords: AMPHOTERICIN B Antifungal agents Mycoses Peptides  ACP Journal Club.,FUNGAL INFECTIONS,AMPHOTERICIN B
721149036,5/13/2015 18:11:25,1635904056,5/13/2015 18:11:07,false,clixsense,1.0,32549163,CAN,MB,Winnipeg,206.45.167.246,[TREATS],[TREATS],amphotericin B for invasive FUNGAL INFECTIONS,N/A,59,247,-1,75,261,TWrex-cause,804398-FS1,Caspofungin was noninferior to amphotericin B for invasive FUNGAL INFECTIONS in persistent fever and neutropenia and was better tolerated  Hospitalists Hematology/Thrombosis Infectious Disease Critical Care Oncology  About Star Ratings  Keywords: AMPHOTERICIN B Antifungal agents Mycoses Peptides  ACP Journal Club.,FUNGAL INFECTIONS,AMPHOTERICIN B
721149036,5/13/2015 18:14:30,1635905396,5/13/2015 18:13:46,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],was noninferior to,N/A,59,247,-1,75,261,TWrex-cause,804398-FS1,Caspofungin was noninferior to amphotericin B for invasive FUNGAL INFECTIONS in persistent fever and neutropenia and was better tolerated  Hospitalists Hematology/Thrombosis Infectious Disease Critical Care Oncology  About Star Ratings  Keywords: AMPHOTERICIN B Antifungal agents Mycoses Peptides  ACP Journal Club.,FUNGAL INFECTIONS,AMPHOTERICIN B
721149036,5/13/2015 18:18:27,1635906772,5/13/2015 18:17:33,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[TREATS],[TREATS],tolerated,N/A,59,247,-1,75,261,TWrex-cause,804398-FS1,Caspofungin was noninferior to amphotericin B for invasive FUNGAL INFECTIONS in persistent fever and neutropenia and was better tolerated  Hospitalists Hematology/Thrombosis Infectious Disease Critical Care Oncology  About Star Ratings  Keywords: AMPHOTERICIN B Antifungal agents Mycoses Peptides  ACP Journal Club.,FUNGAL INFECTIONS,AMPHOTERICIN B
721149036,5/13/2015 18:18:38,1635906851,5/13/2015 18:17:48,false,instagc,1.0,24252915,GBR,"","",80.44.146.98,[TREATS],[TREATS],amphotericin B for invasive FUNGAL INFECTIONS,N/a,59,247,-1,75,261,TWrex-cause,804398-FS1,Caspofungin was noninferior to amphotericin B for invasive FUNGAL INFECTIONS in persistent fever and neutropenia and was better tolerated  Hospitalists Hematology/Thrombosis Infectious Disease Critical Care Oncology  About Star Ratings  Keywords: AMPHOTERICIN B Antifungal agents Mycoses Peptides  ACP Journal Club.,FUNGAL INFECTIONS,AMPHOTERICIN B
721149036,5/13/2015 18:43:34,1635920278,5/13/2015 18:42:55,false,prodege,1.0,32302664,USA,IL,Geneseo,173.27.241.235,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],in persistent fever and neutropenia and was better tolerated Hospitalists Hematology/Thrombosis Infectious Disease Critical Care Oncology About Star Ratings Keywords:,no comment,59,247,-1,75,261,TWrex-cause,804398-FS1,Caspofungin was noninferior to amphotericin B for invasive FUNGAL INFECTIONS in persistent fever and neutropenia and was better tolerated  Hospitalists Hematology/Thrombosis Infectious Disease Critical Care Oncology  About Star Ratings  Keywords: AMPHOTERICIN B Antifungal agents Mycoses Peptides  ACP Journal Club.,FUNGAL INFECTIONS,AMPHOTERICIN B
721149036,5/13/2015 19:07:40,1635929927,5/13/2015 19:06:14,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[TREATS],[TREATS],noninferior,N/A,59,247,-1,75,261,TWrex-cause,804398-FS1,Caspofungin was noninferior to amphotericin B for invasive FUNGAL INFECTIONS in persistent fever and neutropenia and was better tolerated  Hospitalists Hematology/Thrombosis Infectious Disease Critical Care Oncology  About Star Ratings  Keywords: AMPHOTERICIN B Antifungal agents Mycoses Peptides  ACP Journal Club.,FUNGAL INFECTIONS,AMPHOTERICIN B
721149036,5/13/2015 19:08:38,1635930294,5/13/2015 19:07:37,false,clixsense,1.0,19162475,GBR,P8,Trowbridge,82.33.126.30,[TREATS],[TREATS],Star Keywords:,n/a,59,247,-1,75,261,TWrex-cause,804398-FS1,Caspofungin was noninferior to amphotericin B for invasive FUNGAL INFECTIONS in persistent fever and neutropenia and was better tolerated  Hospitalists Hematology/Thrombosis Infectious Disease Critical Care Oncology  About Star Ratings  Keywords: AMPHOTERICIN B Antifungal agents Mycoses Peptides  ACP Journal Club.,FUNGAL INFECTIONS,AMPHOTERICIN B
721149036,5/13/2015 19:42:51,1635961622,5/13/2015 19:42:21,false,elite,1.0,30064988,GBR,H3,Leeds,92.22.208.245,[TREATS],[TREATS],Antifungal agents,N/A,59,247,-1,75,261,TWrex-cause,804398-FS1,Caspofungin was noninferior to amphotericin B for invasive FUNGAL INFECTIONS in persistent fever and neutropenia and was better tolerated  Hospitalists Hematology/Thrombosis Infectious Disease Critical Care Oncology  About Star Ratings  Keywords: AMPHOTERICIN B Antifungal agents Mycoses Peptides  ACP Journal Club.,FUNGAL INFECTIONS,AMPHOTERICIN B
721149036,5/13/2015 20:02:26,1635976587,5/13/2015 20:01:42,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.156.243,[TREATS],[TREATS],FUNGAL INFECTIONS Keywords: AMPHOTERICIN B Antifungal agents,N/A,59,247,-1,75,261,TWrex-cause,804398-FS1,Caspofungin was noninferior to amphotericin B for invasive FUNGAL INFECTIONS in persistent fever and neutropenia and was better tolerated  Hospitalists Hematology/Thrombosis Infectious Disease Critical Care Oncology  About Star Ratings  Keywords: AMPHOTERICIN B Antifungal agents Mycoses Peptides  ACP Journal Club.,FUNGAL INFECTIONS,AMPHOTERICIN B
721149036,5/13/2015 20:02:57,1635977007,5/13/2015 20:02:10,false,clixsense,1.0,27969116,NLD,"","",212.78.195.38,[OTHER],[OTHER],Ratings Keywords:,none,59,247,-1,75,261,TWrex-cause,804398-FS1,Caspofungin was noninferior to amphotericin B for invasive FUNGAL INFECTIONS in persistent fever and neutropenia and was better tolerated  Hospitalists Hematology/Thrombosis Infectious Disease Critical Care Oncology  About Star Ratings  Keywords: AMPHOTERICIN B Antifungal agents Mycoses Peptides  ACP Journal Club.,FUNGAL INFECTIONS,AMPHOTERICIN B
721149037,5/13/2015 10:16:24,1635681530,5/13/2015 10:15:20,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[PREVENTS],[PREVENTS],EARLY CATARACT FORMATION in GALACTOSEMIA can be reversed by early diagnosis and dietary intervention.,N/A,2,30,1,25,42,TWrex-cause,814353-FS1,• EARLY CATARACT FORMATION in GALACTOSEMIA can be reversed by early diagnosis and dietary intervention.,EARLY CATARACT FORMATION,GALACTOSEMIA
721149037,5/13/2015 10:34:03,1635686626,5/13/2015 10:32:47,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[SYMPTOM],[SYMPTOM],in,N/A,2,30,1,25,42,TWrex-cause,814353-FS1,• EARLY CATARACT FORMATION in GALACTOSEMIA can be reversed by early diagnosis and dietary intervention.,EARLY CATARACT FORMATION,GALACTOSEMIA
721149037,5/13/2015 10:35:44,1635687077,5/13/2015 10:35:16,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[MANIFESTATION],[MANIFESTATION],in,n/a,2,30,1,25,42,TWrex-cause,814353-FS1,• EARLY CATARACT FORMATION in GALACTOSEMIA can be reversed by early diagnosis and dietary intervention.,EARLY CATARACT FORMATION,GALACTOSEMIA
721149037,5/13/2015 10:46:54,1635690313,5/13/2015 10:46:28,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[LOCATION],[LOCATION],GALACTOSEMIA,N/A,2,30,1,25,42,TWrex-cause,814353-FS1,• EARLY CATARACT FORMATION in GALACTOSEMIA can be reversed by early diagnosis and dietary intervention.,EARLY CATARACT FORMATION,GALACTOSEMIA
721149037,5/13/2015 11:08:09,1635696437,5/13/2015 11:06:29,false,neodev,1.0,31706957,NLD,07,Amsterdam,145.100.72.165,[PART_OF],[PART_OF],in GALACTOSEMIA,n/a,2,30,1,25,42,TWrex-cause,814353-FS1,• EARLY CATARACT FORMATION in GALACTOSEMIA can be reversed by early diagnosis and dietary intervention.,EARLY CATARACT FORMATION,GALACTOSEMIA
721149037,5/13/2015 11:12:42,1635697461,5/13/2015 11:12:30,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[ASSOCIATED_WITH],[ASSOCIATED_WITH],in,n/a,2,30,1,25,42,TWrex-cause,814353-FS1,• EARLY CATARACT FORMATION in GALACTOSEMIA can be reversed by early diagnosis and dietary intervention.,EARLY CATARACT FORMATION,GALACTOSEMIA
721149037,5/13/2015 11:26:50,1635701098,5/13/2015 11:26:11,false,prodege,1.0,27934334,GBR,D3,Swadlincote,109.150.228.127,[SYMPTOM],[SYMPTOM],in,N/A,2,30,1,25,42,TWrex-cause,814353-FS1,• EARLY CATARACT FORMATION in GALACTOSEMIA can be reversed by early diagnosis and dietary intervention.,EARLY CATARACT FORMATION,GALACTOSEMIA
721149037,5/13/2015 11:31:48,1635702010,5/13/2015 11:30:50,false,points4rewards,1.0,28703583,USA,"","",97.73.86.35,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],by early diagnosis,N/A,2,30,1,25,42,TWrex-cause,814353-FS1,• EARLY CATARACT FORMATION in GALACTOSEMIA can be reversed by early diagnosis and dietary intervention.,EARLY CATARACT FORMATION,GALACTOSEMIA
721149037,5/13/2015 11:35:08,1635703071,5/13/2015 11:34:31,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[SYMPTOM],[SYMPTOM],EARLY CATARACT FORMATION in GALACTOSEMIA,n/a,2,30,1,25,42,TWrex-cause,814353-FS1,• EARLY CATARACT FORMATION in GALACTOSEMIA can be reversed by early diagnosis and dietary intervention.,EARLY CATARACT FORMATION,GALACTOSEMIA
721149037,5/13/2015 11:43:03,1635705412,5/13/2015 11:42:48,false,neodev,1.0,31726043,GBR,"","",88.150.202.140,[SYMPTOM],[SYMPTOM],FORMATION,645654,2,30,1,25,42,TWrex-cause,814353-FS1,• EARLY CATARACT FORMATION in GALACTOSEMIA can be reversed by early diagnosis and dietary intervention.,EARLY CATARACT FORMATION,GALACTOSEMIA
721149037,5/13/2015 12:16:11,1635716060,5/13/2015 12:15:56,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,[LOCATION],[LOCATION],in,n/a,2,30,1,25,42,TWrex-cause,814353-FS1,• EARLY CATARACT FORMATION in GALACTOSEMIA can be reversed by early diagnosis and dietary intervention.,EARLY CATARACT FORMATION,GALACTOSEMIA
721149037,5/13/2015 12:19:38,1635717549,5/13/2015 12:19:23,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[SYMPTOM],[SYMPTOM],EARLY CATARACT FORMATION in GALACTOSEMIA,n/a,2,30,1,25,42,TWrex-cause,814353-FS1,• EARLY CATARACT FORMATION in GALACTOSEMIA can be reversed by early diagnosis and dietary intervention.,EARLY CATARACT FORMATION,GALACTOSEMIA
721149037,5/13/2015 12:22:04,1635718438,5/13/2015 12:21:24,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[PART_OF],[PART_OF],in,N/A,2,30,1,25,42,TWrex-cause,814353-FS1,• EARLY CATARACT FORMATION in GALACTOSEMIA can be reversed by early diagnosis and dietary intervention.,EARLY CATARACT FORMATION,GALACTOSEMIA
721149037,5/13/2015 12:42:19,1635724389,5/13/2015 12:41:53,false,prodege,1.0,23482077,USA,TX,Garland,71.164.238.226,[SYMPTOM] [MANIFESTATION],"[SYMPTOM]
[MANIFESTATION]",in,N/A,2,30,1,25,42,TWrex-cause,814353-FS1,• EARLY CATARACT FORMATION in GALACTOSEMIA can be reversed by early diagnosis and dietary intervention.,EARLY CATARACT FORMATION,GALACTOSEMIA
721149037,5/13/2015 12:57:03,1635727793,5/13/2015 12:55:44,false,clixsense,1.0,6574449,USA,"","",216.216.68.85,[OTHER],[OTHER],EARLY CATARACT FORMATION GALACTOSEMIA reversed early diagnosis dietary intervention.,na,2,30,1,25,42,TWrex-cause,814353-FS1,• EARLY CATARACT FORMATION in GALACTOSEMIA can be reversed by early diagnosis and dietary intervention.,EARLY CATARACT FORMATION,GALACTOSEMIA
721149038,5/13/2015 16:21:19,1635843014,5/13/2015 16:19:56,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[MANIFESTATION],[MANIFESTATION],accessory pathway,none,177,99,1,187,127,TWrex-cause,813540-FS1,"For almost all patients with PSVT, the underlying mechanism of the tachycardia is atrioventricular NODE REENTRY (AVNRT REENTRY) involving an accessory pathway (AVRT), or atrial TACHYCARDIA.",TACHYCARDIA,NODE REENTRY (AVNRT REENTRY)
721149038,5/13/2015 16:39:20,1635854914,5/13/2015 16:38:45,false,prodege,1.0,16101132,GBR,F9,Hayes,2.223.214.149,[ASSOCIATED_WITH],[ASSOCIATED_WITH],involving,Associated,177,99,1,187,127,TWrex-cause,813540-FS1,"For almost all patients with PSVT, the underlying mechanism of the tachycardia is atrioventricular NODE REENTRY (AVNRT REENTRY) involving an accessory pathway (AVRT), or atrial TACHYCARDIA.",TACHYCARDIA,NODE REENTRY (AVNRT REENTRY)
721149038,5/13/2015 16:42:27,1635856794,5/13/2015 16:41:36,false,clixsense,1.0,31579138,AUS,02,Hurstville,14.200.129.68,[MANIFESTATION],[MANIFESTATION],accessory,N/A,177,99,1,187,127,TWrex-cause,813540-FS1,"For almost all patients with PSVT, the underlying mechanism of the tachycardia is atrioventricular NODE REENTRY (AVNRT REENTRY) involving an accessory pathway (AVRT), or atrial TACHYCARDIA.",TACHYCARDIA,NODE REENTRY (AVNRT REENTRY)
721149038,5/13/2015 17:23:55,1635879508,5/13/2015 17:22:54,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[CAUSES],[CAUSES],underlying mechanism,n/a,177,99,1,187,127,TWrex-cause,813540-FS1,"For almost all patients with PSVT, the underlying mechanism of the tachycardia is atrioventricular NODE REENTRY (AVNRT REENTRY) involving an accessory pathway (AVRT), or atrial TACHYCARDIA.",TACHYCARDIA,NODE REENTRY (AVNRT REENTRY)
721149038,5/13/2015 17:33:56,1635885148,5/13/2015 17:31:10,false,gptking,1.0,31799065,USA,IL,Marion,50.45.43.154,[OTHER],[OTHER],NODE REENTRY (AVNRT REENTRY) pathway TACHYCARDIA.,N/A,177,99,1,187,127,TWrex-cause,813540-FS1,"For almost all patients with PSVT, the underlying mechanism of the tachycardia is atrioventricular NODE REENTRY (AVNRT REENTRY) involving an accessory pathway (AVRT), or atrial TACHYCARDIA.",TACHYCARDIA,NODE REENTRY (AVNRT REENTRY)
721149038,5/13/2015 17:58:07,1635899225,5/13/2015 17:57:40,false,prodege,1.0,14848125,GBR,L6,Shrewsbury,86.138.223.142,[SYMPTOM],[SYMPTOM],underlying mechanism,N/A,177,99,1,187,127,TWrex-cause,813540-FS1,"For almost all patients with PSVT, the underlying mechanism of the tachycardia is atrioventricular NODE REENTRY (AVNRT REENTRY) involving an accessory pathway (AVRT), or atrial TACHYCARDIA.",TACHYCARDIA,NODE REENTRY (AVNRT REENTRY)
721149038,5/13/2015 18:10:51,1635903808,5/13/2015 18:10:17,false,clixsense,1.0,32549163,CAN,MB,Winnipeg,206.45.167.246,[LOCATION],[LOCATION],NODE REENTRY (AVNRT REENTRY) involving atrial TACHYCARDIA.,N/A,177,99,1,187,127,TWrex-cause,813540-FS1,"For almost all patients with PSVT, the underlying mechanism of the tachycardia is atrioventricular NODE REENTRY (AVNRT REENTRY) involving an accessory pathway (AVRT), or atrial TACHYCARDIA.",TACHYCARDIA,NODE REENTRY (AVNRT REENTRY)
721149038,5/13/2015 18:12:55,1635904651,5/13/2015 18:12:29,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[PART_OF],[PART_OF],involving,N/A,177,99,1,187,127,TWrex-cause,813540-FS1,"For almost all patients with PSVT, the underlying mechanism of the tachycardia is atrioventricular NODE REENTRY (AVNRT REENTRY) involving an accessory pathway (AVRT), or atrial TACHYCARDIA.",TACHYCARDIA,NODE REENTRY (AVNRT REENTRY)
721149038,5/13/2015 18:16:24,1635906036,5/13/2015 18:15:12,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[ASSOCIATED_WITH],[ASSOCIATED_WITH],involving,N/A,177,99,1,187,127,TWrex-cause,813540-FS1,"For almost all patients with PSVT, the underlying mechanism of the tachycardia is atrioventricular NODE REENTRY (AVNRT REENTRY) involving an accessory pathway (AVRT), or atrial TACHYCARDIA.",TACHYCARDIA,NODE REENTRY (AVNRT REENTRY)
721149038,5/13/2015 18:16:41,1635906088,5/13/2015 18:14:46,false,instagc,1.0,24252915,GBR,"","",80.44.146.98,[NONE],[NONE],N/a,Unrelated items,177,99,1,187,127,TWrex-cause,813540-FS1,"For almost all patients with PSVT, the underlying mechanism of the tachycardia is atrioventricular NODE REENTRY (AVNRT REENTRY) involving an accessory pathway (AVRT), or atrial TACHYCARDIA.",TACHYCARDIA,NODE REENTRY (AVNRT REENTRY)
721149038,5/13/2015 18:42:08,1635919610,5/13/2015 18:41:27,false,prodege,1.0,32302664,USA,IL,Geneseo,173.27.241.235,[ASSOCIATED_WITH],[ASSOCIATED_WITH],"involving an accessory pathway (AVRT), or atrial",no comment,177,99,1,187,127,TWrex-cause,813540-FS1,"For almost all patients with PSVT, the underlying mechanism of the tachycardia is atrioventricular NODE REENTRY (AVNRT REENTRY) involving an accessory pathway (AVRT), or atrial TACHYCARDIA.",TACHYCARDIA,NODE REENTRY (AVNRT REENTRY)
721149038,5/13/2015 19:01:52,1635927677,5/13/2015 18:59:51,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[IS_A],[IS_A],underlying mechanism,N/A,177,99,1,187,127,TWrex-cause,813540-FS1,"For almost all patients with PSVT, the underlying mechanism of the tachycardia is atrioventricular NODE REENTRY (AVNRT REENTRY) involving an accessory pathway (AVRT), or atrial TACHYCARDIA.",TACHYCARDIA,NODE REENTRY (AVNRT REENTRY)
721149038,5/13/2015 19:05:32,1635929030,5/13/2015 19:02:43,false,clixsense,1.0,19162475,GBR,P8,Trowbridge,82.33.126.30,[ASSOCIATED_WITH],[ASSOCIATED_WITH],tachycardia atrioventricular,n/a,177,99,1,187,127,TWrex-cause,813540-FS1,"For almost all patients with PSVT, the underlying mechanism of the tachycardia is atrioventricular NODE REENTRY (AVNRT REENTRY) involving an accessory pathway (AVRT), or atrial TACHYCARDIA.",TACHYCARDIA,NODE REENTRY (AVNRT REENTRY)
721149038,5/13/2015 19:41:50,1635960979,5/13/2015 19:41:18,false,elite,1.0,30064988,GBR,H3,Leeds,92.22.208.245,[OTHER],[OTHER],underlying mechanism,N/A,177,99,1,187,127,TWrex-cause,813540-FS1,"For almost all patients with PSVT, the underlying mechanism of the tachycardia is atrioventricular NODE REENTRY (AVNRT REENTRY) involving an accessory pathway (AVRT), or atrial TACHYCARDIA.",TACHYCARDIA,NODE REENTRY (AVNRT REENTRY)
721149038,5/13/2015 20:01:14,1635975565,5/13/2015 20:00:51,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.156.243,[IS_A],[IS_A],NODE REENTRY (AVNRT REENTRY),N/A,177,99,1,187,127,TWrex-cause,813540-FS1,"For almost all patients with PSVT, the underlying mechanism of the tachycardia is atrioventricular NODE REENTRY (AVNRT REENTRY) involving an accessory pathway (AVRT), or atrial TACHYCARDIA.",TACHYCARDIA,NODE REENTRY (AVNRT REENTRY)
721149039,5/13/2015 10:15:19,1635681226,5/13/2015 10:14:25,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[TREATS] [DIAGNOSE_BY_TEST_OR_DRUG],"[TREATS]
[DIAGNOSE_BY_TEST_OR_DRUG]",CLONIDINE HYDROCHLORIDE A centrally acting alpha agonist drug used to treat HYPERTENSION and opiate withdrawal.,N/A,103,0,-1,114,23,TWrex-cause,800110-FS1,CLONIDINE HYDROCHLORIDE    (              audio )  A centrally acting alpha agonist drug used to treat HYPERTENSION and opiate withdrawal.,HYPERTENSION,CLONIDINE HYDROCHLORIDE
721149039,5/13/2015 10:31:14,1635685882,5/13/2015 10:30:30,false,clixsense,1.0,26847653,NLD,03,Warnsveld,213.93.50.164,[DIAGNOSE_BY_TEST_OR_DRUG] [TREATS],"[TREATS]
[DIAGNOSE_BY_TEST_OR_DRUG]",A centrally acting alpha agonist drug used to treat,n/a,103,0,-1,114,23,TWrex-cause,800110-FS1,CLONIDINE HYDROCHLORIDE    (              audio )  A centrally acting alpha agonist drug used to treat HYPERTENSION and opiate withdrawal.,HYPERTENSION,CLONIDINE HYDROCHLORIDE
721149039,5/13/2015 10:32:43,1635686271,5/13/2015 10:32:03,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[TREATS],[TREATS],treat,N/A,103,0,-1,114,23,TWrex-cause,800110-FS1,CLONIDINE HYDROCHLORIDE    (              audio )  A centrally acting alpha agonist drug used to treat HYPERTENSION and opiate withdrawal.,HYPERTENSION,CLONIDINE HYDROCHLORIDE
721149039,5/13/2015 10:35:15,1635686935,5/13/2015 10:33:28,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[TREATS],[TREATS],used to treat,n/a,103,0,-1,114,23,TWrex-cause,800110-FS1,CLONIDINE HYDROCHLORIDE    (              audio )  A centrally acting alpha agonist drug used to treat HYPERTENSION and opiate withdrawal.,HYPERTENSION,CLONIDINE HYDROCHLORIDE
721149039,5/13/2015 10:46:27,1635690187,5/13/2015 10:45:39,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[TREATS],[TREATS],HYPERTENSION,N/A,103,0,-1,114,23,TWrex-cause,800110-FS1,CLONIDINE HYDROCHLORIDE    (              audio )  A centrally acting alpha agonist drug used to treat HYPERTENSION and opiate withdrawal.,HYPERTENSION,CLONIDINE HYDROCHLORIDE
721149039,5/13/2015 11:06:28,1635696071,5/13/2015 11:05:58,false,neodev,1.0,31706957,NLD,07,Amsterdam,145.100.72.165,[TREATS],[TREATS],drug used to treat,n/a,103,0,-1,114,23,TWrex-cause,800110-FS1,CLONIDINE HYDROCHLORIDE    (              audio )  A centrally acting alpha agonist drug used to treat HYPERTENSION and opiate withdrawal.,HYPERTENSION,CLONIDINE HYDROCHLORIDE
721149039,5/13/2015 11:12:28,1635697381,5/13/2015 11:12:10,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[TREATS],[TREATS],treat,n/a,103,0,-1,114,23,TWrex-cause,800110-FS1,CLONIDINE HYDROCHLORIDE    (              audio )  A centrally acting alpha agonist drug used to treat HYPERTENSION and opiate withdrawal.,HYPERTENSION,CLONIDINE HYDROCHLORIDE
721149039,5/13/2015 11:22:01,1635699740,5/13/2015 11:21:43,false,prodege,1.0,27934334,GBR,D3,Swadlincote,109.150.228.127,[TREATS],[TREATS],treat,N/A,103,0,-1,114,23,TWrex-cause,800110-FS1,CLONIDINE HYDROCHLORIDE    (              audio )  A centrally acting alpha agonist drug used to treat HYPERTENSION and opiate withdrawal.,HYPERTENSION,CLONIDINE HYDROCHLORIDE
721149039,5/13/2015 11:30:45,1635701822,5/13/2015 11:30:13,false,points4rewards,1.0,28703583,USA,"","",97.73.86.35,[TREATS],[TREATS],used to treat,N/A,103,0,-1,114,23,TWrex-cause,800110-FS1,CLONIDINE HYDROCHLORIDE    (              audio )  A centrally acting alpha agonist drug used to treat HYPERTENSION and opiate withdrawal.,HYPERTENSION,CLONIDINE HYDROCHLORIDE
721149039,5/13/2015 11:34:29,1635702649,5/13/2015 11:34:01,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[TREATS],[TREATS],CLONIDINE HYDROCHLORIDE used to treat HYPERTENSION,n/a,103,0,-1,114,23,TWrex-cause,800110-FS1,CLONIDINE HYDROCHLORIDE    (              audio )  A centrally acting alpha agonist drug used to treat HYPERTENSION and opiate withdrawal.,HYPERTENSION,CLONIDINE HYDROCHLORIDE
721149039,5/13/2015 11:42:39,1635705345,5/13/2015 11:42:23,false,neodev,1.0,31726043,GBR,"","",88.150.202.140,[CAUSES],[CAUSES],agonist,54,103,0,-1,114,23,TWrex-cause,800110-FS1,CLONIDINE HYDROCHLORIDE    (              audio )  A centrally acting alpha agonist drug used to treat HYPERTENSION and opiate withdrawal.,HYPERTENSION,CLONIDINE HYDROCHLORIDE
721149039,5/13/2015 12:15:55,1635715941,5/13/2015 12:15:21,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,[TREATS],[TREATS],used to treat,n/a,103,0,-1,114,23,TWrex-cause,800110-FS1,CLONIDINE HYDROCHLORIDE    (              audio )  A centrally acting alpha agonist drug used to treat HYPERTENSION and opiate withdrawal.,HYPERTENSION,CLONIDINE HYDROCHLORIDE
721149039,5/13/2015 12:19:09,1635717315,5/13/2015 12:19:01,false,clixsense,1.0,28457001,CAN,ON,North Bay,24.204.202.220,[TREATS],[TREATS],treat,n/a,103,0,-1,114,23,TWrex-cause,800110-FS1,CLONIDINE HYDROCHLORIDE    (              audio )  A centrally acting alpha agonist drug used to treat HYPERTENSION and opiate withdrawal.,HYPERTENSION,CLONIDINE HYDROCHLORIDE
721149039,5/13/2015 12:19:22,1635717457,5/13/2015 12:19:07,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[TREATS],[TREATS],CLONIDINE HYDROCHLORIDE drug used to treat HYPERTENSION,n/a,103,0,-1,114,23,TWrex-cause,800110-FS1,CLONIDINE HYDROCHLORIDE    (              audio )  A centrally acting alpha agonist drug used to treat HYPERTENSION and opiate withdrawal.,HYPERTENSION,CLONIDINE HYDROCHLORIDE
721149039,5/13/2015 12:21:22,1635718142,5/13/2015 12:20:20,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[TREATS],[TREATS],treat,N/A,103,0,-1,114,23,TWrex-cause,800110-FS1,CLONIDINE HYDROCHLORIDE    (              audio )  A centrally acting alpha agonist drug used to treat HYPERTENSION and opiate withdrawal.,HYPERTENSION,CLONIDINE HYDROCHLORIDE
721149040,5/13/2015 18:22:12,1635908736,5/13/2015 18:21:54,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[TREATS],[TREATS],"therapy,",N/A,98,32,1,109,35,TWrex-cause,812970-FS1,"Treatment  To simplify therapy, SLE should be classified as mild (eg, fever, arthritis, pleurisy, PERICARDITIS headache, rash) or severe (eg, hemolytic anemia, thrombocytopenic purpura, massive pleural and pericardial involvement, significant renal damage, acute vasculitis of the extremities or GI tract, florid CNS involvement.",PERICARDITIS,SLE
721149040,5/13/2015 18:35:10,1635915960,5/13/2015 18:34:06,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[SYMPTOM],[SYMPTOM],classified as,N/A,98,32,1,109,35,TWrex-cause,812970-FS1,"Treatment  To simplify therapy, SLE should be classified as mild (eg, fever, arthritis, pleurisy, PERICARDITIS headache, rash) or severe (eg, hemolytic anemia, thrombocytopenic purpura, massive pleural and pericardial involvement, significant renal damage, acute vasculitis of the extremities or GI tract, florid CNS involvement.",PERICARDITIS,SLE
721149040,5/13/2015 18:55:52,1635925304,5/13/2015 18:53:38,false,prodege,1.0,32302664,USA,IL,Geneseo,173.27.241.235,[MANIFESTATION],[MANIFESTATION],"should be classified as mild (eg, fever, arthritis, pleurisy,",no comment,98,32,1,109,35,TWrex-cause,812970-FS1,"Treatment  To simplify therapy, SLE should be classified as mild (eg, fever, arthritis, pleurisy, PERICARDITIS headache, rash) or severe (eg, hemolytic anemia, thrombocytopenic purpura, massive pleural and pericardial involvement, significant renal damage, acute vasculitis of the extremities or GI tract, florid CNS involvement.",PERICARDITIS,SLE
721149040,5/13/2015 19:28:42,1635952536,5/13/2015 19:27:04,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[IS_A],[IS_A],classified as,N/A,98,32,1,109,35,TWrex-cause,812970-FS1,"Treatment  To simplify therapy, SLE should be classified as mild (eg, fever, arthritis, pleurisy, PERICARDITIS headache, rash) or severe (eg, hemolytic anemia, thrombocytopenic purpura, massive pleural and pericardial involvement, significant renal damage, acute vasculitis of the extremities or GI tract, florid CNS involvement.",PERICARDITIS,SLE
721149040,5/13/2015 19:51:27,1635968108,5/13/2015 19:50:55,false,elite,1.0,30064988,GBR,H3,Leeds,92.22.208.245,[SYMPTOM],[SYMPTOM],mild,N/A,98,32,1,109,35,TWrex-cause,812970-FS1,"Treatment  To simplify therapy, SLE should be classified as mild (eg, fever, arthritis, pleurisy, PERICARDITIS headache, rash) or severe (eg, hemolytic anemia, thrombocytopenic purpura, massive pleural and pericardial involvement, significant renal damage, acute vasculitis of the extremities or GI tract, florid CNS involvement.",PERICARDITIS,SLE
721149040,5/13/2015 20:11:22,1635984168,5/13/2015 20:10:50,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.156.243,[SYMPTOM],[SYMPTOM],"SLE classified as mild (eg, PERICARDITIS headache,",N/A,98,32,1,109,35,TWrex-cause,812970-FS1,"Treatment  To simplify therapy, SLE should be classified as mild (eg, fever, arthritis, pleurisy, PERICARDITIS headache, rash) or severe (eg, hemolytic anemia, thrombocytopenic purpura, massive pleural and pericardial involvement, significant renal damage, acute vasculitis of the extremities or GI tract, florid CNS involvement.",PERICARDITIS,SLE
721149040,5/13/2015 20:38:02,1636002757,5/13/2015 20:37:49,false,neodev,1.0,20961587,NLD,05,Maastricht,84.26.48.136,[TREATS],[TREATS],Treatment,N/A,98,32,1,109,35,TWrex-cause,812970-FS1,"Treatment  To simplify therapy, SLE should be classified as mild (eg, fever, arthritis, pleurisy, PERICARDITIS headache, rash) or severe (eg, hemolytic anemia, thrombocytopenic purpura, massive pleural and pericardial involvement, significant renal damage, acute vasculitis of the extremities or GI tract, florid CNS involvement.",PERICARDITIS,SLE
721149040,5/13/2015 21:08:42,1636023773,5/13/2015 21:08:06,false,elite,1.0,32732290,GBR,A7,Birmingham,86.147.79.250,[IS_A],[IS_A],classified as,N/A,98,32,1,109,35,TWrex-cause,812970-FS1,"Treatment  To simplify therapy, SLE should be classified as mild (eg, fever, arthritis, pleurisy, PERICARDITIS headache, rash) or severe (eg, hemolytic anemia, thrombocytopenic purpura, massive pleural and pericardial involvement, significant renal damage, acute vasculitis of the extremities or GI tract, florid CNS involvement.",PERICARDITIS,SLE
721149040,5/13/2015 21:25:07,1636034821,5/13/2015 21:24:18,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[ASSOCIATED_WITH],[ASSOCIATED_WITH],"SLE (eg, PERICARDITIS",N/A,98,32,1,109,35,TWrex-cause,812970-FS1,"Treatment  To simplify therapy, SLE should be classified as mild (eg, fever, arthritis, pleurisy, PERICARDITIS headache, rash) or severe (eg, hemolytic anemia, thrombocytopenic purpura, massive pleural and pericardial involvement, significant renal damage, acute vasculitis of the extremities or GI tract, florid CNS involvement.",PERICARDITIS,SLE
721149040,5/13/2015 21:40:08,1636044615,5/13/2015 21:39:10,false,neodev,1.0,30749660,USA,NC,Durham,24.211.188.217,[CAUSES] [DIAGNOSE_BY_TEST_OR_DRUG] [PREVENTS],"[PREVENTS]
[DIAGNOSE_BY_TEST_OR_DRUG]
[CAUSES]","fever, arthritis, pleurisy, PERICARDITIS headache, rash)",n/a,98,32,1,109,35,TWrex-cause,812970-FS1,"Treatment  To simplify therapy, SLE should be classified as mild (eg, fever, arthritis, pleurisy, PERICARDITIS headache, rash) or severe (eg, hemolytic anemia, thrombocytopenic purpura, massive pleural and pericardial involvement, significant renal damage, acute vasculitis of the extremities or GI tract, florid CNS involvement.",PERICARDITIS,SLE
721149040,5/13/2015 21:49:46,1636050544,5/13/2015 21:48:56,false,instagc,1.0,13763729,USA,NC,Apex,75.182.91.110,[SYMPTOM],[SYMPTOM],"classified as mild (eg,",N/A,98,32,1,109,35,TWrex-cause,812970-FS1,"Treatment  To simplify therapy, SLE should be classified as mild (eg, fever, arthritis, pleurisy, PERICARDITIS headache, rash) or severe (eg, hemolytic anemia, thrombocytopenic purpura, massive pleural and pericardial involvement, significant renal damage, acute vasculitis of the extremities or GI tract, florid CNS involvement.",PERICARDITIS,SLE
721149040,5/13/2015 21:51:26,1636051483,5/13/2015 21:50:43,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,75.147.181.53,[PART_OF],[PART_OF],should be classified as,N/A,98,32,1,109,35,TWrex-cause,812970-FS1,"Treatment  To simplify therapy, SLE should be classified as mild (eg, fever, arthritis, pleurisy, PERICARDITIS headache, rash) or severe (eg, hemolytic anemia, thrombocytopenic purpura, massive pleural and pericardial involvement, significant renal damage, acute vasculitis of the extremities or GI tract, florid CNS involvement.",PERICARDITIS,SLE
721149040,5/13/2015 22:20:49,1636067188,5/13/2015 22:20:00,false,clixsense,1.0,8888883,USA,"","",73.21.180.112,[MANIFESTATION],[MANIFESTATION],classified as mild,N/A,98,32,1,109,35,TWrex-cause,812970-FS1,"Treatment  To simplify therapy, SLE should be classified as mild (eg, fever, arthritis, pleurisy, PERICARDITIS headache, rash) or severe (eg, hemolytic anemia, thrombocytopenic purpura, massive pleural and pericardial involvement, significant renal damage, acute vasculitis of the extremities or GI tract, florid CNS involvement.",PERICARDITIS,SLE
721149040,5/13/2015 22:33:21,1636074286,5/13/2015 22:32:49,false,clixsense,1.0,19294877,USA,MA,Cambridge,71.174.188.109,[IS_A] [PART_OF],"[IS_A]
[PART_OF]","SLE should be classified as mild (eg, fever, pleurisy, PERICARDITIS headache,",n/a,98,32,1,109,35,TWrex-cause,812970-FS1,"Treatment  To simplify therapy, SLE should be classified as mild (eg, fever, arthritis, pleurisy, PERICARDITIS headache, rash) or severe (eg, hemolytic anemia, thrombocytopenic purpura, massive pleural and pericardial involvement, significant renal damage, acute vasculitis of the extremities or GI tract, florid CNS involvement.",PERICARDITIS,SLE
721149040,5/13/2015 22:50:26,1636083614,5/13/2015 22:49:54,false,superrewards,1.0,24796792,USA,NY,New York,72.80.63.240,[SIDE_EFFECT],[SIDE_EFFECT],Treatment mild,n/a,98,32,1,109,35,TWrex-cause,812970-FS1,"Treatment  To simplify therapy, SLE should be classified as mild (eg, fever, arthritis, pleurisy, PERICARDITIS headache, rash) or severe (eg, hemolytic anemia, thrombocytopenic purpura, massive pleural and pericardial involvement, significant renal damage, acute vasculitis of the extremities or GI tract, florid CNS involvement.",PERICARDITIS,SLE
721149041,5/13/2015 09:57:22,1635676633,5/13/2015 09:57:07,false,neodev,1.0,32103286,CAN,AB,Edmonton,208.123.223.37,[CAUSES] [LOCATION] [SYMPTOM] [NONE],"[CAUSES]
[LOCATION]
[SYMPTOM]
[NONE]",no,no,81,33,-1,91,45,TWrex-cause,803620-FS1,"Peck GL, Olsen TG, Butkus D et alISOTRETINOIN versus placebo in the treatment of CYSTIC ACNE: a randomized double blind study.",CYSTIC ACNE,ISOTRETINOIN
721149041,5/13/2015 10:09:07,1635679619,5/13/2015 10:07:49,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[TREATS] [DIAGNOSE_BY_TEST_OR_DRUG],"[TREATS]
[DIAGNOSE_BY_TEST_OR_DRUG]",alISOTRETINOIN versus placebo in the treatment of CYSTIC ACNE:,N/A,81,33,-1,91,45,TWrex-cause,803620-FS1,"Peck GL, Olsen TG, Butkus D et alISOTRETINOIN versus placebo in the treatment of CYSTIC ACNE: a randomized double blind study.",CYSTIC ACNE,ISOTRETINOIN
721149041,5/13/2015 10:26:21,1635684130,5/13/2015 10:25:13,false,clixsense,1.0,26847653,NLD,03,Warnsveld,213.93.50.164,[TREATS] [DIAGNOSE_BY_TEST_OR_DRUG],"[TREATS]
[DIAGNOSE_BY_TEST_OR_DRUG]",the treatment of a randomized double blind study.,n/a,81,33,-1,91,45,TWrex-cause,803620-FS1,"Peck GL, Olsen TG, Butkus D et alISOTRETINOIN versus placebo in the treatment of CYSTIC ACNE: a randomized double blind study.",CYSTIC ACNE,ISOTRETINOIN
721149041,5/13/2015 10:28:50,1635684980,5/13/2015 10:27:18,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[TREATS],[TREATS],in the treatment of,n/a,81,33,-1,91,45,TWrex-cause,803620-FS1,"Peck GL, Olsen TG, Butkus D et alISOTRETINOIN versus placebo in the treatment of CYSTIC ACNE: a randomized double blind study.",CYSTIC ACNE,ISOTRETINOIN
721149041,5/13/2015 10:28:53,1635685006,5/13/2015 10:27:54,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[TREATS],[TREATS],treatment of,N/A,81,33,-1,91,45,TWrex-cause,803620-FS1,"Peck GL, Olsen TG, Butkus D et alISOTRETINOIN versus placebo in the treatment of CYSTIC ACNE: a randomized double blind study.",CYSTIC ACNE,ISOTRETINOIN
721149041,5/13/2015 10:43:18,1635689250,5/13/2015 10:42:19,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[TREATS],[TREATS],CYSTIC ACNE:,N/A,81,33,-1,91,45,TWrex-cause,803620-FS1,"Peck GL, Olsen TG, Butkus D et alISOTRETINOIN versus placebo in the treatment of CYSTIC ACNE: a randomized double blind study.",CYSTIC ACNE,ISOTRETINOIN
721149041,5/13/2015 10:59:42,1635694084,5/13/2015 10:59:01,false,neodev,1.0,29579905,GBR,"","",5.152.206.71,[PREVENTS] [CAUSES] [SYMPTOM],"[PREVENTS]
[CAUSES]
[SYMPTOM]",Olsen alISOTRETINOIN placebo CYSTIC,N/A,81,33,-1,91,45,TWrex-cause,803620-FS1,"Peck GL, Olsen TG, Butkus D et alISOTRETINOIN versus placebo in the treatment of CYSTIC ACNE: a randomized double blind study.",CYSTIC ACNE,ISOTRETINOIN
721149041,5/13/2015 11:02:14,1635694893,5/13/2015 11:01:40,false,neodev,1.0,31706957,NLD,07,Amsterdam,145.100.72.165,[TREATS],[TREATS],in the treatment,n/a,81,33,-1,91,45,TWrex-cause,803620-FS1,"Peck GL, Olsen TG, Butkus D et alISOTRETINOIN versus placebo in the treatment of CYSTIC ACNE: a randomized double blind study.",CYSTIC ACNE,ISOTRETINOIN
721149041,5/13/2015 11:11:01,1635697115,5/13/2015 11:10:47,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[TREATS],[TREATS],treatment,n/a,81,33,-1,91,45,TWrex-cause,803620-FS1,"Peck GL, Olsen TG, Butkus D et alISOTRETINOIN versus placebo in the treatment of CYSTIC ACNE: a randomized double blind study.",CYSTIC ACNE,ISOTRETINOIN
721149041,5/13/2015 11:19:44,1635699360,5/13/2015 11:19:26,false,prodege,1.0,27934334,GBR,D3,Swadlincote,109.150.228.127,[TREATS],[TREATS],treatment,N/A,81,33,-1,91,45,TWrex-cause,803620-FS1,"Peck GL, Olsen TG, Butkus D et alISOTRETINOIN versus placebo in the treatment of CYSTIC ACNE: a randomized double blind study.",CYSTIC ACNE,ISOTRETINOIN
721149041,5/13/2015 11:25:46,1635700760,5/13/2015 11:25:14,false,points4rewards,1.0,28703583,USA,"","",97.73.86.35,[TREATS],[TREATS],treatment of,N/A,81,33,-1,91,45,TWrex-cause,803620-FS1,"Peck GL, Olsen TG, Butkus D et alISOTRETINOIN versus placebo in the treatment of CYSTIC ACNE: a randomized double blind study.",CYSTIC ACNE,ISOTRETINOIN
721149041,5/13/2015 11:29:36,1635701621,5/13/2015 11:29:07,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[TREATS],[TREATS],alISOTRETINOIN in treatment of CYSTIC ACNE:,n/a,81,33,-1,91,45,TWrex-cause,803620-FS1,"Peck GL, Olsen TG, Butkus D et alISOTRETINOIN versus placebo in the treatment of CYSTIC ACNE: a randomized double blind study.",CYSTIC ACNE,ISOTRETINOIN
721149041,5/13/2015 11:40:29,1635704929,5/13/2015 11:40:12,false,neodev,1.0,31726043,GBR,"","",88.150.202.140,[MANIFESTATION],[MANIFESTATION],placebo,saasd,81,33,-1,91,45,TWrex-cause,803620-FS1,"Peck GL, Olsen TG, Butkus D et alISOTRETINOIN versus placebo in the treatment of CYSTIC ACNE: a randomized double blind study.",CYSTIC ACNE,ISOTRETINOIN
721149041,5/13/2015 12:11:53,1635714145,5/13/2015 12:10:55,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,[TREATS],[TREATS],treatment,n/a,81,33,-1,91,45,TWrex-cause,803620-FS1,"Peck GL, Olsen TG, Butkus D et alISOTRETINOIN versus placebo in the treatment of CYSTIC ACNE: a randomized double blind study.",CYSTIC ACNE,ISOTRETINOIN
721149041,5/13/2015 12:16:48,1635716300,5/13/2015 12:16:32,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[TREATS],[TREATS],alISOTRETINOIN in the treatment of CYSTIC ACNE:,n/a,81,33,-1,91,45,TWrex-cause,803620-FS1,"Peck GL, Olsen TG, Butkus D et alISOTRETINOIN versus placebo in the treatment of CYSTIC ACNE: a randomized double blind study.",CYSTIC ACNE,ISOTRETINOIN
721149042,5/13/2015 13:22:46,1635735260,5/13/2015 13:22:18,false,clixsense,1.0,23197581,NLD,11,Den Haag,82.217.5.55,[PREVENTS],[PREVENTS],even greater risk reduction for,N/A,73,26,-1,84,29,TWrex-cause,805008-FS1,"Use of LMWH compared with UFH results in even greater risk reduction for PROXIMAL DVT than for total DVT and, therefore, should be considered the prophylactic agent of choice in these high risk groups (3 6.",PROXIMAL DVT,UFH
721149042,5/13/2015 13:59:41,1635747341,5/13/2015 13:59:17,false,neodev,1.0,24564999,GBR,H9,London,86.145.227.9,[PREVENTS],[PREVENTS],risk reduction for,N/A,73,26,-1,84,29,TWrex-cause,805008-FS1,"Use of LMWH compared with UFH results in even greater risk reduction for PROXIMAL DVT than for total DVT and, therefore, should be considered the prophylactic agent of choice in these high risk groups (3 6.",PROXIMAL DVT,UFH
721149042,5/13/2015 14:04:15,1635749388,5/13/2015 14:03:10,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[PREVENTS],[PREVENTS],risk reduction,N/A,73,26,-1,84,29,TWrex-cause,805008-FS1,"Use of LMWH compared with UFH results in even greater risk reduction for PROXIMAL DVT than for total DVT and, therefore, should be considered the prophylactic agent of choice in these high risk groups (3 6.",PROXIMAL DVT,UFH
721149042,5/13/2015 14:28:24,1635759624,5/13/2015 14:27:31,false,prodege,1.0,24403612,CAN,ON,Ajax,99.239.181.149,[PREVENTS],[PREVENTS],UFH results in reduction for PROXIMAL DVT,N/a,73,26,-1,84,29,TWrex-cause,805008-FS1,"Use of LMWH compared with UFH results in even greater risk reduction for PROXIMAL DVT than for total DVT and, therefore, should be considered the prophylactic agent of choice in these high risk groups (3 6.",PROXIMAL DVT,UFH
721149042,5/13/2015 14:38:36,1635765605,5/13/2015 14:38:08,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[PREVENTS] [TREATS],"[TREATS]
[PREVENTS]",risk reduction,N/A,73,26,-1,84,29,TWrex-cause,805008-FS1,"Use of LMWH compared with UFH results in even greater risk reduction for PROXIMAL DVT than for total DVT and, therefore, should be considered the prophylactic agent of choice in these high risk groups (3 6.",PROXIMAL DVT,UFH
721149042,5/13/2015 15:22:02,1635799231,5/13/2015 15:21:30,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,[CAUSES],[CAUSES],risk,n/a,73,26,-1,84,29,TWrex-cause,805008-FS1,"Use of LMWH compared with UFH results in even greater risk reduction for PROXIMAL DVT than for total DVT and, therefore, should be considered the prophylactic agent of choice in these high risk groups (3 6.",PROXIMAL DVT,UFH
721149042,5/13/2015 16:13:38,1635838395,5/13/2015 16:12:43,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[PREVENTS],[PREVENTS],prophylactic,none,73,26,-1,84,29,TWrex-cause,805008-FS1,"Use of LMWH compared with UFH results in even greater risk reduction for PROXIMAL DVT than for total DVT and, therefore, should be considered the prophylactic agent of choice in these high risk groups (3 6.",PROXIMAL DVT,UFH
721149042,5/13/2015 16:35:02,1635852311,5/13/2015 16:34:23,false,prodege,1.0,16101132,GBR,F9,Hayes,2.223.214.149,[OTHER],[OTHER],risk,Risk,73,26,-1,84,29,TWrex-cause,805008-FS1,"Use of LMWH compared with UFH results in even greater risk reduction for PROXIMAL DVT than for total DVT and, therefore, should be considered the prophylactic agent of choice in these high risk groups (3 6.",PROXIMAL DVT,UFH
721149042,5/13/2015 16:37:30,1635853895,5/13/2015 16:36:51,false,clixsense,1.0,31579138,AUS,02,Hurstville,14.200.129.68,[PREVENTS],[PREVENTS],risk reduction,N/A,73,26,-1,84,29,TWrex-cause,805008-FS1,"Use of LMWH compared with UFH results in even greater risk reduction for PROXIMAL DVT than for total DVT and, therefore, should be considered the prophylactic agent of choice in these high risk groups (3 6.",PROXIMAL DVT,UFH
721149042,5/13/2015 17:17:10,1635875634,5/13/2015 17:16:47,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[PREVENTS],[PREVENTS],prophylactic agent,n/a,73,26,-1,84,29,TWrex-cause,805008-FS1,"Use of LMWH compared with UFH results in even greater risk reduction for PROXIMAL DVT than for total DVT and, therefore, should be considered the prophylactic agent of choice in these high risk groups (3 6.",PROXIMAL DVT,UFH
721149042,5/13/2015 17:19:48,1635877148,5/13/2015 17:18:52,false,gptking,1.0,31799065,USA,IL,Marion,50.45.43.154,[TREATS],[TREATS],UFH PROXIMAL DVT,N/A,73,26,-1,84,29,TWrex-cause,805008-FS1,"Use of LMWH compared with UFH results in even greater risk reduction for PROXIMAL DVT than for total DVT and, therefore, should be considered the prophylactic agent of choice in these high risk groups (3 6.",PROXIMAL DVT,UFH
721149042,5/13/2015 17:53:49,1635897686,5/13/2015 17:53:16,false,prodege,1.0,14848125,GBR,L6,Shrewsbury,86.138.223.142,[PREVENTS],[PREVENTS],greater risk,N/A,73,26,-1,84,29,TWrex-cause,805008-FS1,"Use of LMWH compared with UFH results in even greater risk reduction for PROXIMAL DVT than for total DVT and, therefore, should be considered the prophylactic agent of choice in these high risk groups (3 6.",PROXIMAL DVT,UFH
721149042,5/13/2015 18:04:07,1635901144,5/13/2015 18:02:12,false,clixsense,1.0,6574449,USA,"","",216.216.68.85,[OTHER],[OTHER],Use LMWH compared UFH results greater risk reduction PROXIMAL DVT considered prophylactic agent choice high risk groups,na,73,26,-1,84,29,TWrex-cause,805008-FS1,"Use of LMWH compared with UFH results in even greater risk reduction for PROXIMAL DVT than for total DVT and, therefore, should be considered the prophylactic agent of choice in these high risk groups (3 6.",PROXIMAL DVT,UFH
721149042,5/13/2015 18:07:19,1635902311,5/13/2015 18:06:36,false,clixsense,1.0,32549163,CAN,MB,Winnipeg,206.45.167.246,[PREVENTS],[PREVENTS],Use of LMWH compared with UFH results in even greater risk reduction for PROXIMAL DVT,N/A,73,26,-1,84,29,TWrex-cause,805008-FS1,"Use of LMWH compared with UFH results in even greater risk reduction for PROXIMAL DVT than for total DVT and, therefore, should be considered the prophylactic agent of choice in these high risk groups (3 6.",PROXIMAL DVT,UFH
721149042,5/13/2015 18:07:38,1635902414,5/13/2015 18:05:37,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[IS_A],[IS_A],than for total,N/A,73,26,-1,84,29,TWrex-cause,805008-FS1,"Use of LMWH compared with UFH results in even greater risk reduction for PROXIMAL DVT than for total DVT and, therefore, should be considered the prophylactic agent of choice in these high risk groups (3 6.",PROXIMAL DVT,UFH
721149043,5/13/2015 09:56:34,1635676406,5/13/2015 09:56:24,false,neodev,1.0,32103286,CAN,AB,Edmonton,208.123.223.37,[PREVENTS] [CAUSES] [LOCATION] [NONE],"[PREVENTS]
[CAUSES]
[LOCATION]
[NONE]",no,no,147,16,1,152,40,TWrex-cause,812972-FS1,"Formerly called BENIGN JUVENILE MELANOMA spindle cell nevus usually arises in childhood as a pink or reddish brown, smooth or slightly scaly, firm PAPULE with a predilection for the face, especially the cheeks [ see  Figure 13.",PAPULE,BENIGN JUVENILE MELANOMA
721149043,5/13/2015 10:05:20,1635678627,5/13/2015 10:03:45,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[LOCATION],[LOCATION],"Formerly called BENIGN JUVENILE MELANOMA spindle cell nevus usually arises in childhood as a pink or reddish brown, smooth or slightly scaly, firm PAPULE with a predilection for the face,",N/A,147,16,1,152,40,TWrex-cause,812972-FS1,"Formerly called BENIGN JUVENILE MELANOMA spindle cell nevus usually arises in childhood as a pink or reddish brown, smooth or slightly scaly, firm PAPULE with a predilection for the face, especially the cheeks [ see  Figure 13.",PAPULE,BENIGN JUVENILE MELANOMA
721149043,5/13/2015 10:22:17,1635683290,5/13/2015 10:19:29,false,clixsense,1.0,26847653,NLD,03,Warnsveld,213.93.50.164,[SYMPTOM],[SYMPTOM],"arises in childhood as a pink or reddish brown, smooth or slightly scaly, firm PAPULE",n/a,147,16,1,152,40,TWrex-cause,812972-FS1,"Formerly called BENIGN JUVENILE MELANOMA spindle cell nevus usually arises in childhood as a pink or reddish brown, smooth or slightly scaly, firm PAPULE with a predilection for the face, especially the cheeks [ see  Figure 13.",PAPULE,BENIGN JUVENILE MELANOMA
721149043,5/13/2015 10:25:11,1635683919,5/13/2015 10:24:10,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[MANIFESTATION],[MANIFESTATION],usually arises as,n/a,147,16,1,152,40,TWrex-cause,812972-FS1,"Formerly called BENIGN JUVENILE MELANOMA spindle cell nevus usually arises in childhood as a pink or reddish brown, smooth or slightly scaly, firm PAPULE with a predilection for the face, especially the cheeks [ see  Figure 13.",PAPULE,BENIGN JUVENILE MELANOMA
721149043,5/13/2015 10:26:06,1635684095,5/13/2015 10:25:03,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[MANIFESTATION],[MANIFESTATION],usually arises,N/A,147,16,1,152,40,TWrex-cause,812972-FS1,"Formerly called BENIGN JUVENILE MELANOMA spindle cell nevus usually arises in childhood as a pink or reddish brown, smooth or slightly scaly, firm PAPULE with a predilection for the face, especially the cheeks [ see  Figure 13.",PAPULE,BENIGN JUVENILE MELANOMA
721149043,5/13/2015 10:41:40,1635688631,5/13/2015 10:40:53,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[CAUSES],[CAUSES],JUVENILE MELANOMA,N/A,147,16,1,152,40,TWrex-cause,812972-FS1,"Formerly called BENIGN JUVENILE MELANOMA spindle cell nevus usually arises in childhood as a pink or reddish brown, smooth or slightly scaly, firm PAPULE with a predilection for the face, especially the cheeks [ see  Figure 13.",PAPULE,BENIGN JUVENILE MELANOMA
721149043,5/13/2015 10:53:50,1635692476,5/13/2015 10:52:50,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,[MANIFESTATION],[MANIFESTATION],arises as,n/a,147,16,1,152,40,TWrex-cause,812972-FS1,"Formerly called BENIGN JUVENILE MELANOMA spindle cell nevus usually arises in childhood as a pink or reddish brown, smooth or slightly scaly, firm PAPULE with a predilection for the face, especially the cheeks [ see  Figure 13.",PAPULE,BENIGN JUVENILE MELANOMA
721149043,5/13/2015 10:57:05,1635693296,5/13/2015 10:56:07,false,neodev,1.0,29579905,GBR,"","",5.152.206.71,[DIAGNOSE_BY_TEST_OR_DRUG] [SIDE_EFFECT],"[DIAGNOSE_BY_TEST_OR_DRUG]
[SIDE_EFFECT]","JUVENILE spindle face,",N/A,147,16,1,152,40,TWrex-cause,812972-FS1,"Formerly called BENIGN JUVENILE MELANOMA spindle cell nevus usually arises in childhood as a pink or reddish brown, smooth or slightly scaly, firm PAPULE with a predilection for the face, especially the cheeks [ see  Figure 13.",PAPULE,BENIGN JUVENILE MELANOMA
721149043,5/13/2015 10:59:33,1635694005,5/13/2015 10:56:35,false,neodev,1.0,31706957,NLD,07,Amsterdam,145.100.72.165,[CAUSES],[CAUSES],usually arises in childhood,n/a,147,16,1,152,40,TWrex-cause,812972-FS1,"Formerly called BENIGN JUVENILE MELANOMA spindle cell nevus usually arises in childhood as a pink or reddish brown, smooth or slightly scaly, firm PAPULE with a predilection for the face, especially the cheeks [ see  Figure 13.",PAPULE,BENIGN JUVENILE MELANOMA
721149043,5/13/2015 11:10:09,1635696911,5/13/2015 11:09:43,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[ASSOCIATED_WITH],[ASSOCIATED_WITH],arises in,n/a,147,16,1,152,40,TWrex-cause,812972-FS1,"Formerly called BENIGN JUVENILE MELANOMA spindle cell nevus usually arises in childhood as a pink or reddish brown, smooth or slightly scaly, firm PAPULE with a predilection for the face, especially the cheeks [ see  Figure 13.",PAPULE,BENIGN JUVENILE MELANOMA
721149043,5/13/2015 11:18:21,1635699113,5/13/2015 11:17:32,false,prodege,1.0,27934334,GBR,D3,Swadlincote,109.150.228.127,[MANIFESTATION],[MANIFESTATION],arises as,N/A,147,16,1,152,40,TWrex-cause,812972-FS1,"Formerly called BENIGN JUVENILE MELANOMA spindle cell nevus usually arises in childhood as a pink or reddish brown, smooth or slightly scaly, firm PAPULE with a predilection for the face, especially the cheeks [ see  Figure 13.",PAPULE,BENIGN JUVENILE MELANOMA
721149043,5/13/2015 11:23:20,1635700010,5/13/2015 11:21:50,false,points4rewards,1.0,28703583,USA,"","",97.73.86.35,[MANIFESTATION],[MANIFESTATION],"usually arises in childhood as a pink or reddish brown, smooth or slightly scaly, firm",N/A,147,16,1,152,40,TWrex-cause,812972-FS1,"Formerly called BENIGN JUVENILE MELANOMA spindle cell nevus usually arises in childhood as a pink or reddish brown, smooth or slightly scaly, firm PAPULE with a predilection for the face, especially the cheeks [ see  Figure 13.",PAPULE,BENIGN JUVENILE MELANOMA
721149043,5/13/2015 11:25:47,1635700761,5/13/2015 11:25:02,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[SYMPTOM],[SYMPTOM],BENIGN JUVENILE MELANOMA arises as PAPULE,n/a,147,16,1,152,40,TWrex-cause,812972-FS1,"Formerly called BENIGN JUVENILE MELANOMA spindle cell nevus usually arises in childhood as a pink or reddish brown, smooth or slightly scaly, firm PAPULE with a predilection for the face, especially the cheeks [ see  Figure 13.",PAPULE,BENIGN JUVENILE MELANOMA
721149043,5/13/2015 11:39:11,1635704654,5/13/2015 11:38:28,false,neodev,1.0,31726043,GBR,"","",88.150.202.140,[LOCATION],[LOCATION],usually,oipjkij,147,16,1,152,40,TWrex-cause,812972-FS1,"Formerly called BENIGN JUVENILE MELANOMA spindle cell nevus usually arises in childhood as a pink or reddish brown, smooth or slightly scaly, firm PAPULE with a predilection for the face, especially the cheeks [ see  Figure 13.",PAPULE,BENIGN JUVENILE MELANOMA
721149043,5/13/2015 12:15:23,1635715827,5/13/2015 12:14:56,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[CAUSES],[CAUSES],BENIGN JUVENILE MELANOMA usually arises as firm PAPULE,n/a,147,16,1,152,40,TWrex-cause,812972-FS1,"Formerly called BENIGN JUVENILE MELANOMA spindle cell nevus usually arises in childhood as a pink or reddish brown, smooth or slightly scaly, firm PAPULE with a predilection for the face, especially the cheeks [ see  Figure 13.",PAPULE,BENIGN JUVENILE MELANOMA
721149044,5/13/2015 10:17:35,1635681770,5/13/2015 10:16:26,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[TREATS] [DIAGNOSE_BY_TEST_OR_DRUG] [SYMPTOM],"[TREATS]
[DIAGNOSE_BY_TEST_OR_DRUG]
[SYMPTOM]","Antispasmodics, primarily anticholinergic agents (e.g., dicyclomine hydrochloride, clidinium bromide, hyoscyamine, PROPANTHELINE or belladonna alkaloids), can treat cramping abdominal discomfort or the symptoms of IBS that accompany UC and CD.",N/A,214,115,-1,216,128,TWrex-cause,803348-FS1,"Antispasmodics, primarily anticholinergic agents (e.g., dicyclomine hydrochloride, clidinium bromide, hyoscyamine, PROPANTHELINE or belladonna alkaloids), can treat cramping abdominal discomfort or the symptoms of IBS that accompany UC and CD.",IBS,PROPANTHELINE
721149044,5/13/2015 10:35:06,1635686859,5/13/2015 10:34:07,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[TREATS],[TREATS],can treat,N/A,214,115,-1,216,128,TWrex-cause,803348-FS1,"Antispasmodics, primarily anticholinergic agents (e.g., dicyclomine hydrochloride, clidinium bromide, hyoscyamine, PROPANTHELINE or belladonna alkaloids), can treat cramping abdominal discomfort or the symptoms of IBS that accompany UC and CD.",IBS,PROPANTHELINE
721149044,5/13/2015 10:36:32,1635687326,5/13/2015 10:35:45,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[TREATS],[TREATS],can treat symptoms of,n/a,214,115,-1,216,128,TWrex-cause,803348-FS1,"Antispasmodics, primarily anticholinergic agents (e.g., dicyclomine hydrochloride, clidinium bromide, hyoscyamine, PROPANTHELINE or belladonna alkaloids), can treat cramping abdominal discomfort or the symptoms of IBS that accompany UC and CD.",IBS,PROPANTHELINE
721149044,5/13/2015 10:47:52,1635690572,5/13/2015 10:46:55,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[CAUSES],[CAUSES],"hyoscyamine,",N/A,214,115,-1,216,128,TWrex-cause,803348-FS1,"Antispasmodics, primarily anticholinergic agents (e.g., dicyclomine hydrochloride, clidinium bromide, hyoscyamine, PROPANTHELINE or belladonna alkaloids), can treat cramping abdominal discomfort or the symptoms of IBS that accompany UC and CD.",IBS,PROPANTHELINE
721149044,5/13/2015 11:09:46,1635696828,5/13/2015 11:08:10,false,neodev,1.0,31706957,NLD,07,Amsterdam,145.100.72.165,[SYMPTOM],[SYMPTOM],the symptoms of,n/a,214,115,-1,216,128,TWrex-cause,803348-FS1,"Antispasmodics, primarily anticholinergic agents (e.g., dicyclomine hydrochloride, clidinium bromide, hyoscyamine, PROPANTHELINE or belladonna alkaloids), can treat cramping abdominal discomfort or the symptoms of IBS that accompany UC and CD.",IBS,PROPANTHELINE
721149044,5/13/2015 11:12:55,1635697518,5/13/2015 11:12:43,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[TREATS],[TREATS],treat,n/a,214,115,-1,216,128,TWrex-cause,803348-FS1,"Antispasmodics, primarily anticholinergic agents (e.g., dicyclomine hydrochloride, clidinium bromide, hyoscyamine, PROPANTHELINE or belladonna alkaloids), can treat cramping abdominal discomfort or the symptoms of IBS that accompany UC and CD.",IBS,PROPANTHELINE
721149044,5/13/2015 11:27:16,1635701195,5/13/2015 11:26:51,false,prodege,1.0,27934334,GBR,D3,Swadlincote,109.150.228.127,[TREATS],[TREATS],treat,N/A,214,115,-1,216,128,TWrex-cause,803348-FS1,"Antispasmodics, primarily anticholinergic agents (e.g., dicyclomine hydrochloride, clidinium bromide, hyoscyamine, PROPANTHELINE or belladonna alkaloids), can treat cramping abdominal discomfort or the symptoms of IBS that accompany UC and CD.",IBS,PROPANTHELINE
721149044,5/13/2015 11:32:52,1635702235,5/13/2015 11:31:59,false,points4rewards,1.0,28703583,USA,"","",97.73.86.35,[TREATS],[TREATS],can treat,N/A,214,115,-1,216,128,TWrex-cause,803348-FS1,"Antispasmodics, primarily anticholinergic agents (e.g., dicyclomine hydrochloride, clidinium bromide, hyoscyamine, PROPANTHELINE or belladonna alkaloids), can treat cramping abdominal discomfort or the symptoms of IBS that accompany UC and CD.",IBS,PROPANTHELINE
721149044,5/13/2015 11:35:46,1635703485,5/13/2015 11:35:14,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[TREATS],[TREATS],PROPANTHELINE can treat symptoms of IBS,n/a,214,115,-1,216,128,TWrex-cause,803348-FS1,"Antispasmodics, primarily anticholinergic agents (e.g., dicyclomine hydrochloride, clidinium bromide, hyoscyamine, PROPANTHELINE or belladonna alkaloids), can treat cramping abdominal discomfort or the symptoms of IBS that accompany UC and CD.",IBS,PROPANTHELINE
721149044,5/13/2015 11:43:28,1635705486,5/13/2015 11:43:11,false,neodev,1.0,31726043,GBR,"","",88.150.202.140,[LOCATION],[LOCATION],IBS,651,214,115,-1,216,128,TWrex-cause,803348-FS1,"Antispasmodics, primarily anticholinergic agents (e.g., dicyclomine hydrochloride, clidinium bromide, hyoscyamine, PROPANTHELINE or belladonna alkaloids), can treat cramping abdominal discomfort or the symptoms of IBS that accompany UC and CD.",IBS,PROPANTHELINE
721149044,5/13/2015 12:16:41,1635716267,5/13/2015 12:16:13,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,[TREATS],[TREATS],treat,n/a,214,115,-1,216,128,TWrex-cause,803348-FS1,"Antispasmodics, primarily anticholinergic agents (e.g., dicyclomine hydrochloride, clidinium bromide, hyoscyamine, PROPANTHELINE or belladonna alkaloids), can treat cramping abdominal discomfort or the symptoms of IBS that accompany UC and CD.",IBS,PROPANTHELINE
721149044,5/13/2015 12:20:18,1635717819,5/13/2015 12:19:40,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[TREATS],[TREATS],PROPANTHELINE can treat symptoms of IBS,n/a,214,115,-1,216,128,TWrex-cause,803348-FS1,"Antispasmodics, primarily anticholinergic agents (e.g., dicyclomine hydrochloride, clidinium bromide, hyoscyamine, PROPANTHELINE or belladonna alkaloids), can treat cramping abdominal discomfort or the symptoms of IBS that accompany UC and CD.",IBS,PROPANTHELINE
721149044,5/13/2015 12:23:03,1635718852,5/13/2015 12:22:06,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[TREATS],[TREATS],treat,N/A,214,115,-1,216,128,TWrex-cause,803348-FS1,"Antispasmodics, primarily anticholinergic agents (e.g., dicyclomine hydrochloride, clidinium bromide, hyoscyamine, PROPANTHELINE or belladonna alkaloids), can treat cramping abdominal discomfort or the symptoms of IBS that accompany UC and CD.",IBS,PROPANTHELINE
721149044,5/13/2015 12:44:04,1635724724,5/13/2015 12:42:22,false,prodege,1.0,23482077,USA,TX,Garland,71.164.238.226,[TREATS],[TREATS],can treat,N/A,214,115,-1,216,128,TWrex-cause,803348-FS1,"Antispasmodics, primarily anticholinergic agents (e.g., dicyclomine hydrochloride, clidinium bromide, hyoscyamine, PROPANTHELINE or belladonna alkaloids), can treat cramping abdominal discomfort or the symptoms of IBS that accompany UC and CD.",IBS,PROPANTHELINE
721149044,5/13/2015 12:57:43,1635727894,5/13/2015 12:57:05,false,clixsense,1.0,6574449,USA,"","",216.216.68.85,[OTHER],[OTHER],"Antispasmodics, primarily anticholinergic agents PROPANTHELINE belladonna alkaloids), treat cramping abdominal discomfort symptoms IBS accompany UC CD.",na,214,115,-1,216,128,TWrex-cause,803348-FS1,"Antispasmodics, primarily anticholinergic agents (e.g., dicyclomine hydrochloride, clidinium bromide, hyoscyamine, PROPANTHELINE or belladonna alkaloids), can treat cramping abdominal discomfort or the symptoms of IBS that accompany UC and CD.",IBS,PROPANTHELINE
721149045,5/13/2015 09:56:53,1635676526,5/13/2015 09:56:36,false,neodev,1.0,32103286,CAN,AB,Edmonton,208.123.223.37,[LOCATION] [CAUSES] [SYMPTOM] [NONE],"[CAUSES]
[LOCATION]
[SYMPTOM]
[NONE]",no,no,16,126,-1,56,135,TWrex-cause,800117-FS1,b  Treatment of CHRONIC HEPATITIS C VIRUS (HCV INFECTION)  >    Concomitant Therapy with Interferon Alfa 2b (Intron ®  A) and RIBAVIRIN  Sub Q:  Children ≥3 years of age: Interferon alfa 2b 3 million units 3 times weekly.,CHRONIC HEPATITIS C VIRUS (HCV INFECTION),RIBAVIRIN
721149045,5/13/2015 10:06:32,1635678988,5/13/2015 10:05:20,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[TREATS] [DIAGNOSE_BY_TEST_OR_DRUG],"[TREATS]
[DIAGNOSE_BY_TEST_OR_DRUG]",Treatment of CHRONIC HEPATITIS C VIRUS (HCV INFECTION) Concomitant Therapy with Interferon Alfa 2b (Intron ® A) and RIBAVIRIN Sub Q: Children ≥3 years of age: Interferon alfa 2b 3 million units 3 times weekly.,N/A,16,126,-1,56,135,TWrex-cause,800117-FS1,b  Treatment of CHRONIC HEPATITIS C VIRUS (HCV INFECTION)  >    Concomitant Therapy with Interferon Alfa 2b (Intron ®  A) and RIBAVIRIN  Sub Q:  Children ≥3 years of age: Interferon alfa 2b 3 million units 3 times weekly.,CHRONIC HEPATITIS C VIRUS (HCV INFECTION),RIBAVIRIN
721149045,5/13/2015 10:23:28,1635683538,5/13/2015 10:22:18,false,clixsense,1.0,26847653,NLD,03,Warnsveld,213.93.50.164,[TREATS],[TREATS],Treatment of,n/a,16,126,-1,56,135,TWrex-cause,800117-FS1,b  Treatment of CHRONIC HEPATITIS C VIRUS (HCV INFECTION)  >    Concomitant Therapy with Interferon Alfa 2b (Intron ®  A) and RIBAVIRIN  Sub Q:  Children ≥3 years of age: Interferon alfa 2b 3 million units 3 times weekly.,CHRONIC HEPATITIS C VIRUS (HCV INFECTION),RIBAVIRIN
721149045,5/13/2015 10:25:37,1635683954,5/13/2015 10:25:12,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[TREATS],[TREATS],Therapy with,n/a,16,126,-1,56,135,TWrex-cause,800117-FS1,b  Treatment of CHRONIC HEPATITIS C VIRUS (HCV INFECTION)  >    Concomitant Therapy with Interferon Alfa 2b (Intron ®  A) and RIBAVIRIN  Sub Q:  Children ≥3 years of age: Interferon alfa 2b 3 million units 3 times weekly.,CHRONIC HEPATITIS C VIRUS (HCV INFECTION),RIBAVIRIN
721149045,5/13/2015 10:27:09,1635684345,5/13/2015 10:26:11,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[TREATS],[TREATS],Treatment of,N/A,16,126,-1,56,135,TWrex-cause,800117-FS1,b  Treatment of CHRONIC HEPATITIS C VIRUS (HCV INFECTION)  >    Concomitant Therapy with Interferon Alfa 2b (Intron ®  A) and RIBAVIRIN  Sub Q:  Children ≥3 years of age: Interferon alfa 2b 3 million units 3 times weekly.,CHRONIC HEPATITIS C VIRUS (HCV INFECTION),RIBAVIRIN
721149045,5/13/2015 10:42:00,1635688723,5/13/2015 10:41:41,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[CAUSES],[CAUSES],HEPATITIS,N/A,16,126,-1,56,135,TWrex-cause,800117-FS1,b  Treatment of CHRONIC HEPATITIS C VIRUS (HCV INFECTION)  >    Concomitant Therapy with Interferon Alfa 2b (Intron ®  A) and RIBAVIRIN  Sub Q:  Children ≥3 years of age: Interferon alfa 2b 3 million units 3 times weekly.,CHRONIC HEPATITIS C VIRUS (HCV INFECTION),RIBAVIRIN
721149045,5/13/2015 10:58:20,1635693741,5/13/2015 10:57:09,false,neodev,1.0,29579905,GBR,"","",5.152.206.71,[MANIFESTATION] [IS_A] [OTHER],"[MANIFESTATION]
[IS_A]
[OTHER]",VIRUS Concomitant Interferon million,N/A,16,126,-1,56,135,TWrex-cause,800117-FS1,b  Treatment of CHRONIC HEPATITIS C VIRUS (HCV INFECTION)  >    Concomitant Therapy with Interferon Alfa 2b (Intron ®  A) and RIBAVIRIN  Sub Q:  Children ≥3 years of age: Interferon alfa 2b 3 million units 3 times weekly.,CHRONIC HEPATITIS C VIRUS (HCV INFECTION),RIBAVIRIN
721149045,5/13/2015 11:00:25,1635694293,5/13/2015 10:59:34,false,neodev,1.0,31706957,NLD,07,Amsterdam,145.100.72.165,[TREATS],[TREATS],Treatment with,n/a,16,126,-1,56,135,TWrex-cause,800117-FS1,b  Treatment of CHRONIC HEPATITIS C VIRUS (HCV INFECTION)  >    Concomitant Therapy with Interferon Alfa 2b (Intron ®  A) and RIBAVIRIN  Sub Q:  Children ≥3 years of age: Interferon alfa 2b 3 million units 3 times weekly.,CHRONIC HEPATITIS C VIRUS (HCV INFECTION),RIBAVIRIN
721149045,5/13/2015 11:10:28,1635696996,5/13/2015 11:10:11,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[TREATS],[TREATS],Treatment of,n/a,16,126,-1,56,135,TWrex-cause,800117-FS1,b  Treatment of CHRONIC HEPATITIS C VIRUS (HCV INFECTION)  >    Concomitant Therapy with Interferon Alfa 2b (Intron ®  A) and RIBAVIRIN  Sub Q:  Children ≥3 years of age: Interferon alfa 2b 3 million units 3 times weekly.,CHRONIC HEPATITIS C VIRUS (HCV INFECTION),RIBAVIRIN
721149045,5/13/2015 11:18:46,1635699195,5/13/2015 11:18:22,false,prodege,1.0,27934334,GBR,D3,Swadlincote,109.150.228.127,[TREATS],[TREATS],Therapy,N/A,16,126,-1,56,135,TWrex-cause,800117-FS1,b  Treatment of CHRONIC HEPATITIS C VIRUS (HCV INFECTION)  >    Concomitant Therapy with Interferon Alfa 2b (Intron ®  A) and RIBAVIRIN  Sub Q:  Children ≥3 years of age: Interferon alfa 2b 3 million units 3 times weekly.,CHRONIC HEPATITIS C VIRUS (HCV INFECTION),RIBAVIRIN
721149045,5/13/2015 11:23:59,1635700180,5/13/2015 11:23:25,false,points4rewards,1.0,28703583,USA,"","",97.73.86.35,[TREATS],[TREATS],Treatment of,N/A,16,126,-1,56,135,TWrex-cause,800117-FS1,b  Treatment of CHRONIC HEPATITIS C VIRUS (HCV INFECTION)  >    Concomitant Therapy with Interferon Alfa 2b (Intron ®  A) and RIBAVIRIN  Sub Q:  Children ≥3 years of age: Interferon alfa 2b 3 million units 3 times weekly.,CHRONIC HEPATITIS C VIRUS (HCV INFECTION),RIBAVIRIN
721149045,5/13/2015 11:28:12,1635701397,5/13/2015 11:25:48,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[TREATS],[TREATS],Treatment of CHRONIC HEPATITIS C VIRUS (HCV INFECTION) Therapy with RIBAVIRIN,n/a,16,126,-1,56,135,TWrex-cause,800117-FS1,b  Treatment of CHRONIC HEPATITIS C VIRUS (HCV INFECTION)  >    Concomitant Therapy with Interferon Alfa 2b (Intron ®  A) and RIBAVIRIN  Sub Q:  Children ≥3 years of age: Interferon alfa 2b 3 million units 3 times weekly.,CHRONIC HEPATITIS C VIRUS (HCV INFECTION),RIBAVIRIN
721149045,5/13/2015 11:39:34,1635704775,5/13/2015 11:39:17,false,neodev,1.0,31726043,GBR,"","",88.150.202.140,[CAUSES],[CAUSES],Concomitant,oijhun,16,126,-1,56,135,TWrex-cause,800117-FS1,b  Treatment of CHRONIC HEPATITIS C VIRUS (HCV INFECTION)  >    Concomitant Therapy with Interferon Alfa 2b (Intron ®  A) and RIBAVIRIN  Sub Q:  Children ≥3 years of age: Interferon alfa 2b 3 million units 3 times weekly.,CHRONIC HEPATITIS C VIRUS (HCV INFECTION),RIBAVIRIN
721149045,5/13/2015 12:09:50,1635713328,5/13/2015 12:08:51,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,[TREATS],[TREATS],Therapy with Interferon Alfa 2b and RIBAVIRIN,n/a,16,126,-1,56,135,TWrex-cause,800117-FS1,b  Treatment of CHRONIC HEPATITIS C VIRUS (HCV INFECTION)  >    Concomitant Therapy with Interferon Alfa 2b (Intron ®  A) and RIBAVIRIN  Sub Q:  Children ≥3 years of age: Interferon alfa 2b 3 million units 3 times weekly.,CHRONIC HEPATITIS C VIRUS (HCV INFECTION),RIBAVIRIN
721149045,5/13/2015 12:16:06,1635716027,5/13/2015 12:15:25,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[TREATS],[TREATS],Treatment of CHRONIC HEPATITIS C VIRUS (HCV INFECTION) RIBAVIRIN,n/a,16,126,-1,56,135,TWrex-cause,800117-FS1,b  Treatment of CHRONIC HEPATITIS C VIRUS (HCV INFECTION)  >    Concomitant Therapy with Interferon Alfa 2b (Intron ®  A) and RIBAVIRIN  Sub Q:  Children ≥3 years of age: Interferon alfa 2b 3 million units 3 times weekly.,CHRONIC HEPATITIS C VIRUS (HCV INFECTION),RIBAVIRIN
721149046,5/13/2015 13:04:57,1635730314,5/13/2015 13:04:39,false,neodev,1.0,30504276,CAN,ON,Sudbury,66.103.55.12,[PART_OF],[PART_OF],part of,N/A,83,35,1,115,67,TWrex-cause,813947-FS1,"Rarely, varicose veins are part of KLIPPEL TRENAUNAY WEBER SYNDROME which includes CONGENITAL ARTERIOVENOUS FISTULAS and diffuse cutaneous capillary angiomas.",CONGENITAL ARTERIOVENOUS FISTULAS,KLIPPEL TRENAUNAY WEBER SYNDROME
721149046,5/13/2015 13:07:48,1635731153,5/13/2015 13:07:29,false,clixsense,1.0,24329110,USA,FL,Jacksonville,12.168.136.2,[ASSOCIATED_WITH],[ASSOCIATED_WITH],which includes,n/a,83,35,1,115,67,TWrex-cause,813947-FS1,"Rarely, varicose veins are part of KLIPPEL TRENAUNAY WEBER SYNDROME which includes CONGENITAL ARTERIOVENOUS FISTULAS and diffuse cutaneous capillary angiomas.",CONGENITAL ARTERIOVENOUS FISTULAS,KLIPPEL TRENAUNAY WEBER SYNDROME
721149046,5/13/2015 13:14:17,1635732789,5/13/2015 13:13:53,false,clixsense,1.0,23197581,NLD,11,Den Haag,82.217.5.55,[SYMPTOM],[SYMPTOM],which includes,N/A,83,35,1,115,67,TWrex-cause,813947-FS1,"Rarely, varicose veins are part of KLIPPEL TRENAUNAY WEBER SYNDROME which includes CONGENITAL ARTERIOVENOUS FISTULAS and diffuse cutaneous capillary angiomas.",CONGENITAL ARTERIOVENOUS FISTULAS,KLIPPEL TRENAUNAY WEBER SYNDROME
721149046,5/13/2015 13:15:35,1635733248,5/13/2015 13:14:36,false,prodege,1.0,23482077,USA,TX,Garland,71.164.238.226,[ASSOCIATED_WITH] [MANIFESTATION] [SYMPTOM],"[SYMPTOM]
[MANIFESTATION]
[ASSOCIATED_WITH]",which includes,N/A,83,35,1,115,67,TWrex-cause,813947-FS1,"Rarely, varicose veins are part of KLIPPEL TRENAUNAY WEBER SYNDROME which includes CONGENITAL ARTERIOVENOUS FISTULAS and diffuse cutaneous capillary angiomas.",CONGENITAL ARTERIOVENOUS FISTULAS,KLIPPEL TRENAUNAY WEBER SYNDROME
721149046,5/13/2015 13:35:41,1635738397,5/13/2015 13:33:19,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[IS_A] [PART_OF],"[IS_A]
[PART_OF]",KLIPPEL TRENAUNAY WEBER SYNDROME includes CONGENITAL ARTERIOVENOUS FISTULAS,N/A,83,35,1,115,67,TWrex-cause,813947-FS1,"Rarely, varicose veins are part of KLIPPEL TRENAUNAY WEBER SYNDROME which includes CONGENITAL ARTERIOVENOUS FISTULAS and diffuse cutaneous capillary angiomas.",CONGENITAL ARTERIOVENOUS FISTULAS,KLIPPEL TRENAUNAY WEBER SYNDROME
721149046,5/13/2015 13:39:08,1635739457,5/13/2015 13:38:33,false,bitcoinget,1.0,21614812,USA,PA,Erie,174.100.250.115,[ASSOCIATED_WITH],[ASSOCIATED_WITH],which includes,N/A,83,35,1,115,67,TWrex-cause,813947-FS1,"Rarely, varicose veins are part of KLIPPEL TRENAUNAY WEBER SYNDROME which includes CONGENITAL ARTERIOVENOUS FISTULAS and diffuse cutaneous capillary angiomas.",CONGENITAL ARTERIOVENOUS FISTULAS,KLIPPEL TRENAUNAY WEBER SYNDROME
721149046,5/13/2015 13:46:29,1635741886,5/13/2015 13:46:12,false,neodev,1.0,24564999,GBR,H9,London,86.145.227.9,[IS_A],[IS_A],which includes,N/A,83,35,1,115,67,TWrex-cause,813947-FS1,"Rarely, varicose veins are part of KLIPPEL TRENAUNAY WEBER SYNDROME which includes CONGENITAL ARTERIOVENOUS FISTULAS and diffuse cutaneous capillary angiomas.",CONGENITAL ARTERIOVENOUS FISTULAS,KLIPPEL TRENAUNAY WEBER SYNDROME
721149046,5/13/2015 13:54:30,1635745196,5/13/2015 13:54:04,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[ASSOCIATED_WITH],[ASSOCIATED_WITH],includes,N/A,83,35,1,115,67,TWrex-cause,813947-FS1,"Rarely, varicose veins are part of KLIPPEL TRENAUNAY WEBER SYNDROME which includes CONGENITAL ARTERIOVENOUS FISTULAS and diffuse cutaneous capillary angiomas.",CONGENITAL ARTERIOVENOUS FISTULAS,KLIPPEL TRENAUNAY WEBER SYNDROME
721149046,5/13/2015 14:16:04,1635754433,5/13/2015 14:15:10,false,prodege,1.0,24403612,CAN,ON,Ajax,99.239.181.149,[SYMPTOM],[SYMPTOM],KLIPPEL TRENAUNAY WEBER SYNDROME which includes CONGENITAL ARTERIOVENOUS FISTULAS,N/a,83,35,1,115,67,TWrex-cause,813947-FS1,"Rarely, varicose veins are part of KLIPPEL TRENAUNAY WEBER SYNDROME which includes CONGENITAL ARTERIOVENOUS FISTULAS and diffuse cutaneous capillary angiomas.",CONGENITAL ARTERIOVENOUS FISTULAS,KLIPPEL TRENAUNAY WEBER SYNDROME
721149046,5/13/2015 14:25:18,1635757979,5/13/2015 14:25:02,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[PART_OF],[PART_OF],which includes,N/A,83,35,1,115,67,TWrex-cause,813947-FS1,"Rarely, varicose veins are part of KLIPPEL TRENAUNAY WEBER SYNDROME which includes CONGENITAL ARTERIOVENOUS FISTULAS and diffuse cutaneous capillary angiomas.",CONGENITAL ARTERIOVENOUS FISTULAS,KLIPPEL TRENAUNAY WEBER SYNDROME
721149046,5/13/2015 15:10:32,1635789927,5/13/2015 15:10:14,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,[PART_OF],[PART_OF],part of,n/a,83,35,1,115,67,TWrex-cause,813947-FS1,"Rarely, varicose veins are part of KLIPPEL TRENAUNAY WEBER SYNDROME which includes CONGENITAL ARTERIOVENOUS FISTULAS and diffuse cutaneous capillary angiomas.",CONGENITAL ARTERIOVENOUS FISTULAS,KLIPPEL TRENAUNAY WEBER SYNDROME
721149046,5/13/2015 15:39:51,1635813179,5/13/2015 15:39:25,false,clixsense,1.0,32549163,CAN,MB,Winnipeg,206.45.167.246,[SYMPTOM],[SYMPTOM],KLIPPEL TRENAUNAY WEBER SYNDROME which includes CONGENITAL ARTERIOVENOUS FISTULAS,N/A,83,35,1,115,67,TWrex-cause,813947-FS1,"Rarely, varicose veins are part of KLIPPEL TRENAUNAY WEBER SYNDROME which includes CONGENITAL ARTERIOVENOUS FISTULAS and diffuse cutaneous capillary angiomas.",CONGENITAL ARTERIOVENOUS FISTULAS,KLIPPEL TRENAUNAY WEBER SYNDROME
721149046,5/13/2015 15:55:43,1635825268,5/13/2015 15:55:15,false,instagc,1.0,24252915,GBR,F2,Gosport,92.24.208.155,[PART_OF],[PART_OF],KLIPPEL TRENAUNAY WEBER SYNDROME which includes CONGENITAL ARTERIOVENOUS FISTULAS,N/a,83,35,1,115,67,TWrex-cause,813947-FS1,"Rarely, varicose veins are part of KLIPPEL TRENAUNAY WEBER SYNDROME which includes CONGENITAL ARTERIOVENOUS FISTULAS and diffuse cutaneous capillary angiomas.",CONGENITAL ARTERIOVENOUS FISTULAS,KLIPPEL TRENAUNAY WEBER SYNDROME
721149046,5/13/2015 15:58:49,1635827824,5/13/2015 15:57:57,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[MANIFESTATION],[MANIFESTATION],includes,none,83,35,1,115,67,TWrex-cause,813947-FS1,"Rarely, varicose veins are part of KLIPPEL TRENAUNAY WEBER SYNDROME which includes CONGENITAL ARTERIOVENOUS FISTULAS and diffuse cutaneous capillary angiomas.",CONGENITAL ARTERIOVENOUS FISTULAS,KLIPPEL TRENAUNAY WEBER SYNDROME
721149046,5/13/2015 16:26:20,1635846507,5/13/2015 16:25:44,false,prodege,1.0,16101132,GBR,F9,Hayes,2.223.214.149,[ASSOCIATED_WITH],[ASSOCIATED_WITH],includes,Associated with,83,35,1,115,67,TWrex-cause,813947-FS1,"Rarely, varicose veins are part of KLIPPEL TRENAUNAY WEBER SYNDROME which includes CONGENITAL ARTERIOVENOUS FISTULAS and diffuse cutaneous capillary angiomas.",CONGENITAL ARTERIOVENOUS FISTULAS,KLIPPEL TRENAUNAY WEBER SYNDROME
721149047,5/13/2015 16:49:36,1635860937,5/13/2015 16:48:49,false,clixsense,1.0,31579138,AUS,02,Hurstville,14.200.129.68,[TREATS],[TREATS],REDUCED MORTALITY,N/A,132,0,-1,152,28,TWrex-cause,804563-FS1,CARVEDILOL REDUCED MORTALITY and morbidity caused by myocardial infarction in patients with left ventricular dysfunction  Keywords: MYOCARDIAL INFARCTION Left ventricular function Adrenergic beta agonists  ACP Journal Club.,MYOCARDIAL INFARCTION,CARVEDILOL REDUCED MORTALITY
721149047,5/13/2015 17:31:08,1635883585,5/13/2015 17:29:44,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[CAUSES],[CAUSES],caused by,n/a,132,0,-1,152,28,TWrex-cause,804563-FS1,CARVEDILOL REDUCED MORTALITY and morbidity caused by myocardial infarction in patients with left ventricular dysfunction  Keywords: MYOCARDIAL INFARCTION Left ventricular function Adrenergic beta agonists  ACP Journal Club.,MYOCARDIAL INFARCTION,CARVEDILOL REDUCED MORTALITY
721149047,5/13/2015 17:39:00,1635887834,5/13/2015 17:38:11,false,gptking,1.0,31799065,USA,IL,Marion,50.45.43.154,[CAUSES],[CAUSES],CARVEDILOL REDUCED MORTALITY caused by MYOCARDIAL INFARCTION,N/A,132,0,-1,152,28,TWrex-cause,804563-FS1,CARVEDILOL REDUCED MORTALITY and morbidity caused by myocardial infarction in patients with left ventricular dysfunction  Keywords: MYOCARDIAL INFARCTION Left ventricular function Adrenergic beta agonists  ACP Journal Club.,MYOCARDIAL INFARCTION,CARVEDILOL REDUCED MORTALITY
721149047,5/13/2015 18:13:56,1635905160,5/13/2015 18:13:20,false,clixsense,1.0,32549163,CAN,MB,Winnipeg,206.45.167.246,[CAUSES],[CAUSES],CARVEDILOL REDUCED MORTALITY caused by myocardial infarction,N/A,132,0,-1,152,28,TWrex-cause,804563-FS1,CARVEDILOL REDUCED MORTALITY and morbidity caused by myocardial infarction in patients with left ventricular dysfunction  Keywords: MYOCARDIAL INFARCTION Left ventricular function Adrenergic beta agonists  ACP Journal Club.,MYOCARDIAL INFARCTION,CARVEDILOL REDUCED MORTALITY
721149047,5/13/2015 18:16:42,1635906114,5/13/2015 18:16:14,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[CAUSES],[CAUSES],caused by,N/A,132,0,-1,152,28,TWrex-cause,804563-FS1,CARVEDILOL REDUCED MORTALITY and morbidity caused by myocardial infarction in patients with left ventricular dysfunction  Keywords: MYOCARDIAL INFARCTION Left ventricular function Adrenergic beta agonists  ACP Journal Club.,MYOCARDIAL INFARCTION,CARVEDILOL REDUCED MORTALITY
721149047,5/13/2015 18:21:15,1635908186,5/13/2015 18:20:47,false,instagc,1.0,24252915,GBR,"","",80.44.146.98,[CAUSES],[CAUSES],caused by,N/a,132,0,-1,152,28,TWrex-cause,804563-FS1,CARVEDILOL REDUCED MORTALITY and morbidity caused by myocardial infarction in patients with left ventricular dysfunction  Keywords: MYOCARDIAL INFARCTION Left ventricular function Adrenergic beta agonists  ACP Journal Club.,MYOCARDIAL INFARCTION,CARVEDILOL REDUCED MORTALITY
721149047,5/13/2015 18:23:14,1635909389,5/13/2015 18:21:42,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[CAUSES],[CAUSES],caused by,N/A,132,0,-1,152,28,TWrex-cause,804563-FS1,CARVEDILOL REDUCED MORTALITY and morbidity caused by myocardial infarction in patients with left ventricular dysfunction  Keywords: MYOCARDIAL INFARCTION Left ventricular function Adrenergic beta agonists  ACP Journal Club.,MYOCARDIAL INFARCTION,CARVEDILOL REDUCED MORTALITY
721149047,5/13/2015 18:46:47,1635921480,5/13/2015 18:46:15,false,prodege,1.0,32302664,USA,IL,Geneseo,173.27.241.235,[CAUSES],[CAUSES],and morbidity caused by myocardial infarction in patients with left ventricular dysfunction Keywords:,no comment,132,0,-1,152,28,TWrex-cause,804563-FS1,CARVEDILOL REDUCED MORTALITY and morbidity caused by myocardial infarction in patients with left ventricular dysfunction  Keywords: MYOCARDIAL INFARCTION Left ventricular function Adrenergic beta agonists  ACP Journal Club.,MYOCARDIAL INFARCTION,CARVEDILOL REDUCED MORTALITY
721149047,5/13/2015 19:09:52,1635930780,5/13/2015 19:09:39,false,clixsense,1.0,19162475,GBR,P8,Trowbridge,82.33.126.30,[ASSOCIATED_WITH],[ASSOCIATED_WITH],and,n/a,132,0,-1,152,28,TWrex-cause,804563-FS1,CARVEDILOL REDUCED MORTALITY and morbidity caused by myocardial infarction in patients with left ventricular dysfunction  Keywords: MYOCARDIAL INFARCTION Left ventricular function Adrenergic beta agonists  ACP Journal Club.,MYOCARDIAL INFARCTION,CARVEDILOL REDUCED MORTALITY
721149047,5/13/2015 19:12:46,1635932796,5/13/2015 19:12:26,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[CAUSES],[CAUSES],caused,N/A,132,0,-1,152,28,TWrex-cause,804563-FS1,CARVEDILOL REDUCED MORTALITY and morbidity caused by myocardial infarction in patients with left ventricular dysfunction  Keywords: MYOCARDIAL INFARCTION Left ventricular function Adrenergic beta agonists  ACP Journal Club.,MYOCARDIAL INFARCTION,CARVEDILOL REDUCED MORTALITY
721149047,5/13/2015 19:45:14,1635963240,5/13/2015 19:44:49,false,elite,1.0,30064988,GBR,H3,Leeds,92.22.208.245,[CAUSES],[CAUSES],caused by,N/A,132,0,-1,152,28,TWrex-cause,804563-FS1,CARVEDILOL REDUCED MORTALITY and morbidity caused by myocardial infarction in patients with left ventricular dysfunction  Keywords: MYOCARDIAL INFARCTION Left ventricular function Adrenergic beta agonists  ACP Journal Club.,MYOCARDIAL INFARCTION,CARVEDILOL REDUCED MORTALITY
721149047,5/13/2015 20:05:49,1635979516,5/13/2015 20:05:25,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.156.243,[ASSOCIATED_WITH],[ASSOCIATED_WITH],CARVEDILOL REDUCED MORTALITY Keywords: MYOCARDIAL INFARCTION,N/A,132,0,-1,152,28,TWrex-cause,804563-FS1,CARVEDILOL REDUCED MORTALITY and morbidity caused by myocardial infarction in patients with left ventricular dysfunction  Keywords: MYOCARDIAL INFARCTION Left ventricular function Adrenergic beta agonists  ACP Journal Club.,MYOCARDIAL INFARCTION,CARVEDILOL REDUCED MORTALITY
721149047,5/13/2015 20:05:55,1635979636,5/13/2015 20:05:27,false,clixsense,1.0,27969116,NLD,"","",212.78.195.38,[CAUSES],[CAUSES],caused by myocardial Club.,caused by it.,132,0,-1,152,28,TWrex-cause,804563-FS1,CARVEDILOL REDUCED MORTALITY and morbidity caused by myocardial infarction in patients with left ventricular dysfunction  Keywords: MYOCARDIAL INFARCTION Left ventricular function Adrenergic beta agonists  ACP Journal Club.,MYOCARDIAL INFARCTION,CARVEDILOL REDUCED MORTALITY
721149047,5/13/2015 20:32:57,1635999441,5/13/2015 20:32:45,false,neodev,1.0,20961587,NLD,05,Maastricht,84.26.48.136,[CAUSES],[CAUSES],caused,N/A,132,0,-1,152,28,TWrex-cause,804563-FS1,CARVEDILOL REDUCED MORTALITY and morbidity caused by myocardial infarction in patients with left ventricular dysfunction  Keywords: MYOCARDIAL INFARCTION Left ventricular function Adrenergic beta agonists  ACP Journal Club.,MYOCARDIAL INFARCTION,CARVEDILOL REDUCED MORTALITY
721149047,5/13/2015 20:44:23,1636007291,5/13/2015 20:42:03,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[CAUSES] [PREVENTS],"[PREVENTS]
[CAUSES]",CARVEDILOL REDUCED MORTALITY caused by MYOCARDIAL INFARCTION,N/A,132,0,-1,152,28,TWrex-cause,804563-FS1,CARVEDILOL REDUCED MORTALITY and morbidity caused by myocardial infarction in patients with left ventricular dysfunction  Keywords: MYOCARDIAL INFARCTION Left ventricular function Adrenergic beta agonists  ACP Journal Club.,MYOCARDIAL INFARCTION,CARVEDILOL REDUCED MORTALITY
721149048,5/13/2015 16:19:55,1635842138,5/13/2015 16:18:56,false,clixsense,1,11106820,USA,MA,Taunton,173.48.52.95,[MANIFESTATION],[MANIFESTATION],indicate,none,122,24,1,140,47,TWrex-cause,814004-FS1,• Reviews indicate that ACUTE HEPATIC PORPHYRIA with neuropsychiatric disturbances and signs of autonomic dysfunction and ASCENDING PARALYSIS with bilateral facial weakness may mimic rabies.,ASCENDING PARALYSIS,ACUTE HEPATIC PORPHYRIA
721149048,5/13/2015 16:38:43,1635854569,5/13/2015 16:38:10,false,prodege,1,16101132,GBR,F9,Hayes,2.223.214.149,[ASSOCIATED_WITH],[ASSOCIATED_WITH],indicate,Associated with,122,24,1,140,47,TWrex-cause,814004-FS1,• Reviews indicate that ACUTE HEPATIC PORPHYRIA with neuropsychiatric disturbances and signs of autonomic dysfunction and ASCENDING PARALYSIS with bilateral facial weakness may mimic rabies.,ASCENDING PARALYSIS,ACUTE HEPATIC PORPHYRIA
721149048,5/13/2015 16:41:34,1635856266,5/13/2015 16:40:36,false,clixsense,1,31579138,AUS,02,Hurstville,14.200.129.68,[ASSOCIATED_WITH],[ASSOCIATED_WITH],mimic,N/A,122,24,1,140,47,TWrex-cause,814004-FS1,• Reviews indicate that ACUTE HEPATIC PORPHYRIA with neuropsychiatric disturbances and signs of autonomic dysfunction and ASCENDING PARALYSIS with bilateral facial weakness may mimic rabies.,ASCENDING PARALYSIS,ACUTE HEPATIC PORPHYRIA
721149048,5/13/2015 17:22:52,1635879018,5/13/2015 17:22:00,false,elite,1,31883685,GBR,H2,Accrington,80.47.186.28,[SYMPTOM],[SYMPTOM],with ASCENDING PARALYSIS,n/a,122,24,1,140,47,TWrex-cause,814004-FS1,• Reviews indicate that ACUTE HEPATIC PORPHYRIA with neuropsychiatric disturbances and signs of autonomic dysfunction and ASCENDING PARALYSIS with bilateral facial weakness may mimic rabies.,ASCENDING PARALYSIS,ACUTE HEPATIC PORPHYRIA
721149048,5/13/2015 17:31:10,1635883589,5/13/2015 17:30:10,false,gptking,1,31799065,USA,IL,Marion,50.45.43.154,[ASSOCIATED_WITH],[ASSOCIATED_WITH],ACUTE HEPATIC PORPHYRIA ASCENDING PARALYSIS,N/A,122,24,1,140,47,TWrex-cause,814004-FS1,• Reviews indicate that ACUTE HEPATIC PORPHYRIA with neuropsychiatric disturbances and signs of autonomic dysfunction and ASCENDING PARALYSIS with bilateral facial weakness may mimic rabies.,ASCENDING PARALYSIS,ACUTE HEPATIC PORPHYRIA
721149048,5/13/2015 17:57:39,1635899065,5/13/2015 17:57:05,false,prodege,1,14848125,GBR,L6,Shrewsbury,86.138.223.142,[ASSOCIATED_WITH],[ASSOCIATED_WITH],with signs of,N/A,122,24,1,140,47,TWrex-cause,814004-FS1,• Reviews indicate that ACUTE HEPATIC PORPHYRIA with neuropsychiatric disturbances and signs of autonomic dysfunction and ASCENDING PARALYSIS with bilateral facial weakness may mimic rabies.,ASCENDING PARALYSIS,ACUTE HEPATIC PORPHYRIA
721149048,5/13/2015 18:10:16,1635903602,5/13/2015 18:09:55,false,clixsense,1,32549163,CAN,MB,Winnipeg,206.45.167.246,[ASSOCIATED_WITH],[ASSOCIATED_WITH],ACUTE HEPATIC PORPHYRIA and signs of ASCENDING PARALYSIS,N/A,122,24,1,140,47,TWrex-cause,814004-FS1,• Reviews indicate that ACUTE HEPATIC PORPHYRIA with neuropsychiatric disturbances and signs of autonomic dysfunction and ASCENDING PARALYSIS with bilateral facial weakness may mimic rabies.,ASCENDING PARALYSIS,ACUTE HEPATIC PORPHYRIA
721149048,5/13/2015 18:12:28,1635904522,5/13/2015 18:11:49,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],Reviews indicate,N/A,122,24,1,140,47,TWrex-cause,814004-FS1,• Reviews indicate that ACUTE HEPATIC PORPHYRIA with neuropsychiatric disturbances and signs of autonomic dysfunction and ASCENDING PARALYSIS with bilateral facial weakness may mimic rabies.,ASCENDING PARALYSIS,ACUTE HEPATIC PORPHYRIA
721149048,5/13/2015 18:14:45,1635905492,5/13/2015 18:13:58,false,instagc,1.0,24252915,GBR,"","",80.44.146.98,[ASSOCIATED_WITH],[ASSOCIATED_WITH],with,N/a,122,24,1,140,47,TWrex-cause,814004-FS1,• Reviews indicate that ACUTE HEPATIC PORPHYRIA with neuropsychiatric disturbances and signs of autonomic dysfunction and ASCENDING PARALYSIS with bilateral facial weakness may mimic rabies.,ASCENDING PARALYSIS,ACUTE HEPATIC PORPHYRIA
721149048,5/13/2015 18:15:11,1635905621,5/13/2015 18:13:59,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[ASSOCIATED_WITH],[ASSOCIATED_WITH],with and,N/A,122,24,1,140,47,TWrex-cause,814004-FS1,• Reviews indicate that ACUTE HEPATIC PORPHYRIA with neuropsychiatric disturbances and signs of autonomic dysfunction and ASCENDING PARALYSIS with bilateral facial weakness may mimic rabies.,ASCENDING PARALYSIS,ACUTE HEPATIC PORPHYRIA
721149048,5/13/2015 18:41:26,1635919090,5/13/2015 18:40:43,false,prodege,1.0,32302664,USA,IL,Geneseo,173.27.241.235,[ASSOCIATED_WITH],[ASSOCIATED_WITH],with neuropsychiatric disturbances and signs of autonomic dysfunction and,no comment,122,24,1,140,47,TWrex-cause,814004-FS1,• Reviews indicate that ACUTE HEPATIC PORPHYRIA with neuropsychiatric disturbances and signs of autonomic dysfunction and ASCENDING PARALYSIS with bilateral facial weakness may mimic rabies.,ASCENDING PARALYSIS,ACUTE HEPATIC PORPHYRIA
721149048,5/13/2015 18:59:49,1635926767,5/13/2015 18:58:19,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[SYMPTOM],[SYMPTOM],signs of,N/A,122,24,1,140,47,TWrex-cause,814004-FS1,• Reviews indicate that ACUTE HEPATIC PORPHYRIA with neuropsychiatric disturbances and signs of autonomic dysfunction and ASCENDING PARALYSIS with bilateral facial weakness may mimic rabies.,ASCENDING PARALYSIS,ACUTE HEPATIC PORPHYRIA
721149048,5/13/2015 19:02:41,1635928019,5/13/2015 19:02:19,false,clixsense,1,19162475,GBR,P8,Trowbridge,82.33.126.30,[CAUSES],[CAUSES],neuropsychiatric disturbances,n/a,122,24,1,140,47,TWrex-cause,814004-FS1,• Reviews indicate that ACUTE HEPATIC PORPHYRIA with neuropsychiatric disturbances and signs of autonomic dysfunction and ASCENDING PARALYSIS with bilateral facial weakness may mimic rabies.,ASCENDING PARALYSIS,ACUTE HEPATIC PORPHYRIA
721149048,5/13/2015 19:41:16,1635960650,5/13/2015 19:40:09,false,elite,1.0,30064988,GBR,H3,Leeds,92.22.208.245,[OTHER],[OTHER],may mimic,N/A,122,24,1,140,47,TWrex-cause,814004-FS1,• Reviews indicate that ACUTE HEPATIC PORPHYRIA with neuropsychiatric disturbances and signs of autonomic dysfunction and ASCENDING PARALYSIS with bilateral facial weakness may mimic rabies.,ASCENDING PARALYSIS,ACUTE HEPATIC PORPHYRIA
721149048,5/13/2015 20:00:49,1635975246,5/13/2015 20:00:07,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.156.243,[SYMPTOM],[SYMPTOM],ACUTE HEPATIC PORPHYRIA and signs of ASCENDING PARALYSIS,N/A,122,24,1,140,47,TWrex-cause,814004-FS1,• Reviews indicate that ACUTE HEPATIC PORPHYRIA with neuropsychiatric disturbances and signs of autonomic dysfunction and ASCENDING PARALYSIS with bilateral facial weakness may mimic rabies.,ASCENDING PARALYSIS,ACUTE HEPATIC PORPHYRIA
721149049,5/13/2015 18:21:53,1635908547,5/13/2015 18:21:20,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[SYMPTOM],[SYMPTOM],Signs of,N/A,210,120,-1,245,155,TWrex-cause,802148-FS1,Tendon reflexes are depressed more frequently in demyelinating or large fiber polyneuropathies and are not depressed in PURE 'SMALL FIBER' POLYNEUROPATHIES Physical exam  Autonomic dysfunction         Signs of AUTONOMIC NERVOUS SYSTEM DYSFUNCTION may be seen in polyneuropathy if autonomic fibers are involved,AUTONOMIC NERVOUS SYSTEM DYSFUNCTION,PURE 'SMALL FIBER' POLYNEUROPATHIES
721149049,5/13/2015 18:34:04,1635915475,5/13/2015 18:32:58,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[MANIFESTATION],[MANIFESTATION],Signs of,N/A,210,120,-1,245,155,TWrex-cause,802148-FS1,Tendon reflexes are depressed more frequently in demyelinating or large fiber polyneuropathies and are not depressed in PURE 'SMALL FIBER' POLYNEUROPATHIES Physical exam  Autonomic dysfunction         Signs of AUTONOMIC NERVOUS SYSTEM DYSFUNCTION may be seen in polyneuropathy if autonomic fibers are involved,AUTONOMIC NERVOUS SYSTEM DYSFUNCTION,PURE 'SMALL FIBER' POLYNEUROPATHIES
721149049,5/13/2015 18:53:37,1635924358,5/13/2015 18:52:44,false,prodege,1.0,32302664,USA,IL,Geneseo,173.27.241.235,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],Physical exam Autonomic dysfunction Signs of,no comment,210,120,-1,245,155,TWrex-cause,802148-FS1,Tendon reflexes are depressed more frequently in demyelinating or large fiber polyneuropathies and are not depressed in PURE 'SMALL FIBER' POLYNEUROPATHIES Physical exam  Autonomic dysfunction         Signs of AUTONOMIC NERVOUS SYSTEM DYSFUNCTION may be seen in polyneuropathy if autonomic fibers are involved,AUTONOMIC NERVOUS SYSTEM DYSFUNCTION,PURE 'SMALL FIBER' POLYNEUROPATHIES
721149049,5/13/2015 19:27:02,1635951447,5/13/2015 19:25:43,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[MANIFESTATION],[MANIFESTATION],Signs of,N/A,210,120,-1,245,155,TWrex-cause,802148-FS1,Tendon reflexes are depressed more frequently in demyelinating or large fiber polyneuropathies and are not depressed in PURE 'SMALL FIBER' POLYNEUROPATHIES Physical exam  Autonomic dysfunction         Signs of AUTONOMIC NERVOUS SYSTEM DYSFUNCTION may be seen in polyneuropathy if autonomic fibers are involved,AUTONOMIC NERVOUS SYSTEM DYSFUNCTION,PURE 'SMALL FIBER' POLYNEUROPATHIES
721149049,5/13/2015 19:50:54,1635967719,5/13/2015 19:50:02,false,elite,1.0,30064988,GBR,H3,Leeds,92.22.208.245,[OTHER],[OTHER],not depressed in,N/A,210,120,-1,245,155,TWrex-cause,802148-FS1,Tendon reflexes are depressed more frequently in demyelinating or large fiber polyneuropathies and are not depressed in PURE 'SMALL FIBER' POLYNEUROPATHIES Physical exam  Autonomic dysfunction         Signs of AUTONOMIC NERVOUS SYSTEM DYSFUNCTION may be seen in polyneuropathy if autonomic fibers are involved,AUTONOMIC NERVOUS SYSTEM DYSFUNCTION,PURE 'SMALL FIBER' POLYNEUROPATHIES
721149049,5/13/2015 20:10:49,1635983684,5/13/2015 20:09:57,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.156.243,[SYMPTOM],[SYMPTOM],PURE 'SMALL FIBER' POLYNEUROPATHIES Physical exam Signs of AUTONOMIC NERVOUS SYSTEM DYSFUNCTION,N/A,210,120,-1,245,155,TWrex-cause,802148-FS1,Tendon reflexes are depressed more frequently in demyelinating or large fiber polyneuropathies and are not depressed in PURE 'SMALL FIBER' POLYNEUROPATHIES Physical exam  Autonomic dysfunction         Signs of AUTONOMIC NERVOUS SYSTEM DYSFUNCTION may be seen in polyneuropathy if autonomic fibers are involved,AUTONOMIC NERVOUS SYSTEM DYSFUNCTION,PURE 'SMALL FIBER' POLYNEUROPATHIES
721149049,5/13/2015 20:37:48,1636002560,5/13/2015 20:37:12,false,neodev,1.0,20961587,NLD,05,Maastricht,84.26.48.136,[LOCATION],[LOCATION],involved,N/A,210,120,-1,245,155,TWrex-cause,802148-FS1,Tendon reflexes are depressed more frequently in demyelinating or large fiber polyneuropathies and are not depressed in PURE 'SMALL FIBER' POLYNEUROPATHIES Physical exam  Autonomic dysfunction         Signs of AUTONOMIC NERVOUS SYSTEM DYSFUNCTION may be seen in polyneuropathy if autonomic fibers are involved,AUTONOMIC NERVOUS SYSTEM DYSFUNCTION,PURE 'SMALL FIBER' POLYNEUROPATHIES
721149049,5/13/2015 21:08:04,1636023364,5/13/2015 21:07:45,false,elite,1.0,32732290,GBR,A7,Birmingham,86.147.79.250,[NONE],[NONE],N/A,No clear relation.,210,120,-1,245,155,TWrex-cause,802148-FS1,Tendon reflexes are depressed more frequently in demyelinating or large fiber polyneuropathies and are not depressed in PURE 'SMALL FIBER' POLYNEUROPATHIES Physical exam  Autonomic dysfunction         Signs of AUTONOMIC NERVOUS SYSTEM DYSFUNCTION may be seen in polyneuropathy if autonomic fibers are involved,AUTONOMIC NERVOUS SYSTEM DYSFUNCTION,PURE 'SMALL FIBER' POLYNEUROPATHIES
721149049,5/13/2015 21:24:16,1636034182,5/13/2015 21:22:59,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[MANIFESTATION],[MANIFESTATION],PURE 'SMALL FIBER' POLYNEUROPATHIES AUTONOMIC NERVOUS SYSTEM DYSFUNCTION may be seen in polyneuropathy,N/A,210,120,-1,245,155,TWrex-cause,802148-FS1,Tendon reflexes are depressed more frequently in demyelinating or large fiber polyneuropathies and are not depressed in PURE 'SMALL FIBER' POLYNEUROPATHIES Physical exam  Autonomic dysfunction         Signs of AUTONOMIC NERVOUS SYSTEM DYSFUNCTION may be seen in polyneuropathy if autonomic fibers are involved,AUTONOMIC NERVOUS SYSTEM DYSFUNCTION,PURE 'SMALL FIBER' POLYNEUROPATHIES
721149049,5/13/2015 21:39:09,1636043861,5/13/2015 21:37:37,false,neodev,1,30749660,USA,NC,Durham,24.211.188.217,[DIAGNOSE_BY_TEST_OR_DRUG] [PREVENTS],"[PREVENTS]
[DIAGNOSE_BY_TEST_OR_DRUG]",large fiber polyneuropathies and are not depressed in PURE,n/a,210,120,-1,245,155,TWrex-cause,802148-FS1,Tendon reflexes are depressed more frequently in demyelinating or large fiber polyneuropathies and are not depressed in PURE 'SMALL FIBER' POLYNEUROPATHIES Physical exam  Autonomic dysfunction         Signs of AUTONOMIC NERVOUS SYSTEM DYSFUNCTION may be seen in polyneuropathy if autonomic fibers are involved,AUTONOMIC NERVOUS SYSTEM DYSFUNCTION,PURE 'SMALL FIBER' POLYNEUROPATHIES
721149049,5/13/2015 21:48:55,1636050103,5/13/2015 21:47:31,false,instagc,1,13763729,USA,NC,Apex,75.182.91.110,[SYMPTOM],[SYMPTOM],Signs of may be seen,N/A,210,120,-1,245,155,TWrex-cause,802148-FS1,Tendon reflexes are depressed more frequently in demyelinating or large fiber polyneuropathies and are not depressed in PURE 'SMALL FIBER' POLYNEUROPATHIES Physical exam  Autonomic dysfunction         Signs of AUTONOMIC NERVOUS SYSTEM DYSFUNCTION may be seen in polyneuropathy if autonomic fibers are involved,AUTONOMIC NERVOUS SYSTEM DYSFUNCTION,PURE 'SMALL FIBER' POLYNEUROPATHIES
721149049,5/13/2015 21:50:41,1636051147,5/13/2015 21:49:51,false,bitcoinget,1,21743413,USA,WA,Lynnwood,75.147.181.53,[MANIFESTATION],[MANIFESTATION],may be seen in,N/A,210,120,-1,245,155,TWrex-cause,802148-FS1,Tendon reflexes are depressed more frequently in demyelinating or large fiber polyneuropathies and are not depressed in PURE 'SMALL FIBER' POLYNEUROPATHIES Physical exam  Autonomic dysfunction         Signs of AUTONOMIC NERVOUS SYSTEM DYSFUNCTION may be seen in polyneuropathy if autonomic fibers are involved,AUTONOMIC NERVOUS SYSTEM DYSFUNCTION,PURE 'SMALL FIBER' POLYNEUROPATHIES
721149049,5/13/2015 22:20:00,1636066847,5/13/2015 22:19:07,false,clixsense,1,8888883,USA,"","",73.21.180.112,[ASSOCIATED_WITH],[ASSOCIATED_WITH],Signs of,N/A,210,120,-1,245,155,TWrex-cause,802148-FS1,Tendon reflexes are depressed more frequently in demyelinating or large fiber polyneuropathies and are not depressed in PURE 'SMALL FIBER' POLYNEUROPATHIES Physical exam  Autonomic dysfunction         Signs of AUTONOMIC NERVOUS SYSTEM DYSFUNCTION may be seen in polyneuropathy if autonomic fibers are involved,AUTONOMIC NERVOUS SYSTEM DYSFUNCTION,PURE 'SMALL FIBER' POLYNEUROPATHIES
721149049,5/13/2015 22:20:50,1636067207,5/13/2015 22:18:47,false,clixsense,1,19294877,USA,MA,Cambridge,71.174.188.109,[NONE],[NONE],n/a,too complicated to understand,210,120,-1,245,155,TWrex-cause,802148-FS1,Tendon reflexes are depressed more frequently in demyelinating or large fiber polyneuropathies and are not depressed in PURE 'SMALL FIBER' POLYNEUROPATHIES Physical exam  Autonomic dysfunction         Signs of AUTONOMIC NERVOUS SYSTEM DYSFUNCTION may be seen in polyneuropathy if autonomic fibers are involved,AUTONOMIC NERVOUS SYSTEM DYSFUNCTION,PURE 'SMALL FIBER' POLYNEUROPATHIES
721149049,5/13/2015 22:49:52,1636083342,5/13/2015 22:49:15,false,superrewards,1,24796792,USA,NY,New York,72.80.63.240,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],if autonomic fibers are involved,n/a,210,120,-1,245,155,TWrex-cause,802148-FS1,Tendon reflexes are depressed more frequently in demyelinating or large fiber polyneuropathies and are not depressed in PURE 'SMALL FIBER' POLYNEUROPATHIES Physical exam  Autonomic dysfunction         Signs of AUTONOMIC NERVOUS SYSTEM DYSFUNCTION may be seen in polyneuropathy if autonomic fibers are involved,AUTONOMIC NERVOUS SYSTEM DYSFUNCTION,PURE 'SMALL FIBER' POLYNEUROPATHIES
721149050,5/13/2015 09:56:10,1635676320,5/13/2015 09:55:58,false,neodev,1.0,32103286,CAN,AB,Edmonton,208.123.223.37,[CAUSES] [LOCATION] [NONE],"[CAUSES]
[LOCATION]
[NONE]",no,no,136,104,-1,148,114,TWrex-cause,803876-FS1,"1]  Sachs G, Chengappa KN, Suppes T, Mullen JA, Brecher M, Devine NA, et al. Quetiapine with lithium or DIVALPROEX for the treatment of BIPOLAR MANIA: a randomized, double blind, placebo controlled study.",BIPOLAR MANIA,DIVALPROEX
721149050,5/13/2015 10:03:01,1635678116,5/13/2015 10:02:03,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[TREATS],[TREATS],Quetiapine with lithium or DIVALPROEX for the treatment of BIPOLAR MANIA:,N/A,136,104,-1,148,114,TWrex-cause,803876-FS1,"1]  Sachs G, Chengappa KN, Suppes T, Mullen JA, Brecher M, Devine NA, et al. Quetiapine with lithium or DIVALPROEX for the treatment of BIPOLAR MANIA: a randomized, double blind, placebo controlled study.",BIPOLAR MANIA,DIVALPROEX
721149050,5/13/2015 10:18:41,1635682011,5/13/2015 10:18:03,false,clixsense,1.0,26847653,NLD,03,Warnsveld,213.93.50.164,[TREATS],[TREATS],for the treatment of,n/a,136,104,-1,148,114,TWrex-cause,803876-FS1,"1]  Sachs G, Chengappa KN, Suppes T, Mullen JA, Brecher M, Devine NA, et al. Quetiapine with lithium or DIVALPROEX for the treatment of BIPOLAR MANIA: a randomized, double blind, placebo controlled study.",BIPOLAR MANIA,DIVALPROEX
721149050,5/13/2015 10:23:48,1635683617,5/13/2015 10:23:24,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[TREATS],[TREATS],treatment of,n/a,136,104,-1,148,114,TWrex-cause,803876-FS1,"1]  Sachs G, Chengappa KN, Suppes T, Mullen JA, Brecher M, Devine NA, et al. Quetiapine with lithium or DIVALPROEX for the treatment of BIPOLAR MANIA: a randomized, double blind, placebo controlled study.",BIPOLAR MANIA,DIVALPROEX
721149050,5/13/2015 10:24:35,1635683772,5/13/2015 10:23:49,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[TREATS],[TREATS],treatment of,N/A,136,104,-1,148,114,TWrex-cause,803876-FS1,"1]  Sachs G, Chengappa KN, Suppes T, Mullen JA, Brecher M, Devine NA, et al. Quetiapine with lithium or DIVALPROEX for the treatment of BIPOLAR MANIA: a randomized, double blind, placebo controlled study.",BIPOLAR MANIA,DIVALPROEX
721149050,5/13/2015 10:29:55,1635685380,5/13/2015 10:29:44,false,pocketmoneygpt,1.0,28884030,USA,WI,Minocqua,75.143.134.247,[TREATS],[TREATS],treatment,n/a,136,104,-1,148,114,TWrex-cause,803876-FS1,"1]  Sachs G, Chengappa KN, Suppes T, Mullen JA, Brecher M, Devine NA, et al. Quetiapine with lithium or DIVALPROEX for the treatment of BIPOLAR MANIA: a randomized, double blind, placebo controlled study.",BIPOLAR MANIA,DIVALPROEX
721149050,5/13/2015 10:40:33,1635688360,5/13/2015 10:40:10,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[CAUSES],[CAUSES],lithium,N/A,136,104,-1,148,114,TWrex-cause,803876-FS1,"1]  Sachs G, Chengappa KN, Suppes T, Mullen JA, Brecher M, Devine NA, et al. Quetiapine with lithium or DIVALPROEX for the treatment of BIPOLAR MANIA: a randomized, double blind, placebo controlled study.",BIPOLAR MANIA,DIVALPROEX
721149050,5/13/2015 10:52:29,1635692076,5/13/2015 10:51:47,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,[TREATS],[TREATS],treatment,n/a,136,104,-1,148,114,TWrex-cause,803876-FS1,"1]  Sachs G, Chengappa KN, Suppes T, Mullen JA, Brecher M, Devine NA, et al. Quetiapine with lithium or DIVALPROEX for the treatment of BIPOLAR MANIA: a randomized, double blind, placebo controlled study.",BIPOLAR MANIA,DIVALPROEX
721149050,5/13/2015 10:55:32,1635692786,5/13/2015 10:54:39,false,neodev,1.0,29579905,GBR,"","",5.152.206.71,[PREVENTS] [SYMPTOM],"[PREVENTS]
[SYMPTOM]","Suppes Mullen Brecher blind,",N/A,136,104,-1,148,114,TWrex-cause,803876-FS1,"1]  Sachs G, Chengappa KN, Suppes T, Mullen JA, Brecher M, Devine NA, et al. Quetiapine with lithium or DIVALPROEX for the treatment of BIPOLAR MANIA: a randomized, double blind, placebo controlled study.",BIPOLAR MANIA,DIVALPROEX
721149050,5/13/2015 10:55:54,1635692912,5/13/2015 10:55:36,false,neodev,1.0,31706957,NLD,07,Amsterdam,145.100.72.165,[TREATS],[TREATS],the treatment,n/a,136,104,-1,148,114,TWrex-cause,803876-FS1,"1]  Sachs G, Chengappa KN, Suppes T, Mullen JA, Brecher M, Devine NA, et al. Quetiapine with lithium or DIVALPROEX for the treatment of BIPOLAR MANIA: a randomized, double blind, placebo controlled study.",BIPOLAR MANIA,DIVALPROEX
721149050,5/13/2015 11:07:36,1635696323,5/13/2015 11:07:15,false,instagc,1.0,24252915,GBR,K6,Portsmouth,89.240.160.95,[TREATS],[TREATS],DIVALPROEX for the treatment of BIPOLAR MANIA:,N/a,136,104,-1,148,114,TWrex-cause,803876-FS1,"1]  Sachs G, Chengappa KN, Suppes T, Mullen JA, Brecher M, Devine NA, et al. Quetiapine with lithium or DIVALPROEX for the treatment of BIPOLAR MANIA: a randomized, double blind, placebo controlled study.",BIPOLAR MANIA,DIVALPROEX
721149050,5/13/2015 11:09:28,1635696778,5/13/2015 11:09:15,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[TREATS],[TREATS],treatment,n/a,136,104,-1,148,114,TWrex-cause,803876-FS1,"1]  Sachs G, Chengappa KN, Suppes T, Mullen JA, Brecher M, Devine NA, et al. Quetiapine with lithium or DIVALPROEX for the treatment of BIPOLAR MANIA: a randomized, double blind, placebo controlled study.",BIPOLAR MANIA,DIVALPROEX
721149050,5/13/2015 11:17:07,1635698798,5/13/2015 11:16:36,false,prodege,1.0,27934334,GBR,D3,Swadlincote,109.150.228.127,[TREATS],[TREATS],treatment,N/A,136,104,-1,148,114,TWrex-cause,803876-FS1,"1]  Sachs G, Chengappa KN, Suppes T, Mullen JA, Brecher M, Devine NA, et al. Quetiapine with lithium or DIVALPROEX for the treatment of BIPOLAR MANIA: a randomized, double blind, placebo controlled study.",BIPOLAR MANIA,DIVALPROEX
721149050,5/13/2015 11:20:42,1635699541,5/13/2015 11:20:11,false,points4rewards,1.0,28703583,USA,"","",97.73.86.35,[TREATS],[TREATS],for the treatment of,N/A,136,104,-1,148,114,TWrex-cause,803876-FS1,"1]  Sachs G, Chengappa KN, Suppes T, Mullen JA, Brecher M, Devine NA, et al. Quetiapine with lithium or DIVALPROEX for the treatment of BIPOLAR MANIA: a randomized, double blind, placebo controlled study.",BIPOLAR MANIA,DIVALPROEX
721149050,5/13/2015 11:23:42,1635700121,5/13/2015 11:22:21,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[TREATS],[TREATS],DIVALPROEX for treatment of BIPOLAR MANIA:,n/a,136,104,-1,148,114,TWrex-cause,803876-FS1,"1]  Sachs G, Chengappa KN, Suppes T, Mullen JA, Brecher M, Devine NA, et al. Quetiapine with lithium or DIVALPROEX for the treatment of BIPOLAR MANIA: a randomized, double blind, placebo controlled study.",BIPOLAR MANIA,DIVALPROEX
721149051,5/13/2015 16:41:54,1635856510,5/13/2015 16:41:25,false,prodege,1.0,16101132,GBR,F9,Hayes,2.223.214.149,[CAUSES],[CAUSES],causes,Caused by,213,36,1,221,58,TWrex-cause,810960-FS1,"SYN:   Treacher Collins syndrome    FRANCISELLA TULARENSIS    (                                audio )  [Edward Francis, Tulare County, California] A gram negative, aerobic, non spore forming bacillus that causes TULAREMIA in humans and animals.",TULAREMIA,FRANCISELLA TULARENSIS
721149051,5/13/2015 16:46:58,1635859418,5/13/2015 16:44:48,false,clixsense,1.0,31579138,AUS,02,Hurstville,14.200.129.68,[CAUSES],[CAUSES],causes,N/A,213,36,1,221,58,TWrex-cause,810960-FS1,"SYN:   Treacher Collins syndrome    FRANCISELLA TULARENSIS    (                                audio )  [Edward Francis, Tulare County, California] A gram negative, aerobic, non spore forming bacillus that causes TULAREMIA in humans and animals.",TULAREMIA,FRANCISELLA TULARENSIS
721149051,5/13/2015 17:27:03,1635881390,5/13/2015 17:25:58,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[NONE],[NONE],n/a,no connection,213,36,1,221,58,TWrex-cause,810960-FS1,"SYN:   Treacher Collins syndrome    FRANCISELLA TULARENSIS    (                                audio )  [Edward Francis, Tulare County, California] A gram negative, aerobic, non spore forming bacillus that causes TULAREMIA in humans and animals.",TULAREMIA,FRANCISELLA TULARENSIS
721149051,5/13/2015 17:37:13,1635886831,5/13/2015 17:36:34,false,gptking,1.0,31799065,USA,IL,Marion,50.45.43.154,[CAUSES],[CAUSES],FRANCISELLA TULARENSIS causes TULAREMIA,N/A,213,36,1,221,58,TWrex-cause,810960-FS1,"SYN:   Treacher Collins syndrome    FRANCISELLA TULARENSIS    (                                audio )  [Edward Francis, Tulare County, California] A gram negative, aerobic, non spore forming bacillus that causes TULAREMIA in humans and animals.",TULAREMIA,FRANCISELLA TULARENSIS
721149051,5/13/2015 18:12:29,1635904526,5/13/2015 18:11:43,false,clixsense,1.0,32549163,CAN,MB,Winnipeg,206.45.167.246,[OTHER],[OTHER],FRANCISELLA TULARENSIS TULAREMIA,N/A,213,36,1,221,58,TWrex-cause,810960-FS1,"SYN:   Treacher Collins syndrome    FRANCISELLA TULARENSIS    (                                audio )  [Edward Francis, Tulare County, California] A gram negative, aerobic, non spore forming bacillus that causes TULAREMIA in humans and animals.",TULAREMIA,FRANCISELLA TULARENSIS
721149051,5/13/2015 18:15:16,1635905638,5/13/2015 18:14:53,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[CAUSES],[CAUSES],causes,N/A,213,36,1,221,58,TWrex-cause,810960-FS1,"SYN:   Treacher Collins syndrome    FRANCISELLA TULARENSIS    (                                audio )  [Edward Francis, Tulare County, California] A gram negative, aerobic, non spore forming bacillus that causes TULAREMIA in humans and animals.",TULAREMIA,FRANCISELLA TULARENSIS
721149051,5/13/2015 18:19:39,1635907276,5/13/2015 18:19:13,false,instagc,1.0,24252915,GBR,"","",80.44.146.98,[CAUSES],[CAUSES],causes,N/a,213,36,1,221,58,TWrex-cause,810960-FS1,"SYN:   Treacher Collins syndrome    FRANCISELLA TULARENSIS    (                                audio )  [Edward Francis, Tulare County, California] A gram negative, aerobic, non spore forming bacillus that causes TULAREMIA in humans and animals.",TULAREMIA,FRANCISELLA TULARENSIS
721149051,5/13/2015 18:19:54,1635907397,5/13/2015 18:19:08,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[CAUSES],[CAUSES],causes,N/A,213,36,1,221,58,TWrex-cause,810960-FS1,"SYN:   Treacher Collins syndrome    FRANCISELLA TULARENSIS    (                                audio )  [Edward Francis, Tulare County, California] A gram negative, aerobic, non spore forming bacillus that causes TULAREMIA in humans and animals.",TULAREMIA,FRANCISELLA TULARENSIS
721149051,5/13/2015 18:45:07,1635920825,5/13/2015 18:44:24,false,prodege,1.0,32302664,USA,IL,Geneseo,173.27.241.235,[MANIFESTATION],[MANIFESTATION],"audio [Edward Francis, Tulare County, California] A gram negative, aerobic, non spore forming bacillus that causes",no comment,213,36,1,221,58,TWrex-cause,810960-FS1,"SYN:   Treacher Collins syndrome    FRANCISELLA TULARENSIS    (                                audio )  [Edward Francis, Tulare County, California] A gram negative, aerobic, non spore forming bacillus that causes TULAREMIA in humans and animals.",TULAREMIA,FRANCISELLA TULARENSIS
721149051,5/13/2015 19:09:09,1635930514,5/13/2015 19:08:55,false,clixsense,1.0,19162475,GBR,P8,Trowbridge,82.33.126.30,[ASSOCIATED_WITH],[ASSOCIATED_WITH],FRANCISELLA TULARENSIS TULAREMIA,n/a,213,36,1,221,58,TWrex-cause,810960-FS1,"SYN:   Treacher Collins syndrome    FRANCISELLA TULARENSIS    (                                audio )  [Edward Francis, Tulare County, California] A gram negative, aerobic, non spore forming bacillus that causes TULAREMIA in humans and animals.",TULAREMIA,FRANCISELLA TULARENSIS
721149051,5/13/2015 19:09:27,1635930627,5/13/2015 19:08:10,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[CAUSES],[CAUSES],causes,N/A,213,36,1,221,58,TWrex-cause,810960-FS1,"SYN:   Treacher Collins syndrome    FRANCISELLA TULARENSIS    (                                audio )  [Edward Francis, Tulare County, California] A gram negative, aerobic, non spore forming bacillus that causes TULAREMIA in humans and animals.",TULAREMIA,FRANCISELLA TULARENSIS
721149051,5/13/2015 19:43:42,1635962236,5/13/2015 19:43:14,false,elite,1.0,30064988,GBR,H3,Leeds,92.22.208.245,[CAUSES],[CAUSES],causes,N/A,213,36,1,221,58,TWrex-cause,810960-FS1,"SYN:   Treacher Collins syndrome    FRANCISELLA TULARENSIS    (                                audio )  [Edward Francis, Tulare County, California] A gram negative, aerobic, non spore forming bacillus that causes TULAREMIA in humans and animals.",TULAREMIA,FRANCISELLA TULARENSIS
721149051,5/13/2015 20:03:41,1635977699,5/13/2015 20:02:51,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.156.243,[CAUSES],[CAUSES],FRANCISELLA TULARENSIS causes TULAREMIA,N/A,213,36,1,221,58,TWrex-cause,810960-FS1,"SYN:   Treacher Collins syndrome    FRANCISELLA TULARENSIS    (                                audio )  [Edward Francis, Tulare County, California] A gram negative, aerobic, non spore forming bacillus that causes TULAREMIA in humans and animals.",TULAREMIA,FRANCISELLA TULARENSIS
721149051,5/13/2015 20:04:01,1635978000,5/13/2015 20:03:30,false,clixsense,1.0,27969116,NLD,"","",212.78.195.38,[CAUSES],[CAUSES],that causes,it causes it.,213,36,1,221,58,TWrex-cause,810960-FS1,"SYN:   Treacher Collins syndrome    FRANCISELLA TULARENSIS    (                                audio )  [Edward Francis, Tulare County, California] A gram negative, aerobic, non spore forming bacillus that causes TULAREMIA in humans and animals.",TULAREMIA,FRANCISELLA TULARENSIS
721149051,5/13/2015 20:07:06,1635980686,5/13/2015 20:05:50,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[CAUSES],[CAUSES],FRANCISELLA TULARENSIS causes TULAREMIA,N/A,213,36,1,221,58,TWrex-cause,810960-FS1,"SYN:   Treacher Collins syndrome    FRANCISELLA TULARENSIS    (                                audio )  [Edward Francis, Tulare County, California] A gram negative, aerobic, non spore forming bacillus that causes TULAREMIA in humans and animals.",TULAREMIA,FRANCISELLA TULARENSIS
721149052,5/13/2015 16:22:11,1635843565,5/13/2015 16:21:23,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[CONTRAINDICATES],[CONTRAINDICATES],not recommended,none,51,0,-1,88,7,TWrex-cause,803117-FS1,HEPARIN is not recommended in patients who develop DISSEMINATED INTRAVASCULAR COAGULATION,DISSEMINATED INTRAVASCULAR COAGULATION,HEPARIN
721149052,5/13/2015 16:39:48,1635855239,5/13/2015 16:39:21,false,prodege,1.0,16101132,GBR,F9,Hayes,2.223.214.149,[CONTRAINDICATES],[CONTRAINDICATES],not,Contraindicated,51,0,-1,88,7,TWrex-cause,803117-FS1,HEPARIN is not recommended in patients who develop DISSEMINATED INTRAVASCULAR COAGULATION,DISSEMINATED INTRAVASCULAR COAGULATION,HEPARIN
721149052,5/13/2015 16:43:10,1635857322,5/13/2015 16:42:28,false,clixsense,1.0,31579138,AUS,02,Hurstville,14.200.129.68,[CONTRAINDICATES],[CONTRAINDICATES],not recommended,N/A,51,0,-1,88,7,TWrex-cause,803117-FS1,HEPARIN is not recommended in patients who develop DISSEMINATED INTRAVASCULAR COAGULATION,DISSEMINATED INTRAVASCULAR COAGULATION,HEPARIN
721149052,5/13/2015 17:24:23,1635879926,5/13/2015 17:23:56,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[CONTRAINDICATES],[CONTRAINDICATES],is not recommended,n/a,51,0,-1,88,7,TWrex-cause,803117-FS1,HEPARIN is not recommended in patients who develop DISSEMINATED INTRAVASCULAR COAGULATION,DISSEMINATED INTRAVASCULAR COAGULATION,HEPARIN
721149052,5/13/2015 17:34:26,1635885423,5/13/2015 17:33:57,false,gptking,1.0,31799065,USA,IL,Marion,50.45.43.154,[CONTRAINDICATES],[CONTRAINDICATES],HEPARIN DISSEMINATED INTRAVASCULAR COAGULATION,N/A,51,0,-1,88,7,TWrex-cause,803117-FS1,HEPARIN is not recommended in patients who develop DISSEMINATED INTRAVASCULAR COAGULATION,DISSEMINATED INTRAVASCULAR COAGULATION,HEPARIN
721149052,5/13/2015 17:58:28,1635899323,5/13/2015 17:58:09,false,prodege,1.0,14848125,GBR,L6,Shrewsbury,86.138.223.142,[CONTRAINDICATES],[CONTRAINDICATES],not recommended,N/A,51,0,-1,88,7,TWrex-cause,803117-FS1,HEPARIN is not recommended in patients who develop DISSEMINATED INTRAVASCULAR COAGULATION,DISSEMINATED INTRAVASCULAR COAGULATION,HEPARIN
721149052,5/13/2015 18:11:07,1635903920,5/13/2015 18:10:52,false,clixsense,1.0,32549163,CAN,MB,Winnipeg,206.45.167.246,[CONTRAINDICATES],[CONTRAINDICATES],HEPARIN is not recommended in patients who develop DISSEMINATED INTRAVASCULAR COAGULATION,N/A,51,0,-1,88,7,TWrex-cause,803117-FS1,HEPARIN is not recommended in patients who develop DISSEMINATED INTRAVASCULAR COAGULATION,DISSEMINATED INTRAVASCULAR COAGULATION,HEPARIN
721149052,5/13/2015 18:13:45,1635905046,5/13/2015 18:12:56,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[CONTRAINDICATES],[CONTRAINDICATES],is not recommended,N/A,51,0,-1,88,7,TWrex-cause,803117-FS1,HEPARIN is not recommended in patients who develop DISSEMINATED INTRAVASCULAR COAGULATION,DISSEMINATED INTRAVASCULAR COAGULATION,HEPARIN
721149052,5/13/2015 18:17:32,1635906412,5/13/2015 18:16:27,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[CONTRAINDICATES],[CONTRAINDICATES],not recommended,N/A,51,0,-1,88,7,TWrex-cause,803117-FS1,HEPARIN is not recommended in patients who develop DISSEMINATED INTRAVASCULAR COAGULATION,DISSEMINATED INTRAVASCULAR COAGULATION,HEPARIN
721149052,5/13/2015 18:17:46,1635906527,5/13/2015 18:16:43,false,instagc,1.0,24252915,GBR,"","",80.44.146.98,[OTHER],[OTHER],is not recommended,N/a,51,0,-1,88,7,TWrex-cause,803117-FS1,HEPARIN is not recommended in patients who develop DISSEMINATED INTRAVASCULAR COAGULATION,DISSEMINATED INTRAVASCULAR COAGULATION,HEPARIN
721149052,5/13/2015 18:42:54,1635919937,5/13/2015 18:42:12,false,prodege,1.0,32302664,USA,IL,Geneseo,173.27.241.235,[CONTRAINDICATES],[CONTRAINDICATES],is not recommended in patients who develop,no comment,51,0,-1,88,7,TWrex-cause,803117-FS1,HEPARIN is not recommended in patients who develop DISSEMINATED INTRAVASCULAR COAGULATION,DISSEMINATED INTRAVASCULAR COAGULATION,HEPARIN
721149052,5/13/2015 19:02:38,1635928014,5/13/2015 19:01:54,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[CONTRAINDICATES],[CONTRAINDICATES],not recommended,N/A,51,0,-1,88,7,TWrex-cause,803117-FS1,HEPARIN is not recommended in patients who develop DISSEMINATED INTRAVASCULAR COAGULATION,DISSEMINATED INTRAVASCULAR COAGULATION,HEPARIN
721149052,5/13/2015 19:07:36,1635929879,5/13/2015 19:05:34,false,clixsense,1.0,19162475,GBR,P8,Trowbridge,82.33.126.30,[ASSOCIATED_WITH] [MANIFESTATION],"[MANIFESTATION]
[ASSOCIATED_WITH]",develop,n/a,51,0,-1,88,7,TWrex-cause,803117-FS1,HEPARIN is not recommended in patients who develop DISSEMINATED INTRAVASCULAR COAGULATION,DISSEMINATED INTRAVASCULAR COAGULATION,HEPARIN
721149052,5/13/2015 19:42:18,1635961363,5/13/2015 19:41:52,false,elite,1.0,30064988,GBR,H3,Leeds,92.22.208.245,[OTHER],[OTHER],not recommended,N/A,51,0,-1,88,7,TWrex-cause,803117-FS1,HEPARIN is not recommended in patients who develop DISSEMINATED INTRAVASCULAR COAGULATION,DISSEMINATED INTRAVASCULAR COAGULATION,HEPARIN
721149052,5/13/2015 20:01:40,1635975993,5/13/2015 20:01:15,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.156.243,[CONTRAINDICATES],[CONTRAINDICATES],HEPARIN not recommended DISSEMINATED INTRAVASCULAR COAGULATION,N/A,51,0,-1,88,7,TWrex-cause,803117-FS1,HEPARIN is not recommended in patients who develop DISSEMINATED INTRAVASCULAR COAGULATION,DISSEMINATED INTRAVASCULAR COAGULATION,HEPARIN
721149053,5/13/2015 16:51:03,1635861710,5/13/2015 16:50:32,false,clixsense,1.0,31579138,AUS,02,Hurstville,14.200.129.68,[TREATS],[TREATS],reducing,N/A,408,212,-1,431,222,TWrex-cause,804329-FS1,"MAIN RESULTS  Traditional anticonvulsants (sodium valproate, lamotrigine, and carbamazepine), newer generation anticonvulsants (gabapentin, pregabalin, and oxcarbazepine), tricyclic antidepressants (desipramine, IMIPRAMINE and amitriptyline), a serotonin noradrenaline reuptake inhibitor (duloxetine), and opioids (controlled release oxycodone and tramadol) were all more effective than placebo for reducing DIABETIC NEUROPATHY PAIN (Table.",DIABETIC NEUROPATHY PAIN,IMIPRAMINE
721149053,5/13/2015 17:34:38,1635885523,5/13/2015 17:33:48,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[TREATS],[TREATS],all more effective for reducing,n/a,408,212,-1,431,222,TWrex-cause,804329-FS1,"MAIN RESULTS  Traditional anticonvulsants (sodium valproate, lamotrigine, and carbamazepine), newer generation anticonvulsants (gabapentin, pregabalin, and oxcarbazepine), tricyclic antidepressants (desipramine, IMIPRAMINE and amitriptyline), a serotonin noradrenaline reuptake inhibitor (duloxetine), and opioids (controlled release oxycodone and tramadol) were all more effective than placebo for reducing DIABETIC NEUROPATHY PAIN (Table.",DIABETIC NEUROPATHY PAIN,IMIPRAMINE
721149053,5/13/2015 17:40:46,1635889052,5/13/2015 17:40:08,false,gptking,1.0,31799065,USA,IL,Marion,50.45.43.154,[TREATS],[TREATS],IMIPRAMINE DIABETIC NEUROPATHY PAIN,N/A,408,212,-1,431,222,TWrex-cause,804329-FS1,"MAIN RESULTS  Traditional anticonvulsants (sodium valproate, lamotrigine, and carbamazepine), newer generation anticonvulsants (gabapentin, pregabalin, and oxcarbazepine), tricyclic antidepressants (desipramine, IMIPRAMINE and amitriptyline), a serotonin noradrenaline reuptake inhibitor (duloxetine), and opioids (controlled release oxycodone and tramadol) were all more effective than placebo for reducing DIABETIC NEUROPATHY PAIN (Table.",DIABETIC NEUROPATHY PAIN,IMIPRAMINE
721149053,5/13/2015 18:16:43,1635906126,5/13/2015 18:16:24,false,clixsense,1.0,32549163,CAN,MB,Winnipeg,206.45.167.246,[TREATS],[TREATS],IMIPRAMINE more effective than placebo for reducing DIABETIC NEUROPATHY PAIN,N/A,408,212,-1,431,222,TWrex-cause,804329-FS1,"MAIN RESULTS  Traditional anticonvulsants (sodium valproate, lamotrigine, and carbamazepine), newer generation anticonvulsants (gabapentin, pregabalin, and oxcarbazepine), tricyclic antidepressants (desipramine, IMIPRAMINE and amitriptyline), a serotonin noradrenaline reuptake inhibitor (duloxetine), and opioids (controlled release oxycodone and tramadol) were all more effective than placebo for reducing DIABETIC NEUROPATHY PAIN (Table.",DIABETIC NEUROPATHY PAIN,IMIPRAMINE
721149053,5/13/2015 18:18:17,1635906743,5/13/2015 18:17:27,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],RESULTS,N/A,408,212,-1,431,222,TWrex-cause,804329-FS1,"MAIN RESULTS  Traditional anticonvulsants (sodium valproate, lamotrigine, and carbamazepine), newer generation anticonvulsants (gabapentin, pregabalin, and oxcarbazepine), tricyclic antidepressants (desipramine, IMIPRAMINE and amitriptyline), a serotonin noradrenaline reuptake inhibitor (duloxetine), and opioids (controlled release oxycodone and tramadol) were all more effective than placebo for reducing DIABETIC NEUROPATHY PAIN (Table.",DIABETIC NEUROPATHY PAIN,IMIPRAMINE
721149053,5/13/2015 18:22:36,1635908984,5/13/2015 18:22:03,false,instagc,1.0,24252915,GBR,"","",80.44.146.98,[TREATS],[TREATS],for reducing,N/a,408,212,-1,431,222,TWrex-cause,804329-FS1,"MAIN RESULTS  Traditional anticonvulsants (sodium valproate, lamotrigine, and carbamazepine), newer generation anticonvulsants (gabapentin, pregabalin, and oxcarbazepine), tricyclic antidepressants (desipramine, IMIPRAMINE and amitriptyline), a serotonin noradrenaline reuptake inhibitor (duloxetine), and opioids (controlled release oxycodone and tramadol) were all more effective than placebo for reducing DIABETIC NEUROPATHY PAIN (Table.",DIABETIC NEUROPATHY PAIN,IMIPRAMINE
721149053,5/13/2015 18:26:20,1635911130,5/13/2015 18:25:22,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[TREATS],[TREATS],more effective,N/A,408,212,-1,431,222,TWrex-cause,804329-FS1,"MAIN RESULTS  Traditional anticonvulsants (sodium valproate, lamotrigine, and carbamazepine), newer generation anticonvulsants (gabapentin, pregabalin, and oxcarbazepine), tricyclic antidepressants (desipramine, IMIPRAMINE and amitriptyline), a serotonin noradrenaline reuptake inhibitor (duloxetine), and opioids (controlled release oxycodone and tramadol) were all more effective than placebo for reducing DIABETIC NEUROPATHY PAIN (Table.",DIABETIC NEUROPATHY PAIN,IMIPRAMINE
721149053,5/13/2015 18:48:30,1635922182,5/13/2015 18:47:43,false,prodege,1.0,32302664,USA,IL,Geneseo,173.27.241.235,[DIAGNOSE_BY_TEST_OR_DRUG] [CAUSES],"[DIAGNOSE_BY_TEST_OR_DRUG]
[CAUSES]","and amitriptyline), a serotonin noradrenaline reuptake inhibitor (duloxetine), and opioids (controlled release oxycodone and tramadol) were all more effective than placebo for reducing",no comment,408,212,-1,431,222,TWrex-cause,804329-FS1,"MAIN RESULTS  Traditional anticonvulsants (sodium valproate, lamotrigine, and carbamazepine), newer generation anticonvulsants (gabapentin, pregabalin, and oxcarbazepine), tricyclic antidepressants (desipramine, IMIPRAMINE and amitriptyline), a serotonin noradrenaline reuptake inhibitor (duloxetine), and opioids (controlled release oxycodone and tramadol) were all more effective than placebo for reducing DIABETIC NEUROPATHY PAIN (Table.",DIABETIC NEUROPATHY PAIN,IMIPRAMINE
721149053,5/13/2015 19:14:47,1635935763,5/13/2015 19:13:36,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[TREATS],[TREATS],reducing,N/A,408,212,-1,431,222,TWrex-cause,804329-FS1,"MAIN RESULTS  Traditional anticonvulsants (sodium valproate, lamotrigine, and carbamazepine), newer generation anticonvulsants (gabapentin, pregabalin, and oxcarbazepine), tricyclic antidepressants (desipramine, IMIPRAMINE and amitriptyline), a serotonin noradrenaline reuptake inhibitor (duloxetine), and opioids (controlled release oxycodone and tramadol) were all more effective than placebo for reducing DIABETIC NEUROPATHY PAIN (Table.",DIABETIC NEUROPATHY PAIN,IMIPRAMINE
721149053,5/13/2015 19:46:32,1635964237,5/13/2015 19:46:01,false,elite,1.0,30064988,GBR,H3,Leeds,92.22.208.245,[TREATS],[TREATS],reducing,N/A,408,212,-1,431,222,TWrex-cause,804329-FS1,"MAIN RESULTS  Traditional anticonvulsants (sodium valproate, lamotrigine, and carbamazepine), newer generation anticonvulsants (gabapentin, pregabalin, and oxcarbazepine), tricyclic antidepressants (desipramine, IMIPRAMINE and amitriptyline), a serotonin noradrenaline reuptake inhibitor (duloxetine), and opioids (controlled release oxycodone and tramadol) were all more effective than placebo for reducing DIABETIC NEUROPATHY PAIN (Table.",DIABETIC NEUROPATHY PAIN,IMIPRAMINE
721149053,5/13/2015 20:07:11,1635980725,5/13/2015 20:06:32,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.156.243,[TREATS],[TREATS],IMIPRAMINE effective for reducing DIABETIC NEUROPATHY PAIN,N/A,408,212,-1,431,222,TWrex-cause,804329-FS1,"MAIN RESULTS  Traditional anticonvulsants (sodium valproate, lamotrigine, and carbamazepine), newer generation anticonvulsants (gabapentin, pregabalin, and oxcarbazepine), tricyclic antidepressants (desipramine, IMIPRAMINE and amitriptyline), a serotonin noradrenaline reuptake inhibitor (duloxetine), and opioids (controlled release oxycodone and tramadol) were all more effective than placebo for reducing DIABETIC NEUROPATHY PAIN (Table.",DIABETIC NEUROPATHY PAIN,IMIPRAMINE
721149053,5/13/2015 20:07:59,1635981397,5/13/2015 20:07:12,false,clixsense,1.0,27969116,NLD,"","",212.78.195.38,[SYMPTOM],[SYMPTOM],and,togheter with another,408,212,-1,431,222,TWrex-cause,804329-FS1,"MAIN RESULTS  Traditional anticonvulsants (sodium valproate, lamotrigine, and carbamazepine), newer generation anticonvulsants (gabapentin, pregabalin, and oxcarbazepine), tricyclic antidepressants (desipramine, IMIPRAMINE and amitriptyline), a serotonin noradrenaline reuptake inhibitor (duloxetine), and opioids (controlled release oxycodone and tramadol) were all more effective than placebo for reducing DIABETIC NEUROPATHY PAIN (Table.",DIABETIC NEUROPATHY PAIN,IMIPRAMINE
721149053,5/13/2015 20:34:16,1636000343,5/13/2015 20:33:28,false,neodev,1.0,20961587,NLD,05,Maastricht,84.26.48.136,[OTHER],[OTHER],reducing,N/A,408,212,-1,431,222,TWrex-cause,804329-FS1,"MAIN RESULTS  Traditional anticonvulsants (sodium valproate, lamotrigine, and carbamazepine), newer generation anticonvulsants (gabapentin, pregabalin, and oxcarbazepine), tricyclic antidepressants (desipramine, IMIPRAMINE and amitriptyline), a serotonin noradrenaline reuptake inhibitor (duloxetine), and opioids (controlled release oxycodone and tramadol) were all more effective than placebo for reducing DIABETIC NEUROPATHY PAIN (Table.",DIABETIC NEUROPATHY PAIN,IMIPRAMINE
721149053,5/13/2015 20:49:19,1636010504,5/13/2015 20:47:11,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[TREATS],[TREATS],IMIPRAMINE for reducing DIABETIC NEUROPATHY PAIN,N/A,408,212,-1,431,222,TWrex-cause,804329-FS1,"MAIN RESULTS  Traditional anticonvulsants (sodium valproate, lamotrigine, and carbamazepine), newer generation anticonvulsants (gabapentin, pregabalin, and oxcarbazepine), tricyclic antidepressants (desipramine, IMIPRAMINE and amitriptyline), a serotonin noradrenaline reuptake inhibitor (duloxetine), and opioids (controlled release oxycodone and tramadol) were all more effective than placebo for reducing DIABETIC NEUROPATHY PAIN (Table.",DIABETIC NEUROPATHY PAIN,IMIPRAMINE
721149053,5/13/2015 20:55:47,1636014860,5/13/2015 20:55:08,false,elite,1.0,32732290,GBR,A7,Birmingham,86.147.79.250,[TREATS],[TREATS],effective for reducing,N/A,408,212,-1,431,222,TWrex-cause,804329-FS1,"MAIN RESULTS  Traditional anticonvulsants (sodium valproate, lamotrigine, and carbamazepine), newer generation anticonvulsants (gabapentin, pregabalin, and oxcarbazepine), tricyclic antidepressants (desipramine, IMIPRAMINE and amitriptyline), a serotonin noradrenaline reuptake inhibitor (duloxetine), and opioids (controlled release oxycodone and tramadol) were all more effective than placebo for reducing DIABETIC NEUROPATHY PAIN (Table.",DIABETIC NEUROPATHY PAIN,IMIPRAMINE
